RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
G
Abat
4-aminobutyrate aminotransferase
IDA
RGD
PMID:10375453
RGD:1598516
NCBI chr10:7,503,351...7,599,474
Ensembl chr10:6,999,819...7,092,835
G
Acta2
actin alpha 2, smooth muscle
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19458120
NCBI chr 1:241,159,723...241,172,503
Ensembl chr 1:231,746,548...231,759,554
G
Adnp
activity-dependent neuroprotector homeobox
IDA
RGD
PMID:18414890
RGD:2312783
NCBI chr 3:177,310,258...177,340,379
Ensembl chr 3:156,891,381...156,917,312
G
Adora1
adenosine A1 receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18950269
NCBI chr13:48,210,922...48,247,826
Ensembl chr13:45,658,872...45,695,801
G
Adora3
adenosine A3 receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:7774659
NCBI chr 2:196,077,042...196,080,686
Ensembl chr 2:193,388,713...193,392,357
G
Akt2
AKT serine/threonine kinase 2
IMP
RGD
PMID:19084003
RGD:2313316
NCBI chr 1:92,004,705...92,061,420
Ensembl chr 1:82,883,547...82,933,817
G
Angpt2
angiopoietin 2
IDA
RGD
PMID:19672036
RGD:2313934
NCBI chr16:77,790,760...77,841,241
Ensembl chr16:71,088,364...71,138,804
G
Anxa1
annexin A1
IEP
RGD
PMID:17653046
RGD:2306896
NCBI chr 1:227,287,713...227,306,739
Ensembl chr 1:217,861,175...217,877,343
G
Arid1b
AT-rich interaction domain 1B
IDA IEP
mRNA,protein:increased expression:renal medulla, cortex of kidney
RGD
PMID:14633620 PMID:14633620
RGD:1302474 , RGD:1302474
NCBI chr 1:47,973,199...48,328,793
Ensembl chr 1:45,563,623...45,923,493
G
Atg5
autophagy related 5
IEP
RGD
PMID:25435100
RGD:11561945
NCBI chr20:49,380,835...49,471,826
Ensembl chr20:47,798,290...47,889,209
G
Avp
arginine vasopressin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:2139164 PMID:10440088
NCBI chr 3:138,246,544...138,248,522
Ensembl chr 3:117,793,457...117,795,425
G
Bax
BCL2 associated X, apoptosis regulator
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15172883
NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:95,938,808...95,945,368
G
Becn1
beclin 1
IEP
RGD
PMID:25435100
RGD:11561945
NCBI chr10:86,731,649...86,747,002
Ensembl chr10:86,231,388...86,246,742
G
Calca
calcitonin-related polypeptide alpha
IMP
RGD
PMID:21181115
RGD:5684019
NCBI chr 1:178,312,636...178,317,588
Ensembl chr 1:168,878,214...168,883,105
G
Ccl2
C-C motif chemokine ligand 2
ISO
RGD
PMID:15308783
RGD:1581163
NCBI chr10:67,503,077...67,504,875
Ensembl chr10:67,005,424...67,007,226
G
Cd68
Cd68 molecule
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19458120
NCBI chr10:54,880,562...54,882,441
Ensembl chr10:54,381,815...54,383,697
G
Ckm
creatine kinase, M-type
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21912612
NCBI chr 1:88,189,382...88,199,717
Ensembl chr 1:79,061,456...79,071,720
G
Cp
ceruloplasmin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15668637 PMID:18091701
NCBI chr 2:104,368,336...104,427,119
Ensembl chr 2:102,439,624...102,498,075
G
Crhr2
corticotropin releasing hormone receptor 2
IDA
RGD
PMID:19429103
RGD:5130953
NCBI chr 4:85,553,163...85,596,203
Ensembl chr 4:84,224,002...84,265,904
G
Cx3cl1
C-X3-C motif chemokine ligand 1
IDA
RGD
PMID:18006432
RGD:4892022
NCBI chr19:10,233,326...10,244,856
Ensembl chr19:10,227,340...10,236,833
G
Cxcl10
C-X-C motif chemokine ligand 10
ISO
mRNA:increased expression:lung
RGD
PMID:16709871
RGD:5135441
NCBI chr14:15,989,066...15,991,263
Ensembl chr14:15,704,758...15,706,975
G
Cxcl12
C-X-C motif chemokine ligand 12
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18227068
NCBI chr 4:152,060,781...152,073,628
Ensembl chr 4:150,388,325...150,401,168
G
Cxcr3
C-X-C motif chemokine receptor 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12517959
NCBI chr X:70,884,293...70,886,944
Ensembl chr X:66,844,318...66,846,969
G
Cycs
cytochrome c, somatic
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15172883
NCBI chr 4:80,982,667...80,984,767
Ensembl chr 4:79,651,378...79,654,054 Ensembl chr18:79,651,378...79,654,054
G
Dll4
delta like canonical Notch ligand 4
ameliorates
IEP ISO
mRNA,protein:increased expression:skin,endothelial cells
RGD
PMID:25834117 PMID:22252294
RGD:155663350 , RGD:155663358
NCBI chr 3:126,770,945...126,780,769
Ensembl chr 3:106,316,986...106,326,931
G
Egr1
early growth response 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12468449
NCBI chr18:26,737,078...26,740,877
Ensembl chr18:26,462,981...26,466,766
G
Flt1
Fms related receptor tyrosine kinase 1
ISO
protein:increased expression:skeletal muscle
RGD
PMID:17823371
RGD:2313719
NCBI chr12:12,333,050...12,504,750
Ensembl chr12:7,297,292...7,468,626
G
Gja1
gap junction protein, alpha 1
IEP
protein:increased expression:urothelium:
RGD
PMID:24728265
RGD:11568671
NCBI chr20:36,302,490...36,315,010
Ensembl chr20:35,755,991...35,768,582
G
Gjb2
gap junction protein, beta 2
IEP
in urinary bladder; protein:increased expression:urothelium:
RGD
PMID:24728265
RGD:11568671
NCBI chr15:35,375,977...35,393,817
Ensembl chr15:31,260,357...31,278,177
G
Hmox1
heme oxygenase 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:15036356 PMID:19667931
NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,467,244...13,474,079
G
Htr1b
5-hydroxytryptamine receptor 1B
IEP
mRNA:increased expression:skeletal muscle
RGD
PMID:12393100
RGD:1626445
NCBI chr 8:91,395,405...91,414,815
Ensembl chr 8:82,517,360...82,534,549
G
Il18
interleukin 18
IEP
RGD
PMID:21289055
RGD:6893448
NCBI chr 8:59,802,072...59,829,275
Ensembl chr 8:50,906,960...50,932,887
G
Il6
interleukin 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18091701
NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,213,394...5,219,178
G
Itgav
integrin subunit alpha V
IDA
RGD
PMID:15956135
RGD:1582457
NCBI chr 3:89,245,382...89,333,512
Ensembl chr 3:68,838,189...68,926,639
G
Lipc
lipase C, hepatic type
IEP
protein:decreased expression:liver (rat)
RGD
PMID:1918876
RGD:2308796
NCBI chr 8:80,390,470...80,516,463
Ensembl chr 8:71,509,635...71,635,464
G
Lonp1
lon peptidase 1, mitochondrial
IDA
RGD
PMID:12082077
RGD:633879
NCBI chr 9:1,534,581...1,546,908
Ensembl chr 9:1,447,447...1,459,771
G
Map1lc3a
microtubule-associated protein 1 light chain 3 alpha
IEP
RGD
PMID:25435100
RGD:11561945
NCBI chr 3:164,243,204...164,244,850
Ensembl chr 3:143,783,024...143,784,670
G
Mapk9
mitogen-activated protein kinase 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19667931
NCBI chr10:34,670,750...34,711,972
Ensembl chr10:34,169,675...34,210,178
G
Mmp14
matrix metallopeptidase 14
IDA
RGD
PMID:16077081
RGD:1582563
NCBI chr15:31,857,824...31,867,049
Ensembl chr15:27,887,727...27,899,864
G
Mmp2
matrix metallopeptidase 2
ISO
RGD
PMID:12842442
RGD:1582562
NCBI chr19:30,327,643...30,355,856
Ensembl chr19:14,154,657...14,182,870
G
Mmp9
matrix metallopeptidase 9
ISO
RGD
PMID:15047130
RGD:1582640
NCBI chr 3:174,103,474...174,111,434
Ensembl chr 3:153,683,858...153,692,120
G
Mthfr
methylenetetrahydrofolate reductase
susceptibility
ISO
associated with Retinal Vein Occlusion;DNA:SNP:cds:677C>T(human)
RGD
PMID:17719079
RGD:7387251
NCBI chr 5:163,748,346...163,768,141
Ensembl chr 5:158,465,296...158,483,797
G
Muc13
mucin 13, cell surface associated
IEP
protein:increased degradation:jejunum
RGD
PMID:22768227
RGD:7349363
NCBI chr11:80,462,350...80,489,773
Ensembl chr11:66,960,595...66,984,727
G
Muc2
mucin 2, oligomeric mucus/gel-forming
IEP
protein:decreased expression:jejunum
RGD
PMID:22768227
RGD:7349363
NCBI chr 1:206,225,775...206,261,280
Ensembl chr 1:196,799,517...196,831,756
G
Nos3
nitric oxide synthase 3
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:15036356
NCBI chr 4:11,686,088...11,706,604
Ensembl chr 4:10,793,834...10,814,166
G
Oxt
oxytocin/neurophysin I prepropeptide
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:10440088
NCBI chr 3:138,235,754...138,236,594
Ensembl chr 3:117,782,650...117,783,490
G
Pcna
proliferating cell nuclear antigen
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19458120
NCBI chr 3:139,951,948...139,955,820
Ensembl chr 3:119,498,810...119,502,995
G
Plau
plasminogen activator, urokinase
ISO
CTD Direct Evidence: therapeutic
CTD RGD
PMID:8662173 PMID:15557913 PMID:17653104
RGD:6484145
NCBI chr15:3,505,485...3,511,987
Ensembl chr15:3,456,232...3,462,775
G
Pparg
peroxisome proliferator-activated receptor gamma
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:12468449 PMID:24433871
NCBI chr 4:150,095,743...150,221,104
Ensembl chr 4:148,423,194...148,548,468
G
Prkca
protein kinase C, alpha
IEP
RGD
PMID:17700073
RGD:2292478
NCBI chr10:93,388,991...93,787,617
Ensembl chr10:92,894,012...93,288,012
G
Ptges
prostaglandin E synthase
IEP
RGD
PMID:12431630
RGD:2300116
NCBI chr 3:34,575,643...34,586,987
G
Ptk2
protein tyrosine kinase 2
IEP
protein:decreased tyrosine phosphorylation:kidney
RGD
PMID:17620366
RGD:2292577
NCBI chr 7:107,015,730...107,220,865
Ensembl chr 7:105,126,728...105,331,783
G
Raf1
Raf-1 proto-oncogene, serine/threonine kinase
ISO
RGD
PMID:16172266
RGD:1580696
NCBI chr 4:150,352,158...150,412,813
Ensembl chr 4:148,679,530...148,740,317
G
Ren
renin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:3915608
NCBI chr13:47,348,312...47,359,539
Ensembl chr13:44,796,091...44,807,489
G
S100a4
S100 calcium-binding protein A4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19458120
NCBI chr 2:178,388,529...178,390,838
Ensembl chr 2:176,091,804...176,093,254
G
Selp
selectin P
ISO
RGD
PMID:21885854
RGD:6218989
NCBI chr13:79,009,379...79,044,994
Ensembl chr13:76,476,295...76,511,845
G
Serpinh1
serpin family H member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19458120
NCBI chr 1:163,055,630...163,063,177
Ensembl chr 1:153,643,510...153,650,801
G
Sf1
splicing factor 1
IDA
RGD
PMID:10103072
RGD:727772
NCBI chr 1:213,090,256...213,112,688
Ensembl chr 1:203,670,018...203,684,330
G
Sod1
superoxide dismutase 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:10698074
NCBI chr11:42,942,742...42,948,399
Ensembl chr11:29,456,558...29,462,249
G
Sod2
superoxide dismutase 2
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:11328670 PMID:18227068
NCBI chr 1:50,043,323...50,050,168
Ensembl chr 1:47,636,528...47,645,189
G
Sst
somatostatin
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:18624922
NCBI chr11:90,461,546...90,462,823
Ensembl chr11:76,956,896...76,958,173
G
Thbd
thrombomodulin
IEP
RGD
PMID:19461288
RGD:2312461
NCBI chr 3:156,316,526...156,320,178
Ensembl chr 3:135,862,835...135,867,193
G
Tnfrsf1a
TNF receptor superfamily member 1A
IDA
RGD
PMID:14970118
RGD:1624195
NCBI chr 4:159,837,119...159,849,817
Ensembl chr 4:158,150,820...158,163,591
G
Tp53
tumor protein p53
IEP ISO
associated with Wounds and Injuries;protein:increased expression:skin CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:15172883 PMID:18337831
RGD:2290551
NCBI chr10:54,798,871...54,810,300
Ensembl chr10:54,300,048...54,311,524
G
Xdh
xanthine dehydrogenase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22688000
NCBI chr 6:27,282,319...27,344,022
Ensembl chr 6:21,530,113...21,592,268
G
Actg1
actin, gamma 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21751358
NCBI chr10:106,118,106...106,120,951
Ensembl chr10:105,619,737...105,624,232 Ensembl chr 3:105,619,737...105,624,232
G
Ager
advanced glycosylation end product-specific receptor
ISO
protein:increased expression:serum (human)
RGD
PMID:21663912
RGD:5508825
NCBI chr20:4,152,758...4,155,956
Ensembl chr20:4,147,890...4,151,078
G
Alb
albumin
treatment
ISO
RGD
PMID:20716836
RGD:11036086
NCBI chr14:17,891,564...17,907,043
Ensembl chr14:17,607,381...17,622,836
G
Arhgdib
Rho GDP dissociation inhibitor beta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21751358
NCBI chr 4:171,554,139...171,573,057
Ensembl chr 4:169,822,952...169,841,658
G
Capzb
capping actin protein of muscle Z-line subunit beta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21751358
NCBI chr 5:156,718,619...156,818,623
Ensembl chr 5:151,434,871...151,535,409
G
Ccn1
cellular communication network factor 1
susceptibility
ISO
DNA:SNP,haplotypes:5'utr: (rs6576776) (human)
RGD
PMID:33906697
RGD:329845569
NCBI chr 2:237,222,730...237,225,689
Ensembl chr 2:234,562,408...234,565,484
G
Cd40
CD40 molecule
ISO
DNA:SNP:5' utr:rs1883832 (human)
RGD
PMID:21091218
RGD:5490523
NCBI chr 3:174,209,113...174,224,592
Ensembl chr 3:153,790,449...153,805,534
G
Cd40lg
CD40 ligand
treatment
ISO
associated with Anxiety Disorders;protein:increased expression:serum
RGD
PMID:20170788 PMID:31624788
RGD:5490548 , RGD:21081509
NCBI chr X:140,164,341...140,176,057
Ensembl chr X:135,126,969...135,138,306
G
Ckb
creatine kinase B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15966572
NCBI chr 6:136,550,583...136,553,464
Ensembl chr 6:130,729,423...130,732,315
G
Ckm
creatine kinase, M-type
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15966572
NCBI chr 1:88,189,382...88,199,717
Ensembl chr 1:79,061,456...79,071,720
G
Crp
C-reactive protein
ISO
CTD Direct Evidence: marker/mechanism protein:increased expression: :
CTD RGD
PMID:15966572 PMID:23305094 PMID:18973750 PMID:21794939
RGD:6907401 , RGD:9491837
NCBI chr13:87,694,062...87,695,978
Ensembl chr13:85,124,977...85,175,178
G
Cyp2c6
cytochrome P450, family 2, subfamily C, polypeptide 6
treatment
ISO
DNA:SNPs::CYP2C19*2 (681G>A,rs4244285), CYP2C19*17 (-806C>T, rs12248560) (human) ClinVar Annotator: match by term: Acute coronary syndrome
ClinVar RGD
PMID:7969038 PMID:9093256 PMID:19444287 PMID:21270786 PMID:27441996 PMID:34384383 More...
RGD:401960861
NCBI chr 1:247,879,058...247,916,804
Ensembl chr 1:237,693,094...238,057,596
G
Eno1
enolase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21751358
NCBI chr 5:166,002,867...166,014,252
Ensembl chr 5:160,719,951...160,731,336 Ensembl chr 3:160,719,951...160,731,336
G
F2
coagulation factor II, thrombin
ISO
RGD
PMID:21496882
RGD:5147784
NCBI chr 3:98,051,958...98,065,246
Ensembl chr 3:77,596,198...77,609,486
G
Fasn
fatty acid synthase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23305094
NCBI chr10:106,570,415...106,588,581
Ensembl chr10:106,072,091...106,090,261
G
Fto
FTO, alpha-ketoglutarate dependent dioxygenase
susceptibility
ISO
DNA:SNP: :rs17817449 (human)
RGD
PMID:20362563
RGD:329813083
NCBI chr19:31,456,749...31,865,011
Ensembl chr19:15,349,696...15,692,083
G
Gapdh
glyceraldehyde-3-phosphate dehydrogenase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21751358
NCBI chr 4:159,648,592...159,653,436
Ensembl chr 4:157,962,343...157,966,235
G
Gch1
GTP cyclohydrolase 1
ISO
DNa:SNP: :rs3783637 (human)
RGD
PMID:26232608
RGD:329961571
NCBI chr15:22,884,006...22,917,412
Ensembl chr15:20,402,527...20,437,698
G
Gp6
glycoprotein VI
disease_progression
ISO
protein:increased expression:platelet (human)
RGD
PMID:17340467 PMID:20071043
RGD:401794408 , RGD:401824680
NCBI chr 1:78,471,900...78,535,374
Ensembl chr 1:69,465,789...69,491,326
G
Gpx1
glutathione peroxidase 1
ISO
mRNA, protein:increased expression:blood, plasma
RGD
PMID:28298473
RGD:401827171
NCBI chr 8:117,905,462...117,906,588
Ensembl chr 8:109,026,905...109,028,024
G
Gpx3
glutathione peroxidase 3
ISO
mRNA, protein:increased expression:blood, plasma
RGD
PMID:28298473
RGD:401827171
NCBI chr10:39,529,335...39,537,406
Ensembl chr10:39,028,570...39,037,035
G
Gpx4
glutathione peroxidase 4
ISO
mRNA, protein:increased expression:blood, plasma
RGD
PMID:28298473
RGD:401827171
NCBI chr 7:10,300,833...10,303,629
Ensembl chr 7:9,650,185...9,652,982
G
Gsn
gelsolin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21751358
NCBI chr 3:38,982,605...39,035,849
Ensembl chr 3:18,585,172...18,638,402
G
Gstp1
glutathione S-transferase pi 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21751358
NCBI chr 1:210,767,237...210,770,242
Ensembl chr 1:201,321,672...201,340,226
G
Hspa1a
heat shock protein family A (Hsp70) member 1A
ISO
DNA:SNP: :190G>C(human)
RGD
PMID:21849784
RGD:7257650
NCBI chr20:3,875,411...3,877,866
Ensembl chr20:3,856,006...3,873,227
G
Hspa8
heat shock protein family A (Hsp70) member 8
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21751358
NCBI chr 8:50,080,514...50,084,376
Ensembl chr 8:41,183,264...41,187,259
G
Hspd1
heat shock protein family D (Hsp60) member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21751358
NCBI chr 9:64,073,610...64,084,332
Ensembl chr 9:56,579,201...56,589,662
G
Il6
interleukin 6
treatment
ISO IEP
CTD Direct Evidence: marker/mechanism protein:increased expression:blood serum (human)
CTD RGD
PMID:23305094 PMID:32178736 PMID:32178736
RGD:155230830 , RGD:155230830
NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,213,394...5,219,178
G
Itgb3
integrin subunit beta 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15840736
NCBI chr10:90,009,927...90,067,787
Ensembl chr10:89,509,989...89,564,679
G
Ldhb
lactate dehydrogenase B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21751358
NCBI chr 4:177,159,389...177,177,408
Ensembl chr 4:175,428,385...175,446,403
G
Mir145
microRNA 145
disease_progression treatment
ISO IEP
RNA:decreased expression:blood serum (human)
RGD
PMID:32178736 PMID:32178736
RGD:155230830 , RGD:155230830
NCBI chr18:57,369,983...57,370,070
Ensembl chr18:55,099,640...55,099,727
G
Mmp9
matrix metallopeptidase 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20981132
NCBI chr 3:174,103,474...174,111,434
Ensembl chr 3:153,683,858...153,692,120
G
Ogg1
8-oxoguanine DNA glycosylase
susceptibility
ISO
DNA:SNP,haplotype: :p.S326C (rs1052133) (human)
RGD
PMID:23368530
RGD:401827273
NCBI chr 4:148,030,237...148,037,599
Ensembl chr 4:146,474,750...146,484,766
G
Pappa
pappalysin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11586954
NCBI chr 5:83,513,358...83,751,364
Ensembl chr 5:78,498,300...78,730,666
G
Pdia3
protein disulfide isomerase family A, member 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21751358
NCBI chr 3:128,841,781...128,865,733
Ensembl chr 3:108,388,245...108,413,236
G
Pecam1
platelet and endothelial cell adhesion molecule 1
ISO
protein:increased expression:coronary artery, intima (human)
RGD
PMID:22336504
RGD:6767292
NCBI chr10:92,090,263...92,152,002
Ensembl chr10:91,590,521...91,652,116
G
Phactr1
phosphatase and actin regulator 1
exacerbates
ISO
protein:increased expression:monocyte (human)
RGD
PMID:32857129
RGD:401900689
NCBI chr17:21,769,006...22,246,227
Ensembl chr17:21,562,721...22,039,831
G
Pla2g7
phospholipase A2 group VII
disease_progression
ISO
RGD
PMID:22024276
RGD:6482773
NCBI chr 9:24,859,491...24,901,747
Ensembl chr 9:17,362,225...17,404,476
G
Pon1
paraoxonase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26241956
NCBI chr 4:34,261,312...34,292,327
Ensembl chr 4:33,294,722...33,321,360
G
Psmb1
proteasome 20S subunit beta 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21751358
NCBI chr 1:65,115,770...65,136,516
Ensembl chr 1:56,420,618...56,463,560
G
Rab7b
Rab7b, member RAS oncogene family
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21751358
NCBI chr13:45,673,396...45,699,798
Ensembl chr13:43,121,226...43,147,581
G
Rbp4
retinol binding protein 4
severity onset
ISO
protein:increased expression:blood plasma (human) protein:increased expression:blood serum (human)
RGD
PMID:25437889 PMID:32449048
RGD:329845573 , RGD:329845576
NCBI chr 1:245,306,349...245,313,551
Ensembl chr 1:235,893,917...235,901,399
G
S100b
S100 calcium binding protein B
ISO
protein:increased expression:serum
RGD
PMID:21663912
RGD:5508825
NCBI chr20:12,372,345...12,381,159
Ensembl chr20:12,372,881...12,394,743
G
Serpinc1
serpin family C member 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:7923645
NCBI chr13:75,790,558...75,804,826
Ensembl chr13:73,257,179...73,284,293
G
Sod2
superoxide dismutase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21751358
NCBI chr 1:50,043,323...50,050,168
Ensembl chr 1:47,636,528...47,645,189
G
Tlr4
toll-like receptor 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20981132
NCBI chr 5:85,161,247...85,174,882
Ensembl chr 5:80,145,826...80,159,628
G
Tnf
tumor necrosis factor
treatment
ISO IEP
CTD Direct Evidence: marker/mechanism protein:increased expression:blood serum (human)
CTD RGD
PMID:20981132 PMID:32178736 PMID:32178736
RGD:155230830 , RGD:155230830
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,622,011...3,624,629
G
Tnni3
troponin I3, cardiac type
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15966572
NCBI chr 1:78,342,571...78,346,255
Ensembl chr 1:69,299,900...69,303,580
G
Tnnt2
troponin T2, cardiac type
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15966572
NCBI chr13:49,819,123...49,837,125
Ensembl chr13:47,267,204...47,285,388
G
Tpm4
tropomyosin 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21751358
NCBI chr16:17,718,442...17,732,483
Ensembl chr16:17,683,195...17,705,984
G
Tuba1c
tubulin, alpha 1C
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21751358
NCBI chr 7:131,636,974...132,078,589
Ensembl chr 7:130,192,016...130,199,647 Ensembl chr X:130,192,016...130,199,647
G
Tubb1
tubulin, beta 1 class VI
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21751358
NCBI chr 3:183,666,189...183,675,656
Ensembl chr 3:163,247,967...163,256,063
G
Vcl
vinculin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21751358
NCBI chr15:3,315,069...3,404,891
Ensembl chr15:3,265,815...3,355,606
G
Vim
vimentin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21751358
NCBI chr17:81,577,261...81,585,746
Ensembl chr17:76,668,647...76,677,187
G
Arhgap17
Rho GTPase activating protein 17
ameliorates
IEP
RGD
PMID:32068187
RGD:267358468
NCBI chr 1:187,238,675...187,328,093
Ensembl chr 1:177,807,583...177,896,854
G
Bax
BCL2 associated X, apoptosis regulator
ameliorates
IEP
RGD
PMID:32068187
RGD:267358468
NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:95,938,808...95,945,368
G
C3
complement C3
ISO
RGD
PMID:26476955
RGD:11552746
NCBI chr 9:2,174,412...2,201,339
Ensembl chr 9:2,087,437...2,114,429
G
Cacng4
calcium voltage-gated channel auxiliary subunit gamma 4
ISO
mRNA:decreased expression:blood:
RGD
PMID:27746059
RGD:13524557
NCBI chr10:93,183,410...93,245,470
Ensembl chr10:92,683,761...92,746,126
G
Casp3
caspase 3
treatment
IEP
RGD
PMID:26550220
RGD:13782284
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:45,662,910...45,684,648
G
Casp7
caspase 7
treatment
IEP
RGD
PMID:26550220
RGD:13782284
NCBI chr 1:265,442,647...265,481,938
Ensembl chr 1:255,437,172...255,476,729
G
Ccn1
cellular communication network factor 1
ameliorates
ISO
RGD
PMID:30371213
RGD:329845516
NCBI chr 2:237,222,730...237,225,689
Ensembl chr 2:234,562,408...234,565,484
G
Dram1
DNA-damage regulated autophagy modulator 1
ameliorates
IEP ISO
mRNA,protein:decreased expression:heart
RGD
PMID:30144448 PMID:30144448
RGD:407571674 , RGD:407571674
NCBI chr 7:24,630,233...24,665,270
Ensembl chr 7:22,742,849...22,776,765
G
Dsc2
desmocollin 2
ameliorates
IEP
RGD
PMID:32068187
RGD:267358468
NCBI chr18:11,725,466...11,757,591
Ensembl chr18:11,450,390...11,482,392
G
Fos
Fos proto-oncogene, AP-1 transcription factor subunit
treatment
IEP
RGD
PMID:23054911
RGD:405650598
NCBI chr 6:110,852,188...110,855,054
Ensembl chr 6:105,121,170...105,124,036
G
Fto
FTO, alpha-ketoglutarate dependent dioxygenase
ISO
mRNA:increased expression:blood
RGD
PMID:35693610
RGD:329901852
NCBI chr19:31,456,749...31,865,011
Ensembl chr19:15,349,696...15,692,083
G
Gata5
GATA binding protein 5
susceptibility
ISO
DNA:SNPs:promoter:rs80197101, rs77067995 (human)
RGD
PMID:33684162
RGD:155260335
NCBI chr 3:187,796,140...187,804,327
Ensembl chr 3:167,418,565...167,426,751
G
Gp6
glycoprotein VI
ameliorates sexual_dimorphism
ISO
DNA:missense mutation:CDS:p.S219P (rs1613662) (human) DNA:missense mutation:intron 1, intron 5: (rs1671207, rs11084382) (human)
RGD
PMID:20227257 PMID:20227257
RGD:401794138 , RGD:401794138
NCBI chr 1:78,471,900...78,535,374
Ensembl chr 1:69,465,789...69,491,326
G
Gpx3
glutathione peroxidase 3
ISO
protein:increased expression:plasma
RGD
PMID:28374671
RGD:401827832
NCBI chr10:39,529,335...39,537,406
Ensembl chr10:39,028,570...39,037,035
G
Gsk3b
glycogen synthase kinase 3 beta
treatment ameliorates
IEP
RGD
PMID:26591365 PMID:32068187
RGD:13792778 , RGD:267358468
NCBI chr11:76,004,502...76,154,665
Ensembl chr11:62,504,316...62,648,646
G
H19
H19 imprinted maternally expressed transcript
ameliorates
IMP
RGD
PMID:31755219
RGD:213230161
NCBI chr 1:207,160,175...207,162,851
Ensembl chr 1:197,730,698...197,733,134
G
Idh2
isocitrate dehydrogenase (NADP(+)) 2
ISO
ClinVar Annotator: match by term: Acute myocardial infarction
ClinVar
NCBI chr 1:143,447,925...143,467,248
Ensembl chr 1:134,029,772...134,058,025
G
Ifng
interferon gamma
ameliorates
IEP
RGD
PMID:32068187
RGD:267358468
NCBI chr 7:55,789,180...55,793,216
Ensembl chr 7:53,903,337...53,907,375
G
Ikbkg
inhibitor of nuclear factor kappa B kinase regulatory subunit gamma
ameliorates
IEP
RGD
PMID:32068187
RGD:267358468
NCBI chr X:157,358,279...157,397,563
Ensembl chr X:152,216,596...152,239,499
G
Il10
interleukin 10
ameliorates
IEP
RGD
PMID:32068187
RGD:267358468
NCBI chr13:45,024,921...45,029,586
Ensembl chr13:42,472,839...42,477,313
G
Il17a
interleukin 17A
ameliorates
IEP
RGD
PMID:32068187
RGD:267358468
NCBI chr 9:30,640,844...30,644,331
Ensembl chr 9:23,144,402...23,147,889
G
Il1b
interleukin 1 beta
ameliorates
IEP
RGD
PMID:32068187
RGD:267358468
NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:116,577,010...116,583,415
G
Il1rl1
interleukin 1 receptor-like 1
IEP
RGD
PMID:24837094
RGD:40813741
NCBI chr 9:50,157,326...50,222,888
Ensembl chr 9:42,697,192...42,727,256
G
Il33
interleukin 33
IEP
RGD
PMID:24837094
RGD:40813741
NCBI chr 1:237,115,478...237,149,897
Ensembl chr 1:227,721,435...227,736,373
G
Il4
interleukin 4
ameliorates
IEP
RGD
PMID:32068187
RGD:267358468
NCBI chr10:38,272,003...38,277,549
Ensembl chr10:37,771,203...37,776,750
G
Il6
interleukin 6
ameliorates
IEP
RGD
PMID:32068187
RGD:267358468
NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,213,394...5,219,178
G
Itgam
integrin subunit alpha M
treatment
ISO
RGD
PMID:21238619
RGD:329901664
NCBI chr 1:192,089,496...192,139,947
Ensembl chr 1:182,659,000...182,709,503
G
Kif6
kinesin family member 6
ISO
DNA:SNP: :p.W719R (rs20455) (human)
RGD
PMID:20044086
RGD:243048455
NCBI chr 9:18,573,925...18,870,789
Ensembl chr 9:11,072,824...11,373,006
G
Map1lc3a
microtubule-associated protein 1 light chain 3 alpha
treatment
IEP
RGD
PMID:30144448
RGD:407571674
NCBI chr 3:164,243,204...164,244,850
Ensembl chr 3:143,783,024...143,784,670
G
Mir126a
microRNA 126a
disease_progression
ISO
RGD
PMID:36523365 PMID:32595526
RGD:401851047 , RGD:401851053
NCBI chr 3:29,813,150...29,813,267
Ensembl chr 3:9,415,063...9,415,180
G
Mir146a
microRNA 146a
ISO
miRNA:increased expression:peripheral blood mononuclear cell, plasma
RGD
PMID:31866771
RGD:21081515
NCBI chr10:28,349,996...28,350,090
Ensembl chr10:27,848,516...27,848,610
G
Mir155
microRNA 155
ISO
miRNA:decreased expression:peripheral blood mononuclear cell, plasma
RGD
PMID:31866771
RGD:21081515
NCBI chr11:37,261,114...37,261,178
Ensembl chr11:23,774,654...23,774,718
G
Mir17
microRNA 17
treatment
IMP
RGD
PMID:29536180
RGD:329403057
NCBI chr15:98,587,848...98,587,931
Ensembl chr15:92,180,629...92,180,712
G
Mir21
microRNA 21
ISO
miRNA:increased expression:peripheral blood mononuclear cell, plasma RNA:decreased expression:serum
RGD
PMID:31866771 PMID:32595526
RGD:21081515 , RGD:401851053
NCBI chr10:71,902,600...71,902,691
Ensembl chr10:71,405,257...71,405,348
G
Mir223
microRNA 223
treatment
IMP
RGD
PMID:29689569
RGD:25823140
NCBI chr X:65,151,383...65,151,492
Ensembl chr X:61,141,887...61,141,996
G
Mir320a
microRNA 320a
ISO
RGD
PMID:29990866
RGD:155882565
NCBI chr15:51,926,088...51,926,169
Ensembl chr15:45,516,392...45,516,473
G
Mt-co2
mitochondrially encoded cytochrome c oxidase II
ameliorates
IEP
RGD
PMID:32068187
RGD:267358468
NCBI chr MT:7,006...7,689
Ensembl chr MT:7,006...7,689
G
Ndufb5
NADH:ubiquinone oxidoreductase subunit B5
ameliorates
IEP
associated with obesity
RGD
PMID:35257523
RGD:401794445
NCBI chr 2:117,447,605...117,461,943
Ensembl chr 2:115,519,154...115,533,589
G
Pf4
platelet factor 4
treatment
IEP
RGD
PMID:29407168
RGD:329901925
NCBI chr14:17,582,477...17,583,392
Ensembl chr14:17,298,308...17,299,365
G
Plcg1
phospholipase C, gamma 1
ameliorates
IEP
RGD
PMID:32068187
RGD:267358468
NCBI chr 3:169,805,299...169,836,040
Ensembl chr 3:149,385,587...149,416,330
G
Ppbp
pro-platelet basic protein
treatment
IEP
RGD
PMID:29407168
RGD:329901925
NCBI chr14:17,586,495...17,587,299
Ensembl chr14:17,302,326...17,303,130
G
Pten
phosphatase and tensin homolog
ameliorates
IEP ISO
mRNA:decreased expression:heart left ventricle (rat) RNA:increased expression:serum
RGD
PMID:26973267 PMID:32595526 PMID:29990866
RGD:11526378 , RGD:401851053 , RGD:155882565
NCBI chr 1:240,043,707...240,110,330
Ensembl chr 1:230,630,338...230,696,838
G
Rhoa
ras homolog family member A
ameliorates
IEP
RGD
PMID:32068187
RGD:267358468
NCBI chr 8:117,870,548...117,904,303
Ensembl chr 8:108,991,954...109,025,746
G
Rit2
Ras-like without CAAX 2
ameliorates
IEP
RGD
PMID:32068187
RGD:267358468
NCBI chr18:22,839,914...23,196,137
Ensembl chr18:22,565,404...22,921,648
G
Sdhb
succinate dehydrogenase complex iron sulfur subunit B
ameliorates
IEP
associated with obesity
RGD
PMID:35257523
RGD:401794445
NCBI chr 5:158,547,775...158,568,589
Ensembl chr 5:153,264,899...153,314,293
G
Serping1
serpin family G member 1
ISO IEP
mRNA:increased expression:heart
RGD
PMID:26476955 PMID:26476955
RGD:11552746 , RGD:11552746
NCBI chr 3:90,249,410...90,259,299
Ensembl chr 3:69,842,739...69,852,034
G
Sqstm1
sequestosome 1
treatment
IEP
RGD
PMID:30144448
RGD:407571674
NCBI chr10:35,026,598...35,037,750
Ensembl chr10:34,525,519...34,536,673
G
Tbx1
T-box transcription factor 1
treatment
IEP
RGD
PMID:27422448
RGD:155882497
NCBI chr11:95,913,610...95,923,392
Ensembl chr11:82,409,275...82,418,380
G
Tnf
tumor necrosis factor
ameliorates
IEP
RGD
PMID:32068187
RGD:267358468
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,622,011...3,624,629
G
Zeb1
zinc finger E-box binding homeobox 1
ameliorates
IEP
RGD
PMID:32068187
RGD:267358468
NCBI chr17:56,644,397...56,811,155
Ensembl chr17:51,948,948...52,115,214
G
Adrb1
adrenoceptor beta 1
ISO
RGD
PMID:11527135
RGD:5129114
NCBI chr 1:265,777,103...265,780,114
Ensembl chr 1:255,771,597...255,807,259
G
Adrb2
adrenoceptor beta 2
ISO
RGD
PMID:11527135
RGD:5129114
NCBI chr18:57,912,760...57,914,802
Ensembl chr18:55,502,903...55,644,512
G
Avp
arginine vasopressin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11128043 PMID:11791009
NCBI chr 3:138,246,544...138,248,522
Ensembl chr 3:117,793,457...117,795,425
G
Cpb2
carboxypeptidase B2
ISO
RGD
PMID:12624641
RGD:1598479
NCBI chr15:56,967,128...57,015,964
Ensembl chr15:50,557,717...50,606,556
G
Mir146a
microRNA 146a
ISO
miRNA:increased expression:peripheral blood mononuclear cell, plasma
RGD
PMID:31866771
RGD:21081515
NCBI chr10:28,349,996...28,350,090
Ensembl chr10:27,848,516...27,848,610
G
Mir155
microRNA 155
ISO
miRNA:decreased expression:peripheral blood mononuclear cell, plasma
RGD
PMID:31866771
RGD:21081515
NCBI chr11:37,261,114...37,261,178
Ensembl chr11:23,774,654...23,774,718
G
Mir21
microRNA 21
ISO
miRNA:increased expression:peripheral blood mononuclear cell, plasma
RGD
PMID:31866771
RGD:21081515
NCBI chr10:71,902,600...71,902,691
Ensembl chr10:71,405,257...71,405,348
G
Plau
plasminogen activator, urokinase
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:1730212
NCBI chr15:3,505,485...3,511,987
Ensembl chr15:3,456,232...3,462,775
G
Ppbp
pro-platelet basic protein
ISO
protein:increased expression:plasma
RGD
PMID:17045893
RGD:401794448
NCBI chr14:17,586,495...17,587,299
Ensembl chr14:17,302,326...17,303,130
G
Spp1
secreted phosphoprotein 1
ISO
RGD
PMID:16421174
RGD:1581390
NCBI chr14:5,613,569...5,620,695
Ensembl chr14:5,308,885...5,315,162
G
Edn1
endothelin 1
ISO
protein:increased expression:aortic root, coronary sinus, plasma (human)
RGD
PMID:12581682
RGD:8661757
NCBI chr17:22,660,799...22,666,687
Ensembl chr17:22,454,420...22,460,885
G
Serpine1
serpin family E member 1
disease_progression
ISO
protein:decreased expression, decreased activity:heart:
RGD
PMID:12615902 PMID:12615902
RGD:13208541 , RGD:13208541
NCBI chr12:25,237,977...25,248,356
Ensembl chr12:19,601,272...19,611,657
G
Acvr2b
activin A receptor type 2B
severity
ISO
mRNA, protein:increased expression:umbilical cord blood (human)
RGD
PMID:27957679
RGD:329849106
NCBI chr 8:128,016,589...128,056,193
Ensembl chr 8:119,138,812...119,170,458
G
Ada
adenosine deaminase
IEP
protein:increased activity:brain:
RGD
PMID:25720338
RGD:152995398
NCBI chr 3:172,818,174...172,842,283
Ensembl chr 3:152,398,747...152,447,088
G
Adk
adenosine kinase
IEP
protein:decreased expression:brain:
RGD
PMID:25720338
RGD:152995398
NCBI chr15:2,912,543...3,295,745
Ensembl chr15:2,863,244...3,246,510
G
Adnp
activity-dependent neuroprotector homeobox
IDA
RGD
PMID:16938277
RGD:2312775
NCBI chr 3:177,310,258...177,340,379
Ensembl chr 3:156,891,381...156,917,312
G
Adora1
adenosine A1 receptor
IEP
protein:decreased expression:brain:
RGD
PMID:25720338
RGD:152995398
NCBI chr13:48,210,922...48,247,826
Ensembl chr13:45,658,872...45,695,801
G
Agtr2
angiotensin II receptor, type 2
IMP
RGD
PMID:22569153
RGD:6903872
NCBI chr X:116,914,320...116,918,504
Ensembl chr X:112,120,228...112,124,057
G
Aif1
allograft inflammatory factor 1
IEP
protein:increased expression:right cerebral hemisphere (rat)
RGD
PMID:19447505
RGD:2313021
NCBI chr20:3,651,435...3,657,341
Ensembl chr20:3,646,777...3,652,668
G
Aifm1
apoptosis inducing factor, mitochondria associated 1
IEP
protein:increased expression:nucleus:
RGD
PMID:12871572 PMID:28108258
RGD:10053564 , RGD:13524865
NCBI chr X:132,528,107...132,567,237
Ensembl chr X:127,650,226...127,689,256
G
Bax
BCL2 associated X, apoptosis regulator
treatment
IEP
RGD
PMID:21189961 PMID:24089674 PMID:29635023
RGD:10054502 , RGD:155882465 , RGD:13782292
NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:95,938,808...95,945,368
G
Bcan
brevican
IEP
RGD
PMID:15817274
RGD:14392799
NCBI chr 2:175,752,333...175,765,766
Ensembl chr 2:173,454,482...173,467,460
G
Bcl2
BCL2, apoptosis regulator
treatment
IEP
RGD
PMID:21189961 PMID:24089674 PMID:29635023
RGD:10054502 , RGD:155882465 , RGD:13782292
NCBI chr13:23,204,464...23,366,900
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
Bcl2l1
Bcl2-like 1
IDA
RGD
PMID:24195677
RGD:10053669
NCBI chr 3:161,713,777...161,764,844
Ensembl chr 3:141,253,523...141,303,479 Ensembl chr 1:141,253,523...141,303,479
G
Becn1
beclin 1
IEP
protein:increased expression:cerebral cortex protein:increased expression:brain
RGD
PMID:22449108 PMID:25919564
RGD:6483050 , RGD:11558017
NCBI chr10:86,731,649...86,747,002
Ensembl chr10:86,231,388...86,246,742
G
Bmal1
basic helix-loop-helix ARNT like 1
IEP
protein:increased expression:pineal gland
RGD
PMID:23336172
RGD:10043348
NCBI chr 1:176,766,222...176,864,741
Ensembl chr 1:167,331,633...167,430,231
G
Bmp4
bone morphogenetic protein 4
IEP
mRNA,protein:decreased expression:brain:
RGD
PMID:23236544
RGD:8699519
NCBI chr15:22,098,191...22,113,145
Ensembl chr15:19,618,542...19,623,306
G
Casp1
caspase 1
IEP
RGD
PMID:23046993
RGD:13782359
NCBI chr 8:10,746,338...10,882,295
Ensembl chr 8:2,587,831...2,597,383
G
Casp12
caspase 12
IDA
protein:increased activity:cerebral cortex, hippocampus
RGD
PMID:18603371
RGD:2311455
NCBI chr 8:10,927,188...10,954,442
Ensembl chr 8:2,642,434...2,674,037
G
Casp3
caspase 3
treatment
IDA IEP
protein:increased activity:cerebral cortex, hippocampus
RGD
PMID:18603371 PMID:24089674 PMID:23046993 PMID:29635023 PMID:27216999 PMID:21189961 More...
RGD:2311455 , RGD:155882465 , RGD:13782359 , RGD:13782292 , RGD:13782279 , RGD:10054502
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:45,662,910...45,684,648
G
Casp8
caspase 8
treatment
IEP
RGD
PMID:29635023 PMID:23046993
RGD:13782292 , RGD:13782359
NCBI chr 9:67,747,109...67,806,699
Ensembl chr 9:60,264,075...60,312,542
G
Casp9
caspase 9
treatment
IEP
RGD
PMID:23046993 PMID:24089674
RGD:13782359 , RGD:155882465
Ensembl chr 5:154,109,046...154,126,626
G
Cast
calpastatin
IEP
RGD
PMID:10318818
RGD:5683321
NCBI chr 2:5,707,633...5,817,213
Ensembl chr 2:3,973,112...4,082,659
G
Cat
catalase
treatment
ISO
RGD
PMID:21978706
RGD:9068474
NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:89,842,399...89,874,478
G
Ccl2
C-C motif chemokine ligand 2
IEP
protein:increased expression:forebrain (rat)
RGD
PMID:9270493
RGD:8549543
NCBI chr10:67,503,077...67,504,875
Ensembl chr10:67,005,424...67,007,226
G
Ccr2
C-C motif chemokine receptor 2
IEP
mRNA, protein:increased expression:brain
RGD
PMID:18095591
RGD:4144890
NCBI chr 8:132,611,883...132,619,106
Ensembl chr 8:123,734,430...123,742,100
G
Ccr5
C-C motif chemokine receptor 5
IEP
mRNA:increased expression:cerebral hemisphere (rat)
RGD
PMID:16516309
RGD:4890442
NCBI chr 8:132,629,097...132,660,980
Ensembl chr 8:123,752,325...123,759,260
G
Cdk5r1
cyclin-dependent kinase 5 regulatory subunit 1
treatment
IMP
RGD
PMID:25665755
RGD:13782373
NCBI chr10:65,981,692...65,985,831
Ensembl chr10:65,483,941...65,488,456
G
Clock
clock circadian regulator
IEP
protein:increased expression:pineal gland
RGD
PMID:23336172
RGD:10043348
NCBI chr14:32,262,747...32,346,872
Ensembl chr14:31,908,566...31,990,400
G
Cnp
2',3'-cyclic nucleotide 3' phosphodiesterase
IEP
RGD
PMID:19747899
RGD:6483337
NCBI chr10:86,011,504...86,018,063
Ensembl chr10:85,511,160...85,517,720
G
Crp
C-reactive protein
ISO
RGD
PMID:20220110
RGD:9585994
NCBI chr13:87,694,062...87,695,978
Ensembl chr13:85,124,977...85,175,178
G
Cs
citrate synthase
treatment
IDA
RGD
PMID:15132986 PMID:15569775
RGD:243048479 , RGD:243048481
NCBI chr 7:1,348,389...1,374,624
Ensembl chr 7:758,345...791,421
G
Csf1r
colony stimulating factor 1 receptor
exacerbates
IMP IEP
protein:increased expression:right cerebral hemisphere, astrocyte, neuron (rat)
RGD
PMID:32522286 PMID:33101590
RGD:151665765 , RGD:151665766
NCBI chr18:56,834,152...56,860,804
Ensembl chr18:54,546,659...54,590,415
G
Cxcr3
C-X-C motif chemokine receptor 3
IEP
mRNA:increased expression:brain
RGD
PMID:17549754
RGD:2311381
NCBI chr X:70,884,293...70,886,944
Ensembl chr X:66,844,318...66,846,969
G
Daxx
death-domain associated protein
IMP
RGD
PMID:21843499
RGD:9587791
NCBI chr20:4,971,973...4,978,062
Ensembl chr20:4,970,092...4,975,843
G
Dnmt3a
DNA methyltransferase 3 alpha
IEP
protein:decreased expression:brain:
RGD
PMID:23716065
RGD:9588620
NCBI chr 6:32,507,316...32,621,678
Ensembl chr 6:26,822,609...26,896,687
G
Egr1
early growth response 1
IEP
mRNA:increased expression:forebrain (rat)
RGD
PMID:7684483
RGD:2289081
NCBI chr18:26,737,078...26,740,877
Ensembl chr18:26,462,981...26,466,766
G
Eif2s1
eukaryotic translation initiation factor 2 subunit alpha
IDA
RGD
PMID:8092984
RGD:10395352
NCBI chr 6:103,405,880...103,430,549
Ensembl chr 6:97,672,766...97,706,225
G
Epha4
Eph receptor A4
IEP
protein:increased expression:brain
RGD
PMID:21736568
RGD:5688765
NCBI chr 9:86,263,982...86,406,744
Ensembl chr 9:78,815,460...78,958,139
G
Epo
erythropoietin
treatment
IEP ISO
RGD
PMID:24034924 PMID:22156696
RGD:10400911 , RGD:10401072
NCBI chr12:24,841,285...24,844,725
Ensembl chr12:19,204,508...19,207,946
G
Ero1a
endoplasmic reticulum oxidoreductase 1 alpha
IEP
mRNA:increased expression:hippocampus
RGD
PMID:12694393
RGD:632668
NCBI chr15:20,974,771...21,010,170
Ensembl chr15:18,492,945...18,530,478
G
Fadd
Fas associated via death domain
treatment
IEP
RGD
PMID:29635023
RGD:13782292
NCBI chr 1:209,169,245...209,175,423
Ensembl chr 1:199,739,994...199,745,653
G
Fas
Fas cell surface death receptor
IEP
RGD
PMID:21843499
RGD:9587791
NCBI chr 1:241,212,155...241,245,774
Ensembl chr 1:231,798,960...231,832,591
G
Fos
Fos proto-oncogene, AP-1 transcription factor subunit
IEP
protein:decreased expression:hippocampus
RGD
PMID:25262910
RGD:405650622
NCBI chr 6:110,852,188...110,855,054
Ensembl chr 6:105,121,170...105,124,036
G
Foxo3
forkhead box O3
IEP
protein:increased expression:cerebral cortex,nucleus:
RGD
PMID:24229603
RGD:10402203
NCBI chr20:47,251,968...47,348,254
Ensembl chr20:45,672,995...45,764,561
G
Fst
follistatin
IEP
mRNA:decreased expression:brain (rat)
RGD
PMID:10415398
RGD:329322882
NCBI chr 2:47,856,345...47,863,670
Ensembl chr 2:46,123,439...46,130,571
G
Ghr
growth hormone receptor
IEP
protein:increased expression:brain
RGD
PMID:19524466
RGD:2315620
NCBI chr 2:54,269,066...54,532,595
Ensembl chr 2:52,542,594...52,804,735
G
Grin1
glutamate ionotropic receptor NMDA type subunit 1
IEP
mRNA:decreased expression:hippocampus (rat)
RGD
PMID:19761817
RGD:2325954
NCBI chr 3:28,501,836...28,528,754
Ensembl chr 3:8,103,680...8,130,603
G
Grin2a
glutamate ionotropic receptor NMDA type subunit 2A
IEP
mRNA:decreased expression:hippocampus (rat)
RGD
PMID:19761817
RGD:2325954
NCBI chr10:6,136,458...6,560,003
Ensembl chr10:5,631,369...6,044,637
G
Grin2b
glutamate ionotropic receptor NMDA type subunit 2B
IEP
mRNA:decreased expression:hippocampus (rat)
RGD
PMID:19761817
RGD:2325954
NCBI chr 4:170,297,811...170,775,420
Ensembl chr 4:168,599,546...169,042,279
G
Gsn
gelsolin
severity
ISO
protein:decreased expression:blood plasma (human)
RGD
PMID:29466895
RGD:329333029
NCBI chr 3:38,982,605...39,035,849
Ensembl chr 3:18,585,172...18,638,402
G
Hcn1
hyperpolarization-activated cyclic nucleotide-gated potassium channel 1
IEP
mRNA:decreased expression:hippocampus,cortex:
RGD
PMID:19892002
RGD:9686395
NCBI chr 2:51,228,710...51,632,806
Ensembl chr 2:49,495,771...49,899,774
G
Hdac3
histone deacetylase 3
IEP
protein:decreased expression:brain:
RGD
PMID:23716065
RGD:9588620
NCBI chr18:30,021,847...30,041,061
Ensembl chr18:29,770,636...29,793,856
G
Hif1a
hypoxia inducible factor 1 subunit alpha
treatment
IEP ISO IDA
protein:increased expression:brain (rat) mRNA, protein:increased expression:brain,kidney (rat) CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:23694759 PMID:18210138 PMID:31784544 PMID:19595151
RGD:9068873 , RGD:155882534 , RGD:9068901
NCBI chr 6:98,357,788...98,405,068
Ensembl chr 6:92,624,390...92,669,261
G
Hmox1
heme oxygenase 1
treatment
IEP
RGD
PMID:25447631
RGD:10766440
NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,467,244...13,474,079
G
Hspa1a
heat shock protein family A (Hsp70) member 1A
IEP
RGD
PMID:22526757
RGD:7257595
NCBI chr20:3,875,411...3,877,866
Ensembl chr20:3,856,006...3,873,227
G
Hspa1b
heat shock protein family A (Hsp70) member 1B
IMP
RGD
PMID:16397188
RGD:1626654
NCBI chr20:3,859,756...3,863,800
Ensembl chr20:3,856,006...3,873,240 Ensembl chr20:3,856,006...3,873,240
G
Igf1
insulin-like growth factor 1
treatment
ISO IDA IEP
RGD
PMID:11672597 PMID:23694759 PMID:19766709
RGD:8549456 , RGD:12904932 , RGD:10046049
NCBI chr 7:24,169,608...24,249,446
Ensembl chr 7:22,282,930...22,359,296
G
Igf2
insulin-like growth factor 2
disease_progression
ISO
RGD
PMID:16787587
RGD:5510005
NCBI chr 1:207,243,873...207,261,263
Ensembl chr 1:197,814,410...197,823,018
G
Igfbp3
insulin-like growth factor binding protein 3
IEP
RGD
PMID:10709766
RGD:10402756
NCBI chr14:86,270,208...86,277,944
Ensembl chr14:82,056,347...82,064,083
G
Il1b
interleukin 1 beta
IEP
protein:increased expression:brain (rat)
RGD
PMID:23110519
RGD:7204438
NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:116,577,010...116,583,415
G
Il6
interleukin 6
severity
ISO
DNA:polymorphism: :174G>C(human)
RGD
PMID:22117975
RGD:12792241
NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,213,394...5,219,178
G
Inhba
inhibin subunit beta A
severity treatment
IEP ISO
mRNA:increased expression:brain (rat) mRNA, protein:increased expression:umbilical cord blood (human) human construct in rat model
RGD
PMID:10415398 PMID:27957679 PMID:10415398
RGD:329322882 , RGD:329849106 , RGD:329322882
NCBI chr17:53,787,159...53,810,942
Ensembl chr17:49,095,920...49,108,982
G
Irak1
interleukin-1 receptor-associated kinase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21925238
NCBI chr X:156,919,927...156,929,825
Ensembl chr X:151,768,777...151,778,521
G
Irak4
interleukin-1 receptor-associated kinase 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21925238
NCBI chr 7:127,561,777...127,588,762
Ensembl chr 7:125,682,488...125,717,837
G
Ireb2
iron responsive element binding protein 2
IEP
mRNA:increased expression:brain (rat)
RGD
PMID:27602087
RGD:12903962
NCBI chr 8:64,124,152...64,207,702
Ensembl chr 8:55,228,085...55,311,611
G
Kdr
kinase insert domain receptor
IMP
RGD
PMID:21277350
RGD:5684383
NCBI chr14:32,572,031...32,615,204
Ensembl chr14:32,217,871...32,261,018
G
Map1lc3a
microtubule-associated protein 1 light chain 3 alpha
IEP
RGD
PMID:25919564
RGD:11558017
NCBI chr 3:164,243,204...164,244,850
Ensembl chr 3:143,783,024...143,784,670
G
Map2
microtubule-associated protein 2
IDA
RGD
PMID:21300124
RGD:6483088
NCBI chr 9:75,173,038...75,431,606
Ensembl chr 9:67,723,371...67,979,809
G
Map3k5
mitogen-activated protein kinase kinase kinase 5
IEP
RGD
PMID:21843499
RGD:9587791
NCBI chr 1:16,505,387...16,723,899
Ensembl chr 1:14,685,492...14,904,800
G
Map3k7
mitogen activated protein kinase kinase kinase 7
ameliorates
ISO IEP
protein:increased expression:brain (rat)
RGD
PMID:29138854 PMID:32734729
RGD:155804273 , RGD:155804275
NCBI chr 5:51,149,524...51,212,012
Ensembl chr 5:46,357,931...46,415,597
G
Mapt
microtubule-associated protein tau
treatment
IDA
RGD
PMID:25665755
RGD:13782373
NCBI chr10:89,638,618...89,736,108
Ensembl chr10:89,138,627...89,236,129
G
Mbd2
methyl-CpG binding domain protein 2
IEP
protein:increased expression:brain:
RGD
PMID:23716065
RGD:9588620
NCBI chr18:66,449,196...66,516,112
Ensembl chr18:64,174,002...64,240,794
G
Mbp
myelin basic protein
IEP
protein:decreased expression:white matter:
RGD
PMID:23715956
RGD:7327196
NCBI chr18:78,130,652...78,241,174
Ensembl chr18:75,855,878...75,966,404
G
Mir140
microRNA 140
severity
ISO
miRNA:decreased expression:blood serum (human)
RGD
PMID:34331407
RGD:329347831
NCBI chr19:52,375,293...52,375,391
Ensembl chr19:35,465,577...35,465,675
G
Mir17
microRNA 17
ISO
RGD
PMID:35085690
RGD:329349305
NCBI chr15:98,587,848...98,587,931
Ensembl chr15:92,180,629...92,180,712
G
Mir210
microRNA 210
treatment disease_progression
IMP ISO
miRNA:decreased expression:blood serum (human) associated with Brain Injuries;miRNA:increased expression:brain, cerebral hemisphere (human)
RGD
PMID:26875527 PMID:24089674 PMID:29568675 PMID:33402183
RGD:11572290 , RGD:155882465 , RGD:155598592 , RGD:155582222
NCBI chr 1:205,755,923...205,756,032
Ensembl chr 1:196,326,337...196,326,454
G
Mmp3
matrix metallopeptidase 3
treatment
IEP
RGD
PMID:21038694
RGD:8694100
NCBI chr 8:12,925,267...12,938,828
Ensembl chr 8:4,640,416...4,653,961
G
Mpo
myeloperoxidase
IEP
protein:increased activity:brain:
RGD
PMID:25720338
RGD:152995398
NCBI chr10:73,092,124...73,102,057
Ensembl chr10:72,594,661...72,604,819
G
Naglu
N-acetyl-alpha-glucosaminidase
IEP
protein:increased activity:brain:
RGD
PMID:25720338
RGD:152995398
NCBI chr10:86,501,864...86,509,333
Ensembl chr10:86,001,566...86,008,972
G
Nos2
nitric oxide synthase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23694759
NCBI chr10:64,313,335...64,349,221
Ensembl chr10:63,815,308...63,851,210
G
Nrf1
nuclear respiratory factor 1
IEP
mRNA, protein:increase expression:cerebral cortex
RGD
PMID:18723421
RGD:2302400
NCBI chr 4:59,632,366...59,738,166
Ensembl chr 4:58,664,957...58,825,328
G
Ntrk1
neurotrophic receptor tyrosine kinase 1
IEP
mRNA:increased expression:brain
RGD
PMID:19633950
RGD:5684358
NCBI chr 2:175,534,844...175,551,664
Ensembl chr 2:173,236,963...173,253,770
G
Pdgfb
platelet derived growth factor subunit B
IEP
RGD
PMID:10215166
RGD:10449494
NCBI chr 7:113,419,882...113,438,343
Ensembl chr 7:111,540,345...111,557,984
G
Plat
plasminogen activator, tissue type
onset
IEP
RGD
PMID:18467699
RGD:6483831
NCBI chr16:75,943,061...76,022,037
Ensembl chr16:69,240,585...69,268,223
G
Plau
plasminogen activator, urokinase
IDA IEP
mRNA, protein:increased expression, increased activity:hippocampus (rat)
RGD
PMID:19587273 PMID:18467699
RGD:2316117 , RGD:6483831
NCBI chr15:3,505,485...3,511,987
Ensembl chr15:3,456,232...3,462,775
G
Ppp1r1b
protein phosphatase 1, regulatory (inhibitor) subunit 1B
IEP
RGD
PMID:23153068
RGD:13515077
NCBI chr10:83,843,948...83,853,063
Ensembl chr10:83,347,731...83,356,775
G
Prkdc
protein kinase, DNA-activated, catalytic subunit
treatment
IMP
RGD
PMID:30485360
RGD:39938998
NCBI chr11:98,544,952...98,762,499
Ensembl chr11:85,040,792...85,257,952
G
Prkdcem1Sage
protein kinase, DNA-activated, catalytic subunit; ZFN induced mutant 1, Sage
treatment
IMP
RGD
PMID:30485360
RGD:39938998
G
Ptpn5
protein tyrosine phosphatase, non-receptor type 5
IEP
STEP33;protein:increased expression:forebrain (rat)
RGD
PMID:10537057
RGD:9835021
NCBI chr 1:106,756,896...106,817,369
Ensembl chr 1:97,620,642...97,679,882
G
Ptprz1
protein tyrosine phosphatase, receptor type Z1
IEP
RGD
PMID:16041802
RGD:9590116
NCBI chr 4:52,363,006...52,560,905
Ensembl chr 4:51,397,601...51,595,218
G
Rnf146
ring finger protein 146
IEP
RGD
PMID:28108258
RGD:13524865
NCBI chr 1:28,458,864...28,475,758
Ensembl chr 1:28,458,887...28,475,923
G
Robo1
roundabout guidance receptor 1
exacerbates
IMP
RGD
PMID:31356825
RGD:242905191
NCBI chr11:24,067,869...25,108,694
Ensembl chr11:10,580,908...11,620,203
G
S100b
S100 calcium binding protein B
severity
ISO
associated with Asphyxia Neonatorum;protein:increased expression:urine protein:increased expression:blood serum (human)
RGD
PMID:14707571 PMID:29568675
RGD:5508819 , RGD:155598592
NCBI chr20:12,372,345...12,381,159
Ensembl chr20:12,372,881...12,394,743
G
Serpine1
serpin family E member 1
ISO
RGD
PMID:19587273
RGD:2316117
NCBI chr12:25,237,977...25,248,356
Ensembl chr12:19,601,272...19,611,657
G
Slc9a1
solute carrier family 9 member A1
IMP
RGD
PMID:20883671
RGD:6771331
NCBI chr 5:150,859,412...150,913,525
Ensembl chr 5:145,576,334...145,629,624
G
Slit2
slit guidance ligand 2
treatment
IEP
RGD
PMID:31356825
RGD:242905191
NCBI chr14:66,829,661...67,168,517
Ensembl chr14:62,617,067...62,955,948
G
Spi1
Spi-1 proto-oncogene
IEP
protein:increased expression:CA1 field of hippocampus
RGD
PMID:10713349
RGD:9586724
NCBI chr 3:97,529,509...97,548,204
Ensembl chr 3:77,073,012...77,092,393
G
Srgap1
SLIT-ROBO Rho GTPase activating protein 1
exacerbates
IMP
RGD
PMID:31356825
RGD:242905191
NCBI chr 7:59,215,007...59,479,600
Ensembl chr 7:57,329,532...57,596,196
G
Tert
telomerase reverse transcriptase
treatment
IDA
RGD
PMID:21940960
RGD:11038672
NCBI chr 1:31,465,766...31,488,650
Ensembl chr 1:29,637,506...29,659,561
G
Tf
transferrin
treatment
ISO
RGD
PMID:22736466
RGD:7244383
NCBI chr 8:112,668,667...112,695,376
Ensembl chr 8:103,767,995...103,816,511
G
Tfam
transcription factor A, mitochondrial
IEP
mRNA:increased expression:cerebral cortex
RGD
PMID:18723421
RGD:2302400
NCBI chr20:17,355,373...17,367,422
Ensembl chr20:17,356,197...17,368,292
G
Tlr2
toll-like receptor 2
ISO IEP
protein:increased expression:hippocampus mRNA, protein:increased expression:brain
RGD
PMID:28139935 PMID:25530127 PMID:26475712
RGD:15090829 , RGD:11096611 , RGD:11353246
NCBI chr 2:171,499,189...171,504,831
Ensembl chr 2:169,197,419...169,206,630
G
Tlr4
toll-like receptor 4
IEP
protein:increased expression:hippocampus
RGD
PMID:25530127
RGD:11096611
NCBI chr 5:85,161,247...85,174,882
Ensembl chr 5:80,145,826...80,159,628
G
Trpc6
transient receptor potential cation channel, subfamily C, member 6
IEP
mRNA:increased expression:glomerular podocytes (rat)
RGD
PMID:31784544
RGD:155882534
NCBI chr 8:14,044,216...14,148,808
Ensembl chr 8:5,758,935...5,828,092
G
Vegfa
vascular endothelial growth factor A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23694759
NCBI chr 9:22,452,854...22,468,194
Ensembl chr 9:14,955,300...14,970,641
G
Zeb2
zinc finger E-box binding homeobox 2
IEP IMP
mRNA:increased expression:glomerular podocytes (rat)
RGD
PMID:31784544 PMID:34852714
RGD:155882534 , RGD:155882542
NCBI chr 3:49,624,028...49,754,323
Ensembl chr 3:29,218,301...29,345,157
G
Adipoq
adiponectin, C1Q and collagen domain containing
IDA
RGD
PMID:19362080
RGD:5686830
NCBI chr11:91,226,524...91,240,244
Ensembl chr11:77,721,912...77,735,564
G
Adk
adenosine kinase
ISO IMP
RGD
PMID:16685255 PMID:9731623
RGD:6482657 , RGD:6482667
NCBI chr15:2,912,543...3,295,745
Ensembl chr15:2,863,244...3,246,510
G
Adm
adrenomedullin
treatment
ISO
RGD
PMID:21695352
RGD:5508764
NCBI chr 1:174,164,178...174,182,372
Ensembl chr 1:164,745,466...164,747,654
G
Adnp
activity-dependent neuroprotector homeobox
IDA
RGD
PMID:11935065
RGD:1358226
NCBI chr 3:177,310,258...177,340,379
Ensembl chr 3:156,891,381...156,917,312
G
Aif1
allograft inflammatory factor 1
IEP ISO
protein:increased expression:brain subventricular zone (rat) protein:increased expression:brain white matter (human)
RGD
PMID:19053043 PMID:10683518
RGD:2313025 , RGD:2313026
NCBI chr20:3,651,435...3,657,341
Ensembl chr20:3,646,777...3,652,668
G
Aldh2
aldehyde dehydrogenase 2 family member
susceptibility
ISO
RGD
PMID:17388993
RGD:1601161
NCBI chr12:40,610,244...40,643,220
Ensembl chr12:34,901,219...34,982,521
G
Alox5ap
arachidonate 5-lipoxygenase activating protein
ISO
associated with Metabolic Syndrome X; DNA:polymorphism:g.162A>C rs4769055 (human)
RGD
PMID:18506375
RGD:2311309
NCBI chr12:10,785,254...10,809,295
Ensembl chr12:5,748,944...5,772,986
G
Arrb2
arrestin, beta 2
IEP
protein:increased expression:spleen
RGD
PMID:29636059
RGD:401938621
NCBI chr10:55,645,539...55,653,485
Ensembl chr10:55,146,818...55,154,850
G
Atp2b2
ATPase plasma membrane Ca2+ transporting 2
IEP
mRNA:decreased expression:brain (rat)
RGD
PMID:23251410
RGD:329845556
NCBI chr 4:148,450,207...148,763,653
Ensembl chr 4:146,896,332...147,140,665
G
Becn1
beclin 1
IEP
protein:increased expression:brain
RGD
PMID:22227058
RGD:6483057
NCBI chr10:86,731,649...86,747,002
Ensembl chr10:86,231,388...86,246,742
G
Cacna2d1
calcium voltage-gated channel auxiliary subunit alpha2delta 1
IEP
mRNA:decreased expression:brain (rat)
RGD
PMID:23251410
RGD:329845556
NCBI chr 4:19,902,324...20,330,287
Ensembl chr 4:18,951,002...19,374,969
G
Calcrl
calcitonin receptor like receptor
IEP
mRNA:increased expression:brain (rat)
RGD
PMID:23251410
RGD:329845556
NCBI chr 3:89,835,071...89,932,616
Ensembl chr 3:69,430,120...69,525,910
G
Cd8a
CD8 subunit alpha
IEP
mRNA:increased expression:brain (rat)
RGD
PMID:23251410
RGD:329845556
NCBI chr 4:104,924,116...104,928,353
Ensembl chr 4:103,365,804...103,370,040
G
Cfh
complement factor H
treatment
ISO
RGD
PMID:21695352
RGD:5508764
NCBI chr13:54,063,079...54,164,523
Ensembl chr13:51,511,828...51,613,838
G
Cort
cortistatin
IEP
mRNA:decreased expression:brain (rat)
RGD
PMID:23251410
RGD:329845556
NCBI chr 5:164,843,682...164,845,796
G
Ctsb
cathepsin B
IEP
protein:increased expression:cerebral cortical segment, cytoplasm (rat)
RGD
PMID:19941836
RGD:2315502
NCBI chr15:41,565,607...41,586,479
Ensembl chr15:37,389,629...37,410,500
G
Cxcl10
C-X-C motif chemokine ligand 10
IEP
protein:increased expression:brain (rat)
RGD
PMID:19895873
RGD:2325193
NCBI chr14:15,989,066...15,991,263
Ensembl chr14:15,704,758...15,706,975
G
Cybb
cytochrome b-245 beta chain
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19417757
NCBI chr X:16,030,596...16,065,065
Ensembl chr X:13,359,430...13,392,586
G
Cyp11b1
cytochrome P450, family 11, subfamily b, polypeptide 1
IEP
mRNA:decreased expression:brain (rat)
RGD
PMID:23251410
RGD:329845556
NCBI chr 7:108,653,385...108,660,062
Ensembl chr 7:106,718,274...106,779,278
G
Cyp2r1
cytochrome P450, family 2, subfamily r, polypeptide 1
ISO
DNA:variants:CDS:multiple (human)
RGD
PMID:36762557
RGD:401901151
NCBI chr 1:178,166,984...178,232,191
Ensembl chr 1:168,751,038...168,797,759
G
Dcx
doublecortin
IEP
protein:altered expression:brain (rat)
RGD
PMID:12161747
RGD:155630606
NCBI chr X:112,227,455...112,370,291
Ensembl chr X:107,430,767...107,507,476
G
Ece1
endothelin converting enzyme 1
ISO
RGD
PMID:15485550
RGD:1580908
NCBI chr 5:155,361,031...155,462,723
Ensembl chr 5:150,077,644...150,179,371
G
Fgf2
fibroblast growth factor 2
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:17524524
NCBI chr 2:122,164,454...122,218,796
Ensembl chr 2:120,236,328...120,291,221
G
Gpnmb
glycoprotein nmb
IEP
mRNA:increased expression:brain (rat)
RGD
PMID:23251410
RGD:329845556
NCBI chr 4:79,341,128...79,362,366
Ensembl chr 4:78,010,197...78,049,367
G
Gpr17
G protein-coupled receptor 17
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:18974869
NCBI chr18:23,850,460...23,857,381
Ensembl chr18:23,577,242...23,582,966
G
Gzmb
granzyme B
IEP
protein:increased expression:brain (rat)
RGD
PMID:19895873
RGD:2325193
NCBI chr15:34,459,007...34,462,469
Ensembl chr15:30,173,603...30,346,814
G
Hgf
hepatocyte growth factor
treatment
IDA
RGD
PMID:16421510
RGD:8548626
NCBI chr 4:19,628,902...19,700,467
Ensembl chr 4:18,677,101...18,745,409
G
Hif1a
hypoxia inducible factor 1 subunit alpha
exacerbates
IMP
RGD
PMID:30052311
RGD:155663378
NCBI chr 6:98,357,788...98,405,068
Ensembl chr 6:92,624,390...92,669,261
G
Hmgb1
high mobility group box 1
IMP
RGD
PMID:19944723
RGD:2316741
NCBI chr12:11,009,236...11,015,941
Ensembl chr12:5,901,586...5,978,565 Ensembl chr16:5,901,586...5,978,565
G
Hnmt
histamine N-methyltransferase
severity
IMP
RGD
PMID:21131122 PMID:16330002
RGD:5509772 , RGD:5509773
NCBI chr 3:26,978,274...27,010,291
Ensembl chr 3:6,591,463...6,624,012
G
Htr2b
5-hydroxytryptamine receptor 2B
IEP
mRNA:increased expression:brain (rat)
RGD
PMID:23251410
RGD:329845556
NCBI chr 9:94,184,442...94,206,851
Ensembl chr 9:86,742,102...86,755,108
G
Icam1
intercellular adhesion molecule 1
ISO
associated with Diabetes Mellitus, Non-Insulin-Dependent;protein:increased expression:serum
RGD
PMID:18692933
RGD:2313474
NCBI chr 8:27,829,688...27,841,618
Ensembl chr 8:19,553,645...19,565,438
G
Igf2
insulin-like growth factor 2
IEP
mRNA, protein:increased expression:brain
RGD
PMID:7770004
RGD:5509999
NCBI chr 1:207,243,873...207,261,263
Ensembl chr 1:197,814,410...197,823,018
G
Il15
interleukin 15
ISO
associated with Hypertension;protein:increased expression:serum
RGD
PMID:16109314
RGD:1626610
NCBI chr19:42,536,160...42,611,349
Ensembl chr19:25,640,251...25,706,820
G
Il1b
interleukin 1 beta
IEP
protein:increased expression:cerebral cortex (rat)
RGD
PMID:17678971
RGD:1626644
NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:116,577,010...116,583,415
G
Il2
interleukin 2
IEP
protein:increased expression:brain (rat)
RGD
PMID:19895873
RGD:2325193
NCBI chr 2:121,932,968...121,937,672
Ensembl chr 2:120,004,862...120,009,566
G
Kcnk6
potassium two pore domain channel subfamily K member 6
IEP
mRNA:increased expression:brain (rat)
RGD
PMID:23251410
RGD:329845556
NCBI chr 1:93,652,888...93,661,419
Ensembl chr 1:84,525,590...84,534,677
G
Mdk
midkine
IDA
RGD
PMID:15450683
RGD:1582478
NCBI chr 3:98,356,789...98,358,960
Ensembl chr 3:77,901,158...77,903,130
G
Meis2
Meis homeobox 2
IEP
protein:altered expression:brain (rat)
RGD
PMID:12161747
RGD:155630606
NCBI chr 3:123,197,066...123,399,002
Ensembl chr 3:102,742,900...102,949,696
G
Mgp
matrix Gla protein
IEP
mRNA:increased expression:brain (rat)
RGD
PMID:23251410
RGD:329845556
NCBI chr 4:171,497,472...171,500,888
Ensembl chr 4:169,766,279...169,769,667
G
Mir223
microRNA 223
IEP
RNA:increased expression:brain,blood
RGD
PMID:31342956
RGD:25824952
NCBI chr X:65,151,383...65,151,492
Ensembl chr X:61,141,887...61,141,996
G
Mmp14
matrix metallopeptidase 14
IEP
mRNA:increased expression:brain (rat)
RGD
PMID:23251410
RGD:329845556
NCBI chr15:31,857,824...31,867,049
Ensembl chr15:27,887,727...27,899,864
G
Mmp8
matrix metallopeptidase 8
IEP
mRNA:increased expression:brain (rat)
RGD
PMID:23251410
RGD:329845556
NCBI chr 8:13,008,873...13,018,729
Ensembl chr 8:4,724,029...4,733,520
G
Mmp9
matrix metallopeptidase 9
ISO
RGD
PMID:16599837
RGD:1582617
NCBI chr 3:174,103,474...174,111,434
Ensembl chr 3:153,683,858...153,692,120
G
Msi1
musashi RNA-binding protein 1
IEP
RGD
PMID:15250238
RGD:1582664
NCBI chr12:46,815,225...46,911,852
Ensembl chr12:41,158,599...41,191,076
G
Nes
nestin
IEP
associated with Hypertension
RGD
PMID:16321245
RGD:1642069
NCBI chr 2:175,735,715...175,745,631
Ensembl chr 2:173,438,734...173,447,777
G
Parg
poly (ADP-ribose) glycohydrolase
IMP
associated with Reperfusion Injury
RGD
PMID:12834903
RGD:2316742
NCBI chr16:7,442,696...7,550,585
Ensembl chr16:7,436,476...7,544,273
G
Pbx1
PBX homeobox 1
IEP
protein:altered expression:brain (rat)
RGD
PMID:12161747
RGD:155630606
NCBI chr13:82,811,664...83,121,447
Ensembl chr13:80,278,770...80,588,594
G
Plat
plasminogen activator, tissue type
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:16190367
NCBI chr16:75,943,061...76,022,037
Ensembl chr16:69,240,585...69,268,223
G
Ppp1r1b
protein phosphatase 1, regulatory (inhibitor) subunit 1B
IEP
protein:altered expression:brain (rat)
RGD
PMID:12161747
RGD:155630606
NCBI chr10:83,843,948...83,853,063
Ensembl chr10:83,347,731...83,356,775
G
Prcp
prolylcarboxypeptidase
IEP
mRNA:increased expression:brain (rat)
RGD
PMID:23251410
RGD:329845556
NCBI chr 1:156,343,894...156,396,295
Ensembl chr 1:146,930,561...146,984,530
G
Rbfox3
RNA binding fox-1 homolog 3
IEP
protein:altered expression:brain (rat)
RGD
PMID:12161747
RGD:155630606
NCBI chr10:104,218,940...104,655,863
Ensembl chr10:103,720,636...104,156,935
G
RT1-Ba
RT1 class II, locus Ba
ISO
DNA:polymorphisms (human)
RGD
PMID:11798899
RGD:5147807
NCBI chr20:4,577,057...4,581,650
Ensembl chr20:4,575,134...4,579,744
G
Scn7a
sodium voltage-gated channel alpha subunit 7
IEP
mRNA:increased expression:brain (rat)
RGD
PMID:23251410
RGD:329845556
NCBI chr 3:71,743,873...71,846,454
Ensembl chr 3:51,335,841...51,438,256
G
Sirt1
sirtuin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22878646
NCBI chr20:25,305,953...25,328,000
Ensembl chr20:25,306,917...25,329,260
G
Tbxas1
thromboxane A synthase 1
IDA
RGD
PMID:14650360
RGD:1601455
NCBI chr 4:68,631,841...68,803,959
Ensembl chr 4:67,665,007...67,837,096
G
Tnf
tumor necrosis factor
IEP
protein:increased expression:brain (rat)
RGD
PMID:19895873
RGD:2325193
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,622,011...3,624,629
G
Tpcn2
two pore segment channel 2
IEP
mRNA:increased expression:brain (rat)
RGD
PMID:23251410
RGD:329845556
NCBI chr 1:209,845,827...209,875,561
Ensembl chr 1:200,416,540...200,446,236
G
Abcb1b
ATP-binding cassette, sub-family B member 1B
IEP
RGD
PMID:15049514
RGD:1598554
NCBI chr 4:26,197,706...26,280,156
Ensembl chr 4:25,242,798...25,325,199
G
Ace
angiotensin I converting enzyme
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15534175
NCBI chr10:91,410,129...91,430,246
Ensembl chr10:90,910,316...90,931,131
G
Adamts1
ADAM metallopeptidase with thrombospondin type 1 motif, 1
IEP
mRNA:increased expression:brain
RGD
PMID:17073862
RGD:9681750
NCBI chr11:38,418,565...38,427,384
Ensembl chr11:24,931,761...24,941,103
G
Add3
adducin 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17901229
NCBI chr 1:262,152,722...262,260,504
Ensembl chr 1:252,147,386...252,255,124
G
Adk
adenosine kinase
ISO
RGD
PMID:21427729 PMID:17457365
RGD:6482652 , RGD:6482655
NCBI chr15:2,912,543...3,295,745
Ensembl chr15:2,863,244...3,246,510
G
Ager
advanced glycosylation end product-specific receptor
IEP
mRNA:increased expression:pyramidal cell, hippocampus
RGD
PMID:12618340
RGD:1625348
NCBI chr20:4,152,758...4,155,956
Ensembl chr20:4,147,890...4,151,078
G
Aif1
allograft inflammatory factor 1
IEP
protein:increased expression:cerebral cortex (rat)
RGD
PMID:18301954
RGD:2313032
NCBI chr20:3,651,435...3,657,341
Ensembl chr20:3,646,777...3,652,668
G
Akap1
A-kinase anchoring protein 1
IEP
protein:altered expression:parietal cortex, hippocampus (rat)
RGD
PMID:18323779
RGD:2313128
NCBI chr10:74,118,232...74,151,366
Ensembl chr10:73,621,883...73,653,896
G
Akap12
A-kinase anchoring protein 12
IEP
RGD
PMID:21334414
RGD:14348963
NCBI chr 1:43,135,515...43,225,245
Ensembl chr 1:40,730,123...40,819,886
G
Akt1
AKT serine/threonine kinase 1
IEP
protein:decreased serine phosphorylation:cerebral cortex
RGD
PMID:21596097
RGD:5509066
NCBI chr 6:137,534,810...137,555,131
Ensembl chr 6:131,713,720...131,733,921
G
Alb
albumin
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:16809570
NCBI chr14:17,891,564...17,907,043
Ensembl chr14:17,607,381...17,622,836
G
Alox15
arachidonate 15-lipoxygenase
IEP
mRNA, protein:increased expression:brain
RGD
PMID:20167207
RGD:5509598
NCBI chr10:55,559,060...55,567,535
Ensembl chr10:55,060,412...55,068,874
G
Alox5
arachidonate 5-lipoxygenase
IMP
RGD
PMID:20204486
RGD:2317525
NCBI chr 4:151,203,948...151,251,126
Ensembl chr 4:149,531,515...149,578,743
G
Angpt1
angiopoietin 1
ISO
RGD
PMID:17637706
RGD:1643339
NCBI chr 7:75,415,959...75,668,696
Ensembl chr 7:73,531,486...73,784,067
G
Angpt2
angiopoietin 2
IDA
RGD
PMID:17494864
RGD:2314206
NCBI chr16:77,790,760...77,841,241
Ensembl chr16:71,088,364...71,138,804
G
Anxa1
annexin A1
treatment
ISO IMP
RGD
PMID:1830327 PMID:1830327
RGD:7421662 , RGD:7421662
NCBI chr 1:227,287,713...227,306,739
Ensembl chr 1:217,861,175...217,877,343
G
Apaf1
apoptotic peptidase activating factor 1
IEP
protein:increased expression:striatum
RGD
PMID:17640469
RGD:2325742
NCBI chr 7:27,381,392...27,466,772
Ensembl chr 7:25,494,609...25,579,540
G
Apex1
apurinic/apyrimidinic endodeoxyribonuclease 1
IEP
protein:decreased expression:hippocampus CA1, neuron
RGD
PMID:9030714
RGD:2315686
NCBI chr15:26,618,146...26,620,330
Ensembl chr15:24,144,362...24,146,785
G
Aqp3
aquaporin 3 (Gill blood group)
IEP
RGD
PMID:19616516
RGD:5490152
NCBI chr 5:61,035,165...61,040,683
Ensembl chr 5:56,239,201...56,244,720
G
Aqp4
aquaporin 4
IEP
RGD
PMID:19616516
RGD:5490152
NCBI chr18:6,782,389...6,799,034
Ensembl chr18:6,507,903...6,524,856
G
Aqp5
aquaporin 5
IEP
RGD
PMID:19616516
RGD:5490152
NCBI chr 7:132,601,528...132,605,060
Ensembl chr 7:130,721,748...130,726,209
G
Aqp8
aquaporin 8
IEP
RGD
PMID:19616516
RGD:5490152
NCBI chr 1:177,993,313...177,999,158
Ensembl chr 1:177,993,305...177,999,158
G
Asic1
acid sensing ion channel subunit 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21307247
NCBI chr 7:132,677,158...132,707,379
Ensembl chr 7:130,799,917...130,828,541
G
Bad
BCL2-associated agonist of cell death
IEP
protein:decreased serine phosphorylation:brain
RGD
PMID:18078455 PMID:22843461
RGD:2292681 , RGD:10053716
NCBI chr 1:213,562,719...213,572,034
Ensembl chr 1:204,131,501...204,142,823
G
Bbc3
Bcl-2 binding component 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19095966
NCBI chr 1:86,141,450...86,150,666
Ensembl chr 1:77,014,543...77,022,509
G
Bcl2
BCL2, apoptosis regulator
treatment
IDA
RGD
PMID:15585409
RGD:11522731
NCBI chr13:23,204,464...23,366,900
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
Bcl2l1
Bcl2-like 1
IEP
protein:increased expression:cerebral cortex
RGD
PMID:17706879 PMID:22843461
RGD:1643491 , RGD:10053716
NCBI chr 3:161,713,777...161,764,844
Ensembl chr 3:141,253,523...141,303,479 Ensembl chr 1:141,253,523...141,303,479
G
Bdnf
brain-derived neurotrophic factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19922383
NCBI chr 3:116,619,633...116,670,212
Ensembl chr 3:96,165,042...96,215,615
G
Becn1
beclin 1
IMP IEP
protein:increased expression:hippocampus, frontal cortex
RGD
PMID:19574998 PMID:17936001
RGD:6483094 , RGD:6483313
NCBI chr10:86,731,649...86,747,002
Ensembl chr10:86,231,388...86,246,742
G
Bmp6
bone morphogenetic protein 6
IEP
RGD
PMID:11245809
RGD:2289024
NCBI chr17:26,523,704...26,785,558
Ensembl chr17:26,318,569...26,470,365
G
Btg2
BTG anti-proliferation factor 2
IEP
mRNA:increased expression:forebrain (rat)
RGD
PMID:7684483
RGD:2289081
NCBI chr13:48,083,931...48,087,690
Ensembl chr13:45,531,925...45,535,628
G
C3
complement C3
IEP
protein:increased expression:brain
RGD
PMID:14561876
RGD:5129543
NCBI chr 9:2,174,412...2,201,339
Ensembl chr 9:2,087,437...2,114,429
G
Casp12
caspase 12
IEP
mRNA, protein:increased expresssion:brain
RGD
PMID:12598725
RGD:1299333
NCBI chr 8:10,927,188...10,954,442
Ensembl chr 8:2,642,434...2,674,037
G
Casp3
caspase 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11756504 PMID:17901229
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:45,662,910...45,684,648
G
Casp6
caspase 6
IEP
mRNA:increased expression:cerebral cortex
RGD
PMID:11311984
RGD:2301331
NCBI chr 2:221,140,287...221,152,727
Ensembl chr 2:218,466,076...218,478,502
G
Casp9
caspase 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11756504
Ensembl chr 5:154,109,046...154,126,626
G
Cast
calpastatin
IDA
RGD
PMID:16467455
RGD:5509813
NCBI chr 2:5,707,633...5,817,213
Ensembl chr 2:3,973,112...4,082,659
G
Cat
catalase
IDA ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:17564305 PMID:21213399
RGD:5130891
NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:89,842,399...89,874,478
G
Cav1
caveolin 1
IEP
RGD
PMID:16417587
RGD:1581152
NCBI chr 4:46,606,538...46,639,616
Ensembl chr 4:45,634,918...45,673,705
G
Ccl11
C-C motif chemokine ligand 11
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15829914
NCBI chr10:67,525,975...67,530,576
Ensembl chr10:67,028,328...67,032,926
G
Ccl12
C-C motif chemokine ligand 12
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15829914
NCBI chr10:67,567,876...67,569,426
Ensembl chr10:67,070,230...67,071,780
G
Ccl2
C-C motif chemokine ligand 2
IEP ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:15829914 PMID:17394460 PMID:19260320
RGD:2306998
NCBI chr10:67,503,077...67,504,875
Ensembl chr10:67,005,424...67,007,226
G
Ccl20
C-C motif chemokine ligand 20
IEP
mRNA:increased expression:cerebral cortex
RGD
PMID:9916893
RGD:69987
NCBI chr 9:91,837,139...91,839,736
Ensembl chr 9:84,388,904...84,391,629
G
Ccl3
C-C motif chemokine ligand 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15829914 PMID:17394460
NCBI chr10:68,948,889...68,950,439
Ensembl chr10:68,451,388...68,452,938
G
Ccl4
C-C motif chemokine ligand 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15829914
NCBI chr10:68,963,893...68,965,728
Ensembl chr10:68,452,052...68,468,231
G
Ccr4
C-C motif chemokine receptor 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15829914
NCBI chr 8:123,054,505...123,060,244
Ensembl chr 8:114,176,974...114,178,056
G
Ccr5
C-C motif chemokine receptor 5
IEP
mRNA:increased expression:brain (rat)
RGD
PMID:9670989
RGD:632396
NCBI chr 8:132,629,097...132,660,980
Ensembl chr 8:123,752,325...123,759,260
G
Cd36
CD36 molecule
ISO
RGD
PMID:20360550
RGD:6893498
NCBI chr 4:18,209,088...18,302,142
Ensembl chr 4:17,354,466...17,513,903
G
Cdk5
cyclin-dependent kinase 5
IMP
RGD
PMID:14502288
RGD:734740
NCBI chr 4:11,647,098...11,651,606
Ensembl chr 4:10,754,687...10,760,112
G
Cebpb
CCAAT/enhancer binding protein beta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17394460
NCBI chr 3:176,817,005...176,818,436
Ensembl chr 3:156,397,052...156,399,473
G
Chrm1
cholinergic receptor, muscarinic 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18501976
NCBI chr 1:214,996,180...215,012,136
Ensembl chr 1:205,567,220...205,582,356
G
Cited2
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2
IEP
RGD
PMID:16434029
RGD:1581188
NCBI chr 1:14,132,303...14,134,746
Ensembl chr 1:12,312,160...12,314,897
G
Clu
clusterin
IEP
RGD
PMID:12782389
RGD:727237
NCBI chr15:44,336,619...44,375,861
Ensembl chr15:40,174,617...40,200,315
G
Cp
ceruloplasmin
IEP
mRNA, protein:decreased expression:cerebral cortex, hippocampus
RGD
PMID:18273071
RGD:2314688
NCBI chr 2:104,368,336...104,427,119
Ensembl chr 2:102,439,624...102,498,075
G
Creb1
cAMP responsive element binding protein 1
treatment
IEP
mRNA,protein:decreased expression,decreased phosphorylation:brain:
RGD
PMID:23644141
RGD:10059580
NCBI chr 9:73,397,333...73,466,339
Ensembl chr 9:65,903,547...65,970,816
G
Crh
corticotropin releasing hormone
IEP
mRNA:increased expression:cerebral cortex (rat)
RGD
PMID:8541482
RGD:1581300
NCBI chr 2:104,059,184...104,061,048
Ensembl chr 2:102,143,055...102,144,919
G
Csf2rb
colony stimulating factor 2 receptor subunit beta
IEP
mRNA:increased expression:brain
RGD
PMID:7643220
RGD:632531
NCBI chr 7:111,756,950...111,782,089
Ensembl chr 7:109,886,425...109,904,157
G
Csf3
colony stimulating factor 3
ISO
associated with Diabetes Mellitus, Experimental
RGD
PMID:18832793
RGD:2311241
NCBI chr10:84,157,485...84,159,860
Ensembl chr10:83,661,207...83,663,603
G
Cspg4
chondroitin sulfate proteoglycan 4
IEP
RGD
PMID:21864831
RGD:5686850
NCBI chr 8:66,160,942...66,195,987
Ensembl chr 8:57,264,962...57,300,010
G
Cst3
cystatin C
ISO
protein:decreased expression:cerebrospinal fluid
RGD
PMID:18261165
RGD:2314349
NCBI chr 3:156,790,061...156,794,116
Ensembl chr 3:136,336,920...136,340,822
G
Ctsb
cathepsin B
IEP
protein:increased activity:cerebrum (rat)
RGD
PMID:18404379
RGD:2315571
NCBI chr15:41,565,607...41,586,479
Ensembl chr15:37,389,629...37,410,500
G
Ctsc
cathepsin C
IEP
mRNA:increased expression:cerebral cortex
RGD
PMID:12843783
RGD:1599640
NCBI chr 1:151,440,860...151,472,430
Ensembl chr 1:142,028,392...142,060,387
G
Ctsl
cathepsin L
IEP
protein:increased activity:cerebrum (rat)
RGD
PMID:18404379
RGD:2315571
NCBI chr17:770,104...776,266
Ensembl chr17:764,309...770,548
G
Cxcl10
C-X-C motif chemokine ligand 10
IEP ISO
mRNA:increased expression:brain CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:15829914 PMID:17549754
RGD:2311381
NCBI chr14:15,989,066...15,991,263
Ensembl chr14:15,704,758...15,706,975
G
Cxcl12
C-X-C motif chemokine ligand 12
IEP
mRNA, protein:increased expression:brain
RGD
PMID:18206136
RGD:2306577
NCBI chr 4:152,060,781...152,073,628
Ensembl chr 4:150,388,325...150,401,168
G
Cycs
cytochrome c, somatic
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11756504
NCBI chr 4:80,982,667...80,984,767
Ensembl chr 4:79,651,378...79,654,054 Ensembl chr18:79,651,378...79,654,054
G
Dbh
dopamine beta-hydroxylase
IEP
protein:decreased expression:forebrain (rat)
RGD
PMID:18356740
RGD:5129691
NCBI chr 3:30,886,313...30,903,313
Ensembl chr 3:10,488,260...10,505,248
G
Ddit3
DNA-damage inducible transcript 3
IEP
Protein:increased expression:brain
RGD
PMID:15921666
RGD:1599731
NCBI chr 7:65,001,695...65,006,517
Ensembl chr 7:63,116,380...63,121,201
G
Diablo
diablo, IAP-binding mitochondrial protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11756504
NCBI chr12:38,716,668...38,731,285
Ensembl chr12:33,055,263...33,070,387
G
Dpysl2
dihydropyrimidinase-like 2
IEP
mRNA:increased expression:brain
RGD
PMID:19524114
RGD:2316241
NCBI chr15:45,181,041...45,287,065
Ensembl chr15:41,005,551...41,111,829
G
Drd2
dopamine receptor D2
IEP
RGD
PMID:11474153
RGD:1580883
NCBI chr 8:58,605,403...58,669,339
Ensembl chr 8:49,708,927...49,772,875
G
Dusp6
dual specificity phosphatase 6
IEP
mRNA:increased expression:brain
RGD
PMID:10908038
RGD:2316092
NCBI chr 7:35,979,502...35,983,834
Ensembl chr 7:34,092,943...34,097,185
G
Dynll1
dynein light chain LC8-type 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:9522364
NCBI chr12:46,945,291...46,976,867
Ensembl chr12:41,312,367...41,314,741
G
Edn1
endothelin 1
IEP
protein:increased expression:cerebral cortex (rat)
RGD
PMID:8113329
RGD:4144887
NCBI chr17:22,660,799...22,666,687
Ensembl chr17:22,454,420...22,460,885
G
Egr1
early growth response 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17394460
NCBI chr18:26,737,078...26,740,877
Ensembl chr18:26,462,981...26,466,766
G
Endog
endonuclease G
IEP
RGD
PMID:18568342
RGD:9685367
NCBI chr 3:33,846,935...33,849,531
Ensembl chr 3:13,449,086...13,451,932
G
Epor
erythropoietin receptor
IEP
protein:increased expression:brain:
RGD
PMID:14732457
RGD:11041652
NCBI chr 8:28,765,738...28,770,371
Ensembl chr 8:20,489,678...20,494,257
G
Esr2
estrogen receptor 2
IEP
mRNA:decreased expression:cerebral cortex, ipsilateral side (rat)
RGD
PMID:10414967
RGD:8694344
NCBI chr 6:100,589,553...100,645,240
Ensembl chr 6:94,809,547...94,908,919
G
F2
coagulation factor II, thrombin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:14753426 PMID:15534175
NCBI chr 3:98,051,958...98,065,246
Ensembl chr 3:77,596,198...77,609,486
G
F2r
coagulation factor II (thrombin) receptor
IEP
RGD
PMID:14705148
RGD:1302269
NCBI chr 2:28,604,066...28,620,579
Ensembl chr 2:26,868,404...26,885,870
G
F5
coagulation factor V
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15534175
NCBI chr13:79,046,657...79,116,247
Ensembl chr13:76,513,255...76,582,317
G
Fas
Fas cell surface death receptor
IEP
protein:increased expression:brain
RGD
PMID:16796407
RGD:1600333
NCBI chr 1:241,212,155...241,245,774
Ensembl chr 1:231,798,960...231,832,591
G
Faslg
Fas ligand
IEP
protein:increased expression:brain
RGD
PMID:18410517
RGD:2311437
NCBI chr13:76,680,885...76,706,042
Ensembl chr13:74,154,954...74,162,215
G
Fga
fibrinogen alpha chain
treatment
IDA
RGD
PMID:22737923
RGD:11040923
NCBI chr 2:170,672,169...170,679,572
Ensembl chr 2:168,374,120...168,381,528
G
Fgf1
fibroblast growth factor 1
IDA ISO
Rat model using human FGF1
RGD
PMID:19497570 PMID:16635575
RGD:5509879 , RGD:5509881
NCBI chr18:30,937,670...31,023,786
Ensembl chr18:30,686,581...30,772,357
G
Gal
galanin and GMAP prepropeptide
IEP
RGD
PMID:16458372
RGD:1624341
NCBI chr 1:210,079,709...210,084,572
Ensembl chr 1:200,650,439...200,654,959
G
Gc
GC, vitamin D binding protein
IEP
protein:increased expression:urine
RGD
PMID:11239198
RGD:1625796
NCBI chr14:18,916,255...18,951,670
Ensembl chr14:18,632,135...18,667,567
G
Gfra1
GDNF family receptor alpha 1
IEP
protein:increased expression:cerebral cortex
RGD
PMID:10407114
RGD:6218981
NCBI chr 1:267,325,297...267,557,037
Ensembl chr 1:257,321,742...257,551,473
G
Gja1
gap junction protein, alpha 1
IEP
protein:increased expression:cerebral cortex
RGD
PMID:21718970
RGD:6480433
NCBI chr20:36,302,490...36,315,010
Ensembl chr20:35,755,991...35,768,582
G
Glud1
glutamate dehydrogenase 1
IEP
protein:decreased activity:brain
RGD
PMID:7808037
RGD:6484655
NCBI chr16:9,646,569...9,680,215
Ensembl chr16:9,640,312...9,673,957
G
Gp1ba
glycoprotein Ib platelet subunit alpha
exacerbates
ISO
associated with Pneumococcal Infections
RGD
PMID:24644058
RGD:42722626
NCBI chr10:55,831,901...55,856,729
Ensembl chr10:55,352,899...55,356,774
G
Gpx1
glutathione peroxidase 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:12531513
NCBI chr 8:117,905,462...117,906,588
Ensembl chr 8:109,026,905...109,028,024
G
Gpx3
glutathione peroxidase 3
ISO
protein:increased expression:plasma
RGD
PMID:30025402
RGD:401827828
NCBI chr10:39,529,335...39,537,406
Ensembl chr10:39,028,570...39,037,035
G
Hif1a
hypoxia inducible factor 1 subunit alpha
treatment
ISO IDA IEP
protein:increased expression:brain CTD Direct Evidence: marker/mechanism mRNA, protein:increased expression:cerebral cortex (rat)
CTD RGD
PMID:19429140 PMID:17554006 PMID:18369388 PMID:17101276
RGD:1626331 , RGD:9068895 , RGD:9068892
NCBI chr 6:98,357,788...98,405,068
Ensembl chr 6:92,624,390...92,669,261
G
Hmox1
heme oxygenase 1
IEP IMP
RGD
PMID:16464361 PMID:21276833
RGD:1582709 , RGD:10755576
NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,467,244...13,474,079
G
Hspa1b
heat shock protein family A (Hsp70) member 1B
ISO
associated with advanced age and Diabetes Mellitus, Type 2 (MeSH:D003924)
RGD
PMID:15992611
RGD:1626649
NCBI chr20:3,859,756...3,863,800
Ensembl chr20:3,856,006...3,873,240 Ensembl chr20:3,856,006...3,873,240
G
Hspa8
heat shock protein family A (Hsp70) member 8
IEP
RGD
PMID:16805800
RGD:6480229
NCBI chr 8:50,080,514...50,084,376
Ensembl chr 8:41,183,264...41,187,259
G
Hspa9
heat shock protein family A (Hsp70) member 9
IEP
mRNA:increased expression:brain
RGD
PMID:7629893
RGD:6784525
NCBI chr18:26,810,004...26,832,958
Ensembl chr18:26,535,798...26,554,292
G
Icam1
intercellular adhesion molecule 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17394460 PMID:19417757
NCBI chr 8:27,829,688...27,841,618
Ensembl chr 8:19,553,645...19,565,438
G
Igf1
insulin-like growth factor 1
IDA ISO
RGD
PMID:16882007 PMID:19332057
RGD:1598411 , RGD:2306694
NCBI chr 7:24,169,608...24,249,446
Ensembl chr 7:22,282,930...22,359,296
G
Il10rb
interleukin 10 receptor subunit beta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15829914
NCBI chr11:44,132,471...44,154,062
Ensembl chr11:30,652,096...30,668,074
G
Il12rb1
interleukin 12 receptor subunit beta 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15829914
NCBI chr16:18,654,207...18,668,887
Ensembl chr16:18,620,770...18,632,769
G
Il17a
interleukin 17A
IEP ISO
protein, mRNA:increased expression:brain CTD Direct Evidence: marker/mechanism protein:increased expression:brain
CTD RGD
PMID:15829914 PMID:16305645 PMID:16305645
RGD:4846398 , RGD:4846398
NCBI chr 9:30,640,844...30,644,331
Ensembl chr 9:23,144,402...23,147,889
G
Il17ra
interleukin 17 receptor A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15829914
NCBI chr 4:155,339,742...155,362,382
Ensembl chr 4:153,667,534...153,690,174
G
Il18
interleukin 18
IEP ISO
mRNA:increased expression:brain CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:15829914 PMID:11807395
RGD:4889510
NCBI chr 8:59,802,072...59,829,275
Ensembl chr 8:50,906,960...50,932,887
G
Il1a
interleukin 1 alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15829914
NCBI chr 3:136,979,804...136,990,236
Ensembl chr 3:116,526,604...116,536,822
G
Il1b
interleukin 1 beta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:9236716 PMID:15737438 PMID:15756928 PMID:17394460
NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:116,577,010...116,583,415
G
Il1rn
interleukin 1 receptor antagonist
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:9236716
NCBI chr 3:27,509,836...27,525,738
Ensembl chr 3:7,111,550...7,127,445
G
Il6
interleukin 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15829914 PMID:17394460
NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,213,394...5,219,178
G
Il6st
interleukin 6 cytokine family signal transducer
IEP
mRNA:increased expression:brain, astrocyte
RGD
PMID:15469886
RGD:1627568
NCBI chr 2:45,798,872...45,839,501
Ensembl chr 2:44,066,130...44,109,936
G
Irak1
interleukin-1 receptor-associated kinase 1
IEP
mRNA, protein:increased expression:cerebral cortex
RGD
PMID:21925238
RGD:7495802
NCBI chr X:156,919,927...156,929,825
Ensembl chr X:151,768,777...151,778,521
G
Irak4
interleukin-1 receptor-associated kinase 4
IEP
mRNA, protein:increased expression:cerebral cortex
RGD
PMID:21925238
RGD:7495802
NCBI chr 7:127,561,777...127,588,762
Ensembl chr 7:125,682,488...125,717,837
G
Itgam
integrin subunit alpha M
IEP
associated with Hypotension;protein:increased expression:pyramidal layer of CA1 (rat)
RGD
PMID:19019197
RGD:329853772
NCBI chr 1:192,089,496...192,139,947
Ensembl chr 1:182,659,000...182,709,503
G
Jun
Jun proto-oncogene, AP-1 transcription factor subunit
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17901229
NCBI chr 5:115,009,900...115,012,993
Ensembl chr 5:109,893,145...109,897,656
G
Kcnk10
potassium two pore domain channel subfamily K member 10
IEP
mRNA, protein:increased expression:cerebral cortex, hippocampus (rat)
RGD
PMID:15652517
RGD:9831167
NCBI chr 6:117,690,052...117,826,120
Ensembl chr 6:117,694,222...117,825,695
G
Kcnk2
potassium two pore domain channel subfamily K member 2
IEP
mRNA:increased expression:hippocampus (rat)
RGD
PMID:14741413
RGD:9831127
NCBI chr13:103,297,387...103,494,686
Ensembl chr13:100,766,113...100,963,435
G
Kdr
kinase insert domain receptor
IMP
RGD
PMID:18951929
RGD:5684407
NCBI chr14:32,572,031...32,615,204
Ensembl chr14:32,217,871...32,261,018
G
Lgals3
galectin 3
IEP
RGD
PMID:10931529
RGD:9685227
NCBI chr15:23,099,795...23,111,731
Ensembl chr15:20,607,692...20,632,025
G
Lif
LIF, interleukin 6 family cytokine
IEP
mRNA:increased expression:brain
RGD
PMID:20221422
RGD:2326053
NCBI chr14:83,354,602...83,364,053
Ensembl chr14:79,134,574...79,140,482
G
Lonp1
lon peptidase 1, mitochondrial
IDA
RGD
PMID:12082077
RGD:633879
NCBI chr 9:1,534,581...1,546,908
Ensembl chr 9:1,447,447...1,459,771
G
Map2
microtubule-associated protein 2
IEP
protein:increased expression:serum
RGD
PMID:21948028
RGD:6483082
NCBI chr 9:75,173,038...75,431,606
Ensembl chr 9:67,723,371...67,979,809
G
Map2k1
mitogen activated protein kinase kinase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:17901229 PMID:10536014
RGD:1582169
NCBI chr 8:73,578,747...73,650,184
Ensembl chr 8:64,683,449...64,755,147
G
Map3k7
mitogen activated protein kinase kinase kinase 7
treatment
ISO
RGD
PMID:21475303
RGD:155882442
NCBI chr 5:51,149,524...51,212,012
Ensembl chr 5:46,357,931...46,415,597
G
Mapk1
mitogen activated protein kinase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:17901229 PMID:15669185
RGD:1582281
NCBI chr11:97,462,025...97,529,193
Ensembl chr11:83,957,813...84,023,616
G
Mapk3
mitogen activated protein kinase 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17901229
NCBI chr 1:190,797,189...190,803,411
Ensembl chr 1:181,366,637...181,372,863
G
Mapk8
mitogen-activated protein kinase 8
IDA
RGD
PMID:15797868
RGD:1582325
NCBI chr16:8,645,171...8,728,225
Ensembl chr16:8,638,924...8,721,981
G
Mapt
microtubule-associated protein tau
IDA
protein:increased phosphorylation
RGD
PMID:15353210
RGD:1599927
NCBI chr10:89,638,618...89,736,108
Ensembl chr10:89,138,627...89,236,129
G
Mdh2
malate dehydrogenase 2
IDA
RGD
PMID:6282622
RGD:1582465
NCBI chr12:26,530,886...26,543,841
Ensembl chr12:20,894,262...20,907,271
G
Mdk
midkine
ISO
RGD
PMID:12127679
RGD:1582476
NCBI chr 3:98,356,789...98,358,960
Ensembl chr 3:77,901,158...77,903,130
G
Mir223
microRNA 223
treatment
IMP
RGD
PMID:31791013
RGD:26884340
NCBI chr X:65,151,383...65,151,492
Ensembl chr X:61,141,887...61,141,996
G
Mmp13
matrix metallopeptidase 13
IDA
RGD
PMID:16112096
RGD:1582554
NCBI chr 8:12,782,829...12,793,108
Ensembl chr 8:4,497,960...4,508,239
G
Mmp14
matrix metallopeptidase 14
IEP
RGD
PMID:15963646
RGD:1582577
NCBI chr15:31,857,824...31,867,049
Ensembl chr15:27,887,727...27,899,864
G
Mmp2
matrix metallopeptidase 2
IEP
RGD
PMID:15963646
RGD:1582577
NCBI chr19:30,327,643...30,355,856
Ensembl chr19:14,154,657...14,182,870
G
Mmp9
matrix metallopeptidase 9
IDA ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:15060315 PMID:16846501
RGD:1582611
NCBI chr 3:174,103,474...174,111,434
Ensembl chr 3:153,683,858...153,692,120
G
Mpo
myeloperoxidase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19417757
NCBI chr10:73,092,124...73,102,057
Ensembl chr10:72,594,661...72,604,819
G
Msi1
musashi RNA-binding protein 1
IEP
RGD
PMID:12205668
RGD:633285
NCBI chr12:46,815,225...46,911,852
Ensembl chr12:41,158,599...41,191,076
G
Mthfr
methylenetetrahydrofolate reductase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15534175
NCBI chr 5:163,748,346...163,768,141
Ensembl chr 5:158,465,296...158,483,797
G
Naip6
NLR family, apoptosis inhibitory protein 6
IEP
protein:increased expression:thalamus (rat)
RGD
PMID:9288726
RGD:2317254
NCBI chr 2:33,241,520...33,293,184
Ensembl chr 2:31,507,424...31,570,542
G
Nes
nestin
IEP
protein:increased expression:hippocampus
RGD
PMID:17697621
RGD:1642071
NCBI chr 2:175,735,715...175,745,631
Ensembl chr 2:173,438,734...173,447,777
G
Nfkb1
nuclear factor kappa B subunit 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:18628779
NCBI chr 2:226,689,745...226,805,897
Ensembl chr 2:224,016,214...224,110,404
G
Nfkbia
NFKB inhibitor alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18628779
NCBI chr 6:78,593,844...78,597,307
Ensembl chr 6:72,858,712...72,861,941
G
Nos1
nitric oxide synthase 1
IMP IEP
protein:decreased expression:hippocampus
RGD
PMID:17451676 PMID:21718970
RGD:1642142 , RGD:6480433
NCBI chr12:44,276,011...44,456,371
Ensembl chr12:38,626,714...38,710,945
G
Nos2
nitric oxide synthase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:9778187 PMID:17394460
NCBI chr10:64,313,335...64,349,221
Ensembl chr10:63,815,308...63,851,210
G
Nos3
nitric oxide synthase 3
IDA IMP
RGD
PMID:21212863 PMID:17600658
RGD:4891961 , RGD:2292134
NCBI chr 4:11,686,088...11,706,604
Ensembl chr 4:10,793,834...10,814,166
G
Nox4
NADPH oxidase 4
ISO
mRNA, protein:increased expression:cerebral cortex (human)
RGD
PMID:15802177
RGD:1580980
NCBI chr 1:150,313,736...150,491,480
Ensembl chr 1:140,901,097...141,077,406
G
Nppa
natriuretic peptide A
no_association
ISO
RGD
PMID:11706124
RGD:1626244
NCBI chr 5:163,712,184...163,713,493
Ensembl chr 5:158,429,042...158,430,351
G
Nptxr
neuronal pentraxin receptor
IEP
mRNA:decreased expression:neocortex
RGD
PMID:12242102
RGD:1642302
NCBI chr 7:113,217,046...113,235,122
Ensembl chr 7:111,336,664...111,354,802
G
Nr3c1
nuclear receptor subfamily 3, group C, member 1
IEP
protein:decreased expression:brain cortex
RGD
PMID:17344647
RGD:4892115
NCBI chr18:31,522,783...31,644,508
Ensembl chr18:31,271,681...31,393,375
G
Oaz1
ornithine decarboxylase antizyme 1
IEP
mRNA:altered expression:cerebral cortex (rat)
RGD
PMID:19531214
RGD:401851038
NCBI chr 7:9,534,530...9,536,990
Ensembl chr 7:8,883,851...8,886,310
G
Oprm1
opioid receptor, mu 1
IEP
RGD
PMID:16176345
RGD:2316630
NCBI chr 1:45,565,371...45,818,722
Ensembl chr 1:43,160,057...43,413,409
G
Pak1
p21 (RAC1) activated kinase 1
IEP
protein:increased expression:brain
RGD
PMID:17997827
RGD:2299171
NCBI chr 1:161,522,399...161,637,623
Ensembl chr 1:152,111,188...152,226,383
G
Parp1
poly (ADP-ribose) polymerase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17640816
NCBI chr13:94,839,484...94,871,295
Ensembl chr13:92,307,586...92,339,404
G
Pcna
proliferating cell nuclear antigen
IEP
protein:increased expression:brain
RGD
PMID:12099899
RGD:729592
NCBI chr 3:139,951,948...139,955,820
Ensembl chr 3:119,498,810...119,502,995
G
Pgf
placental growth factor
ISO
RGD
PMID:16901914
RGD:6483783
NCBI chr 6:110,547,165...110,557,747
Ensembl chr 6:104,816,104...104,826,685
G
Pla2g4a
phospholipase A2 group 4A
IEP
mRNA:increased expression:hippocampus
RGD
PMID:15306117
RGD:1642465
NCBI chr13:64,427,921...64,572,352
Ensembl chr13:61,877,813...62,022,266
G
Plat
plasminogen activator, tissue type
no_association
ISO
DNA:polymorphism:-7351C>T (human) CTD Direct Evidence: therapeutic
CTD RGD
PMID:7477192 PMID:9259745 PMID:9400355 PMID:9479658 PMID:9566367 PMID:9633741 PMID:10572812 PMID:11108748 PMID:11940547 PMID:12221155 PMID:12511774 PMID:14986460 PMID:15017018 PMID:15087567 PMID:16126134 PMID:16763187 PMID:16809570 PMID:17086147 PMID:17525387 PMID:17903870 PMID:20123226 PMID:20212195 PMID:20488584 PMID:20536612 PMID:21037505 PMID:23876515 PMID:16179568 More...
RGD:1580879
NCBI chr16:75,943,061...76,022,037
Ensembl chr16:69,240,585...69,268,223
G
Plau
plasminogen activator, urokinase
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:9731615 PMID:10472989 PMID:10512912 PMID:17927297
NCBI chr15:3,505,485...3,511,987
Ensembl chr15:3,456,232...3,462,775
G
Ppbp
pro-platelet basic protein
ISO
RGD
PMID:26307429
RGD:11553187
NCBI chr14:17,586,495...17,587,299
Ensembl chr14:17,302,326...17,303,130
G
Ppid
peptidylprolyl isomerase D
ISO
RGD
PMID:16103352
RGD:1580699
NCBI chr 2:167,025,985...167,037,998
Ensembl chr 2:164,727,779...164,740,221
G
Ppp1r15a
protein phosphatase 1, regulatory subunit 15A
IEP
protein:increased expression:cerebral cortex, caudate nucleus (rat)
RGD
PMID:15713259
RGD:9999408
NCBI chr 1:105,136,521...105,139,596
Ensembl chr 1:96,000,058...96,003,171
G
Prkaca
protein kinase cAMP-activated catalytic subunit alpha
IEP
protein:decreased expression:hippocampus, cerebral cortex, nucleus
RGD
PMID:12150772
RGD:7327190
NCBI chr19:41,059,843...41,083,189
Ensembl chr19:24,155,090...24,178,430
G
Prkacb
protein kinase cAMP-activated catalytic subunit beta
IEP
protein:decreased expression:hippocampus, cerebral cortex, cytosol, nucleus
RGD
PMID:12150772
RGD:7327190
NCBI chr 2:238,297,140...238,389,317
Ensembl chr 2:235,636,885...235,726,198
G
Prkca
protein kinase C, alpha
IEP
associated with Subarachnoid Hemorrhage;protein:increased phosphorylation:cerebral artery
RGD
PMID:18032736
RGD:2293301
NCBI chr10:93,388,991...93,787,617
Ensembl chr10:92,894,012...93,288,012
G
Prkcd
protein kinase C, delta
IMP
RGD
PMID:17350602
RGD:1642524
NCBI chr16:5,775,681...5,806,122
Ensembl chr16:5,769,215...5,799,352
G
Proz
protein Z, vitamin K-dependent plasma glycoprotein
ISO
RGD
PMID:14671240
RGD:1358564
NCBI chr16:83,150,104...83,165,688
Ensembl chr16:76,450,013...76,463,480
G
Ptgis
prostaglandin I2 synthase
IDA
RGD
PMID:16094316
RGD:8693629
NCBI chr 3:176,347,589...176,383,251
Ensembl chr 3:155,916,412...155,965,451
G
Ptgs1
prostaglandin-endoperoxide synthase 1
ISO
protein:increased expression:microglia, macrophage
RGD
PMID:11740205 PMID:10867793
RGD:5688240 , RGD:5688247
NCBI chr 3:39,981,419...40,002,993
Ensembl chr 3:19,584,015...19,605,586
G
Ptgs2
prostaglandin-endoperoxide synthase 2
IEP ISO IDA
protein:increased expression:hippocampus CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:15737438 PMID:17394460 PMID:17564305 PMID:19417757 PMID:21718970 PMID:11158633 PMID:12535784 More...
RGD:6480433 , RGD:5688292 , RGD:1581286
NCBI chr13:64,714,063...64,722,320
Ensembl chr13:62,163,932...62,172,188
G
Ptk2b
protein tyrosine kinase 2 beta
IDA
protein:increased tyrosine phosphorylation:cerebral cortex
RGD
PMID:10964954
RGD:1642647
NCBI chr15:44,536,275...44,656,754
Ensembl chr15:40,360,723...40,481,282
G
Rb1
RB transcriptional corepressor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17901229
NCBI chr15:54,780,858...54,911,989
Ensembl chr15:48,371,296...48,502,302
G
Rela
RELA proto-oncogene, NF-kB subunit
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:18628779
NCBI chr 1:212,354,336...212,364,815
Ensembl chr 1:202,924,945...202,935,484
G
Ret
ret proto-oncogene
IEP
protein:increased expression:cerebral cortex
RGD
PMID:10407114
RGD:6218981
NCBI chr 4:152,998,344...153,040,556
Ensembl chr 4:151,326,431...151,368,176
G
S100b
S100 calcium binding protein B
IEP
protein:increased expression:serum
RGD
PMID:21695352
RGD:5508764
NCBI chr20:12,372,345...12,381,159
Ensembl chr20:12,372,881...12,394,743
G
Scn5a
sodium voltage-gated channel alpha subunit 5
IEP
RGD
PMID:19471098
RGD:6484225
NCBI chr 8:128,098,613...128,196,515
Ensembl chr 8:119,220,905...119,318,769
G
Sele
selectin E
ISO
associated with Hypertension CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:17394460 PMID:19107136
RGD:2313600
NCBI chr13:78,935,997...78,945,905
Ensembl chr13:76,403,304...76,412,741
G
Serpine1
serpin family E member 1
treatment
IDA
RGD
PMID:27108052
RGD:11073613
NCBI chr12:25,237,977...25,248,356
Ensembl chr12:19,601,272...19,611,657
G
Slc11a2
solute carrier family 11 member 2
IEP
protein:increased expression:brain
RGD
PMID:21325818
RGD:5688411
NCBI chr 7:133,381,878...133,429,921
Ensembl chr 7:131,503,081...131,540,145
G
Slc29a1
solute carrier family 29 member 1
IMP
RGD
PMID:15829178
RGD:2316942
NCBI chr 9:22,897,099...22,911,640
Ensembl chr 9:15,399,612...15,414,203
G
Slc6a1
solute carrier family 6 member 1
IMP
RGD
PMID:15084665
RGD:1643209
NCBI chr 4:149,004,447...149,037,840
Ensembl chr 4:147,466,965...147,482,293
G
Slc8a1
solute carrier family 8 member A1
IEP IMP
protein:increased expression:brain mRNA:decreased expression:cerebral cortex (rat)
RGD
PMID:17662498 PMID:22036625 PMID:12377375
RGD:1642717 , RGD:6771236 , RGD:727449
NCBI chr 6:18,975,498...19,299,704
Ensembl chr 6:13,194,662...13,535,628
G
Slc8a2
solute carrier family 8 member A2
IEP
RGD
PMID:16107787
RGD:2316979
NCBI chr 1:85,944,752...85,982,900
Ensembl chr 1:76,808,725...76,847,072
G
Slc8a3
solute carrier family 8 member A3
IEP
RGD
PMID:16107787
RGD:2316979
NCBI chr 6:106,605,611...106,739,208
Ensembl chr 6:100,874,369...101,007,508
G
Sod1
superoxide dismutase 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:11756504
NCBI chr11:42,942,742...42,948,399
Ensembl chr11:29,456,558...29,462,249
G
Sod2
superoxide dismutase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:15060315 PMID:17901229 PMID:19429140 PMID:10212301
RGD:1625695
NCBI chr 1:50,043,323...50,050,168
Ensembl chr 1:47,636,528...47,645,189
G
Sod3
superoxide dismutase 3
ISO
RGD
PMID:10833313
RGD:1580852
NCBI chr14:62,822,865...62,828,602
Ensembl chr14:58,609,958...58,615,990
G
Sos1
SOS Ras/Rac guanine nucleotide exchange factor 1
IDA
RGD
PMID:26442853
RGD:155630597
NCBI chr 6:20,286,117...20,363,350
Ensembl chr 6:14,533,360...14,611,107
G
Src
SRC proto-oncogene, non-receptor tyrosine kinase
IDA
RGD
PMID:15854740
RGD:1581411
NCBI chr 3:166,511,616...166,559,463
Ensembl chr 3:146,091,841...146,139,476
G
Stat3
signal transducer and activator of transcription 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17901229
NCBI chr10:86,311,528...86,363,513
Ensembl chr10:85,811,218...85,863,057
G
Tek
TEK receptor tyrosine kinase
IEP
RGD
PMID:11919509
RGD:634324
NCBI chr 5:114,722,815...114,849,535
Ensembl chr 5:109,607,077...109,733,804
G
Tgfb1
transforming growth factor, beta 1
IEP
mRNA:increased expression:brain
RGD
PMID:14997937
RGD:2302105
NCBI chr 1:90,324,312...90,340,627
Ensembl chr 1:81,196,532...81,212,847
G
Th
tyrosine hydroxylase
IEP
protein:decreased expression:solitary tract nucleus, medulla oblongata, locus coeruleus (rat)
RGD
PMID:18356740
RGD:5129691
NCBI chr 1:207,500,959...207,508,276
Ensembl chr 1:198,071,503...198,109,767
G
Tjp1
tight junction protein 1
IEP
protein:decreased expression:brain
RGD
PMID:19712057
RGD:2325131
NCBI chr 1:128,260,330...128,505,018
Ensembl chr 1:118,849,838...119,094,432
G
Tlr4
toll-like receptor 4
no_association
ISO
DNA:polymorphisms: :p.N299G, p.T399I (human)
RGD
PMID:15258789
RGD:1580737
NCBI chr 5:85,161,247...85,174,882
Ensembl chr 5:80,145,826...80,159,628
G
Tnf
tumor necrosis factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15756928
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,622,011...3,624,629
G
Tnfrsf1a
TNF receptor superfamily member 1A
IDA ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:15829914 PMID:16442237
RGD:1624184
NCBI chr 4:159,837,119...159,849,817
Ensembl chr 4:158,150,820...158,163,591
G
Tnfrsf1b
TNF receptor superfamily member 1B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15829914
NCBI chr 5:162,356,250...162,387,411
Ensembl chr 5:157,070,642...157,104,206
G
Tp53
tumor protein p53
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19095966
NCBI chr10:54,798,871...54,810,300
Ensembl chr10:54,300,048...54,311,524
G
Ttr
transthyretin
IEP
RGD
PMID:15469881
RGD:1580523
NCBI chr18:12,216,684...12,225,972
Ensembl chr18:11,943,789...11,951,008
G
Ucp2
uncoupling protein 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17052689
NCBI chr 1:164,251,373...164,257,742
Ensembl chr 1:154,839,209...154,845,611
G
Vip
vasoactive intestinal peptide
IDA
RGD
PMID:18158987
RGD:5685617
NCBI chr 1:44,470,232...44,478,561
Ensembl chr 1:42,065,120...42,073,216
G
Ywhab
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, beta
IEP
protein:increased expression:cerebrospinal fluid
RGD
PMID:15902199
RGD:2306031
NCBI chr 3:173,078,904...173,101,508
Ensembl chr 3:152,659,651...152,682,105
G
F3
coagulation factor III, tissue factor
IEP
RGD
PMID:9916935
RGD:11341701
NCBI chr 2:212,511,675...212,523,375
Ensembl chr 2:209,826,959...209,838,668
G
Hnrnpk
heterogeneous nuclear ribonucleoprotein K
ISO
RGD
PMID:21489814
RGD:155260371
NCBI chr17:6,269,302...6,280,429
Ensembl chr17:6,262,998...6,274,997
G
Pdgfd
platelet derived growth factor D
ISO
RGD
PMID:19213942
RGD:9854642
NCBI chr 8:11,773,335...12,007,277
Ensembl chr 8:3,488,423...3,722,395
G
Epo
erythropoietin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19337937
NCBI chr12:24,841,285...24,844,725
Ensembl chr12:19,204,508...19,207,946
G
Plat
plasminogen activator, tissue type
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:1430592
NCBI chr16:75,943,061...76,022,037
Ensembl chr16:69,240,585...69,268,223
G
Sod2
superoxide dismutase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21062213
NCBI chr 1:50,043,323...50,050,168
Ensembl chr 1:47,636,528...47,645,189
G
Htra1
HtrA serine peptidase 1
ISO
ClinVar Annotator: match by term: CARASIL | ClinVar Annotator: match by term: CARASIL syndrome | ClinVar Annotator: match by term: Cerebrovascular disease with thin skin, alopecia, and disc disease | ClinVar Annotator: match by term: HTRA1-related cerebral small vessel disease
OMIM ClinVar
PMID:11889251 PMID:18316707 PMID:19387015 PMID:20437615 PMID:21115960 PMID:21482952 PMID:22900900 PMID:23963851 PMID:24500651 PMID:24535794 PMID:25506911 PMID:25741868 PMID:25770224 PMID:25772074 PMID:25957642 PMID:26063658 PMID:26467025 PMID:27164673 PMID:27353043 PMID:28492532 PMID:28782182 PMID:29561953 PMID:29895533 PMID:30859180 PMID:31316458 PMID:32042911 PMID:32101834 PMID:32581362 PMID:32719647 PMID:33268848 PMID:34220097 PMID:35307828 PMID:35606766 PMID:36047879 PMID:36253578 PMID:36261288 PMID:36380532 PMID:37348440 More...
NCBI chr 1:194,928,069...194,977,619
Ensembl chr 1:185,497,735...185,547,379
G
Mecp2
methyl CpG binding protein 2
ISO
ClinVar Annotator: match by term: CARASIL
ClinVar
PMID:9536098 PMID:15737703 PMID:17576681 PMID:20142466 PMID:24500651 PMID:24508304 PMID:25741868 PMID:26228846 PMID:26254891 PMID:28492532 PMID:28544139 PMID:30536762 PMID:34619114 PMID:34837432 More...
NCBI chr X:156,932,481...156,995,981
Ensembl chr X:151,789,930...151,844,689
G
Pura
purine rich element binding protein A
ISO
ClinVar Annotator: match by term: Cerebrovascular disease with thin skin, alopecia, and disc disease
ClinVar
PMID:24500651 PMID:27148565
NCBI chr18:28,159,103...28,179,539
Ensembl chr18:27,884,556...27,905,513
G
A2m
alpha-2-macroglobulin
disease_progression
ISO
RGD
PMID:28266892
RGD:13702087
NCBI chr 4:156,570,163...156,619,870
Ensembl chr 4:154,897,877...154,947,786
G
Ace
angiotensin I converting enzyme
ISO
DNA:deletion:intron:IVS16+1464-1751del (human) ClinVar Annotator: match by term: Ischemic stroke, susceptibility to
ClinVar RGD
PMID:1313972 PMID:1319114 PMID:1328889 PMID:1386652 PMID:1976655 PMID:2847529 PMID:2849100 PMID:7593601 PMID:7729604 PMID:7783416 PMID:7854377 PMID:7909524 PMID:8131299 PMID:8131300 PMID:8136829 PMID:8170965 PMID:8208911 PMID:8298638 PMID:8314010 PMID:8541160 PMID:8644984 PMID:8675669 PMID:9120002 PMID:9236417 PMID:9259580 PMID:9699903 PMID:9737775 PMID:9916793 PMID:10099885 PMID:10636736 PMID:10643899 PMID:10841123 PMID:11687636 PMID:11956052 PMID:12220450 PMID:12666117 PMID:14657821 PMID:14872014 PMID:15110771 PMID:15277638 PMID:15381116 PMID:15531537 PMID:15534175 PMID:15635071 PMID:19221299 PMID:11596779 More...
RGD:11038922
NCBI chr10:91,410,129...91,430,246
Ensembl chr10:90,910,316...90,931,131
G
Adora1
adenosine A1 receptor
IDA
RGD
PMID:17067559
RGD:1625229
NCBI chr13:48,210,922...48,247,826
Ensembl chr13:45,658,872...45,695,801
G
Ager
advanced glycosylation end product-specific receptor
ISO
protein:increased expression:plasma
RGD
PMID:23288172
RGD:8696004
NCBI chr20:4,152,758...4,155,956
Ensembl chr20:4,147,890...4,151,078
G
Agxt2
alanine-glyoxylate aminotransferase 2
onset
ISO
DNA:missense mutation:cds:V498L (rs16899974) (human)
RGD
PMID:26984639
RGD:329961314
NCBI chr 2:61,063,416...61,104,828
Ensembl chr 2:59,336,283...59,377,926
G
Ahsp
alpha hemoglobin stabilizing protein
ISO
mRNA:increased expression:venous blood (human)
RGD
PMID:29284304
RGD:329961296
NCBI chr 1:182,879,901...182,885,508
Ensembl chr 1:182,880,076...182,885,506
G
Alox5ap
arachidonate 5-lipoxygenase activating protein
susceptibility
ISO
OMIM
NCBI chr12:10,785,254...10,809,295
Ensembl chr12:5,748,944...5,772,986
G
Ang
angiogenin
severity
ISO
protein:increased expression:serum
RGD
PMID:17823536
RGD:6892714
NCBI chr15:26,786,233...26,796,883
G
Anxa1
annexin A1
treatment
IEP
associated with Ischemic Attack, Transient
RGD
PMID:22617647
RGD:7483559
NCBI chr 1:227,287,713...227,306,739
Ensembl chr 1:217,861,175...217,877,343
G
Apoa5
apolipoprotein A5
ISO
associated with Diabetes Mellitus, Non-Insulin-Dependent;DNA:polymorphism: :-1131T>C (human)
RGD
PMID:19107359
RGD:2313314
NCBI chr 8:55,446,329...55,460,509
Ensembl chr 8:46,561,229...46,563,816
G
Apob
apolipoprotein B
ISO
protein:increased expression:serum
RGD
PMID:2352345
RGD:2313973
NCBI chr 6:36,563,704...36,603,300
Ensembl chr 6:30,844,368...30,892,497
G
Apoe
apolipoprotein E
susceptibility
ISO
DNA:polymorphism: :3932T>C (human)
RGD
PMID:17016617
RGD:1601237
NCBI chr 1:88,481,889...88,485,816
Ensembl chr 1:79,353,916...79,357,932
G
Bhmt
betaine-homocysteine S-methyltransferase
susceptibility
ISO
DNA:SNPs,haplotypes:multiple
RGD
PMID:20458436
RGD:401794454
NCBI chr 2:26,594,852...26,614,429
Ensembl chr 2:24,859,873...24,879,742
G
Brinp3
BMP/retinoic acid inducible neural specific 3
ISO
associated with diabetes mellitus;mRNA:protein:increased expression:blood mononuclear cell:
RGD
PMID:26717922
RGD:14398486
NCBI chr13:60,964,127...61,397,044
Ensembl chr13:58,413,883...58,846,770
G
Cartpt
CART prepropeptide
ameliorates
IDA
RGD
PMID:16971488
RGD:407986645
NCBI chr 2:32,989,215...32,991,794
Ensembl chr 2:31,255,098...31,290,713
G
Cbs
cystathionine beta synthase
susceptibility
ISO
DNA:SNPs,haplotypes:multiple
RGD
PMID:20458436
RGD:401794454
NCBI chr20:9,709,394...9,733,925
Ensembl chr20:9,708,090...9,732,764
G
Ccl2
C-C motif chemokine ligand 2
treatment
ISO
RGD
PMID:29111308
RGD:155260331
NCBI chr10:67,503,077...67,504,875
Ensembl chr10:67,005,424...67,007,226
G
Ccl3
C-C motif chemokine ligand 3
treatment
ISO
RGD
PMID:29111308
RGD:155260331
NCBI chr10:68,948,889...68,950,439
Ensembl chr10:68,451,388...68,452,938
G
Ccr5
C-C motif chemokine receptor 5
ISO
RGD
PMID:23602964
RGD:8552262
NCBI chr 8:132,629,097...132,660,980
Ensembl chr 8:123,752,325...123,759,260
G
Cd36
CD36 molecule
ISO
associated with Hyperlipidemias
RGD
PMID:22718544
RGD:6893487
NCBI chr 4:18,209,088...18,302,142
Ensembl chr 4:17,354,466...17,513,903
G
Ephx2
epoxide hydrolase 2
IDA
RGD
PMID:16306811
RGD:1580986
NCBI chr15:44,465,447...44,503,157
Ensembl chr15:40,289,902...40,327,615
G
F2
coagulation factor II, thrombin
ISO
ClinVar Annotator: match by term: Ischemic stroke | ClinVar Annotator: match by term: Ischemic stroke, susceptibility to
ClinVar OMIM
PMID:2222810 PMID:2429850 PMID:2825773 PMID:6305407 PMID:8696333 PMID:8896550 PMID:8916933 PMID:9106528 PMID:9292507 PMID:9462220 PMID:9493607 PMID:9531249 PMID:9569177 PMID:9694698 PMID:9869612 PMID:10027711 PMID:10233438 PMID:10233439 PMID:10336270 PMID:10348710 PMID:10348711 PMID:10348712 PMID:10406905 PMID:10477778 PMID:10544935 PMID:11358905 PMID:11443298 PMID:11506076 PMID:11796466 PMID:11874997 PMID:11904676 PMID:14629473 PMID:15059842 PMID:15534175 PMID:16493002 PMID:16606808 PMID:19159930 PMID:19289024 PMID:19531787 PMID:19554541 PMID:19560233 PMID:19652888 PMID:20301327 PMID:21243428 PMID:21349849 PMID:23429074 PMID:24033266 PMID:25741868 PMID:27031503 PMID:28492532 PMID:28707429 PMID:30297698 PMID:31064749 PMID:34110897 PMID:34355501 PMID:38498041 More...
NCBI chr 3:98,051,958...98,065,246
Ensembl chr 3:77,596,198...77,609,486
G
F5
coagulation factor V
ISO
ClinVar Annotator: match by term: Ischemic stroke | ClinVar Annotator: match by term: Ischemic stroke, susceptibility to
ClinVar OMIM
PMID:7586244 PMID:7803250 PMID:7877648 PMID:7910348 PMID:7911872 PMID:7968118 PMID:8049422 PMID:8164730 PMID:8164741 PMID:8566967 PMID:8616100 PMID:8822583 PMID:9245936 PMID:9339109 PMID:9372726 PMID:9415695 PMID:9454741 PMID:9459326 PMID:9518910 PMID:9734642 PMID:10328130 PMID:10348711 PMID:10477778 PMID:10494770 PMID:10507841 PMID:10666427 PMID:11018168 PMID:11110695 PMID:11686338 PMID:12069454 PMID:12070000 PMID:12421138 PMID:12816860 PMID:14996674 PMID:15208046 PMID:15534175 PMID:15638861 PMID:15946211 PMID:16199547 PMID:16493002 PMID:16769590 PMID:16931580 PMID:19652888 PMID:20051284 PMID:21116184 PMID:21774968 PMID:22704462 PMID:22992668 PMID:23382263 PMID:23677252 PMID:23900608 PMID:24033266 PMID:25741868 PMID:25977387 PMID:26251307 PMID:26990548 PMID:27797270 PMID:28492532 PMID:28750087 PMID:30924984 PMID:31064749 PMID:31399523 PMID:34355501 More...
NCBI chr13:79,046,657...79,116,247
Ensembl chr13:76,513,255...76,582,317
G
F7
coagulation factor VII
treatment
ISO
protein:increased expression, increased activity:plasma (human) human protein in a mouse model
RGD
PMID:14733777 PMID:21998055
RGD:11049518 , RGD:11049520
NCBI chr16:83,191,896...83,202,775
Ensembl chr16:76,489,717...76,500,610
G
Fbn1
fibrillin 1
ISO
ClinVar Annotator: match by term: Ischemic stroke
ClinVar
PMID:7611299 PMID:8894692 PMID:9401003 PMID:9536098 PMID:10533071 PMID:10874320 PMID:11700157 PMID:12402346 PMID:12938084 PMID:14695540 PMID:16220557 PMID:16222657 PMID:16835936 PMID:17253931 PMID:17576681 PMID:17657824 PMID:17663468 PMID:19159394 PMID:19293843 PMID:21542060 PMID:24033266 PMID:24161884 PMID:25741868 PMID:26133393 PMID:28492532 PMID:29357934 PMID:31098894 PMID:37684520 More...
NCBI chr 3:133,007,693...133,204,277
Ensembl chr 3:112,554,925...112,750,889
G
Folh1
folate hydrolase 1
susceptibility
ISO
DNA:SNPs,haplotypes:multiple
RGD
PMID:20458436
RGD:401794454
NCBI chr 1:149,828,286...149,914,313
Ensembl chr 1:140,428,101...140,501,379
G
Gch1
GTP cyclohydrolase 1
exacerbates treatment
ISO IMP
DNA:SNP:3' UTR:+243C>T (human) DNA:SNP, haplotype:rs841 (human)
RGD
PMID:21181356 PMID:16282548 PMID:21963893
RGD:329961322 , RGD:329961574 , RGD:329961572
NCBI chr15:22,884,006...22,917,412
Ensembl chr15:20,402,527...20,437,698
G
Gp6
glycoprotein VI
ameliorates
ISO
RGD
PMID:34237320
RGD:401794450
NCBI chr 1:78,471,900...78,535,374
Ensembl chr 1:69,465,789...69,491,326
G
Gpx3
glutathione peroxidase 3
susceptibility
ISO
DNA, protein:SNP,decreased expression:promoter,plasma:-861A>T (human) DNA:SNPs, haplotypes:promoter:rs8177412, rs870407, rs870406 (human) DNA:SNPs, haplotype:promoter:-942 A>C, -927 T>C, -861 A>T, -302 A>T, -284 T>A, -568 T>C, -518 T>C, -65 T>C (human)
RGD
PMID:25126700 PMID:20946167 PMID:17122425
RGD:401827128 , RGD:401827165 , RGD:401827163
NCBI chr10:39,529,335...39,537,406
Ensembl chr10:39,028,570...39,037,035
G
Grin1
glutamate ionotropic receptor NMDA type subunit 1
severity
ISO
RGD
PMID:23723305
RGD:13792693
NCBI chr 3:28,501,836...28,528,754
Ensembl chr 3:8,103,680...8,130,603
G
Grn
granulin precursor
ISO
ClinVar Annotator: match by term: Ischemic stroke
ClinVar
PMID:18723524 PMID:25741868 PMID:28492532
NCBI chr10:87,887,834...87,893,938
Ensembl chr10:87,387,638...87,393,775
G
Gsn
gelsolin
severity
ISO
protein:decreased expression:blood plasma (human)
RGD
PMID:21481565
RGD:329337334
NCBI chr 3:38,982,605...39,035,849
Ensembl chr 3:18,585,172...18,638,402
G
H19
H19 imprinted maternally expressed transcript
disease_progression susceptibility ameliorates
ISO
RNA:increased expression:blood plasma, plasma exosome (human) DNA:SNP::(rs217727) (human) DNA:SNPs,haplotypes: (rs217727,rs4929984) (human) associated with atherosclerosis
RGD
PMID:36453417 PMID:33541284 PMID:28203482 PMID:30778327 PMID:36453417
RGD:155882574 , RGD:156430336 , RGD:155900760 , RGD:155900761 , RGD:155882574
NCBI chr 1:207,160,175...207,162,851
Ensembl chr 1:197,730,698...197,733,134
G
Hba-a2
hemoglobin alpha, adult chain 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:1634355
NCBI chr10:15,828,291...15,829,138
Ensembl chr10:15,307,815...15,338,392 Ensembl chr10:15,307,815...15,338,392
G
Hif1a
hypoxia inducible factor 1 subunit alpha
severity
ISO
protein:increased expression:blood serum (human)
RGD
PMID:34708885
RGD:155260326
NCBI chr 6:98,357,788...98,405,068
Ensembl chr 6:92,624,390...92,669,261
G
Hmgb1
high mobility group box 1
ISO
protein:increased expression:plasma
RGD
PMID:23288172
RGD:8696004
NCBI chr12:11,009,236...11,015,941
Ensembl chr12:5,901,586...5,978,565 Ensembl chr16:5,901,586...5,978,565
G
Hmox1
heme oxygenase 1
ISO
RGD
PMID:23311871
RGD:10755574
NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,467,244...13,474,079
G
Hnf1a
HNF1 homeobox A
susceptibility
ISO
DNA:SNPs,haplotypes:multiple
RGD
PMID:28035729
RGD:329901837
NCBI chr12:47,299,171...47,333,457
Ensembl chr12:41,645,587...41,672,104
G
Icam1
intercellular adhesion molecule 1
IEP
mRNA, protein:increased expression:cerebral cortex
RGD
PMID:20083630
RGD:8547724
NCBI chr 8:27,829,688...27,841,618
Ensembl chr 8:19,553,645...19,565,438
G
Ifnb1
interferon beta 1
susceptibility no_association
ISO IDA
DNA:SNP,haplotype: rs9333358(human)
RGD
PMID:31810024 PMID:16514094
RGD:401851921 , RGD:401854228
NCBI chr 5:108,066,650...108,067,487
Ensembl chr 5:103,020,969...103,021,523
G
Il10
interleukin 10
treatment
ISO
RGD
PMID:29111308
RGD:155260331
NCBI chr13:45,024,921...45,029,586
Ensembl chr13:42,472,839...42,477,313
G
Il18
interleukin 18
treatment
IEP
RGD
PMID:20584315
RGD:8655991
NCBI chr 8:59,802,072...59,829,275
Ensembl chr 8:50,906,960...50,932,887
G
Il1b
interleukin 1 beta
treatment
ISO
RGD
PMID:29111308
RGD:155260331
NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:116,577,010...116,583,415
G
Il6
interleukin 6
treatment
ISO
RGD
PMID:29111308
RGD:155260331
NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,213,394...5,219,178
G
Irf8
interferon regulatory factor 8
exacerbates
ISO
RGD
PMID:24528256
RGD:329902074
NCBI chr19:65,699,284...65,721,066
Ensembl chr19:48,790,588...48,811,829
G
Itga9
integrin subunit alpha 9
susceptibility
ISO
DNA:SNPs,haplotype:rs189897,rs2212020(human)
RGD
PMID:21764681
RGD:13602007
NCBI chr 8:127,185,244...127,493,296
Ensembl chr 8:118,307,381...118,613,754
G
Itgam
integrin subunit alpha M
ISO
protein:increased expression:neutrophil (human)
RGD
PMID:31355307
RGD:329901831
NCBI chr 1:192,089,496...192,139,947
Ensembl chr 1:182,659,000...182,709,503
G
Kalrn
kalirin, RhoGEF kinase
susceptibility sexual_dimorphism
ISO
DNA:SNP:intron: (rs6438833) (human) DNA:SNPs, haplotypes:intron,cds: (rs7620580, rs1708303) (human)
RGD
PMID:25917671 PMID:28706949
RGD:11085239 , RGD:329956420
NCBI chr11:79,703,345...80,309,210
Ensembl chr11:66,198,173...66,797,610
G
Kcnn4
potassium calcium-activated channel subfamily N member 4
ameliorates
ISO
RGD
PMID:29037241
RGD:329969881
NCBI chr 1:89,084,306...89,102,279
Ensembl chr 1:79,959,322...79,974,340
G
Lipg
lipase G, endothelial type
susceptibility
ISO
DNA:polymorphism: :584C>T (human)
RGD
PMID:17016617
RGD:1601237
NCBI chr18:70,790,077...70,811,259
Ensembl chr18:68,514,923...68,536,260
G
Lta
lymphotoxin alpha
ISO
RGD
PMID:14593215
RGD:1580416
NCBI chr20:3,622,291...3,625,852
Ensembl chr20:3,618,853...3,620,859
G
Map2
microtubule-associated protein 2
IDA
RGD
PMID:22444278
RGD:6483079
NCBI chr 9:75,173,038...75,431,606
Ensembl chr 9:67,723,371...67,979,809
G
Map3k5
mitogen-activated protein kinase kinase kinase 5
treatment
IMP
RGD
PMID:23968852
RGD:10412642
NCBI chr 1:16,505,387...16,723,899
Ensembl chr 1:14,685,492...14,904,800
G
Mir145
microRNA 145
ameliorates
ISO
miRNA:increased expression:blood (human)
RGD
PMID:22370881 PMID:26722607
RGD:155260291 , RGD:155260295
NCBI chr18:57,369,983...57,370,070
Ensembl chr18:55,099,640...55,099,727
G
Mir21
microRNA 21
IEP
RNA:increased expression:brain
RGD
PMID:20840605
RGD:41410884
NCBI chr10:71,902,600...71,902,691
Ensembl chr10:71,405,257...71,405,348
G
Mir210
microRNA 210
severity treatment
ISO
miRNA:decreased expression:blood (human) miRNA:decreased expression:blood serum (human)
RGD
PMID:21622133 PMID:29111308 PMID:34708885
RGD:155260318 , RGD:155260331 , RGD:155260326
NCBI chr 1:205,755,923...205,756,032
Ensembl chr 1:196,326,337...196,326,454
G
Mir223
microRNA 223
treatment
IEP
RGD
PMID:28469772
RGD:35668865
NCBI chr X:65,151,383...65,151,492
Ensembl chr X:61,141,887...61,141,996
G
Mir30a
microRNA 30a
treatment
IEP
RGD
PMID:28469772
RGD:35668865
NCBI chr 9:33,233,941...33,234,011
Ensembl chr 9:25,737,600...25,737,670
G
Mir383
microRNA 383
treatment
IEP
RGD
PMID:28469772
RGD:35668865
NCBI chr16:60,743,764...60,743,837
Ensembl chr16:54,040,340...54,040,413
G
Mir494
microRNA 494
disease_progression
ISO
RGD
PMID:32239566
RGD:155883173
NCBI chr 6:134,550,115...134,550,197
Ensembl chr 6:128,728,709...128,728,793
G
Mmp2
matrix metallopeptidase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16846501
NCBI chr19:30,327,643...30,355,856
Ensembl chr19:14,154,657...14,182,870
G
Mmp9
matrix metallopeptidase 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16846501
NCBI chr 3:174,103,474...174,111,434
Ensembl chr 3:153,683,858...153,692,120
G
Mt-co2
mitochondrially encoded cytochrome c oxidase II
ISO
ClinVar Annotator: match by term: Ischemic stroke
ClinVar
NCBI chr MT:7,006...7,689
Ensembl chr MT:7,006...7,689
G
Mt-cyb
mitochondrially encoded cytochrome b
ISO
ClinVar Annotator: match by term: Ischemic stroke
ClinVar
NCBI chr MT:14,136...15,278
Ensembl chr MT:14,136...15,278
G
Mthfr
methylenetetrahydrofolate reductase
ISO
DNA:transition:cds:g.677C>T (human)
RGD
PMID:10929044
RGD:1580590
NCBI chr 5:163,748,346...163,768,141
Ensembl chr 5:158,465,296...158,483,797
G
Mtr
5-methyltetrahydrofolate-homocysteine methyltransferase
susceptibility
ISO
DNA:SNPs,haplotypes:multiple
RGD
PMID:20458436
RGD:401794454
NCBI chr17:62,911,705...62,996,544
Ensembl chr17:58,220,071...58,304,822
G
Myrf
myelin regulatory factor
ISO
DNA:SNP:exon:rs174535(human)
RGD
PMID:36193932
RGD:213230151
NCBI chr 1:216,279,057...216,311,155
Ensembl chr 1:206,854,175...206,886,157
G
Ndufa13
NADH:ubiquinone oxidoreductase subunit A13
IEP
protein:increased expression:brain, neuron, astrocyte:
RGD
PMID:17523870
RGD:401854233
NCBI chr16:19,560,526...19,567,500
Ensembl chr16:19,526,565...19,535,726 Ensembl chr 7:19,526,565...19,535,726
G
Nos3
nitric oxide synthase 3
ISO
ClinVar Annotator: match by term: Ischemic stroke
ClinVar
PMID:9737779 PMID:9894802 PMID:10475066 PMID:10510054 PMID:10514107 PMID:11026457 PMID:11354626 PMID:11394896 PMID:11745998 PMID:15007011 PMID:16059745 PMID:16813604 PMID:17165044 PMID:24033266 PMID:25741868 PMID:28492532 More...
NCBI chr 4:11,686,088...11,706,604
Ensembl chr 4:10,793,834...10,814,166
G
Notch3
notch receptor 3
ISO
ClinVar Annotator: match by term: Ischemic stroke
ClinVar
PMID:9388399 PMID:10371548 PMID:10802804 PMID:10854111 PMID:11102981 PMID:11755616 PMID:15364702 PMID:16009764 PMID:16193256 PMID:17729386 PMID:20301673 PMID:25623805 PMID:25741868 PMID:26308724 PMID:26467025 PMID:26843489 PMID:26912635 PMID:27206574 PMID:27890607 PMID:28492532 PMID:28710804 PMID:31915071 PMID:32277177 PMID:32457593 PMID:32581362 PMID:34335700 PMID:34691145 More...
NCBI chr 7:11,783,550...11,834,585
Ensembl chr 7:11,133,706...11,184,025
G
Npy
neuropeptide Y
IEP ISO
protein:increased expression:cerebral cortex CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:11821007 PMID:17123484
RGD:10448931
NCBI chr 4:80,212,111...80,219,310
Ensembl chr 4:78,881,264...78,888,495
G
Nr1h3
nuclear receptor subfamily 1, group H, member 3
susceptibility
ISO
DNA:SNPs, haplotype:promoter:c.-115G>A, c.-840C>A (rs12221497, rs61896015) (human)
RGD
PMID:21903943
RGD:401842365
NCBI chr 3:97,614,616...97,632,053
Ensembl chr 3:77,158,808...77,168,722
G
Ntrk2
neurotrophic receptor tyrosine kinase 2
ISO
DNA:SNPs:peripheral blood, leukocyte, 3' utr
RGD
PMID:33209049
RGD:408418730
NCBI chr17:5,560,558...5,875,899
Ensembl chr17:5,559,043...5,869,136
G
Park7
Parkinsonism associated deglycase
treatment
ISO
RGD
PMID:18003894 PMID:18003894
RGD:13462069 , RGD:13462069
NCBI chr 5:166,636,551...166,659,825
Ensembl chr 5:161,353,719...161,376,970
G
Pdx1
pancreatic and duodenal homeobox 1
ISO
associated with Metabolic Syndrome; DNA:duplication:5' utr:-108 3G>4G (human)
RGD
PMID:18506375
RGD:2311309
NCBI chr12:12,793,957...12,799,156
Ensembl chr12:7,757,865...7,763,064
G
Phactr1
phosphatase and actin regulator 1
ISO
DNA:SNP:intron: (rs12526453) (human)
RGD
PMID:23042660
RGD:401900685
NCBI chr17:21,769,006...22,246,227
Ensembl chr17:21,562,721...22,039,831
G
Pla2g7
phospholipase A2 group VII
ISO
RGD
PMID:18201705
RGD:6482775
NCBI chr 9:24,859,491...24,901,747
Ensembl chr 9:17,362,225...17,404,476
G
Plat
plasminogen activator, tissue type
ISO
CTD Direct Evidence: marker/mechanism|therapeutic
CTD
PMID:1579960 PMID:1899364 PMID:9183334 PMID:16148626 PMID:18195371 PMID:18544249 More...
NCBI chr16:75,943,061...76,022,037
Ensembl chr16:69,240,585...69,268,223
G
Plau
plasminogen activator, urokinase
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:12133459 PMID:16773802
NCBI chr15:3,505,485...3,511,987
Ensembl chr15:3,456,232...3,462,775
G
Plaur
plasminogen activator, urokinase receptor
ISO
RGD
PMID:20138161
RGD:6483804
NCBI chr 1:89,181,363...89,196,308
Ensembl chr 1:80,050,324...80,068,595
G
Pon1
paraoxonase 1
susceptibility
ISO
DNA:missense mutation:cds:p.Q192R (human)
RGD
PMID:10729395
RGD:1580196
NCBI chr 4:34,261,312...34,292,327
Ensembl chr 4:33,294,722...33,321,360
G
Pon2
paraoxonase 2
susceptibility
ISO
DNA:SNPs,haplotypes: (rs11545941, rs6954345) (human)
RGD
PMID:20458436
RGD:401794454
NCBI chr 4:34,356,270...34,391,684
Ensembl chr 4:33,389,714...33,425,248
G
Prkch
protein kinase C, eta
susceptibility
ISO
ClinVar Annotator: match by term: Cerebral infarction, susceptibility to | ClinVar Annotator: match by term: Ischemic stroke
ClinVar OMIM
PMID:12958323 PMID:17206144 PMID:25741868
NCBI chr 6:98,027,830...98,226,486
Ensembl chr 6:92,292,000...92,490,654
G
Proc
protein C, inactivator of coagulation factors Va and VIIIa
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:33761690
NCBI chr18:24,038,596...24,049,061
Ensembl chr18:23,764,368...23,775,133
G
Pros1
protein S
ISO
DNA:missense mutation:exon:p.R355C (1063C>T) (human)
RGD
PMID:21172841
RGD:11250416
NCBI chr11:13,676,310...13,757,858
Ensembl chr11:230,696...311,286
G
Ptgis
prostaglandin I2 synthase
exacerbates treatment
ISO IMP
DNA:SNP, haplotype:3' utr: (rs5602) (human) DNA:SNPs:exon, 3' utr: (rs5629, rs5602) (human) DNA:repeat:promoter:g.-6(CCGCCAGCC)3-7 (human)
RGD
PMID:28478978 PMID:28108096 PMID:11130769 PMID:11997284
RGD:401901149 , RGD:401959400 , RGD:401901269 , RGD:401901194
NCBI chr 3:176,347,589...176,383,251
Ensembl chr 3:155,916,412...155,965,451
G
Rbp4
retinol binding protein 4
exacerbates severity
ISO
protein:increased expression:blood plasma (human) protein:increased expression:blood serum (human) associated with diabetes mellitus; protein:increased expression:blood serum (human)
RGD
PMID:19846170 PMID:30030781 PMID:30038059
RGD:329845582 , RGD:329853305 , RGD:329845588
NCBI chr 1:245,306,349...245,313,551
Ensembl chr 1:235,893,917...235,901,399
G
RT1-CE16
RT1 class I, locus CE16
susceptibility
ISO
DNA:polymorphism::HLA-A31:01 (human)
RGD
PMID:24767290
RGD:401827096
NCBI chr20:3,261,656...3,265,548
Ensembl chr20:3,257,123...3,279,563
G
RT1-Db1
RT1 class II, locus Db1
susceptibility
ISO
DNA:polymorphism,haplotype::HLA-B37:01 (human)
RGD
PMID:24767290
RGD:401827096
NCBI chr20:4,550,594...4,560,182
Ensembl chr20:4,548,666...4,558,258
G
Serpine1
serpin family E member 1
treatment
IDA
RGD
PMID:25702149
RGD:11075081
NCBI chr12:25,237,977...25,248,356
Ensembl chr12:19,601,272...19,611,657
G
Serping1
serpin family G member 1
treatment
ISO
associated with Venous Thrombosis
RGD
PMID:10446335
RGD:8661653
NCBI chr 3:90,249,410...90,259,299
Ensembl chr 3:69,842,739...69,852,034
G
Slc6a1
solute carrier family 6 member 1
IEP
mRNA:increased expression:cerebral cortex, neuron
RGD
PMID:15349978
RGD:1643205
NCBI chr 4:149,004,447...149,037,840
Ensembl chr 4:147,466,965...147,482,293
G
Sos1
SOS Ras/Rac guanine nucleotide exchange factor 1
ISO
mRNA:increased expression:blood (human)
RGD
PMID:35041140
RGD:155598600
NCBI chr 6:20,286,117...20,363,350
Ensembl chr 6:14,533,360...14,611,107
G
Tbxas1
thromboxane A synthase 1
susceptibility
ISO
DNA:polymorphisms: :
RGD
PMID:19403042
RGD:11059536
NCBI chr 4:68,631,841...68,803,959
Ensembl chr 4:67,665,007...67,837,096
G
Thbd
thrombomodulin
susceptibility
ISO
DNA:missense mutation:cds:p.A455V (human)
RGD
PMID:15574195
RGD:5685021
NCBI chr 3:156,316,526...156,320,178
Ensembl chr 3:135,862,835...135,867,193
G
Tnf
tumor necrosis factor
treatment
ISO
RGD
PMID:16173529 PMID:29111308
RGD:1580315 , RGD:155260331
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,622,011...3,624,629
G
Tnfrsf11b
TNF receptor superfamily member 11B
disease_progression
ISO
RGD
PMID:19895657
RGD:7205492
NCBI chr 7:87,456,318...87,484,324
Ensembl chr 7:85,566,520...85,594,538
G
Tomm40
translocase of outer mitochondrial membrane 40
ISO
DNA:SNP: :rs2075650 (human)
RGD
PMID:26171154
RGD:13464126
NCBI chr 1:88,486,745...88,498,833
Ensembl chr 1:79,358,786...79,370,915
G
Tyms
thymidylate synthetase
susceptibility
ISO
DNA:SNPs,haplotypes: (rs502396,rs16430,rs8423)
RGD
PMID:20458436
RGD:401794454
NCBI chr 9:120,760,057...120,776,149
Ensembl chr 9:113,313,452...113,329,536
G
Vim
vimentin
IEP
RGD
PMID:18802758
RGD:6480442
NCBI chr17:81,577,261...81,585,746
Ensembl chr17:76,668,647...76,677,187
G
Ager
advanced glycosylation end product-specific receptor
treatment
IEP
RGD
PMID:22217518 PMID:23769041
RGD:7245568 , RGD:8695995
NCBI chr20:4,152,758...4,155,956
Ensembl chr20:4,147,890...4,151,078
G
C3
complement C3
treatment
IDA
RGD
PMID:25122638
RGD:11040803
NCBI chr 9:2,174,412...2,201,339
Ensembl chr 9:2,087,437...2,114,429
G
Cd40
CD40 molecule
treatment
IDA
RGD
PMID:22826618
RGD:11352297
NCBI chr 3:174,209,113...174,224,592
Ensembl chr 3:153,790,449...153,805,534
G
Cd40lg
CD40 ligand
treatment
IDA
liver
RGD
PMID:22826618
RGD:11352297
NCBI chr X:140,164,341...140,176,057
Ensembl chr X:135,126,969...135,138,306
G
F7
coagulation factor VII
treatment
ISO
human protein in a rat model
RGD
PMID:12095034
RGD:11049508
NCBI chr16:83,191,896...83,202,775
Ensembl chr16:76,489,717...76,500,610
G
Hmgb1
high mobility group box 1
treatment
IEP
RGD
PMID:22217518
RGD:7245568
NCBI chr12:11,009,236...11,015,941
Ensembl chr12:5,901,586...5,978,565 Ensembl chr16:5,901,586...5,978,565
G
Kcnn4
potassium calcium-activated channel subfamily N member 4
ameliorates
IMP
RGD
PMID:24312257
RGD:401700379
NCBI chr 1:89,084,306...89,102,279
Ensembl chr 1:79,959,322...79,974,340
G
Mtor
mechanistic target of rapamycin kinase
treatment
IDA
RGD
PMID:23985719
RGD:10041002
NCBI chr 5:164,167,985...164,277,438
Ensembl chr 5:158,884,804...158,994,311
G
Tnf
tumor necrosis factor
treatment
IMP
RGD
PMID:24598936
RGD:10450586
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,622,011...3,624,629
G
Aco1
aconitase 1
IEP
RGD
PMID:20176611
RGD:11541086
NCBI chr 5:60,055,895...60,111,920
Ensembl chr 5:55,259,827...55,316,391
G
Alb
albumin
disease_progression
ISO
RGD
PMID:24370342
RGD:11035281
NCBI chr14:17,891,564...17,907,043
Ensembl chr14:17,607,381...17,622,836
G
Ccl3
C-C motif chemokine ligand 3
ISO
RGD
PMID:17298994
RGD:7241819
NCBI chr10:68,948,889...68,950,439
Ensembl chr10:68,451,388...68,452,938
G
Ccn2
cellular communication network factor 2
disease_progression
IEP
mRNA, protein:increased expression:kidney (rat)
RGD
PMID:19921985
RGD:150517553
NCBI chr 1:22,621,498...22,624,614
Ensembl chr 1:20,802,199...20,805,734
G
Clu
clusterin
treatment
IEP
RGD
PMID:22494435
RGD:9068431
NCBI chr15:44,336,619...44,375,861
Ensembl chr15:40,174,617...40,200,315
G
Cs
citrate synthase
treatment
IDA
RGD
PMID:20005400
RGD:243048470
NCBI chr 7:1,348,389...1,374,624
Ensembl chr 7:758,345...791,421
G
Mmp3
matrix metallopeptidase 3
ISO
RGD
PMID:22845765
RGD:7241226
NCBI chr 8:12,925,267...12,938,828
Ensembl chr 8:4,640,416...4,653,961
G
Mmp7
matrix metallopeptidase 7
treatment
IDA
RGD
PMID:18209025
RGD:9685339
NCBI chr 8:13,133,043...13,140,761
Ensembl chr 8:4,848,186...4,855,902
G
Pdgfa
platelet derived growth factor subunit A
IEP
RGD
PMID:11889420
RGD:11080974
NCBI chr12:20,759,366...20,780,337
Ensembl chr12:15,645,541...15,666,497
G
Pdgfb
platelet derived growth factor subunit B
IEP
mRNA:increased expression:kidney:
RGD
PMID:15785371 PMID:11889420
RGD:10449491 , RGD:11080974
NCBI chr 7:113,419,882...113,438,343
Ensembl chr 7:111,540,345...111,557,984
G
Pdgfra
platelet derived growth factor receptor alpha
IEP
RGD
PMID:11889420
RGD:11080974
NCBI chr14:33,360,027...33,408,604
Ensembl chr14:33,005,839...33,054,335
G
Pdgfrb
platelet derived growth factor receptor beta
IEP
RGD
PMID:11889420
RGD:11080974
NCBI chr18:56,770,348...56,809,228
Ensembl chr18:54,499,964...54,538,843
G
Plau
plasminogen activator, urokinase
ISO
protein:increased secretion:T lymphocyte (human)
RGD
PMID:16387096
RGD:7241259
NCBI chr15:3,505,485...3,511,987
Ensembl chr15:3,456,232...3,462,775
G
Pparg
peroxisome proliferator-activated receptor gamma
ISO
protein:increased expression:kidney:
RGD
PMID:16221712
RGD:13208600
NCBI chr 4:150,095,743...150,221,104
Ensembl chr 4:148,423,194...148,548,468
G
Serpine1
serpin family E member 1
treatment
ISO
protein:increased expression:kidney:
RGD
PMID:16221712 PMID:18192922
RGD:13208600 , RGD:13208601
NCBI chr12:25,237,977...25,248,356
Ensembl chr12:19,601,272...19,611,657
G
Aco1
aconitase 1
IEP
protein:decreased expression:hippocampus
RGD
PMID:22639386
RGD:11541085
NCBI chr 5:60,055,895...60,111,920
Ensembl chr 5:55,259,827...55,316,391
G
Apoe
apolipoprotein E
IEP
protein:increased expression:cerebral cortex, synapse
RGD
PMID:28620701
RGD:13703133
NCBI chr 1:88,481,889...88,485,816
Ensembl chr 1:79,353,916...79,357,932
G
App
amyloid beta precursor protein
IEP
protein:increased expression:cerebral white matter:
RGD
PMID:11743996
RGD:10054250
NCBI chr11:37,506,207...37,724,351
Ensembl chr11:24,019,778...24,236,561
G
Bace1
beta-secretase 1
IEP
protein:increased expression:hippocampus
RGD
PMID:28683457
RGD:13782142
NCBI chr 8:55,038,842...55,061,138
Ensembl chr 8:46,142,116...46,165,876
G
Bnip3l
BCL2 interacting protein 3 like
IEP
mRNA:increased expression:hippocampus
RGD
PMID:24072673
RGD:10402542
NCBI chr15:45,350,081...45,373,213
Ensembl chr15:41,174,594...41,197,803
G
Dag1
dystroglycan 1
IEP
RGD
PMID:21192954
RGD:11541061
NCBI chr 8:117,769,517...117,834,347
Ensembl chr 8:108,890,929...108,952,325
G
Fth1
ferritin heavy chain 1
IEP
protein:increased expression:hippocampus
RGD
PMID:22639386
RGD:11541085
NCBI chr 1:216,052,037...216,054,325
Ensembl chr 1:206,627,103...206,725,424
G
Gstp1
glutathione S-transferase pi 1
treatment
IDA
RGD
PMID:16645134
RGD:10401930
NCBI chr 1:210,767,237...210,770,242
Ensembl chr 1:201,321,672...201,340,226
G
Hcn1
hyperpolarization-activated cyclic nucleotide-gated potassium channel 1
IEP
RGD
PMID:24838625
RGD:9686415
NCBI chr 2:51,228,710...51,632,806
Ensembl chr 2:49,495,771...49,899,774
G
Hcn2
hyperpolarization activated cyclic nucleotide gated potassium and sodium channel 2
IEP
RGD
PMID:24838625
RGD:9686415
NCBI chr 7:10,620,422...10,639,457
Ensembl chr 7:9,970,368...9,988,841
G
Hif1a
hypoxia inducible factor 1 subunit alpha
IEP
protein:increased expression:hippocampus
RGD
PMID:24072673
RGD:10402542
NCBI chr 6:98,357,788...98,405,068
Ensembl chr 6:92,624,390...92,669,261
G
Map3k5
mitogen-activated protein kinase kinase kinase 5
ISO
protein:hyperphosphorylation:brain:
RGD
PMID:24371084
RGD:10412307
NCBI chr 1:16,505,387...16,723,899
Ensembl chr 1:14,685,492...14,904,800
G
Mapk14
mitogen activated protein kinase 14
ISO
protein:hyperphosphorylation:corpus callosum, endothelial cell, astrocyte:
RGD
PMID:24371084
RGD:10412307
NCBI chr20:6,751,288...6,812,294
Ensembl chr20:6,749,670...6,810,589
G
Mcm2
minichromosome maintenance complex component 2
IEP
protein:increased expression:dentate gyrus
RGD
PMID:17931356
RGD:10412049
NCBI chr 4:122,903,679...122,918,205
Ensembl chr 4:121,346,434...121,360,847
G
Nos3
nitric oxide synthase 3
IMP
RGD
PMID:15703700
RGD:13824977
NCBI chr 4:11,686,088...11,706,604
Ensembl chr 4:10,793,834...10,814,166
G
Nox1
NADPH oxidase 1
ameliorates
IMP
RGD
PMID:24294978
RGD:329955573
NCBI chr X:101,572,338...101,625,571
Ensembl chr X:97,279,056...97,302,236
G
Src
SRC proto-oncogene, non-receptor tyrosine kinase
treatment
IEP
RGD
PMID:32184165
RGD:597538600
NCBI chr 3:166,511,616...166,559,463
Ensembl chr 3:146,091,841...146,139,476
G
Tfrc
transferrin receptor
IEP
protein:increased expression:hippocampus
RGD
PMID:22639386
RGD:11541085
NCBI chr11:81,668,478...81,690,318
Ensembl chr11:68,163,413...68,185,257
G
Epas1
endothelial PAS domain protein 1
IEP
mRNA:increased expression:lung
RGD
PMID:22305384
RGD:10395369
NCBI chr 6:13,543,252...13,626,147
Ensembl chr 6:7,790,647...7,871,228
G
Hpx
hemopexin
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:14500188
NCBI chr 1:169,344,647...169,352,155
Ensembl chr 1:159,932,755...159,940,328
G
Adipoq
adiponectin, C1Q and collagen domain containing
ISO
associated with Mucocutaneous Lymph Node Syndrome;protein:increased expression:serum
RGD
PMID:22683371
RGD:8694456
NCBI chr11:91,226,524...91,240,244
Ensembl chr11:77,721,912...77,735,564
G
Gja1
gap junction protein, alpha 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15548583
NCBI chr20:36,302,490...36,315,010
Ensembl chr20:35,755,991...35,768,582
G
Itpkc
inositol-trisphosphate 3-kinase C
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18084290
NCBI chr 1:91,628,606...91,650,182
Ensembl chr 1:82,500,957...82,522,779
G
Mill1
MHC I like leukocyte 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:10899738
NCBI chr 1:87,500,591...87,526,983
Ensembl chr 1:78,372,802...78,398,930
G
Mmp12
matrix metallopeptidase 12
susceptibility
ISO
RGD
PMID:12103254
RGD:1582363
NCBI chr 8:12,866,652...12,876,554
Ensembl chr 8:4,581,785...4,599,611
G
Abca1
ATP binding cassette subfamily A member 1
ISO
RGD GAD
PMID:11086027 PMID:15118671
RGD:1600951 , RGD:1331525
NCBI chr 5:72,473,676...72,596,563
Ensembl chr 5:67,681,297...67,801,170
G
Abcc6
ATP binding cassette subfamily C member 6
ISO
DNA:nonsense mutation:exon:p.R1141X (3421C>T) (human)
RGD
PMID:12176944
RGD:11038788
NCBI chr 1:105,583,681...105,637,895
Ensembl chr 1:96,447,251...96,501,464
G
Abcg5
ATP binding cassette subfamily G member 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11099417 PMID:11138003
NCBI chr 6:15,717,936...15,743,376
Ensembl chr 6:9,965,118...9,990,563
G
Abcg8
ATP binding cassette subfamily G member 8
ISO
CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Premature coronary artery atherosclerosis
CTD ClinVar
PMID:11099417 PMID:25741868
NCBI chr 6:15,698,448...15,717,730
Ensembl chr 6:9,945,629...9,964,912
G
Abo
ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21378990
NCBI chr 3:30,560,172...30,604,758
Ensembl chr 3:10,162,096...10,191,423
G
Acat2
acetyl-CoA acetyltransferase 2
susceptibility
ISO
DNA:polymorphisms: :41A>G, 734C>T, IVS4-57_58ins48bp
RGD
PMID:16195894
RGD:1601112
NCBI chr 1:50,100,840...50,118,886
Ensembl chr 1:47,695,788...47,752,821
G
Ace
angiotensin I converting enzyme
susceptibility
ISO
DNA:deletion:intron:IVS16+1464-1751del (human) CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:14989558 PMID:12975417 PMID:15118671
RGD:1566498 , RGD:1331525
NCBI chr10:91,410,129...91,430,246
Ensembl chr10:90,910,316...90,931,131
G
Acp1
acid phosphatase 1
ISO
RGD
PMID:19246900
RGD:2313179
NCBI chr 6:53,233,937...53,249,576
Ensembl chr 6:47,506,380...47,522,021
G
Adamts7
ADAM metallopeptidase with thrombospondin type 1 motif, 7
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21378990
NCBI chr 8:99,584,529...99,624,132
Ensembl chr 8:90,704,727...90,744,328
G
Adipoq
adiponectin, C1Q and collagen domain containing
susceptibility
ISO
protein:decreased expression:adipose tissue associated with type 2 diabetes mellitus; DNA:SNP: (rs2241766) +45T>G(human)
RGD
PMID:17878891 PMID:27218147
RGD:5686802 , RGD:329956419
NCBI chr11:91,226,524...91,240,244
Ensembl chr11:77,721,912...77,735,564
G
Adrb3
adrenoceptor beta 3
no_association
ISO
DNA:missense mutation:cds:p.W64R (human) DNA:missense mutation:cds:p.W64R rs4994 (human)
RGD
PMID:9126344 PMID:11229427
RGD:1559325 , RGD:5684412
NCBI chr16:71,544,603...71,547,410
Ensembl chr16:64,841,788...64,844,552
G
Adtrp
androgen-dependent TFPI-regulating protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21378986
NCBI chr17:23,113,578...23,199,616
Ensembl chr17:22,930,740...22,993,826
G
Ager
advanced glycosylation end product-specific receptor
susceptibility
ISO
DNA:polymorphism:cds:p.G82S (human) associated with Mucocutaneous Lymph Node Syndrome
RGD
PMID:20668462 PMID:22337222
RGD:6767569 , RGD:8695960
NCBI chr20:4,152,758...4,155,956
Ensembl chr20:4,147,890...4,151,078
G
Agt
angiotensinogen
ISO
GAD
PMID:15118671
RGD:1331525
NCBI chr19:69,426,540...69,447,017
Ensembl chr19:52,529,185...52,540,977
G
Agtr1a
angiotensin II receptor, type 1a
susceptibility
ISO
DNA:polymorphism:3' utr:1166A>C
RGD GAD
PMID:12975417 PMID:15118671
RGD:1566498 , RGD:1331525
NCBI chr17:34,383,397...34,435,523
Ensembl chr17:34,174,429...34,226,946
G
Agxt2
alanine-glyoxylate aminotransferase 2
ISO
DNA:missense mutation:cds:rs37369, rs16899974 (human)
RGD
PMID:30284143
RGD:329961317
NCBI chr 2:61,063,416...61,104,828
Ensembl chr 2:59,336,283...59,377,926
G
Ahsg
alpha-2-HS-glycoprotein
susceptibility
ISO
associated with Diabetes Mellitus, Type 2;DNA:SNPs
RGD
PMID:17062776 PMID:17062776
RGD:1625792 , RGD:1625792
NCBI chr11:91,625,975...91,632,583
Ensembl chr11:78,117,918...78,145,999
G
Akt1
AKT serine/threonine kinase 1
ISO
RGD
PMID:18054314
RGD:5509083
NCBI chr 6:137,534,810...137,555,131
Ensembl chr 6:131,713,720...131,733,921
G
Alox5ap
arachidonate 5-lipoxygenase activating protein
ISO
DNA:snps:multiple (human)
RGD
PMID:19596330
RGD:2313883
NCBI chr12:10,785,254...10,809,295
Ensembl chr12:5,748,944...5,772,986
G
Ampd1
adenosine monophosphate deaminase 1
susceptibility
ISO
DNA:SNP:exon 2:34C>T (human)
RGD
PMID:11028479
RGD:329349360
NCBI chr 2:193,287,219...193,308,446
Ensembl chr 2:190,598,700...190,619,938
G
Angptl4
angiopoietin-like 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27135400
NCBI chr 7:15,252,450...15,259,971
Ensembl chr 7:14,550,311...14,556,519
G
Anks1a
ankyrin repeat and sterile alpha motif domain containing 1A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21378990
NCBI chr20:5,965,421...6,118,875
Ensembl chr20:5,963,678...6,117,148
G
Apcs
amyloid P component, serum
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12714198
NCBI chr13:87,905,532...87,906,508
Ensembl chr13:85,373,220...85,374,298
G
Aph1b
aph-1 homolog B, gamma secretase subunit
ISO
DNA:SNP:CDS:p.F217L (rs1047552) (human)
RGD
PMID:18987747
RGD:13703124
NCBI chr 8:76,310,380...76,334,146
Ensembl chr 8:67,429,198...67,450,243
G
Apoa1
apolipoprotein A1
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:27135400 PMID:2128269 PMID:15118671
RGD:1601188 , RGD:1331525
NCBI chr 8:55,423,945...55,425,729
Ensembl chr 8:46,527,144...46,529,035
G
Apoa2
apolipoprotein A2
ISO
protein:decreased expression:serum
RGD
PMID:17923573
RGD:2313956
NCBI chr13:86,176,767...86,178,819
Ensembl chr13:83,644,470...83,646,355
G
Apoa5
apolipoprotein A5
no_association
ISO
DNA:polymorphism:promoter:-1131T>C (human) CTD Direct Evidence: marker/mechanism DNA:polymorphism:promoter:-1131T>C, c.56C>G (human)
CTD RGD
PMID:24097064 PMID:15177130 PMID:15306190
RGD:2313322 , RGD:1578412
NCBI chr 8:55,446,329...55,460,509
Ensembl chr 8:46,561,229...46,563,816
G
Apob
apolipoprotein B
no_association
ISO
DNA:SNP:CDS:rs1042031 (human)
RGD GAD
PMID:9585673 PMID:28167353 PMID:15118671 PMID:1732399
RGD:1578418 , RGD:329901772 , RGD:1331525 , RGD:1578417
NCBI chr 6:36,563,704...36,603,300
Ensembl chr 6:30,844,368...30,892,497
G
Apoc3
apolipoprotein C3
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:24097064 PMID:14709372 PMID:15118671 PMID:15059615
RGD:1578443 , RGD:1331525 , RGD:1626412
NCBI chr 8:55,428,172...55,430,352
Ensembl chr 8:46,531,478...46,533,583
G
Apoe
apolipoprotein E
susceptibility
ISO IMP
DNA:snp, missense mutation:promoter, cds:g.-219G>T, p.C112R (human) associated with Diabetes Mellitus, Non-Insulin Dependent;DNA:SNP:promoter:-219G>T (human) DNA:missense mutation:cds:p.C112R (human)
RGD GAD
PMID:14563588 PMID:28808185 PMID:15118671 PMID:15059615 PMID:12860263
RGD:1580039 , RGD:13703132 , RGD:1331525 , RGD:1626412 , RGD:1578449
NCBI chr 1:88,481,889...88,485,816
Ensembl chr 1:79,353,916...79,357,932
G
Apom
apolipoprotein M
susceptibility
ISO
DNA:SNP:promoter:g.-778T>C(rs805296)(human)
RGD
PMID:17674965
RGD:2314241
NCBI chr20:3,695,618...3,698,218
Ensembl chr20:3,688,413...3,693,550
G
Ar
androgen receptor
ISO
GAD
PMID:15118671
RGD:1331525
NCBI chr X:67,135,317...67,304,476
Ensembl chr X:63,104,771...63,273,925
G
Arhgap31
Rho GTPase activating protein 31
susceptibility
ISO
associated with nicotine dependence;DNA:SNP: (rs10934490) (human)
RGD
PMID:19706030
RGD:329970276
NCBI chr11:75,544,176...75,657,087
Ensembl chr11:62,038,635...62,151,564
G
Atp2b1
ATPase plasma membrane Ca2+ transporting 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22751097
NCBI chr 7:35,622,267...35,731,904
Ensembl chr 7:33,735,871...33,843,295
G
Bche
butyrylcholinesterase
susceptibility
ISO
DNA:polymorphism: :p.A539T (human)
RGD
PMID:17852836
RGD:2306777
NCBI chr 2:160,607,289...160,699,760
Ensembl chr 2:158,307,584...158,401,148
G
Brinp3
BMP/retinoic acid inducible neural specific 3
ISO
DNA:SNP: :rs12732361(human), associated with male.
RGD
PMID:27461004
RGD:14398490
NCBI chr13:60,964,127...61,397,044
Ensembl chr13:58,413,883...58,846,770
G
Btnl2
butyrophilin-like 2
susceptibility
ISO
associated with Mucocutaneous Lymph Node Syndrome; DNA:SNP: :rs 2395158(human)
RGD
PMID:19882345
RGD:9685030
NCBI chr20:4,492,100...4,505,932
Ensembl chr20:4,489,517...4,503,341
G
C5h1orf167
similar to human chromosome 1 open reading frame 167
ISO
DNA:SNP: :rs56001051(human)
RGD
PMID:31175347
RGD:14696712
NCBI chr 5:163,770,495...163,788,791
G
Carf
calcium responsive transcription factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:34961328
NCBI chr 9:68,996,419...69,046,480
Ensembl chr 9:61,506,956...61,550,462
G
Cbs
cystathionine beta synthase
ISO
CBS variant c.844ins68
RGD
PMID:12855221
RGD:1600626
NCBI chr20:9,709,394...9,733,925
Ensembl chr20:9,708,090...9,732,764
G
Ccl2
C-C motif chemokine ligand 2
IEP ISO
protein:increased expression:myocardium (rat) ClinVar Annotator: match by term: Coronary artery disease, modifier of CTD Direct Evidence: marker/mechanism protein:increased expression:serum (human)
ClinVar CTD RGD
PMID:11500196 PMID:15466648 PMID:16352737 PMID:16596675 PMID:16934270 PMID:18940815 PMID:16297799 PMID:9537339 More...
RGD:8549513 , RGD:8549577
NCBI chr10:67,503,077...67,504,875
Ensembl chr10:67,005,424...67,007,226
G
Ccl26
C-C motif chemokine ligand 26
susceptibility
ISO
protein:decreased expression:plasma (human)
RGD
PMID:16620281
RGD:11081161
NCBI chr12:26,745,972...26,750,924
Ensembl chr12:21,109,421...21,114,335
G
Ccr1
C-C motif chemokine receptor 1
ISO
RGD
PMID:12742282
RGD:5508477
NCBI chr 8:132,433,711...132,439,266
G
Ccr2
C-C motif chemokine receptor 2
ISO
RGD
PMID:12426226
RGD:1581178
NCBI chr 8:132,611,883...132,619,106
Ensembl chr 8:123,734,430...123,742,100
G
Ccr5
C-C motif chemokine receptor 5
IEP
mRNA:increased expression:heart (rat)
RGD
PMID:17449418
RGD:4890438
NCBI chr 8:132,629,097...132,660,980
Ensembl chr 8:123,752,325...123,759,260
G
Cd14
CD14 molecule
no_association
ISO
DNA:SNP:promoter
RGD
PMID:18157711
RGD:2314154
NCBI chr18:28,609,558...28,611,409
Ensembl chr18:28,335,340...28,337,261
G
Cd36
CD36 molecule
ISO
ClinVar Annotator: match by term: Premature coronary artery atherosclerosis
ClinVar
PMID:25741868
NCBI chr 4:18,209,088...18,302,142
Ensembl chr 4:17,354,466...17,513,903
G
Cd40lg
CD40 ligand
ISO IEP
protein:increased expression:serum CTD Direct Evidence: marker/mechanism associated with Mucocutaneous Lymph Node Syndrome;DNA:SNP: :rs4810485 (human) protein:increased expression:coronary artery, serum associated with Kidney Failure, Chronic
CTD RGD
PMID:16368305 PMID:17635572 PMID:22645426 PMID:23819214 PMID:16494885
RGD:2314209 , RGD:8547776 , RGD:7248750 , RGD:7248436
NCBI chr X:140,164,341...140,176,057
Ensembl chr X:135,126,969...135,138,306
G
Cdh5
cadherin 5
ISO
RGD
PMID:14695457
RGD:1598391
NCBI chr19:821,875...860,931
Ensembl chr19:815,411...854,368
G
Cdkn2b
cyclin-dependent kinase inhibitor 2B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23104008 PMID:34961328
NCBI chr 5:109,123,308...109,134,906
Ensembl chr 5:104,010,680...104,019,050
G
Cela2a
chymotrypsin like elastase 2A
ISO
ClinVar Annotator: match by term: Coronary artery disease
ClinVar
PMID:25741868 PMID:31358993
NCBI chr 5:159,409,900...159,420,282
Ensembl chr 5:154,126,878...154,136,632
G
Celsr2
cadherin, EGF LAG seven-pass G-type receptor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:34961328
NCBI chr 2:198,717,333...198,741,689
Ensembl chr 2:196,029,434...196,053,845
G
Chi3l1
chitinase 3 like 1
ISO
protein:increased secretion:serum (human)
RGD
PMID:17627189
RGD:4892665
NCBI chr13:48,193,839...48,201,822
Ensembl chr13:45,641,802...45,649,787
G
Clcn6
chloride voltage-gated channel 6
susceptibility
ISO
DNA:SNP: :rs3737964(human)
RGD
PMID:26740945
RGD:14696742
NCBI chr 5:163,715,593...163,748,301
Ensembl chr 5:158,434,299...158,465,059
G
Clu
clusterin
ISO
associated with Mucocutaneous Lymph Node Syndrome;protein:decreased expression:plasma
RGD
PMID:20711835
RGD:9068393
NCBI chr15:44,336,619...44,375,861
Ensembl chr15:40,174,617...40,200,315
G
Cpe
carboxypeptidase E
severity
ISO
DNA:SNPs:CDS:intron 4, exon 4 (A2925G, G2855A) (human)
RGD
PMID:18080843
RGD:405650688
NCBI chr16:29,796,707...29,908,647
Ensembl chr16:25,030,276...25,142,233
G
Crp
C-reactive protein
ISO
associated with Diabetes Mellitus, Non-Insulin-Dependent;protein:increased expression:serum CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:24868163 PMID:19615354
RGD:2313344
NCBI chr13:87,694,062...87,695,978
Ensembl chr13:85,124,977...85,175,178
G
Cst3
cystatin C
ISO
protein:increased expression:serum (human)
RGD
PMID:17983622
RGD:2314352
NCBI chr 3:156,790,061...156,794,116
Ensembl chr 3:136,336,920...136,340,822
G
Cubn
cubilin
susceptibility
ISO
DNA:SNP,haplotypes:intron: (rs2291521)G>A (human)
RGD
PMID:33004870
RGD:329901841
NCBI chr17:81,293,619...81,501,694
Ensembl chr17:76,385,060...76,593,231
G
Cxcl12
C-X-C motif chemokine ligand 12
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21378990
NCBI chr 4:152,060,781...152,073,628
Ensembl chr 4:150,388,325...150,401,168
G
Cyba
cytochrome b-245 alpha chain
ISO
RGD GAD
PMID:14709372 PMID:15118671
RGD:1578443 , RGD:1331525
NCBI chr19:67,396,143...67,404,214
Ensembl chr19:50,487,597...50,495,721
G
Cyp27a1
cytochrome P450, family 27, subfamily a, polypeptide 1
ISO
ClinVar Annotator: match by term: Premature coronary artery atherosclerosis
ClinVar
PMID:25741868 PMID:28492532
NCBI chr 9:83,712,402...83,743,222
Ensembl chr 9:76,264,860...76,294,551
G
Cyp2r1
cytochrome P450, family 2, subfamily r, polypeptide 1
ISO
DNA:SNP:CDS:rs10741657 (human)
RGD
PMID:25003556
RGD:401901077
NCBI chr 1:178,166,984...178,232,191
Ensembl chr 1:168,751,038...168,797,759
G
Dab2ip
DAB2 interacting protein
onset
ISO
DNA:SNP:CDS:rs7025486 (human)
RGD
PMID:30595311
RGD:401938617
NCBI chr 3:39,312,745...39,483,730
Ensembl chr 3:18,915,290...19,086,280
G
Ddah1
dimethylarginine dimethylaminohydrolase 1
ISO
DNA:missense mutation:cds:rs997251 (human)
RGD
PMID:30284143
RGD:329961317
NCBI chr 2:237,327,812...237,460,624
Ensembl chr 2:234,667,491...234,799,339
G
Ddah2
DDAH family member 2, ADMA-independent
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17267746
NCBI chr20:3,766,115...3,769,161
Ensembl chr20:3,761,465...3,764,511
G
Ece1
endothelin converting enzyme 1
ISO
protein:increased expression:smooth muscle cell,macrophage
RGD
PMID:10973835 PMID:8994440
RGD:1580909 , RGD:7244168
NCBI chr 5:155,361,031...155,462,723
Ensembl chr 5:150,077,644...150,179,371
G
Edn1
endothelin 1
treatment severity
ISO IMP
protein:increased expression:atherosclerotic lesions (human) associated with Hypertension;DNA:missense mutation:cds:p.L198N (human)
RGD
PMID:7968078 PMID:11927217 PMID:18923236
RGD:4144886 , RGD:8662294 , RGD:8661705
NCBI chr17:22,660,799...22,666,687
Ensembl chr17:22,454,420...22,460,885
G
Eng
endoglin
severity
ISO
protein:increased expression:plasma (human)
RGD
PMID:21667051
RGD:7248776
NCBI chr 3:36,332,190...36,370,324
Ensembl chr 3:15,934,518...15,973,230
G
Ephx2
epoxide hydrolase 2
ISO
RGD
PMID:14732757
RGD:1580982
NCBI chr15:44,465,447...44,503,157
Ensembl chr15:40,289,902...40,327,615
G
Epo
erythropoietin
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:25245553
NCBI chr12:24,841,285...24,844,725
Ensembl chr12:19,204,508...19,207,946
G
Ercc2
ERCC excision repair 2, TFIIH core complex helicase subunit
susceptibility
ISO
DNA:SNP: :rs13181(human)
RGD
PMID:27566080
RGD:12880440
NCBI chr 1:88,161,342...88,175,102
Ensembl chr 1:79,033,326...79,047,102
G
Esr1
estrogen receptor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:9396482 PMID:20559769 PMID:16159931
RGD:1580335
NCBI chr 1:43,511,685...43,904,454
Ensembl chr 1:41,210,475...41,495,002
G
Esr2
estrogen receptor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:20559769 PMID:16099331
RGD:1581014
NCBI chr 6:100,589,553...100,645,240
Ensembl chr 6:94,809,547...94,908,919
G
F2
coagulation factor II, thrombin
treatment
ISO
RGD
PMID:14961168
RGD:10449426
NCBI chr 3:98,051,958...98,065,246
Ensembl chr 3:77,596,198...77,609,486
G
F7
coagulation factor VII
ISO
associated with Diabetes Mellitus, Non-Insulin-Dependent; protein:increased activity:plasma (human) DNA:polymorphisms:cds:R353Q (human)
RGD
PMID:10599031 PMID:8522401 PMID:11334615
RGD:2312400 , RGD:2312408 , RGD:2312397
NCBI chr16:83,191,896...83,202,775
Ensembl chr16:76,489,717...76,500,610
G
Fabp2
fatty acid binding protein 2
ISO
associated with Diabetes Mellitus, Type 2 (MeSH:D003924)
RGD
PMID:15059615
RGD:1626412
NCBI chr 2:213,724,629...213,728,686
Ensembl chr 2:211,040,032...211,044,089
G
Fcgr2a
Fc gamma receptor 2A
ISO
DNA:polymorphism: :p.H131R (human)
RGD
PMID:20973705
RGD:5147917
NCBI chr13:85,813,516...85,830,269
Ensembl chr13:83,280,784...83,295,967
G
Fcgr3a
Fc gamma receptor 3A
susceptibility
ISO
DNA:SNP:exon:p.F158V (rs396991)(human)
RGD
PMID:15910853
RGD:5508464
NCBI chr13:85,782,636...85,792,656
Ensembl chr13:83,249,872...83,259,921
G
Fes
FES proto-oncogene, tyrosine kinase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:34961328
NCBI chr 1:143,746,945...143,756,181
Ensembl chr 1:134,337,698...134,346,934
G
Fgb
fibrinogen beta chain
ISO
RGD
PMID:8565160
RGD:1580382
NCBI chr 2:170,693,966...170,700,875
Ensembl chr 2:168,394,916...168,405,979
G
Fgf2
fibroblast growth factor 2
ISO
associated with Diabetes Mellitus
RGD
PMID:14585103
RGD:2315879
NCBI chr 2:122,164,454...122,218,796
Ensembl chr 2:120,236,328...120,291,221
G
Fto
FTO, alpha-ketoglutarate dependent dioxygenase
ISO
DNA:SNP: :rs9939609 (human) DNA:SNP:intron:rs9939609 (human)
RGD
PMID:24622111 PMID:28167353
RGD:329812039 , RGD:329901772
NCBI chr19:31,456,749...31,865,011
Ensembl chr19:15,349,696...15,692,083
G
Furin
furin (paired basic amino acid cleaving enzyme)
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:34961328
NCBI chr 1:143,757,389...143,770,430
Ensembl chr 1:134,348,144...134,364,314
G
Gck
glucokinase
susceptibility
ISO
DNA:SNP:promoter:-30G>A (human)
RGD
PMID:15173029
RGD:2301876
NCBI chr14:84,999,019...85,041,098
Ensembl chr14:80,785,060...80,826,995
G
Gdf15
growth differentiation factor 15
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20855664
NCBI chr16:18,838,436...18,842,022
Ensembl chr16:18,805,239...18,808,055
G
Gfod1
Gfo/Idh/MocA-like oxidoreductase domain containing 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:34961328
NCBI chr17:21,606,090...21,710,922
Ensembl chr17:21,399,479...21,499,938
G
Ggcx
gamma-glutamyl carboxylase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:34961328
NCBI chr 4:106,027,918...106,043,653
Ensembl chr 4:104,469,765...104,487,063
G
Gja4
gap junction protein, alpha 4
ISO
RGD
PMID:15059615
RGD:1626412
NCBI chr 5:144,917,791...144,920,324
Ensembl chr 5:139,633,287...139,635,925
G
Gnb3
G protein subunit beta 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16141801
NCBI chr 4:159,325,741...159,331,443
Ensembl chr 4:157,639,469...157,645,173
G
Gp6
glycoprotein VI
treatment
ISO
protein:increased expression:platelet (human)
RGD
PMID:18585516
RGD:401794134
NCBI chr 1:78,471,900...78,535,374
Ensembl chr 1:69,465,789...69,491,326
G
Gpx1
glutathione peroxidase 1
ISO
cardiovascular complications in type 2 diabetics DNA:repeat:exon
RGD
PMID:16338763 PMID:12655278
RGD:1600708 , RGD:1600677
NCBI chr 8:117,905,462...117,906,588
Ensembl chr 8:109,026,905...109,028,024
G
Gpx3
glutathione peroxidase 3
ISO
mRNA:increased expression:epicardial fat
RGD
PMID:21679057
RGD:401827169
NCBI chr10:39,529,335...39,537,406
Ensembl chr10:39,028,570...39,037,035
G
Gsr
glutathione-disulfide reductase
ISO
cardiovascular complications in type 2 diabetics
RGD
PMID:16338763
RGD:1600708
NCBI chr16:65,185,574...65,228,742
Ensembl chr16:58,482,505...58,525,661
G
Gstm1
glutathione S-transferase mu 1
susceptibility
ISO
associated with Diabetes Mellitus, Non-Insulin-Dependent DNA:deletion
RGD
PMID:19102712 PMID:16620396
RGD:2306625 , RGD:2306633
NCBI chr 2:198,338,005...198,346,007
Ensembl chr 2:195,649,845...195,655,411
G
Gstt1
glutathione S-transferase theta 1
susceptibility
ISO
associated with Diabetes Mellitus, Non-Insulin-Dependent DNA:deletion
RGD
PMID:19102712 PMID:16620396
RGD:2306625 , RGD:2306633
NCBI chr20:12,856,068...12,873,020
Ensembl chr20:12,856,669...12,873,585
G
Gucy1a1
guanylate cyclase 1 soluble subunit alpha 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22751097
NCBI chr 2:169,716,684...169,780,360
Ensembl chr 2:167,418,640...167,481,671
G
H19
H19 imprinted maternally expressed transcript
susceptibility
ISO
DNA:SNPs,haplotype:intron: (rs2735971,rs2839698,rs3024270) (human)
RGD
PMID:32454910
RGD:242905209
NCBI chr 1:207,160,175...207,162,851
Ensembl chr 1:197,730,698...197,733,134
G
Hectd4
HECT domain E3 ubiquitin protein ligase 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22751097
NCBI chr12:40,800,232...40,991,584
Ensembl chr12:35,182,154...35,330,987
G
Hfe
homeostatic iron regulator
no_association
ISO
RGD
PMID:12746412
RGD:1582673
NCBI chr17:41,841,302...41,849,359
Ensembl chr17:41,413,451...41,421,502
G
Hgf
hepatocyte growth factor
ISO
RGD
PMID:11669408
RGD:8548610
NCBI chr 4:19,628,902...19,700,467
Ensembl chr 4:18,677,101...18,745,409
G
Hhipl1
HHIP-like 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21378990
NCBI chr 6:132,984,028...133,008,248
Ensembl chr 6:127,220,014...127,242,564
G
Hmgcr
3-hydroxy-3-methylglutaryl-CoA reductase
ISO
RGD
PMID:12742282
RGD:5508477
NCBI chr 2:29,732,163...29,754,276
Ensembl chr 2:27,997,525...28,019,703
G
Hmox1
heme oxygenase 1
no_association susceptibility
ISO
DNA:repeat:promoter CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:12136229 PMID:14691581 PMID:12377749 PMID:12136229
RGD:1580470 , RGD:1580454 , RGD:1598401
NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,467,244...13,474,079
G
Hnf1a
HNF1 homeobox A
susceptibility
ISO
DNA:SNP:intron 1: (rs7310409) G>A (human) DNA:SNP,haplotypes:intron: (rs55783344) C>T(human) DNA:SNPs,haplotypes:multiple
RGD
PMID:25202455 PMID:33004870 PMID:28035729
RGD:329901832 , RGD:329901841 , RGD:329901837
NCBI chr12:47,299,171...47,333,457
Ensembl chr12:41,645,587...41,672,104
G
Hp
haptoglobin
ISO
protein:increased expression:serum
RGD
PMID:884791
RGD:1626363
NCBI chr19:54,449,151...54,453,701
Ensembl chr19:37,539,627...37,544,523
G
Hs3st1
heparan sulfate-glucosamine 3-sulfotransferase 1
ISO
ClinVar Annotator: match by term: Coronary artery disease
ClinVar
PMID:15266341 PMID:15965027 PMID:16024819 PMID:16410828 PMID:17179217 PMID:17558387 PMID:17568005 PMID:19122651 PMID:19303047 PMID:19858363 PMID:21152010 PMID:22090374 PMID:28126521 More...
NCBI chr14:75,398,101...75,429,628
Ensembl chr14:71,185,682...71,223,248
G
Hsd11b1
hydroxysteroid 11-beta dehydrogenase 1
sexual_dimorphism
ISO
associated with obesity;mRNA,protein:increased expression:multiple (human)
RGD
PMID:23009206
RGD:329901914
NCBI chr13:107,277,526...107,327,462
Ensembl chr13:104,728,539...104,788,687
G
Hspd1
heat shock protein family D (Hsp60) member 1
severity
ISO
RGD
PMID:11222468
RGD:1624218
NCBI chr 9:64,073,610...64,084,332
Ensembl chr 9:56,579,201...56,589,662
G
Ica1l
islet cell autoantigen 1-like
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:34961328
NCBI chr 9:68,906,148...68,964,078
Ensembl chr 9:61,412,091...61,470,134
G
Il10
interleukin 10
no_association susceptibility
ISO
DNA:SNPs:promoter:-592C>A (rs1800872), -819C>T (rs1800871) (human) DNA:SNP:promoter:-1082A>G (rs1800896) (human)
RGD
PMID:16460885 PMID:29525679 PMID:29525679
RGD:1598621 , RGD:14975129 , RGD:14975129
NCBI chr13:45,024,921...45,029,586
Ensembl chr13:42,472,839...42,477,313
G
Il15
interleukin 15
ISO
associated with Hypertension;protein:increased expression:serum
RGD
PMID:16109314
RGD:1626610
NCBI chr19:42,536,160...42,611,349
Ensembl chr19:25,640,251...25,706,820
G
Il1b
interleukin 1 beta
ISO
mRNA:increased expression:peripheral blood (human)
RGD
PMID:22780915
RGD:7175093
NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:116,577,010...116,583,415
G
Il1rl1
interleukin 1 receptor-like 1
severity
ISO
DNA:polymorphisms: :-27307T>A, -27614C>A (human)
RGD
PMID:20602249
RGD:5144241
NCBI chr 9:50,157,326...50,222,888
Ensembl chr 9:42,697,192...42,727,256
G
Il6
interleukin 6
ISO
associated with Diabetes Mellitus, Non-Insulin-Dependent; protein:increased expression:extracellular space (human)
RGD
PMID:19368923
RGD:2307251
NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,213,394...5,219,178
G
Irak1
interleukin-1 receptor-associated kinase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20524934
NCBI chr X:156,919,927...156,929,825
Ensembl chr X:151,768,777...151,778,521
G
Irs1
insulin receptor substrate 1
ISO
DNA:polymorphism:exon:G972R CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:10591678 PMID:10591678
RGD:1624974
NCBI chr 9:91,001,137...91,053,959
Ensembl chr 9:83,548,944...83,606,122
G
Itga2
integrin subunit alpha 2
no_association
ISO
RGD
PMID:15227729
RGD:1582294
NCBI chr 2:48,253,412...48,354,509
Ensembl chr 2:46,523,948...46,621,481
G
Jcad
junctional cadherin 5 associated
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21378988
NCBI chr17:57,784,634...57,826,213
Ensembl chr17:53,089,382...53,130,967
G
Kalrn
kalirin, RhoGEF kinase
susceptibility onset severity
ISO
DNA:SNP:intron: (rs9289231) T>G (human) associated with nicotine dependence; DNA:SNPs:multiple associated with type 2 diabetes mellitus;DNA:SNP:intron: (rs9289231) T>G (human) DNA:SNP:intron: (rs9289231) (human)
RGD
PMID:30483314 PMID:19706030 PMID:27218147 PMID:25316661
RGD:329955537 , RGD:329970276 , RGD:329956419 , RGD:11076452
NCBI chr11:79,703,345...80,309,210
Ensembl chr11:66,198,173...66,797,610
G
Kcne2
potassium voltage-gated channel subfamily E regulatory subunit 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:34961328
NCBI chr11:45,003,468...45,015,942
Ensembl chr11:31,295,614...31,530,043
G
Kcnj8
potassium inwardly-rectifying channel, subfamily J, member 8
ISS
OMIM:300464 | OMIM:607339 | OMIM:608316 | OMIM:608318 | OMIM:608320 | OMIM:608901 | OMIM:610938 | OMIM:610947 | OMIM:611139 | OMIM:612030 | OMIM:614293 | OMIM:614466
MouseDO
NCBI chr 4:177,240,692...177,246,548
Ensembl chr 4:175,508,912...175,515,603
G
Kif6
kinesin family member 6
sexual_dimorphism no_association treatment
ISO
DNA:SNP: :rs20455 (human) associated with type 2 diabetes mellitus;DNA:SNP: :p.W719R (rs20455) (human)
RGD
PMID:18222354 PMID:25629058 PMID:21458191 PMID:26443250 PMID:26997531 PMID:19371834 More...
RGD:243048446 , RGD:243048454 , RGD:243048451 , RGD:11527801 , RGD:243048449 , RGD:243048447
NCBI chr 9:18,573,925...18,870,789
Ensembl chr 9:11,072,824...11,373,006
G
Kl
Klotho
ISO
CTD Direct Evidence: marker/mechanism DNA:SNP:promoter: -G395>A (human)
CTD RGD
PMID:12669274 PMID:16979405 PMID:16579981
RGD:1581721 , RGD:1581723
NCBI chr12:5,326,003...5,367,016
Ensembl chr12:490,399...530,080
G
Ldlr
low density lipoprotein receptor
no_association
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:21378990 PMID:27135400 PMID:16459141
RGD:1581823
NCBI chr 8:28,546,191...28,569,075
Ensembl chr 8:20,270,041...20,294,580
G
Lepr
leptin receptor
susceptibility
ISO
DNA:SNP:cds:p.Q223R(human)
RGD
PMID:27257426
RGD:21079462
NCBI chr 5:121,409,735...121,593,201
Ensembl chr 5:116,289,823...116,475,908
G
Lipa
lipase A, lysosomal acid type
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21378988 PMID:34961328 PMID:35590109
NCBI chr 1:241,437,524...241,470,936
Ensembl chr 1:232,024,356...232,057,633
G
Lipc
lipase C, hepatic type
susceptibility no_association
ISO
associated with Diabetes Mellitus, Insulin-Dependent; DNA:transition:promoter:-480C>T (human) DNA:SNP,haplotypes: (rs17269397)A>G (human)
RGD GAD
PMID:11916946 PMID:33004870 PMID:15118671 PMID:12689525 PMID:15099346
RGD:2308839 , RGD:329901841 , RGD:1331525 , RGD:1600664 , RGD:1600663
NCBI chr 8:80,390,470...80,516,463
Ensembl chr 8:71,509,635...71,635,464
G
Lipg
lipase G, endothelial type
ISO
RGD
PMID:16354105
RGD:1580865
NCBI chr18:70,790,077...70,811,259
Ensembl chr18:68,514,923...68,536,260
G
Lmod1
leiomodin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28530674
NCBI chr13:49,305,693...49,347,970
Ensembl chr13:46,754,033...46,794,900
G
Lox
lysyl oxidase
IDA
RGD
PMID:12393934
RGD:1581886
NCBI chr18:48,162,889...48,175,640
Ensembl chr18:45,967,343...46,041,477
G
Lpl
lipoprotein lipase
ISO
RGD
PMID:8641022
RGD:1580537
NCBI chr16:25,596,205...25,621,928
Ensembl chr16:20,829,465...20,855,249
G
Lrp6
LDL receptor related protein 6
ISO
ClinVar Annotator: match by term: Coronary artery disease
ClinVar
PMID:28492532
NCBI chr 4:168,997,937...169,131,716
Ensembl chr 4:167,270,353...167,400,497
G
Lrp8
LDL receptor related protein 8
no_association onset
ISO
DNA:missense mutation:cds:p.R952Q (human)
RGD
PMID:18592168 PMID:17847002
RGD:2306125 , RGD:2306124
NCBI chr 5:127,792,236...127,864,207
Ensembl chr 5:122,563,453...122,631,352
G
Lta
lymphotoxin alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:15266304 PMID:15973460
RGD:1580414
NCBI chr20:3,622,291...3,625,852
Ensembl chr20:3,618,853...3,620,859
G
Lum
lumican
ISO
RGD
PMID:11890723
RGD:1582121
NCBI chr 7:34,245,323...34,252,510
Ensembl chr 7:32,358,614...32,365,793
G
Map3k7
mitogen activated protein kinase kinase kinase 7
ISO
associated with hypothyroidism;mRNA:decreased expression:venous blood (human)
RGD
PMID:32495070
RGD:155791451
NCBI chr 5:51,149,524...51,212,012
Ensembl chr 5:46,357,931...46,415,597
G
Mat2a
methionine adenosyltransferase 2A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:34961328
NCBI chr 4:106,048,043...106,053,612
Ensembl chr 4:104,488,466...104,495,493
G
Mef2a
myocyte enhancer factor 2a
ISO
RGD
PMID:15811259
RGD:1580548
NCBI chr 1:130,258,083...130,392,819
Ensembl chr 1:120,850,080...120,981,948
G
Mia3
MIA SH3 domain ER export factor 3
ISO
CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Coronary artery disease
CTD ClinVar
PMID:21378990 PMID:25741868 PMID:34961328
NCBI chr13:97,502,040...97,547,155
Ensembl chr13:94,970,424...95,011,972
G
Mir1
microRNA 1
disease_progression
ISO
miRNA:decreased expression:blood plasma (human)
RGD
PMID:25728840
RGD:11056497
NCBI chr18:2,160,327...2,160,413
G
Mir126a
microRNA 126a
disease_progression severity
ISO
miRNA:increased expression:blood plasma (human) associated with Stable Angina,
RGD
PMID:25728840 PMID:27497911
RGD:11056497 , RGD:401850779
NCBI chr 3:29,813,150...29,813,267
Ensembl chr 3:9,415,063...9,415,180
G
Mir133a1
microRNA 133a-1
ISO
miRNA:decreased expression:blood plasma (human)
RGD
PMID:25728840
RGD:11056497
NCBI chr18:2,157,872...2,157,958
G
Mir145
microRNA 145
disease_progression
ISO
miRNA:decreased expression:artery wall (human)
RGD
PMID:25938589
RGD:11054026
NCBI chr18:57,369,983...57,370,070
Ensembl chr18:55,099,640...55,099,727
G
Mir146a
microRNA 146a
susceptibility
ISO
CTD Direct Evidence: marker/mechanism DNA:SNP: (rs2910164) (human) miRNA:increased expression:peripheral blood mononuclear cell, plasma
CTD RGD
PMID:20524934 PMID:26909569 PMID:31866771
RGD:329337364 , RGD:21081515
NCBI chr10:28,349,996...28,350,090
Ensembl chr10:27,848,516...27,848,610
G
Mir146b
microRNA 146b
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20524934
NCBI chr 1:255,144,860...255,144,947
Ensembl chr 1:245,203,438...245,203,525
G
Mir155
microRNA 155
ISO
miRNA:decreased expression:peripheral blood mononuclear cell, plasma
RGD
PMID:31866771
RGD:21081515
NCBI chr11:37,261,114...37,261,178
Ensembl chr11:23,774,654...23,774,718
G
Mir195
microRNA 195
ISO
miRNA:decreased expression:blood plasma (human)
RGD
PMID:25728840
RGD:11056497
NCBI chr10:55,450,495...55,450,581
Ensembl chr10:54,951,838...54,951,924
G
Mir208a
microRNA 208a
ISO
miRNA:decreased expression:blood plasma (human)
RGD
PMID:25728840
RGD:11056497
NCBI chr15:32,395,552...32,395,634
G
Mir21
microRNA 21
ISO
miRNA:increased expression:peripheral blood mononuclear cell, plasma miRNA:increased expression:blood plasma (human)
RGD
PMID:31866771 PMID:25728840
RGD:21081515 , RGD:11056497
NCBI chr10:71,902,600...71,902,691
Ensembl chr10:71,405,257...71,405,348
G
Mir214
microRNA 214
ISO
miRNA:increased expression:blood plasma (human)
RGD
PMID:25728840
RGD:11056497
NCBI chr13:77,121,645...77,121,752
Ensembl chr13:74,588,372...74,588,481
G
Mir223
microRNA 223
treatment
ISO
RGD
PMID:25350775
RGD:11076984
NCBI chr X:65,151,383...65,151,492
Ensembl chr X:61,141,887...61,141,996
G
Mir30a
microRNA 30a
disease_progression
ISO
miRNA:increased expression:blood plasma (human)
RGD
PMID:25728840
RGD:11056497
NCBI chr 9:33,233,941...33,234,011
Ensembl chr 9:25,737,600...25,737,670
G
Mir30e
microRNA 30e
ISO
miRNA:increased expression:plasma, extracellular exosome (human)
RGD
PMID:30816508
RGD:401827150
NCBI chr 5:139,637,450...139,637,541
Ensembl chr 5:134,352,232...134,352,323
G
Mir320a
microRNA 320a
disease_progression
ISO
miRNA:increased expression:blood plasma (human)
RGD
PMID:25728840
RGD:11056497
NCBI chr15:51,926,088...51,926,169
Ensembl chr15:45,516,392...45,516,473
G
Mir423
microRNA 423
disease_progression
ISO
DNA:SNP: :rs6505162 (human) miRNA:decreased expression:serum
RGD
PMID:30289085 PMID:32404537
RGD:158014893 , RGD:158014898
NCBI chr10:62,412,272...62,412,350
Ensembl chr10:61,914,133...61,914,226
G
Mlxipl
MLX interacting protein-like
susceptibility
ISO
DNA:SNPs,haplotypes: (rs3812316) (human) DNA:SNP:cds: G771C, Q241H (rs381231) DNA:SNP:cds: C771G, H241Q
RGD
PMID:21726544 PMID:19571538 PMID:25179879
RGD:401794579 , RGD:401794582 , RGD:401794581
NCBI chr12:27,178,158...27,213,675
Ensembl chr12:21,543,576...21,577,112
G
Mmp1
matrix metallopeptidase 1
severity
ISO
DNA:insertion, haplotype:promoter:g.-1607insG rs799750 (human)
RGD
PMID:15619398 PMID:17893005
RGD:1582527 , RGD:7207049
NCBI chr 8:12,943,453...12,963,966
Ensembl chr 8:4,658,588...4,679,097
G
Mmp12
matrix metallopeptidase 12
susceptibility
ISO
RGD
PMID:10807873
RGD:1582366
NCBI chr 8:12,866,652...12,876,554
Ensembl chr 8:4,581,785...4,599,611
G
Mmp3
matrix metallopeptidase 3
ISO
DNA:insertion, haplotype:promoter:g.-1613insA rs3025058 (human) CTD Direct Evidence: marker/mechanism associated with Mucocutaneous Lymph Node Syndrome
CTD RGD
PMID:8662692 PMID:17893005 PMID:16100452
RGD:7207049 , RGD:8693322
NCBI chr 8:12,925,267...12,938,828
Ensembl chr 8:4,640,416...4,653,961
G
Mmp9
matrix metallopeptidase 9
susceptibility treatment
ISO IEP
RGD
PMID:15191941 PMID:26261622
RGD:1582644 , RGD:11344965
NCBI chr 3:174,103,474...174,111,434
Ensembl chr 3:153,683,858...153,692,120
G
Mras
muscle RAS oncogene homolog
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21378990 PMID:35590109
NCBI chr 8:108,823,374...108,886,104
Ensembl chr 8:99,944,036...99,996,408
G
Mrps6
mitochondrial ribosomal protein S6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21378990 PMID:34961328
NCBI chr11:44,778,667...44,834,420
Ensembl chr11:31,295,614...31,348,484
G
Mthfr
methylenetetrahydrofolate reductase
no_association susceptibility
ISO
DNA:transition:cds:g.677C>T (human) DNA:SNPs: (rs1801133, rs4846049) (Human)
RGD
PMID:15648053 PMID:24315498 PMID:12387655
RGD:1580579 , RGD:401850782 , RGD:6893453
NCBI chr 5:163,748,346...163,768,141
Ensembl chr 5:158,465,296...158,483,797
G
Mylk
myosin light chain kinase
susceptibility
ISO
associated with nicotine dependence; DNA:SNP: (rs16834817)
RGD
PMID:19706030
RGD:329970276
NCBI chr11:79,288,243...79,535,450
Ensembl chr11:65,783,008...66,030,261
G
Nampt
nicotinamide phosphoribosyltransferase
ISO
RGD
PMID:17283255
RGD:1642340
NCBI chr 6:55,152,756...55,189,547
Ensembl chr 6:49,424,332...49,462,100
G
Nat2
N-acetyltransferase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21572414
NCBI chr16:26,974,874...27,005,191
Ensembl chr16:22,208,194...22,238,520
G
Nbeal1
neurobeachin-like 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:34961328
NCBI chr 9:69,069,326...69,237,932
Ensembl chr 9:61,575,356...61,736,750
G
Ngf
nerve growth factor
ISO
RGD
PMID:11935372
RGD:1580935
NCBI chr 2:192,589,580...192,642,971
Ensembl chr 2:189,901,058...189,954,452
G
Ngfr
nerve growth factor receptor
ISO
RGD
PMID:11935372
RGD:1580935
NCBI chr10:81,012,077...81,030,305
Ensembl chr10:80,515,299...80,533,518
G
Nnmt
nicotinamide N-methyltransferase
severity
ISO
protein:increased expression:blood serum (human)
RGD
PMID:28174167
RGD:401793727
NCBI chr 8:57,820,156...57,851,301
Ensembl chr 8:48,933,598...48,946,655
G
Nod2
nucleotide-binding oligomerization domain containing 2
ISO
DNA:polymorphisms: :p.G908R, 3020_3021insC (human)
RGD
PMID:21565239
RGD:5508725
NCBI chr19:34,555,832...34,596,281
Ensembl chr19:18,382,439...18,417,177
G
Nos2
nitric oxide synthase 2
ISO
associated with Mucocutaneous Lymph Node Syndrome; protein:increased expression:neutrophil, monocyte
RGD
PMID:14764920
RGD:1580941
NCBI chr10:64,313,335...64,349,221
Ensembl chr10:63,815,308...63,851,210
G
Nos3
nitric oxide synthase 3
susceptibility
ISO
DNA:duplication:intron:IVS4?-?+27 (human) CTD Direct Evidence: marker/mechanism DNA:snp:promoter:g.-786T>C (human) DNA:snp:cds:c.894G>T (human)
CTD RGD
PMID:10510054 PMID:14989558 PMID:17267746 PMID:19696404 PMID:8564837 PMID:19761682 PMID:16284093 More...
RGD:7421529 , RGD:7771578 , RGD:7771567
NCBI chr 4:11,686,088...11,706,604
Ensembl chr 4:10,793,834...10,814,166
G
Nppa
natriuretic peptide A
ISO
DNA:snp:cds:c.2238T>C (human) associated with Diabetes Mellitus, Type 2;DNA:SNP:exon: 2238T>C,rs5065 (human)
RGD
PMID:12514664 PMID:22170009
RGD:1579982 , RGD:7247716
NCBI chr 5:163,712,184...163,713,493
Ensembl chr 5:158,429,042...158,430,351
G
Nppb
natriuretic peptide B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18022110
NCBI chr 5:163,699,955...163,701,314
Ensembl chr 5:158,416,866...158,418,168
G
Nr1h3
nuclear receptor subfamily 1, group H, member 3
ISO
associated with type 2 diabetes mellitus;mRNA:increased expression:peripheral blood mononuclear cell (human)
RGD
PMID:28871240
RGD:401850555
NCBI chr 3:97,614,616...97,632,053
Ensembl chr 3:77,158,808...77,168,722
G
Nr3c1
nuclear receptor subfamily 3, group C, member 1
ISO
DNA:missense mutation:cds:p.N363S (human)
RGD
PMID:12623935
RGD:1580790
NCBI chr18:31,522,783...31,644,508
Ensembl chr18:31,271,681...31,393,375
G
Ogg1
8-oxoguanine DNA glycosylase
susceptibility
ISO
DNA:SNP,haplotype: :p.S326C (rs1052133) (human)
RGD
PMID:23368530
RGD:401827273
NCBI chr 4:148,030,237...148,037,599
Ensembl chr 4:146,474,750...146,484,766
G
Olr1
oxidized low density lipoprotein receptor 1
severity
ISO
DNA:snp:3' utr:T>C (human) DNA:missense mutation:cds:p.K167N (human)
RGD
PMID:12810610 PMID:15562935
RGD:1580995 , RGD:1580994
NCBI chr 4:164,612,460...164,635,082
Ensembl chr 4:162,926,439...162,948,523
G
Pappa
pappalysin
severity
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:11586954 PMID:16055491
RGD:1642327
NCBI chr 5:83,513,358...83,751,364
Ensembl chr 5:78,498,300...78,730,666
G
Parl
presenilin associated, rhomboid-like
susceptibility
ISO
DNA:missense mutation:cds:p.L262V (human)
RGD
PMID:18758826
RGD:12902623
NCBI chr11:94,097,559...94,124,915
Ensembl chr11:80,593,192...80,620,506
G
Pcsk9
proprotein convertase subtilisin/kexin type 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21378990 PMID:27135400
NCBI chr 5:126,440,102...126,462,507
Ensembl chr 5:121,211,278...121,233,688
G
Pdgfd
platelet derived growth factor D
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21378988 PMID:34961328
NCBI chr 8:11,773,335...12,007,277
Ensembl chr 8:3,488,423...3,722,395
G
Pecam1
platelet and endothelial cell adhesion molecule 1
no_association
ISO
DNA:missense mutations:cds:p.N536S, p.G670R (human) CTD Direct Evidence: marker/mechanism DNA:missense mutation:cds:p.L125V (human) DNA:polymorphism:5' utr:g.53G>A (human)
CTD RGD
PMID:28530674 PMID:11795274 PMID:10780329 PMID:12732396
RGD:2311656 , RGD:6771225 , RGD:1581010
NCBI chr10:92,090,263...92,152,002
Ensembl chr10:91,590,521...91,652,116
G
Phactr1
phosphatase and actin regulator 1
susceptibility sexual_dimorphism
ISO
CTD Direct Evidence: marker/mechanism DNA:hypermethylation, hypomethylation:promoter, exon: (human) DNA:SNP:exon: (rs4714955) (human) DNA:SNPs:intron: (rs9381439, rs9349379) (human) associated with familial hypercholesterolemia;DNA:SNP:intron: (rs12526453) (human) DNA:SNP:intron:g.12903957A>G (rs9349379) (human) DNA:SNP:intron:g.12903725A>G (rs9349379) (human)
CTD RGD
PMID:21378990 PMID:22751097 PMID:26098115 PMID:34961328 PMID:31499127 PMID:27066539 PMID:27893421 PMID:29784573 PMID:27517945 PMID:30777881 More...
RGD:401901251 , RGD:401901243 , RGD:401900688 , RGD:401900687 , RGD:401900135 , RGD:401851919
NCBI chr17:21,769,006...22,246,227
Ensembl chr17:21,562,721...22,039,831
G
Pik3c2g
phosphatidylinositol-4-phosphate 3-kinase, catalytic subunit type 2 gamma
ISO
ClinVar Annotator: match by term: Premature coronary artery atherosclerosis
ClinVar
PMID:25741868
NCBI chr 4:174,215,527...174,583,378
Ensembl chr 4:172,484,345...172,850,544
G
Pla2g7
phospholipase A2 group VII
disease_progression susceptibility
ISO
DNA:polymorphism: :p.A379V (human)
RGD
PMID:17070179 PMID:15115767
RGD:6482777 , RGD:6482781
NCBI chr 9:24,859,491...24,901,747
Ensembl chr 9:17,362,225...17,404,476
G
Plpp3
phospholipid phosphatase 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21378990
NCBI chr 5:125,156,000...125,231,119
Ensembl chr 5:119,927,085...120,002,205
G
Pnpla3
patatin-like phospholipase domain containing 3
ISO
associated with type 2 diabetes mellitus;DNA:SNP: :rs738409 (p.I148M) (human)
RGD
PMID:31377187
RGD:14981594
NCBI chr 7:117,173,485...117,194,065
Ensembl chr 7:115,293,538...115,314,077
G
Pon1
paraoxonase 1
susceptibility
ISO
DNA:missense mutation:cds:p.Q192R (human) ClinVar Annotator: match by term: Coronary artery spasm 2, susceptibility to CTD Direct Evidence: marker/mechanism|therapeutic protein:increased activity:serum (human)
ClinVar CTD RGD
PMID:7916578 PMID:8098250 PMID:8675673 PMID:8770857 PMID:9215303 PMID:9385372 PMID:9443884 PMID:11238489 PMID:11810302 PMID:11888590 PMID:12082503 PMID:15241482 PMID:21170047 PMID:21629682 PMID:25741868 PMID:10729395 PMID:15785307 PMID:11917194 More...
RGD:1580196 , RGD:8547681 , RGD:1580203
NCBI chr 4:34,261,312...34,292,327
Ensembl chr 4:33,294,722...33,321,360
G
Pon2
paraoxonase 2
severity
ISO
DNA:missense mutation:cds:p.C311S (human)
RGD
PMID:12454802
RGD:1580217
NCBI chr 4:34,356,270...34,391,684
Ensembl chr 4:33,389,714...33,425,248
G
Ppara
peroxisome proliferator activated receptor alpha
susceptibility
ISO
DNA:snp:intron: (human)
RGD
PMID:16043164
RGD:1580228
NCBI chr 7:118,712,261...118,780,723
Ensembl chr 7:116,832,756...116,895,346
G
Pparg
peroxisome proliferator-activated receptor gamma
ISO
protein:decreased expression:carotid artery, macrophage, smooth muscle cell (human)
RGD
PMID:21709632
RGD:8552814
NCBI chr 4:150,095,743...150,221,104
Ensembl chr 4:148,423,194...148,548,468
G
Ppp4c
protein phosphatase 4, catalytic subunit
ISO
mRNA:decreased expression:blood (human)
RGD
PMID:30015926
RGD:401901084
NCBI chr 1:190,823,447...190,830,247
Ensembl chr 1:181,392,923...181,399,659
G
Prdm16
PR/SET domain 16
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:35590109
NCBI chr 5:170,162,275...170,486,371
Ensembl chr 5:164,880,587...165,203,601
G
Prkag2
protein kinase AMP-activated non-catalytic subunit gamma 2
ISO
ClinVar Annotator: match by term: Coronary artery disease
ClinVar
PMID:25741868 PMID:28492532
NCBI chr 4:10,744,695...10,985,939
Ensembl chr 4:10,010,890...10,252,142
G
Procr
protein C receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28530674
NCBI chr 3:164,714,727...164,718,994
Ensembl chr 3:144,254,380...144,258,903
G
Psrc1
proline and serine rich coiled-coil 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:34961328
NCBI chr 2:198,710,427...198,715,001
Ensembl chr 2:196,022,361...196,026,874
G
Ptgs2
prostaglandin-endoperoxide synthase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:14642682
NCBI chr13:64,714,063...64,722,320
Ensembl chr13:62,163,932...62,172,188
G
Pth
parathyroid hormone
ISO
protein:increased expression:serum (human)
RGD
PMID:23460043
RGD:7242420
NCBI chr 1:176,942,901...176,946,034
Ensembl chr 1:167,508,598...167,511,530
G
Ptpn1
protein tyrosine phosphatase, non-receptor type 1
ISO
DNA:SNP:exon 8:g.981C>T (human)
RGD
PMID:21676396
RGD:401965429
NCBI chr 3:177,056,588...177,106,424
Ensembl chr 3:156,638,769...156,687,504
G
Ptpn22
protein tyrosine phosphatase, non-receptor type 22
ISO
DNA: snp: cds: rs2476601
RGD
PMID:21846984
RGD:6484553
NCBI chr 2:194,055,165...194,103,209
Ensembl chr 2:191,366,808...191,414,779
G
Ptprd
protein tyrosine phosphatase, receptor type, D
ISO
DNA:SNP:intron: (rs10115782) (human)
RGD
PMID:22216278
RGD:401976461
NCBI chr 5:95,093,221...97,415,498
Ensembl chr 5:90,048,966...92,369,396
G
Rbp4
retinol binding protein 4
sexual_dimorphism susceptibility severity disease_progression
ISO
protein:increased expression:blood plasma (human) DNA:SNP:intron: (rs7094671) (human) associated with hypothyroidism;protein:increased expression:blood serum (human) protein:increased expression:epicardial fat (human)
RGD
PMID:25437889 PMID:25479076 PMID:31278889 PMID:18854400 PMID:21645024
RGD:329845573 , RGD:329845882 , RGD:329845849 , RGD:329845843 , RGD:329845584
NCBI chr 1:245,306,349...245,313,551
Ensembl chr 1:235,893,917...235,901,399
G
Ryr2
ryanodine receptor 2
ISO
ClinVar Annotator: match by term: Premature coronary artery atherosclerosis
ClinVar
PMID:25741868
NCBI chr17:63,081,527...63,667,141
Ensembl chr17:58,389,925...58,975,142
G
Sars1
seryl-tRNA synthetase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:34961328
NCBI chr 2:198,753,673...198,769,411
Ensembl chr 2:196,065,430...196,081,277
G
Sele
selectin E
susceptibility
ISO
associated with Diabetes Mellitus, Non-Insulin-Dependent;DNA:mutation: :p.S128R (human) ClinVar Annotator: match by term: Coronary artery disease
ClinVar RGD
PMID:25741868 PMID:17578587
RGD:2313596
NCBI chr13:78,935,997...78,945,905
Ensembl chr13:76,403,304...76,412,741
G
Selp
selectin P
ISO
ClinVar Annotator: match by term: Premature coronary artery atherosclerosis
ClinVar
NCBI chr13:79,009,379...79,044,994
Ensembl chr13:76,476,295...76,511,845
G
Serpina1
serpin family A member 1
ISO
protein:increased expression:serum
RGD
PMID:7832094
RGD:1643149
NCBI chr 6:128,631,101...128,653,125
Ensembl chr 6:122,866,312...122,888,339
G
Serpine1
serpin family E member 1
susceptibility
ISO
DNA:insertion:promoter: (human)
RGD
PMID:9484978
RGD:1580190
NCBI chr12:25,237,977...25,248,356
Ensembl chr12:19,601,272...19,611,657
G
Serpinf2
serpin family F member 2
ISO
RGD
PMID:9184412
RGD:1625532
NCBI chr10:60,770,698...60,778,782
Ensembl chr10:60,272,400...60,281,243
G
Sh2b3
SH2B adaptor protein 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21378990
NCBI chr12:40,391,755...40,414,336
Ensembl chr12:34,731,911...34,753,616
G
Slc2a4
solute carrier family 2 member 4
ISO
mRNA:decreased expression:epicardial fat, subcutaneous adipose tissue (human)
RGD
PMID:21645024
RGD:329845584
NCBI chr10:55,164,721...55,170,289
Ensembl chr10:54,666,015...54,671,565
G
Slc5a3
solute carrier family 5 member 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:34961328
NCBI chr11:44,799,787...44,802,233
Ensembl chr11:31,295,476...31,318,883
G
Smad3
SMAD family member 3
ISO
ClinVar Annotator: match by term: Coronary artery disease
ClinVar
PMID:25741868
NCBI chr 8:73,022,204...73,132,324
Ensembl chr 8:64,110,039...64,236,960
G
Soat2
sterol O-acyltransferase 2
susceptibility
ISO
DNA:polymorphisms: :p.E41G, p.T734I, IVS4-57_-58ins48bp (human)
RGD
PMID:16195894
RGD:1601112
NCBI chr 7:135,160,424...135,173,521
Ensembl chr 7:133,281,818...133,294,915
G
Sod1
superoxide dismutase 1
ISO
associated with Diabetes Mellitus, Non-Insulin-Dependent
RGD
PMID:16338763
RGD:1600708
NCBI chr11:42,942,742...42,948,399
Ensembl chr11:29,456,558...29,462,249
G
Sod3
superoxide dismutase 3
ISO
RGD
PMID:10811593
RGD:1580853
NCBI chr14:62,822,865...62,828,602
Ensembl chr14:58,609,958...58,615,990
G
Sort1
sortilin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21378990 PMID:34961328
NCBI chr 2:198,609,466...198,690,481
Ensembl chr 2:195,924,099...196,002,354
G
Spp1
secreted phosphoprotein 1
ISO
In type 2 diabetic patients
RGD
PMID:21034455
RGD:6903271
NCBI chr14:5,613,569...5,620,695
Ensembl chr14:5,308,885...5,315,162
G
Srebf1
sterol regulatory element binding transcription factor 1
susceptibility disease_progression severity
ISO
DNA:SNP, haplotype:: -36delG (human) associated with type 2 diabetes mellitus; mRNA:increased expression:epicardial fat (human) mRNA:decreased expression:blood serum (human)
RGD
PMID:12752570 PMID:28367087 PMID:31610782
RGD:401827912 , RGD:401842368 , RGD:401842364
NCBI chr10:45,507,152...45,529,164
Ensembl chr10:45,007,637...45,029,650
G
Srebf2
sterol regulatory element binding transcription factor 2
disease_progression
ISO
associated with type 2 diabetes mellitus;mRNA:increased expression:epicardial fat (human)
RGD
PMID:28367087
RGD:401842368
NCBI chr 7:115,542,774...115,600,945
Ensembl chr 7:113,663,202...113,720,848
G
Tap1
transporter 1, ATP binding cassette subfamily B member
ISO
GAD
PMID:15118671
RGD:1331525
NCBI chr20:4,658,171...4,668,543
Ensembl chr20:4,656,263...4,666,901
G
Tbx2
T-box transcription factor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:35590109
NCBI chr10:71,177,082...71,186,275
Ensembl chr10:70,679,518...70,688,529
G
Tcf21
transcription factor 21
susceptibility
ISO
CTD Direct Evidence: marker/mechanism DNA:SNP: (rs12190287) (human)
CTD RGD
PMID:21378990 PMID:22751097 PMID:26909569
RGD:329337364
NCBI chr 1:24,520,499...24,523,358
Ensembl chr 1:22,701,353...22,704,202
G
Tek
TEK receptor tyrosine kinase
ISO
protein:increased expression:plasma
RGD
PMID:12814387
RGD:1601489
NCBI chr 5:114,722,815...114,849,535
Ensembl chr 5:109,607,077...109,733,804
G
Tert
telomerase reverse transcriptase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16890917
NCBI chr 1:31,465,766...31,488,650
Ensembl chr 1:29,637,506...29,659,561
G
Tgfb1
transforming growth factor, beta 1
ISO
GAD
PMID:15118671
RGD:1331525
NCBI chr 1:90,324,312...90,340,627
Ensembl chr 1:81,196,532...81,212,847
G
Thbd
thrombomodulin
severity
ISO
RGD
PMID:17012137
RGD:1601638
NCBI chr 3:156,316,526...156,320,178
Ensembl chr 3:135,862,835...135,867,193
G
Tll1
tolloid-like 1
severity
ISO
associated with type 2 diabetes:DNA:SNP:CDS:rs1503298 (human)
RGD
PMID:21911782
RGD:155883159
NCBI chr16:30,275,492...30,476,673
Ensembl chr16:25,509,146...25,709,543
G
Tlr4
toll-like receptor 4
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:20524934 PMID:15632890
RGD:1580736
NCBI chr 5:85,161,247...85,174,882
Ensembl chr 5:80,145,826...80,159,628
G
Tnf
tumor necrosis factor
ISO
RGD
PMID:15059615
RGD:1626412
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,622,011...3,624,629
G
Tnfrsf11b
TNF receptor superfamily member 11B
ISO
protein:increased expression:serum
RGD
PMID:15926884
RGD:1620893
NCBI chr 7:87,456,318...87,484,324
Ensembl chr 7:85,566,520...85,594,538
G
Tnfrsf1a
TNF receptor superfamily member 1A
severity
ISO
RGD
PMID:19845893
RGD:5131425
NCBI chr 4:159,837,119...159,849,817
Ensembl chr 4:158,150,820...158,163,591
G
Tnni3
troponin I3, cardiac type
ISO
RGD
PMID:12221049
RGD:1580780
NCBI chr 1:78,342,571...78,346,255
Ensembl chr 1:69,299,900...69,303,580
G
Tp53
tumor protein p53
ISO
DNA:misssense mutation: :p.R72P (rs1042522) (human)
RGD
PMID:29482350
RGD:14995930
NCBI chr10:54,798,871...54,810,300
Ensembl chr10:54,300,048...54,311,524
G
Traf6
TNF receptor associated factor 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20524934
NCBI chr 3:108,418,537...108,443,330
Ensembl chr 3:87,963,514...87,983,507
G
Trib1
tribbles pseudokinase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24097064
NCBI chr 7:93,096,001...93,102,547
Ensembl chr 7:91,206,579...91,214,731
G
Ttn
titin
ISO
RGD
PMID:12221049
RGD:1580780
NCBI chr 3:82,059,648...82,332,130
Ensembl chr 3:61,652,439...61,924,741
G
Twist1
twist family bHLH transcription factor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:34961328
NCBI chr 6:56,402,309...56,404,303
Ensembl chr 6:50,674,678...50,677,653
G
Vamp5
vesicle-associated membrane protein 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:34961328
NCBI chr 4:105,982,004...105,993,247
Ensembl chr 4:104,423,820...104,426,212
G
Vamp8
vesicle-associated membrane protein 8
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:34961328
NCBI chr 4:106,000,570...106,011,081
Ensembl chr 4:104,442,393...104,452,897
G
Vdr
vitamin D receptor
severity
ISO
DNA:SNP (human)
RGD
PMID:9761785
RGD:4889864
NCBI chr 7:130,864,764...130,916,757
Ensembl chr 7:128,987,981...129,037,677
G
Vegfa
vascular endothelial growth factor A
ISO
CTD Direct Evidence: marker/mechanism|therapeutic
CTD RGD
PMID:14668888 PMID:15937083 PMID:15754021
RGD:1580569
NCBI chr 9:22,452,854...22,468,194
Ensembl chr 9:14,955,300...14,970,641
G
Vim
vimentin
ISO
protein:increased expression:monocyte
RGD
PMID:21938407
RGD:6480617
NCBI chr17:81,577,261...81,585,746
Ensembl chr17:76,668,647...76,677,187
G
Vtn
vitronectin
ISO
RGD
PMID:15678274
RGD:1580816
NCBI chr10:63,892,782...63,895,862
Ensembl chr10:63,394,719...63,397,810
G
Wdr12
WD repeat domain 12
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21378990
NCBI chr 9:68,969,547...68,996,811
Ensembl chr 9:61,475,517...61,502,469
G
Wrn
WRN RecQ like helicase
ISO
RGD
PMID:11186893
RGD:1580824
NCBI chr16:65,466,552...65,602,951
Ensembl chr16:58,763,504...58,895,450
G
Xrcc1
X-ray repair cross complementing 1
onset
ISO
DNA:polymorphism:: (rs1799782) (human)
RGD
PMID:24315498
RGD:401850782
NCBI chr 1:89,268,721...89,296,619
Ensembl chr 1:80,141,207...80,168,701
G
Xrcc3
X-ray repair cross complementing 3
susceptibility
ISO
DNA:SNP,haplotypes:exon 7: p.T241M (rs861539) (Human)
RGD
PMID:23368530
RGD:401827273
NCBI chr 6:136,684,558...136,694,822
Ensembl chr 6:130,863,959...130,872,444
G
Zc3hc1
zinc finger, C3HC-type containing 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21378990
NCBI chr 4:59,957,402...59,979,336
Ensembl chr 4:58,989,987...59,011,933
G
Zfyve21
zinc finger FYVE-type containing 21
ISO
ClinVar Annotator: match by term: Premature coronary artery atherosclerosis
ClinVar
PMID:25741868
NCBI chr 6:136,695,132...136,715,601
Ensembl chr 6:130,873,912...130,894,411
G
Mef2a
myocyte enhancer factor 2a
ISO
ClinVar Annotator: match by term: Coronary artery disease, autosomal dominant, 1 | ClinVar Annotator: match by term: Coronary artery disease/myocardial infarction CTD Direct Evidence: marker/mechanism
OMIM ClinVar CTD
PMID:14645853 PMID:15496429 PMID:15841183 PMID:25741868
NCBI chr 1:130,258,083...130,392,819
Ensembl chr 1:120,850,080...120,981,948
G
Cad
carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase
ISO
ClinVar Annotator: match by term: Coronary artery disease, autosomal dominant 2
ClinVar
PMID:25741868 PMID:28492532
NCBI chr 6:31,012,091...31,035,098
Ensembl chr 6:25,292,133...25,319,861
G
Lrp6
LDL receptor related protein 6
ISO
ClinVar Annotator: match by term: Coronary artery disease, autosomal dominant 2 CTD Direct Evidence: marker/mechanism
OMIM ClinVar CTD
PMID:17332414 PMID:23703864 PMID:25741868 PMID:27713038 PMID:28492532 PMID:31589614 PMID:33118644 More...
NCBI chr 4:168,997,937...169,131,716
Ensembl chr 4:167,270,353...167,400,497
G
Ccl2
C-C motif chemokine ligand 2
ISO
ClinVar Annotator: match by term: Coronary artery disease, development of, in HIV
ClinVar
PMID:11500196 PMID:15466648 PMID:16352737 PMID:16596675 PMID:18940815
NCBI chr10:67,503,077...67,504,875
Ensembl chr10:67,005,424...67,007,226
G
Arhgap9
Rho GTPase activating protein 9
ISO
ClinVar Annotator: match by term: Coronary artery spasm 3, susceptibility to CTD Direct Evidence: marker/mechanism
ClinVar CTD
PMID:19911011
NCBI chr 7:65,034,023...65,042,336
Ensembl chr 7:63,148,900...63,157,524
G
Nos3
nitric oxide synthase 3
ISO
CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Coronary artery spasm 1, susceptibility to
CTD ClinVar
PMID:9737779 PMID:9894802 PMID:10359729 PMID:10475066 PMID:10510054 PMID:10514107 PMID:11026457 PMID:11354626 PMID:11394896 PMID:11745998 PMID:15007011 PMID:16059745 PMID:16813604 PMID:17165044 PMID:24033266 PMID:25741868 More...
NCBI chr 4:11,686,088...11,706,604
Ensembl chr 4:10,793,834...10,814,166
G
Pon1
paraoxonase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11810302
NCBI chr 4:34,261,312...34,292,327
Ensembl chr 4:33,294,722...33,321,360
G
Abca1
ATP binding cassette subfamily A member 1
ISO
ClinVar Annotator: match by term: Early-onset coronary artery disease
ClinVar
NCBI chr 5:72,473,676...72,596,563
Ensembl chr 5:67,681,297...67,801,170
G
Abcg5
ATP binding cassette subfamily G member 5
ISO
CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Early-onset coronary artery disease
CTD ClinVar
PMID:19060911 PMID:28492532
NCBI chr 6:15,717,936...15,743,376
Ensembl chr 6:9,965,118...9,990,563
G
Abcg8
ATP binding cassette subfamily G member 8
ISO
ClinVar Annotator: match by term: Early-onset coronary artery disease
ClinVar
PMID:11452359 PMID:15375183 PMID:16029460 PMID:16199547 PMID:28492532
NCBI chr 6:15,698,448...15,717,730
Ensembl chr 6:9,945,629...9,964,912
G
Abo
ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase
ISO
ClinVar Annotator: match by term: Three Vessel Coronary Disease
ClinVar
PMID:25741868
NCBI chr 3:30,560,172...30,604,758
Ensembl chr 3:10,162,096...10,191,423
G
Ace
angiotensin I converting enzyme
susceptibility
ISO
DNA:deletion:intron:IVS16+1464-1751del (human) CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:8170965 PMID:9488209
RGD:8142364
NCBI chr10:91,410,129...91,430,246
Ensembl chr10:90,910,316...90,931,131
G
Ace2
angiotensin converting enzyme 2
susceptibility
ISO
associated with Diabetes Mellitus, Non-Insulin-Dependent;DNA:polymorphism: :8790G>A (human)
RGD
PMID:18753062
RGD:2313798
NCBI chr X:33,925,458...33,972,851
Ensembl chr X:30,293,589...30,340,977
G
Ada
adenosine deaminase
ISO
protein:increased expression:leukocyte
RGD
PMID:17259686
RGD:1624286
NCBI chr 3:172,818,174...172,842,283
Ensembl chr 3:152,398,747...152,447,088
G
Adamts13
ADAM metallopeptidase with thrombospondin type 1 motif, 13
ISO
protein:decreased activity:plasma (human) ClinVar Annotator: match by term: Three Vessel Coronary Disease
ClinVar RGD
PMID:25741868 PMID:28492532 PMID:12670342
RGD:10449044
NCBI chr 3:30,697,354...30,736,539
Ensembl chr 3:10,300,028...10,346,687
G
Adamts7
ADAM metallopeptidase with thrombospondin type 1 motif, 7
ISO
ClinVar Annotator: match by term: Three Vessel Coronary Disease
ClinVar
PMID:25741868
NCBI chr 8:99,584,529...99,624,132
Ensembl chr 8:90,704,727...90,744,328
G
Adipoq
adiponectin, C1Q and collagen domain containing
disease_progression
ISO
associated with Diabetes mellitus, Type2;
RGD
PMID:22207678 PMID:22019747
RGD:5686379 , RGD:5686406
NCBI chr11:91,226,524...91,240,244
Ensembl chr11:77,721,912...77,735,564
G
Adrb2
adrenoceptor beta 2
susceptibility
ISO
DNA:polymorphism: :p.Q27E
RGD
PMID:12682000
RGD:1601128
NCBI chr18:57,912,760...57,914,802
Ensembl chr18:55,502,903...55,644,512
G
Adrb3
adrenoceptor beta 3
susceptibility
ISO
associated with Diabetes Mellitus, Type 2; DNA:missense mutation:cds:p.W64R rs4994(human)
RGD GAD
PMID:10421225 PMID:20536507 PMID:15118671
RGD:1559326 , RGD:5684776 , RGD:1331525
NCBI chr16:71,544,603...71,547,410
Ensembl chr16:64,841,788...64,844,552
G
Ager
advanced glycosylation end product-specific receptor
susceptibility
ISO
protein:decreased expression:plasma (human) associated with Heart Failure; protein:increased expression:plasma (human)
RGD
PMID:23396398 PMID:20685687
RGD:7243186 , RGD:7244134
NCBI chr20:4,152,758...4,155,956
Ensembl chr20:4,147,890...4,151,078
G
Agtr1a
angiotensin II receptor, type 1a
susceptibility no_association
ISO
DNA:polymorphism:3' utr:1166A>C DNA:polymorphism:3' utr:1166A>C (human)
RGD
PMID:9456365 PMID:9857918
RGD:1601152 , RGD:1566499
NCBI chr17:34,383,397...34,435,523
Ensembl chr17:34,174,429...34,226,946
G
Agxt2
alanine-glyoxylate aminotransferase 2
ISO
DNA:missense mutation:cds:V140I (rs37369)(human)
RGD
PMID:24834905
RGD:329961320
NCBI chr 2:61,063,416...61,104,828
Ensembl chr 2:59,336,283...59,377,926
G
Apoa4
apolipoprotein A4
susceptibility no_association
ISO
DNA:missense mutation:cds:p.T347S (human)
RGD
PMID:12676816 PMID:9013087
RGD:1578411 , RGD:5685683
NCBI chr 8:55,435,779...55,438,160
Ensembl chr 8:46,539,082...46,541,469
G
Apob
apolipoprotein B
ISO
CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Early-onset coronary artery disease
CTD ClinVar
PMID:17658632
NCBI chr 6:36,563,704...36,603,300
Ensembl chr 6:30,844,368...30,892,497
G
Apoc2
apolipoprotein C2
susceptibility
ISO
RGD
PMID:7590197
RGD:1601205
NCBI chr 1:88,457,397...88,462,365
Ensembl chr 1:79,329,428...79,334,476
G
Apoc3
apolipoprotein C3
no_association susceptibility
ISO
DNA:polymorphism:promoter:-482C>T ClinVar Annotator: match by term: Coronary heart disease associated with Diabetes Mellitus, Non-Insulin-Dependent
ClinVar RGD
PMID:9536098 PMID:11060345 PMID:17576681 PMID:19074352 PMID:20097930 PMID:23701270 PMID:24941081 PMID:24941082 PMID:25225788 PMID:25741868 PMID:25962519 PMID:27114411 PMID:28406212 PMID:28492532 PMID:28825717 PMID:29237685 PMID:30255797 PMID:32041611 PMID:34548093 PMID:36325899 PMID:36876364 PMID:16321685 PMID:17654446 More...
RGD:1601224 , RGD:2306754
NCBI chr 8:55,428,172...55,430,352
Ensembl chr 8:46,531,478...46,533,583
G
Apoe
apolipoprotein E
onset
ISO
DNA:polymorphisms, haplotype:promoter, cds:g.-219G>T, p.C112R, p.R158C (human) CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:10736278 PMID:11862316 PMID:11862316
RGD:1578479 , RGD:1578479
NCBI chr 1:88,481,889...88,485,816
Ensembl chr 1:79,353,916...79,357,932
G
Ccdc92
coiled-coil domain containing 92
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28869590
NCBI chr12:37,457,676...37,484,080
Ensembl chr12:31,796,684...31,823,337
G
Ccr5
C-C motif chemokine receptor 5
resistance
ISO
DNA:polymorphisms:multiple (human)
RGD
PMID:16055130
RGD:1581176
NCBI chr 8:132,629,097...132,660,980
Ensembl chr 8:123,752,325...123,759,260
G
Cd14
CD14 molecule
ISO
protein:increased expression:monocyte
RGD
PMID:10831941
RGD:2314175
NCBI chr18:28,609,558...28,611,409
Ensembl chr18:28,335,340...28,337,261
G
Cd36
CD36 molecule
ISO
mRNA:increased expression:monocyte ClinVar Annotator: match by term: CORONARY HEART DISEASE, SUSCEPTIBILITY TO, 7 | ClinVar Annotator: match by term: Coronary heart disease, susceptibility to, 7 CTD Direct Evidence: marker/mechanism
OMIM ClinVar CTD RGD
PMID:25741868 PMID:28960434 PMID:33116287 PMID:18067591
RGD:6893507
NCBI chr 4:18,209,088...18,302,142
Ensembl chr 4:17,354,466...17,513,903
G
Cd40lg
CD40 ligand
treatment
IDA
RGD
PMID:23819214
RGD:7248750
NCBI chr X:140,164,341...140,176,057
Ensembl chr X:135,126,969...135,138,306
G
Cdkn2b
cyclin-dependent kinase inhibitor 2B
ISO
ClinVar Annotator: match by term: Three Vessel Coronary Disease
ClinVar
PMID:25741868
NCBI chr 5:109,123,308...109,134,906
Ensembl chr 5:104,010,680...104,019,050
G
Cx3cr1
C-X3-C motif chemokine receptor 1
ISO
DNA:polymorphism: :p.V249I (human) CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Coronary heart disease, susceptibility to, 1
CTD OMIM ClinVar RGD
PMID:25741868 PMID:11532900
RGD:4891901
NCBI chr 8:128,661,294...128,679,048
Ensembl chr 8:119,782,595...119,800,014
G
Cyba
cytochrome b-245 alpha chain
ISO
RGD
PMID:10488959
RGD:1580275
NCBI chr19:67,396,143...67,404,214
Ensembl chr19:50,487,597...50,495,721
G
Cyp2j4
cytochrome P450, family 2, subfamily j, polypeptide 4
resistance
ISO
DNA:polymorphism:promoter:-50G>T (human)
RGD
PMID:17429317
RGD:1625377
NCBI chr 5:116,295,691...116,323,219
Ensembl chr 5:111,178,703...111,244,794
G
Dab2ip
DAB2 interacting protein
ISO
DNA:SNP:CDS:rs7025486 (human)
RGD
PMID:21444365
RGD:401938618
NCBI chr 3:39,312,745...39,483,730
Ensembl chr 3:18,915,290...19,086,280
G
Dnah11
dynein, axonemal, heavy chain 11
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19060911
NCBI chr 6:144,982,130...145,298,523
Ensembl chr 6:138,839,177...139,155,536
G
Ephx2
epoxide hydrolase 2
ISO
RGD
PMID:16595607
RGD:1580981
NCBI chr15:44,465,447...44,503,157
Ensembl chr15:40,289,902...40,327,615
G
Esr2
estrogen receptor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17367797
NCBI chr 6:100,589,553...100,645,240
Ensembl chr 6:94,809,547...94,908,919
G
F12
coagulation factor XII
ISO
protein:decreased activity::
RGD
PMID:18021303
RGD:11041785
NCBI chr17:9,212,819...9,220,664
Ensembl chr17:9,207,683...9,215,530
G
F13a1
coagulation factor XIII A1 chain
ISO
RGD
PMID:11391716
RGD:1581030
NCBI chr17:28,021,197...28,197,960
Ensembl chr17:27,815,702...27,992,700
G
Fgf2
fibroblast growth factor 2
ISO
associated with Diabetes Mellitus
RGD
PMID:15451784
RGD:2315870
NCBI chr 2:122,164,454...122,218,796
Ensembl chr 2:120,236,328...120,291,221
G
Flt1
Fms related receptor tyrosine kinase 1
ISO
mRNA, protein:increased expression:ventricle myocardium
RGD
PMID:16139132
RGD:2313728
NCBI chr12:12,333,050...12,504,750
Ensembl chr12:7,297,292...7,468,626
G
Fto
FTO, alpha-ketoglutarate dependent dioxygenase
ISO
DNA:SNP: :rs9939609 (human)
RGD
PMID:26555680
RGD:11555922
NCBI chr19:31,456,749...31,865,011
Ensembl chr19:15,349,696...15,692,083
G
G6pd
glucose-6-phosphate dehydrogenase
ISO
ClinVar Annotator: match by term: Early-onset coronary artery disease
ClinVar
PMID:1945893 PMID:3198117 PMID:6805883 PMID:7803800 PMID:8244337 PMID:8471773 PMID:9589612 PMID:10502785 PMID:11601226 PMID:12064920 PMID:15727905 PMID:16329560 PMID:16607506 PMID:25741868 PMID:28492532 PMID:29300386 PMID:29339739 PMID:30045279 PMID:30315739 PMID:31489982 PMID:31863082 PMID:33051526 PMID:33072997 PMID:34659341 PMID:34762759 PMID:34895177 PMID:35313968 PMID:35840819 PMID:36353116 More...
NCBI chr X:157,352,364...157,372,144
Ensembl chr X:152,201,098...152,220,801
G
Ggt1
gamma-glutamyltransferase 1
ISO
associated with Diabetes Mellitus, Non-Insulin-Dependent; protein:increased activity:serum
RGD
PMID:16772340
RGD:2315604
NCBI chr20:13,074,141...13,103,551
Ensembl chr20:13,074,700...13,108,442
G
Glul
glutamate-ammonia ligase
ISO
associated with type 2 diabetes mellitus;DNA:SNP: :rs10911021 (human)
RGD
PMID:23982368
RGD:401794410
NCBI chr13:68,519,500...68,585,554
Ensembl chr13:66,025,630...66,035,108
G
Gp1ba
glycoprotein Ib platelet subunit alpha
ISO
RGD
PMID:14592833
RGD:1580433
NCBI chr10:55,831,901...55,856,729
Ensembl chr10:55,352,899...55,356,774
G
Gp6
glycoprotein VI
treatment exacerbates
ISO
protein:increased expression:venous blood, platelet (human) DNA:hypomethylation:promoter
RGD
PMID:17105818 PMID:20049463 PMID:31783053
RGD:401794440 , RGD:401824649 , RGD:401824645
NCBI chr 1:78,471,900...78,535,374
Ensembl chr 1:69,465,789...69,491,326
G
Hmgcr
3-hydroxy-3-methylglutaryl-CoA reductase
disease_progression
ISO
RGD
PMID:15809366
RGD:5508474
NCBI chr 2:29,732,163...29,754,276
Ensembl chr 2:27,997,525...28,019,703
G
Hmox1
heme oxygenase 1
ISO
RGD
PMID:15869055
RGD:1598404
NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,467,244...13,474,079
G
Hnf1a
HNF1 homeobox A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28869590
NCBI chr12:47,299,171...47,333,457
Ensembl chr12:41,645,587...41,672,104
G
Hp
haptoglobin
severity
ISO
RGD
PMID:16673012
RGD:1626344
NCBI chr19:54,449,151...54,453,701
Ensembl chr19:37,539,627...37,544,523
G
Hspa1a
heat shock protein family A (Hsp70) member 1A
ISO
DNA:SNPs: : -110A>C (rs1008438), 190G>C (rs1043618) (human)
RGD
PMID:19333379
RGD:7257652
NCBI chr20:3,875,411...3,877,866
Ensembl chr20:3,856,006...3,873,227
G
Hspd1
heat shock protein family D (Hsp60) member 1
ISO
RGD
PMID:12059985
RGD:1624217
NCBI chr 9:64,073,610...64,084,332
Ensembl chr 9:56,579,201...56,589,662
G
Igf1
insulin-like growth factor 1
ISO
RGD
PMID:15521962
RGD:1626121
NCBI chr 7:24,169,608...24,249,446
Ensembl chr 7:22,282,930...22,359,296
G
Igfals
insulin-like growth factor binding protein, acid labile subunit
ISO
RGD
PMID:15521962
RGD:1626121
NCBI chr10:14,397,076...14,408,439
Ensembl chr10:13,898,395...13,902,677
G
Igfbp3
insulin-like growth factor binding protein 3
ISO
RGD
PMID:15521962
RGD:1626121
NCBI chr14:86,270,208...86,277,944
Ensembl chr14:82,056,347...82,064,083
G
Igfbp5
insulin-like growth factor binding protein 5
ISO
RGD
PMID:15521962
RGD:1626121
NCBI chr 9:81,901,605...81,914,187
Ensembl chr 9:74,448,382...74,465,156
G
Ikbkg
inhibitor of nuclear factor kappa B kinase regulatory subunit gamma
ISO
ClinVar Annotator: match by term: Early-onset coronary artery disease
ClinVar
PMID:1945893 PMID:3198117 PMID:6805883 PMID:7803800 PMID:8244337 PMID:8471773 PMID:9589612 PMID:10502785 PMID:11601226 PMID:12064920 PMID:15727905 PMID:16329560 PMID:16607506 PMID:25741868 PMID:28492532 PMID:29300386 PMID:29339739 PMID:30045279 PMID:30315739 PMID:31489982 PMID:31863082 PMID:33051526 PMID:33072997 PMID:34659341 PMID:34762759 PMID:34895177 PMID:35313968 PMID:35840819 PMID:36353116 More...
NCBI chr X:157,358,279...157,397,563
Ensembl chr X:152,216,596...152,239,499
G
Il18
interleukin 18
ISO
ClinVar Annotator: match by term: Three Vessel Coronary Disease
ClinVar
PMID:25741868
NCBI chr 8:59,802,072...59,829,275
Ensembl chr 8:50,906,960...50,932,887
G
Il1b
interleukin 1 beta
ISO
DNA:polymorphism
RGD
PMID:15379752
RGD:1626636
NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:116,577,010...116,583,415
G
Irf8
interferon regulatory factor 8
susceptibility
ISO
DNA:SNPs:intron 4, intron 2: (rs925994,rs10514610) (human)
RGD
PMID:23661672
RGD:329902076
NCBI chr19:65,699,284...65,721,066
Ensembl chr19:48,790,588...48,811,829
G
Irs1
insulin receptor substrate 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28869590
NCBI chr 9:91,001,137...91,053,959
Ensembl chr 9:83,548,944...83,606,122
G
Itga2
integrin subunit alpha 2
no_association
ISO
RGD
PMID:9684730
RGD:1582306
NCBI chr 2:48,253,412...48,354,509
Ensembl chr 2:46,523,948...46,621,481
G
Itgam
integrin subunit alpha M
exacerbates
ISO
protein:increased expression:monocyte (human)
RGD
PMID:20876457
RGD:329901842
NCBI chr 1:192,089,496...192,139,947
Ensembl chr 1:182,659,000...182,709,503
G
Itgb3
integrin subunit beta 3
ISO
DNA:polymorphism:exon
RGD
PMID:10583927
RGD:5128478
NCBI chr10:90,009,927...90,067,787
Ensembl chr10:89,509,989...89,564,679
G
Kalrn
kalirin, RhoGEF kinase
ISO
ClinVar Annotator: match by term: Coronary heart disease, susceptibility to, 5
ClinVar
PMID:17357071 PMID:25741868
NCBI chr11:79,703,345...80,309,210
Ensembl chr11:66,198,173...66,797,610
G
Kat2b
lysine acetyltransferase 2B
severity
ISO
DNA:snp:promoter:g.-2481G>C (human)
RGD
PMID:21062767
RGD:9590309
NCBI chr 9:6,799,101...6,903,616
Ensembl chr 9:6,562,288...6,667,064
G
Kcnj8
potassium inwardly-rectifying channel, subfamily J, member 8
no_association
ISO
RGD
PMID:12964027
RGD:1581699
NCBI chr 4:177,240,692...177,246,548
Ensembl chr 4:175,508,912...175,515,603
G
Kdr
kinase insert domain receptor
ISO
mRNA, protein:increased expression:ventricle myocardium
RGD
PMID:16139132
RGD:2313728
NCBI chr14:32,572,031...32,615,204
Ensembl chr14:32,217,871...32,261,018
G
Ldlr
low density lipoprotein receptor
ISO
CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Early-onset coronary artery disease
CTD ClinVar
PMID:9430375 PMID:9712531 PMID:10422804 PMID:11810272 PMID:11845603 PMID:17765246 PMID:19318025 PMID:20506408 PMID:21382890 PMID:21642693 PMID:22390909 PMID:23375686 PMID:24033266 PMID:25487149 PMID:25647241 PMID:25741868 PMID:26467025 PMID:28161202 PMID:28492532 PMID:28895539 PMID:29353225 PMID:29396260 PMID:30293936 PMID:30312929 PMID:30637778 PMID:30971288 PMID:32719484 PMID:33418990 PMID:33454241 PMID:33740630 PMID:34037665 PMID:35339733 PMID:35568682 PMID:35910211 PMID:36105085 PMID:36499307 PMID:37409534 PMID:37589137 More...
NCBI chr 8:28,546,191...28,569,075
Ensembl chr 8:20,270,041...20,294,580
G
Lepr
leptin receptor
onset
ISO
DNA:SNP: C>T (rs6656451) (human)
RGD
PMID:29848931
RGD:401799677
NCBI chr 5:121,409,735...121,593,201
Ensembl chr 5:116,289,823...116,475,908
G
Lgals2
galectin 2
susceptibility
ISO
RGD
PMID:17040205
RGD:1581853
NCBI chr 7:112,283,630...112,290,228
Ensembl chr 7:110,403,173...110,404,802
G
Lipc
lipase C, hepatic type
susceptibility
ISO
associated with Obesity and Diabetes; DNA:transition:promoter:-514C>T (human)
RGD
PMID:16570154
RGD:2308824
NCBI chr 8:80,390,470...80,516,463
Ensembl chr 8:71,509,635...71,635,464
G
Lpl
lipoprotein lipase
IEP ISO
ClinVar Annotator: match by term: Coronary heart disease
ClinVar RGD
PMID:8199176 PMID:8541837 PMID:8872057 PMID:10364086 PMID:10517255 PMID:21146168 PMID:24033266 PMID:25741868 PMID:28492532 PMID:27000070 More...
RGD:13794381
NCBI chr16:25,596,205...25,621,928
Ensembl chr16:20,829,465...20,855,249
G
Lrp1
LDL receptor related protein 1
susceptibility
ISO
RGD
PMID:15121769
RGD:1581911
NCBI chr 7:65,265,639...65,346,196
Ensembl chr 7:63,380,356...63,460,910
G
Maco1
macoilin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19060911
NCBI chr 5:152,296,107...152,358,684
Ensembl chr 5:147,012,867...147,075,001
G
Mb
myoglobin
severity
ISO
RGD
PMID:15976963
RGD:1582388
NCBI chr 7:110,640,511...110,647,742
Ensembl chr 7:108,759,904...108,767,383
G
Mgp
matrix Gla protein
susceptibility
ISO
RGD
PMID:16973975
RGD:1582502
NCBI chr 4:171,497,472...171,500,888
Ensembl chr 4:169,766,279...169,769,667
G
Mif
macrophage migration inhibitory factor
IEP
coronary occlusion; mRNA:increased expression:myocardium
RGD
PMID:20367970
RGD:4890973
NCBI chr20:12,767,138...12,791,222
Ensembl chr20:12,790,902...12,799,504 Ensembl chr 4:12,790,902...12,799,504
G
Mlxip
MLX interacting protein
susceptibility
ISO
DNA:SNP:3'utr: (rs4758685) (human)
RGD
PMID:23840567
RGD:401794443
NCBI chr12:38,789,404...38,853,059
Ensembl chr12:33,128,520...33,192,374
G
Mlxipl
MLX interacting protein-like
susceptibility
ISO
DNA:SNP: (rs35493868); in younger than 55 years of age
RGD
PMID:29848931
RGD:401799677
NCBI chr12:27,178,158...27,213,675
Ensembl chr12:21,543,576...21,577,112
G
Mmp1
matrix metallopeptidase 1
susceptibility
ISO
DNA:insertion:promoter:g.-1607insG (human)
RGD
PMID:14499230
RGD:1582537
NCBI chr 8:12,943,453...12,963,966
Ensembl chr 8:4,658,588...4,679,097
G
Mmp3
matrix metallopeptidase 3
susceptibility
ISO
ClinVar Annotator: match by term: Coronary heart disease, susceptibility to, 6 | ClinVar Annotator: match by term: MMP3-related condition CTD Direct Evidence: marker/mechanism
OMIM ClinVar CTD
PMID:7727178 PMID:8662692 PMID:9699891 PMID:10190398 PMID:10351963 PMID:12477941 PMID:12485468 PMID:25741868 PMID:28492532 More...
NCBI chr 8:12,925,267...12,938,828
Ensembl chr 8:4,640,416...4,653,961
G
Mras
muscle RAS oncogene homolog
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28869590
NCBI chr 8:108,823,374...108,886,104
Ensembl chr 8:99,944,036...99,996,408
G
Mthfr
methylenetetrahydrofolate reductase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16792904
NCBI chr 5:163,748,346...163,768,141
Ensembl chr 5:158,465,296...158,483,797
G
Mttp
microsomal triglyceride transfer protein
susceptibility
ISO
DNA:polymorphism:promoter:-493G>T
RGD
PMID:15136504
RGD:1625487
NCBI chr 2:229,286,501...229,327,650
Ensembl chr 2:226,613,090...226,654,239
G
Myh15
myosin, heavy chain 15
ISO
DNA:snp:exon:EX28T>C rs3900940 (human)
RGD
PMID:18073581
RGD:2317145
NCBI chr11:65,084,666...65,226,010
Ensembl chr11:51,622,413...51,762,971
G
Nr1h3
nuclear receptor subfamily 1, group H, member 3
exacerbates
ISO
mRNA:decreased expression:peripheral blood mononuclear cell (human) mRNA:increased expression:peripheral blood mononuclear cell (human)
RGD
PMID:16252156 PMID:19211025
RGD:401827902 , RGD:401850788
NCBI chr 3:97,614,616...97,632,053
Ensembl chr 3:77,158,808...77,168,722
G
Oaz1
ornithine decarboxylase antizyme 1
susceptibility
ISO
DNA:SNP:intron:c.2222A>G (rs2074458) (human)
RGD
PMID:17761941
RGD:401851037
NCBI chr 7:9,534,530...9,536,990
Ensembl chr 7:8,883,851...8,886,310
G
Pcsk9
proprotein convertase subtilisin/kexin type 9
susceptibility
ISO
DNA:missense mutation, nonsense mutations:cds:p.R46L, p.Y142X, p.C679X (human)
RGD
PMID:16554528
RGD:1581000
NCBI chr 5:126,440,102...126,462,507
Ensembl chr 5:121,211,278...121,233,688
G
Pecam1
platelet and endothelial cell adhesion molecule 1
ISO
ClinVar Annotator: match by term: Three Vessel Coronary Disease
ClinVar
PMID:8532023
NCBI chr10:92,090,263...92,152,002
Ensembl chr10:91,590,521...91,652,116
G
Phactr1
phosphatase and actin regulator 1
no_association susceptibility
ISO
DNA:SNP:intron 3: (rs12526453) (human) associated with type 2 diabetes mellitus;DNA:SNP:intron: (rs12526453) (human)
RGD
PMID:28287809 PMID:22152955
RGD:401901081 , RGD:11055500
NCBI chr17:21,769,006...22,246,227
Ensembl chr17:21,562,721...22,039,831
G
Pla2g7
phospholipase A2 group VII
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:21356620 PMID:15699277
RGD:6482780
NCBI chr 9:24,859,491...24,901,747
Ensembl chr 9:17,362,225...17,404,476
G
Plau
plasminogen activator, urokinase
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:1730212 PMID:9181759
NCBI chr15:3,505,485...3,511,987
Ensembl chr15:3,456,232...3,462,775
G
Pltp
phospholipid transfer protein
susceptibility
ISO
protein:increased expression:serum (human)
RGD
PMID:14695459
RGD:1581038
NCBI chr 3:173,994,162...174,011,982
Ensembl chr 3:153,574,825...153,592,647
G
Pon1
paraoxonase 1
severity no_association
ISO
protein:decreased expression:serum ClinVar Annotator: match by term: Coronary artery disease, susceptibility to CTD Direct Evidence: marker/mechanism DNA:missense mutation:cds:p.Q192R (human) associated with Diabetes Mellitus, Type 2;DNA:missense mutation:cds:p.Q192R (human)
ClinVar CTD RGD
PMID:7916578 PMID:8098250 PMID:8675673 PMID:8770857 PMID:9011577 PMID:9215303 PMID:9385372 PMID:9443884 PMID:9661650 PMID:11238489 PMID:11335891 PMID:11788650 PMID:11810302 PMID:11888590 PMID:11889198 PMID:11918623 PMID:12082503 PMID:15241482 PMID:16353344 PMID:16882531 PMID:21170047 PMID:25741868 PMID:19005291 PMID:15214960 PMID:9215303 More...
RGD:2313267 , RGD:8547675 , RGD:1580201
NCBI chr 4:34,261,312...34,292,327
Ensembl chr 4:33,294,722...33,321,360
G
Pon2
paraoxonase 2
susceptibility
ISO
DNA:missense mutation:cds:p.C311S (human)
RGD
PMID:9443862
RGD:1580216
NCBI chr 4:34,356,270...34,391,684
Ensembl chr 4:33,389,714...33,425,248
G
Ppbp
pro-platelet basic protein
ISO
associated with menopause; mRNA,protein:increased expression:peripheral blood mononuclear cell ,plasma
RGD
PMID:35734636
RGD:401794436
NCBI chr14:17,586,495...17,587,299
Ensembl chr14:17,302,326...17,303,130
G
Rbp4
retinol binding protein 4
ISO
protein:increased expression:blood plasma (human)
RGD
PMID:23584360
RGD:329845574
NCBI chr 1:245,306,349...245,313,551
Ensembl chr 1:235,893,917...235,901,399
G
Retn
resistin
ISO
protein:increased expression:blood
RGD
PMID:17175295
RGD:7207156
NCBI chr12:6,508,653...6,511,115
Ensembl chr12:1,710,881...1,712,620
G
Rtel1
regulator of telomere elongation helicase 1
ameliorates
ISO
DNA:SNP:cds:rs6010620|rs4809324 (human)
RGD
PMID:30623606
RGD:152985693
NCBI chr 3:188,778,329...188,842,877
Ensembl chr 3:168,419,579...168,465,348
G
Scarb1
scavenger receptor class B, member 1
ISO
RGD
PMID:15967843
RGD:1580004
NCBI chr12:36,957,302...37,023,982
Ensembl chr12:31,296,156...31,362,647
G
Selp
selectin P
ISO
protein:altered expression:serum
RGD
PMID:11597943
RGD:1580074
NCBI chr13:79,009,379...79,044,994
Ensembl chr13:76,476,295...76,511,845
G
Serpinf2
serpin family F member 2
ISO
protein:increased expression:blood
RGD
PMID:15771120
RGD:1625529
NCBI chr10:60,770,698...60,778,782
Ensembl chr10:60,272,400...60,281,243
G
Tcf7l2
transcription factor 7 like 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28869590
NCBI chr 1:264,791,335...264,984,225
Ensembl chr 1:254,786,091...254,978,967
G
Tert
telomerase reverse transcriptase
ISO
ClinVar Annotator: match by term: Coronary artery disease, susceptibility to
ClinVar
PMID:16890917
NCBI chr 1:31,465,766...31,488,650
Ensembl chr 1:29,637,506...29,659,561
G
Thbd
thrombomodulin
ISO
associated with Diabetes Mellitus, Non-Insulin-Dependent;protein:increased expression:plasma
RGD
PMID:17200788
RGD:2312456
NCBI chr 3:156,316,526...156,320,178
Ensembl chr 3:135,862,835...135,867,193
G
Vegfa
vascular endothelial growth factor A
ISO
mRNA, protein:increased expression:ventricle myocardium
RGD
PMID:16139132
RGD:2313728
NCBI chr 9:22,452,854...22,468,194
Ensembl chr 9:14,955,300...14,970,641
G
Vkorc1
vitamin K epoxide reductase complex, subunit 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16549638
NCBI chr 1:191,932,969...191,935,490
Ensembl chr 1:182,500,844...182,505,008
G
Vwf
von Willebrand factor
ISO
RGD
PMID:11864703
RGD:1580647
NCBI chr 4:160,042,900...160,177,757
Ensembl chr 4:158,360,152...158,491,539
G
Zc3hc1
zinc finger, C3HC-type containing 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28869590
NCBI chr 4:59,957,402...59,979,336
Ensembl chr 4:58,989,987...59,011,933
G
Aldh1a2
aldehyde dehydrogenase 1 family, member A2
disease_progression
ISO
RGD
PMID:26315408
RGD:14367880
NCBI chr 8:80,758,641...80,837,891
Ensembl chr 8:71,877,850...71,957,107
G
Hspa1a
heat shock protein family A (Hsp70) member 1A
ISO
mRNA:increased expression:heart:
RGD
PMID:21439970
RGD:7257651
NCBI chr20:3,875,411...3,877,866
Ensembl chr20:3,856,006...3,873,227
G
Ace
angiotensin I converting enzyme
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:9236417
NCBI chr10:91,410,129...91,430,246
Ensembl chr10:90,910,316...90,931,131
G
Adipoq
adiponectin, C1Q and collagen domain containing
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:12138120
NCBI chr11:91,226,524...91,240,244
Ensembl chr11:77,721,912...77,735,564
G
Ahsp
alpha hemoglobin stabilizing protein
ISO
mRNA:decreased expression:blood (human)
RGD
PMID:35144391
RGD:329961301
NCBI chr 1:182,879,901...182,885,508
Ensembl chr 1:182,880,076...182,885,506
G
Bche
butyrylcholinesterase
susceptibility
ISO
DNA:polymorphism: :p.A539T (human)
RGD
PMID:17275003
RGD:2306778
NCBI chr 2:160,607,289...160,699,760
Ensembl chr 2:158,307,584...158,401,148
G
Cdh13
cadherin 13
IEP
protein:increased expression:artery, smooth muscle cell
RGD
PMID:12376824
RGD:2293553
NCBI chr19:63,258,251...64,296,122
Ensembl chr19:46,349,430...47,387,459
G
Cxcl10
C-X-C motif chemokine ligand 10
ISO
protein:increased expression:plasma
RGD
PMID:14578618
RGD:1598500
NCBI chr14:15,989,066...15,991,263
Ensembl chr14:15,704,758...15,706,975
G
Cxcr3
C-X-C motif chemokine receptor 3
ISO
RGD
PMID:14578618
RGD:1598500
NCBI chr X:70,884,293...70,886,944
Ensembl chr X:66,844,318...66,846,969
G
F2r
coagulation factor II (thrombin) receptor
ISO
RGD
PMID:14529396
RGD:1581036
NCBI chr 2:28,604,066...28,620,579
Ensembl chr 2:26,868,404...26,885,870
G
Hmox1
heme oxygenase 1
susceptibility
ISO
RGD
PMID:16020495 PMID:14529548
RGD:1598402 , RGD:1580472
NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,467,244...13,474,079
G
Itgb2
integrin subunit beta 2
ISO
RGD
PMID:11703955
RGD:1581185
NCBI chr20:11,061,009...11,097,242
Ensembl chr20:11,061,430...11,097,600
G
Lox
lysyl oxidase
IDA
RGD
PMID:15218472
RGD:1581881
NCBI chr18:48,162,889...48,175,640
Ensembl chr18:45,967,343...46,041,477
G
Mapk1
mitogen activated protein kinase 1
IDA
RGD
PMID:15583728
RGD:1582284
NCBI chr11:97,462,025...97,529,193
Ensembl chr11:83,957,813...84,023,616
G
Mbl2
mannose binding lectin 2
susceptibility
ISO
DNA:polymorphisms:5' utr, exon:multiple (human)
RGD
PMID:15790942
RGD:1582150
NCBI chr 1:237,429,873...237,465,567
G
Mmp3
matrix metallopeptidase 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:8662692
NCBI chr 8:12,925,267...12,938,828
Ensembl chr 8:4,640,416...4,653,961
G
Mmp7
matrix metallopeptidase 7
treatment
IEP
RGD
PMID:21139058
RGD:9685362
NCBI chr 8:13,133,043...13,140,761
Ensembl chr 8:4,848,186...4,855,902
G
Mthfr
methylenetetrahydrofolate reductase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16489563
NCBI chr 5:163,748,346...163,768,141
Ensembl chr 5:158,465,296...158,483,797
G
Myc
MYC proto-oncogene, bHLH transcription factor
treatment
IDA
RGD
PMID:7955204
RGD:10059621
NCBI chr 7:95,483,105...95,488,031
Ensembl chr 7:93,593,705...93,598,630
G
Npy5r
neuropeptide Y receptor Y5
IEP
mRNA, protein:increased expression:carotid artery
RGD
PMID:12689918
RGD:1625501
NCBI chr16:27,822,055...27,830,012
Ensembl chr16:23,055,427...23,063,382
G
Oaz1
ornithine decarboxylase antizyme 1
susceptibility
ISO
DNA:SNP:intron:c.2222A>G (rs2074458) (human)
RGD
PMID:17761941
RGD:401851037
NCBI chr 7:9,534,530...9,536,990
Ensembl chr 7:8,883,851...8,886,310
G
Spp1
secreted phosphoprotein 1
ISO
RGD
PMID:12114325 PMID:16373617
RGD:1581358 , RGD:1581366
NCBI chr14:5,613,569...5,620,695
Ensembl chr14:5,308,885...5,315,162
G
Tnf
tumor necrosis factor
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:16319143 PMID:16319143
RGD:1580322
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,622,011...3,624,629
G
Tp53
tumor protein p53
ISO
RGD
PMID:14740296
RGD:1580742
NCBI chr10:54,798,871...54,810,300
Ensembl chr10:54,300,048...54,311,524
G
Ucp3
uncoupling protein 3
susceptibility
ISO
DNA:polymorphism:promoter:-55C>T (human)
RGD
PMID:17786284
RGD:2313513
NCBI chr 1:164,227,910...164,240,893
Ensembl chr 1:154,815,777...154,828,762
G
Apln
apelin
ISO
protein:decreased expression:plasma
RGD
PMID:19015606
RGD:2313942
NCBI chr X:132,058,739...132,091,518
Ensembl chr X:127,203,823...127,213,391
G
Cyp2r1
cytochrome P450, family 2, subfamily r, polypeptide 1
ISO
DNA:SNP:CDS: (Rs6486205|rs10741657|rs2060793)
RGD
PMID:34262949
RGD:401901074
NCBI chr 1:178,166,984...178,232,191
Ensembl chr 1:168,751,038...168,797,759
G
Edn1
endothelin 1
treatment
ISO
RGD
PMID:10854676
RGD:8661796
NCBI chr17:22,660,799...22,666,687
Ensembl chr17:22,454,420...22,460,885
G
Hrh2
histamine receptor H 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12721106
NCBI chr17:10,371,083...10,412,979
Ensembl chr17:10,368,298...10,407,631
G
Igf1
insulin-like growth factor 1
IEP
mRNA:increased expression:myocyte:
RGD
PMID:8102103
RGD:10046053
NCBI chr 7:24,169,608...24,249,446
Ensembl chr 7:22,282,930...22,359,296
G
Igf1r
insulin-like growth factor 1 receptor
IEP
mRNA:increased expression:myocyte:
RGD
PMID:8102103
RGD:10046053
NCBI chr 1:130,959,787...131,248,664
Ensembl chr 1:121,550,743...121,831,777
G
Itgav
integrin subunit alpha V
IDA
RGD
PMID:11922905
RGD:1582454
NCBI chr 3:89,245,382...89,333,512
Ensembl chr 3:68,838,189...68,926,639
G
Lmcd1
LIM and cysteine-rich domains 1
ISO
protein:increased expression:coronary artery
RGD
PMID:32160773
RGD:243065232
NCBI chr 4:146,948,993...147,007,878
Ensembl chr 4:145,393,145...145,452,046
G
Mdk
midkine
IDA
RGD
PMID:10683378
RGD:1299187
NCBI chr 3:98,356,789...98,358,960
Ensembl chr 3:77,901,158...77,903,130
G
Myh7
myosin heavy chain 7
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12721106
NCBI chr15:32,416,525...32,439,851
Ensembl chr15:28,446,550...28,468,217
G
Nppa
natriuretic peptide A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12721106
NCBI chr 5:163,712,184...163,713,493
Ensembl chr 5:158,429,042...158,430,351
G
Pecam1
platelet and endothelial cell adhesion molecule 1
ISO
DNA:missense mutations:cds:p.L125V, p.S563N (human)
RGD
PMID:10571959
RGD:1598382
NCBI chr10:92,090,263...92,152,002
Ensembl chr10:91,590,521...91,652,116
G
Phactr1
phosphatase and actin regulator 1
susceptibility
ISO
DNA:SNP::g.13011943A>G (rs9349379) (human)
RGD
PMID:22745674
RGD:401900726
NCBI chr17:21,769,006...22,246,227
Ensembl chr17:21,562,721...22,039,831
G
Prkce
protein kinase C, epsilon
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16782078
NCBI chr 6:13,718,050...14,204,931
Ensembl chr 6:7,965,048...8,451,719
G
Tnfrsf11b
TNF receptor superfamily member 11B
ISO
protein:increased expression:serum
RGD
PMID:15569000
RGD:1624167
NCBI chr 7:87,456,318...87,484,324
Ensembl chr 7:85,566,520...85,594,538
G
Gp6
glycoprotein VI
ISO
DNA:missense mutation:CDS:c.13254T>C (human)
RGD
PMID:15306180
RGD:401793750
NCBI chr 1:78,471,900...78,535,374
Ensembl chr 1:69,465,789...69,491,326
G
Itgb3
integrin subunit beta 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:8598867
NCBI chr10:90,009,927...90,067,787
Ensembl chr10:89,509,989...89,564,679
G
Plat
plasminogen activator, tissue type
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:1452937 PMID:8172379 PMID:15301905
NCBI chr16:75,943,061...76,022,037
Ensembl chr16:69,240,585...69,268,223
G
Kit
KIT proto-oncogene receptor tyrosine kinase
IEP
mRNA,protein:decreased expression:stomach:
RGD
PMID:20040059
RGD:12911222
NCBI chr14:32,901,615...32,978,895
Ensembl chr14:32,548,877...32,624,652
G
Kitlg
KIT ligand
IEP
mRNA:decreased expression:stomach:
RGD
PMID:20040059
RGD:12911222
NCBI chr 7:36,782,621...36,863,796
Ensembl chr 7:34,896,053...34,977,214
G
Gstm1
glutathione S-transferase mu 1
susceptibility
ISO
DNA:deletion:cds: (human)
RGD
PMID:19279659
RGD:7495846
NCBI chr 2:198,338,005...198,346,007
Ensembl chr 2:195,649,845...195,655,411
G
Nos3
nitric oxide synthase 3
ISO
ClinVar Annotator: match by term: Hypertension resistant to conventional therapy
ClinVar
PMID:9737779 PMID:9894802 PMID:10475066 PMID:10510054 PMID:10514107 PMID:11026457 PMID:11354626 PMID:11394896 PMID:11745998 PMID:15007011 PMID:16059745 PMID:16813604 PMID:17165044 PMID:24033266 PMID:25741868 More...
NCBI chr 4:11,686,088...11,706,604
Ensembl chr 4:10,793,834...10,814,166
G
Ptprd
protein tyrosine phosphatase, receptor type, D
susceptibility
ISO
associated with coronary artery disease;DNA:SNP:intron: (rs324498) (human)
RGD
PMID:30237584
RGD:401976431
NCBI chr 5:95,093,221...97,415,498
Ensembl chr 5:90,048,966...92,369,396
G
Csf3
colony stimulating factor 3
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:15135374
NCBI chr10:84,157,485...84,159,860
Ensembl chr10:83,661,207...83,663,603
G
Epas1
endothelial PAS domain protein 1
IEP
RGD
PMID:12911537
RGD:10395384
NCBI chr 6:13,543,252...13,626,147
Ensembl chr 6:7,790,647...7,871,228
G
Hif1a
hypoxia inducible factor 1 subunit alpha
IEP
RGD
PMID:12911537
RGD:10395384
NCBI chr 6:98,357,788...98,405,068
Ensembl chr 6:92,624,390...92,669,261
G
Notch3
notch receptor 3
TAS
RGD
PMID:11925448
RGD:632418
NCBI chr 7:11,783,550...11,834,585
Ensembl chr 7:11,133,706...11,184,025
G
Polr2a
RNA polymerase II subunit A
IEP
RGD
PMID:22535878
RGD:9681722
NCBI chr10:54,951,162...54,977,179
Ensembl chr10:54,452,441...54,478,455
G
Prl
prolactin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:718334
NCBI chr17:38,287,355...38,298,234
Ensembl chr17:37,860,007...37,870,062
G
Ace
angiotensin I converting enzyme
ISO
mRNA:increased expression:ventricular myocardium (human) mRNA:increased expression:myocardium
RGD
PMID:15131005 PMID:11451295
RGD:8142363 , RGD:8548894
NCBI chr10:91,410,129...91,430,246
Ensembl chr10:90,910,316...90,931,131
G
Agt
angiotensinogen
ISO
mRNA:increased expression:myocardium
RGD
PMID:11451295
RGD:8548894
NCBI chr19:69,426,540...69,447,017
Ensembl chr19:52,529,185...52,540,977
G
Agtr1a
angiotensin II receptor, type 1a
ISO
mRNA:increased expression:myocardium
RGD
PMID:11451295
RGD:8548894
NCBI chr17:34,383,397...34,435,523
Ensembl chr17:34,174,429...34,226,946
G
Akt1
AKT serine/threonine kinase 1
ISO
protein:increased serine phosphorylation:platelet
RGD
PMID:20467748
RGD:5509094
NCBI chr 6:137,534,810...137,555,131
Ensembl chr 6:131,713,720...131,733,921
G
Apoa4
apolipoprotein A4
ISO
protein:decreased expression:blood plasma (human)
RGD
PMID:20367977
RGD:5685646
NCBI chr 8:55,435,779...55,438,160
Ensembl chr 8:46,539,082...46,541,469
G
Bdnf
brain-derived neurotrophic factor
ISO
RGD
PMID:16186425
RGD:4891111
NCBI chr 3:116,619,633...116,670,212
Ensembl chr 3:96,165,042...96,215,615
G
Crp
C-reactive protein
disease_progression
ISO
RGD
PMID:9761079
RGD:9491780
NCBI chr13:87,694,062...87,695,978
Ensembl chr13:85,124,977...85,175,178
G
Edn1
endothelin 1
ISO
associated with Coronary Artery Disease;protein:increased expression:coronary sinus, plasma (human)
RGD
PMID:14556009
RGD:8661755
NCBI chr17:22,660,799...22,666,687
Ensembl chr17:22,454,420...22,460,885
G
F7
coagulation factor VII
ISO
protein:increased expression:plasma (human)
RGD
PMID:10653827
RGD:2312399
NCBI chr16:83,191,896...83,202,775
Ensembl chr16:76,489,717...76,500,610
G
Hmgcr
3-hydroxy-3-methylglutaryl-CoA reductase
ISO
RGD
PMID:18333374
RGD:5508458
NCBI chr 2:29,732,163...29,754,276
Ensembl chr 2:27,997,525...28,019,703
G
Itga2
integrin subunit alpha 2
susceptibility
ISO
RGD
PMID:15104219
RGD:1582303
NCBI chr 2:48,253,412...48,354,509
Ensembl chr 2:46,523,948...46,621,481
G
Itgam
integrin subunit alpha M
ameliorates
ISO
protein:decreased expression:neutrophil (human)
RGD
PMID:18043994
RGD:329901840
NCBI chr 1:192,089,496...192,139,947
Ensembl chr 1:182,659,000...182,709,503
G
Itih4
inter-alpha-trypsin inhibitor heavy chain 4
ISO
RGD
PMID:10486281
RGD:1582334
NCBI chr16:6,086,985...6,102,162
Ensembl chr16:6,080,539...6,095,708
G
Mir126a
microRNA 126a
disease_progression
ISO
RGD
PMID:32595526
RGD:401851053
NCBI chr 3:29,813,150...29,813,267
Ensembl chr 3:9,415,063...9,415,180
G
Mir21
microRNA 21
ISO
RNA:decreased expression:serum
RGD
PMID:32595526
RGD:401851053
NCBI chr10:71,902,600...71,902,691
Ensembl chr10:71,405,257...71,405,348
G
Mmp1
matrix metallopeptidase 1
ISO
RGD
PMID:14675588
RGD:1582536
NCBI chr 8:12,943,453...12,963,966
Ensembl chr 8:4,658,588...4,679,097
G
Pappa
pappalysin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11586954
NCBI chr 5:83,513,358...83,751,364
Ensembl chr 5:78,498,300...78,730,666
G
Plau
plasminogen activator, urokinase
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:2382605
NCBI chr15:3,505,485...3,511,987
Ensembl chr15:3,456,232...3,462,775
G
Pten
phosphatase and tensin homolog
ISO
RNA:increased expression:serum
RGD
PMID:32595526
RGD:401851053
NCBI chr 1:240,043,707...240,110,330
Ensembl chr 1:230,630,338...230,696,838
G
Selp
selectin P
ISO
protein:increased expression:serum
RGD
PMID:21162967
RGD:6219003
NCBI chr13:79,009,379...79,044,994
Ensembl chr13:76,476,295...76,511,845
G
Serpinc1
serpin family C member 1
treatment
ISO
RGD
PMID:8122184
RGD:11035255
NCBI chr13:75,790,558...75,804,826
Ensembl chr13:73,257,179...73,284,293
G
Sod3
superoxide dismutase 3
ISO
RGD
PMID:14592844
RGD:1580841
NCBI chr14:62,822,865...62,828,602
Ensembl chr14:58,609,958...58,615,990
G
Txn1
thioredoxin 1
ISO
RGD
PMID:15749180
RGD:1580784
NCBI chr 5:77,507,455...77,519,685
Ensembl chr 5:72,711,933...72,724,629
G
Adm
adrenomedullin
IEP
protein:decreased expression:plasma
RGD
PMID:17263982
RGD:7364988
NCBI chr 1:174,164,178...174,182,372
Ensembl chr 1:164,745,466...164,747,654
G
Cfh
complement factor H
IEP
protein:decreased expression:plasma
RGD
PMID:17263982
RGD:7364988
NCBI chr13:54,063,079...54,164,523
Ensembl chr13:51,511,828...51,613,838
G
Gch1
GTP cyclohydrolase 1
IEP
associated with Experimental Radiation Injuries;mRNA,protein:decreased expression:mesenteric artery
RGD
PMID:32562786
RGD:329961328
NCBI chr15:22,884,006...22,917,412
Ensembl chr15:20,402,527...20,437,698
G
Npy
neuropeptide Y
IEP
associated with Brain Injuries;mRNA, protein:increased expression:jejunum, plasma
RGD
PMID:23622727
RGD:10448970
NCBI chr 4:80,212,111...80,219,310
Ensembl chr 4:78,881,264...78,888,495
G
Ace
angiotensin I converting enzyme
IEP
RGD
PMID:15001561
RGD:13515113
NCBI chr10:91,410,129...91,430,246
Ensembl chr10:90,910,316...90,931,131
G
Agt
angiotensinogen
IEP
protein:increased expression:plasma
RGD
PMID:15001561
RGD:13515113
NCBI chr19:69,426,540...69,447,017
Ensembl chr19:52,529,185...52,540,977
G
Ahr
aryl hydrocarbon receptor
treatment
IEP
RGD
PMID:22079846 PMID:37387514
RGD:401794136 , RGD:407419876
NCBI chr 6:57,961,423...57,998,901
Ensembl chr 6:52,234,089...52,271,568
G
Atp5f1d
ATP synthase F1 subunit delta
treatment
IEP
RGD
PMID:24232000
RGD:13792678
NCBI chr 7:10,211,260...10,218,989
Ensembl chr 7:9,560,608...9,565,929
G
Casp3
caspase 3
treatment
IEP
RGD
PMID:23946597
RGD:13782356
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:45,662,910...45,684,648
G
Casp9
caspase 9
treatment
IEP
RGD
PMID:23946597
RGD:13782356
Ensembl chr 5:154,109,046...154,126,626
G
Ccl2
C-C motif chemokine ligand 2
IEP
mRNA:increased expression:small intestine
RGD
PMID:18475188
RGD:2307016
NCBI chr10:67,503,077...67,504,875
Ensembl chr10:67,005,424...67,007,226
G
Cd14
CD14 molecule
IEP
protein:increased expression:heart, kidney, liver, lung
RGD
PMID:22493902
RGD:9685194
NCBI chr18:28,609,558...28,611,409
Ensembl chr18:28,335,340...28,337,261
G
Cldn1
claudin 1
IEP
protein:decreased expression:colon:
RGD
PMID:19929946
RGD:2325127
NCBI chr11:87,926,376...87,941,533
Ensembl chr11:74,421,569...74,436,724
G
Cldn3
claudin 3
IEP
protein:decreased expression:colon:
RGD
PMID:19929946
RGD:2325127
NCBI chr12:27,345,075...27,346,547
Ensembl chr12:21,708,398...21,711,001
G
Cldn5
claudin 5
IEP
protein:decreased expression:colon:
RGD
PMID:19929946
RGD:2325127
NCBI chr11:95,717,172...95,718,598
Ensembl chr11:82,211,475...82,214,992
G
Crp
C-reactive protein
IEP
protein:increased expression:intestine:
RGD
PMID:17981193
RGD:5129536
NCBI chr13:87,694,062...87,695,978
Ensembl chr13:85,124,977...85,175,178
G
Csf3
colony stimulating factor 3
treatment
ISO
RGD
PMID:9117128
RGD:11039476
NCBI chr10:84,157,485...84,159,860
Ensembl chr10:83,661,207...83,663,603
G
Cyp1a2
cytochrome P450, family 1, subfamily a, polypeptide 2
treatment
IEP
RGD
PMID:22079846
RGD:401794136
NCBI chr 8:66,971,261...66,978,149
Ensembl chr 8:58,075,367...58,082,312
G
F7
coagulation factor VII
ISO
human protein in a rat model
RGD
PMID:22920553
RGD:11041662
NCBI chr16:83,191,896...83,202,775
Ensembl chr16:76,489,717...76,500,610
G
Faslg
Fas ligand
treatment
IEP
RGD
PMID:29170412
RGD:13792603
NCBI chr13:76,680,885...76,706,042
Ensembl chr13:74,154,954...74,162,215
G
Gpt
glutamic--pyruvic transaminase
IEP
protein:increased expression:serum
RGD
PMID:16557159
RGD:401717563
NCBI chr 7:110,295,599...110,300,134
Ensembl chr 7:108,416,642...108,419,494
G
Hmgb1
high mobility group box 1
IEP
RGD
PMID:22093738
RGD:10402181
NCBI chr12:11,009,236...11,015,941
Ensembl chr12:5,901,586...5,978,565 Ensembl chr16:5,901,586...5,978,565
G
Hmox1
heme oxygenase 1
treatment
IEP
RGD
PMID:19362701
RGD:10766423
NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,467,244...13,474,079
G
Hp
haptoglobin
treatment
IEP
RGD
PMID:11922743
RGD:11041790
NCBI chr19:54,449,151...54,453,701
Ensembl chr19:37,539,627...37,544,523
G
Icam1
intercellular adhesion molecule 1
treatment
IEP
RGD
PMID:12095141 PMID:22079846
RGD:11522715 , RGD:401794136
NCBI chr 8:27,829,688...27,841,618
Ensembl chr 8:19,553,645...19,565,438
G
Il6
interleukin 6
treatment
IDA IEP
RGD
PMID:11959089 PMID:22079846
RGD:11062110 , RGD:401794136
NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,213,394...5,219,178
G
Jak2
Janus kinase 2
IMP
RGD
PMID:22777122
RGD:10403072
NCBI chr 1:236,408,905...236,468,769
Ensembl chr 1:226,995,334...227,054,189
G
Lbp
lipopolysaccharide binding protein
IEP
protein:increased expression:heart, kidney, liver, lung
RGD
PMID:22493902
RGD:9685194
NCBI chr 3:167,373,786...167,400,941
Ensembl chr 3:146,954,015...146,981,586
G
Mbl2
mannose binding lectin 2
severity
ISO
DNA:polymorphisms:exon:
RGD
PMID:19477015
RGD:12910933
NCBI chr 1:237,429,873...237,465,567
G
Mir155
microRNA 155
ISO
miRNA:increased expression:Peyer's patch
RGD
PMID:30206757
RGD:21409753
NCBI chr11:37,261,114...37,261,178
Ensembl chr11:23,774,654...23,774,718
G
Mir21
microRNA 21
IEP
RGD
PMID:30309483
RGD:41410822
NCBI chr10:71,902,600...71,902,691
Ensembl chr10:71,405,257...71,405,348
G
Nfkbia
NFKB inhibitor alpha
treatment
IEP
RGD
PMID:22079846
RGD:401794136
NCBI chr 6:78,593,844...78,597,307
Ensembl chr 6:72,858,712...72,861,941
G
Nos3
nitric oxide synthase 3
treatment
IDA
RGD
PMID:16610051
RGD:7777112
NCBI chr 4:11,686,088...11,706,604
Ensembl chr 4:10,793,834...10,814,166
G
Nqo1
NAD(P)H quinone dehydrogenase 1
treatment
IEP
RGD
PMID:28382390
RGD:13440093
NCBI chr19:52,205,374...52,220,267
Ensembl chr19:35,295,573...35,310,557
G
Nr1h4
nuclear receptor subfamily 1, group H, member 4
disease_progression
IEP
mRNA:decreased expression:liver (rat)
RGD
PMID:23331901
RGD:15042883
NCBI chr 7:25,733,471...25,829,440
Ensembl chr 7:23,846,122...23,942,047
G
Parg
poly (ADP-ribose) glycohydrolase
treatment
IMP
RGD
PMID:15791006
RGD:13514040
NCBI chr16:7,442,696...7,550,585
Ensembl chr16:7,436,476...7,544,273
G
Ppp1r15a
protein phosphatase 1, regulatory subunit 15A
ISO
mRNA:increased expression:jejunum (human)
RGD
PMID:20965186
RGD:9999150
NCBI chr 1:105,136,521...105,139,596
Ensembl chr 1:96,000,058...96,003,171
G
Proc
protein C, inactivator of coagulation factors Va and VIIIa
treatment
ISO
RGD
PMID:15187522
RGD:11250409
NCBI chr18:24,038,596...24,049,061
Ensembl chr18:23,764,368...23,775,133
G
Rela
RELA proto-oncogene, NF-kB subunit
treatment
IEP
RGD
PMID:22079846
RGD:401794136
NCBI chr 1:212,354,336...212,364,815
Ensembl chr 1:202,924,945...202,935,484
G
Serpinc1
serpin family C member 1
treatment
IEP
RGD
PMID:21046505
RGD:11035258
NCBI chr13:75,790,558...75,804,826
Ensembl chr13:73,257,179...73,284,293
G
Serpine1
serpin family E member 1
IDA
protein:increased activity:plasma (rat)
RGD
PMID:12717359
RGD:11081012
NCBI chr12:25,237,977...25,248,356
Ensembl chr12:19,601,272...19,611,657
G
Socs1
suppressor of cytokine signaling 1
treatment
IEP
RGD
PMID:27538408
RGD:151347179
NCBI chr10:5,389,574...5,391,265
Ensembl chr10:4,882,560...4,884,383
G
Tnf
tumor necrosis factor
treatment
IEP
RGD
PMID:22079846
RGD:401794136
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,622,011...3,624,629
G
Traf6
TNF receptor associated factor 6
IEP
RGD
PMID:27538408
RGD:151347179
NCBI chr 3:108,418,537...108,443,330
Ensembl chr 3:87,963,514...87,983,507
G
Trem1
triggering receptor expressed on myeloid cells 1
ameliorates
IDA
associated with mesenteric vascular occlusion;
RGD
PMID:18091551
RGD:127284848
NCBI chr 9:20,259,227...20,276,879
Ensembl chr 9:12,763,819...12,779,203
G
Vwf
von Willebrand factor
IEP
protein:increased expression:plasma:
RGD
PMID:10365842
RGD:11080742
NCBI chr 4:160,042,900...160,177,757
Ensembl chr 4:158,360,152...158,491,539
G
Xdh
xanthine dehydrogenase
treatment
IEP
RGD
PMID:23010742
RGD:13209016
NCBI chr 6:27,282,319...27,344,022
Ensembl chr 6:21,530,113...21,592,268
G
Ace
angiotensin I converting enzyme
IMP
RGD
PMID:21680852
RGD:6893484
NCBI chr10:91,410,129...91,430,246
Ensembl chr10:90,910,316...90,931,131
G
Ace2
angiotensin converting enzyme 2
IEP
mRNA:decreased expression:kidney
RGD
PMID:20528771
RGD:9685432
NCBI chr X:33,925,458...33,972,851
Ensembl chr X:30,293,589...30,340,977
G
Acta1
actin, alpha 1, skeletal muscle
ameliorates
ISO
RGD
PMID:24920753
RGD:329845564
NCBI chr19:68,781,168...68,784,194
Ensembl chr19:51,883,715...51,886,742
G
Acvr2b
activin A receptor type 2B
treatment
ISO
human construct in rat model
RGD
PMID:27732750
RGD:329322881
NCBI chr 8:128,016,589...128,056,193
Ensembl chr 8:119,138,812...119,170,458
G
Adam17
ADAM metallopeptidase domain 17
treatment
IEP
RGD
PMID:22015440
RGD:13703100
NCBI chr 6:46,601,583...46,663,690
Ensembl chr 6:40,872,856...40,920,639
G
Adam2
ADAM metallopeptidase domain 2
IEP
RGD
PMID:11967014
RGD:10047130
NCBI chr15:44,418,191...44,459,570
Ensembl chr15:40,242,783...40,283,952
G
Adamts1
ADAM metallopeptidase with thrombospondin type 1 motif, 1
IEP
RGD
PMID:18272597
RGD:9684850
NCBI chr11:38,418,565...38,427,384
Ensembl chr11:24,931,761...24,941,103
G
Adipoq
adiponectin, C1Q and collagen domain containing
treatment
ISO
RGD
PMID:21412771
RGD:8695946
NCBI chr11:91,226,524...91,240,244
Ensembl chr11:77,721,912...77,735,564
G
Adm
adrenomedullin
treatment
IEP ISO
protein:increased expression:serum:
RGD
PMID:20538296 PMID:20538296
RGD:7364948 , RGD:7364948
NCBI chr 1:174,164,178...174,182,372
Ensembl chr 1:164,745,466...164,747,654
G
Akr1a1
aldo-keto reductase family 1 member A1
ISO
RGD
PMID:31089212
RGD:27226686
NCBI chr 5:135,329,605...135,367,037
Ensembl chr 5:130,092,732...130,113,674
G
Aldh2
aldehyde dehydrogenase 2 family member
ISO
RGD
PMID:22022451
RGD:7241603
NCBI chr12:40,610,244...40,643,220
Ensembl chr12:34,901,219...34,982,521
G
Anxa1
annexin A1
treatment
IDA
RGD
PMID:20953576
RGD:7421585
NCBI chr 1:227,287,713...227,306,739
Ensembl chr 1:217,861,175...217,877,343
G
Anxa5
annexin A5
ISO
RGD
PMID:21918686
RGD:7242028
NCBI chr 2:121,242,133...121,272,935
Ensembl chr 2:119,314,007...119,353,369
G
Apaf1
apoptotic peptidase activating factor 1
treatment
IEP
RGD
PMID:26362957
RGD:13703110
NCBI chr 7:27,381,392...27,466,772
Ensembl chr 7:25,494,609...25,579,540
G
Apoa1
apolipoprotein A1
treatment
ISO
RGD
PMID:18535924
RGD:7241574
NCBI chr 8:55,423,945...55,425,729
Ensembl chr 8:46,527,144...46,529,035
G
Atm
ATM serine/threonine kinase
IEP
protein:increased expression:kidney
RGD
PMID:22768306
RGD:10053607
NCBI chr 8:62,724,939...62,829,040
Ensembl chr 8:53,831,093...53,932,437
G
Bax
BCL2 associated X, apoptosis regulator
treatment
IEP
RGD
PMID:23151253
RGD:10054101
NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:95,938,808...95,945,368
G
Bcl2
BCL2, apoptosis regulator
treatment
IEP
RGD
PMID:18221257 PMID:29285062
RGD:2293026 , RGD:13792599
NCBI chr13:23,204,464...23,366,900
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
Bdkrb1
bradykinin receptor B1
ISO
RGD
PMID:18725957
RGD:7241559
NCBI chr 6:130,275,631...130,284,968
Ensembl chr 6:124,510,870...124,513,747
G
Becn1
beclin 1
treatment
IEP
RGD
PMID:26412257
RGD:11561958
NCBI chr10:86,731,649...86,747,002
Ensembl chr10:86,231,388...86,246,742
G
Bmi1
BMI1 proto-oncogene, polycomb ring finger
ISO
mRNA:altered expression:kidney (mouse)
RGD
PMID:18467665
RGD:155631277
NCBI chr17:86,240,683...86,250,044
Ensembl chr17:81,332,214...81,388,690
G
Bnip3
BCL2 interacting protein 3
IEP
mRNA, protein:increased expression:kidney
RGD
PMID:23698117
RGD:11561968
NCBI chr 1:203,137,778...203,154,962
Ensembl chr 1:193,708,167...193,725,359
G
C3
complement C3
treatment
IEP
RGD
PMID:19691975
RGD:7411689
NCBI chr 9:2,174,412...2,201,339
Ensembl chr 9:2,087,437...2,114,429
G
Calca
calcitonin-related polypeptide alpha
IMP
RGD
PMID:19194162
RGD:7204479
NCBI chr 1:178,312,636...178,317,588
Ensembl chr 1:168,878,214...168,883,105
G
Casp3
caspase 3
treatment
IEP
RGD
PMID:23151253
RGD:10054101
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:45,662,910...45,684,648
G
Casp7
caspase 7
IEP
RGD
PMID:17596683
RGD:5684536
NCBI chr 1:265,442,647...265,481,938
Ensembl chr 1:255,437,172...255,476,729
G
Ccl11
C-C motif chemokine ligand 11
treatment
ISO
RGD
PMID:22160777
RGD:7247742
NCBI chr10:67,525,975...67,530,576
Ensembl chr10:67,028,328...67,032,926
G
Ccl2
C-C motif chemokine ligand 2
ameliorates treatment
ISO IDA
mRNA, protein:increased expression:kidney, lung, serum
RGD
PMID:24920753 PMID:20396927 PMID:18650485
RGD:329845564 , RGD:4891433 , RGD:11526113
NCBI chr10:67,503,077...67,504,875
Ensembl chr10:67,005,424...67,007,226
G
Ccn1
cellular communication network factor 1
ameliorates
ISO
RGD
PMID:24920753
RGD:329845564
NCBI chr 2:237,222,730...237,225,689
Ensembl chr 2:234,562,408...234,565,484
G
Cd14
CD14 molecule
ISO
mRNA,protein:increased expression:kidney
RGD
PMID:10966493
RGD:7204444
NCBI chr18:28,609,558...28,611,409
Ensembl chr18:28,335,340...28,337,261
G
Cd40
CD40 molecule
treatment
IMP
RGD
PMID:25993320
RGD:11251055
NCBI chr 3:174,209,113...174,224,592
Ensembl chr 3:153,790,449...153,805,534
G
Cfb
complement factor B
ISO
RGD
PMID:16467447 PMID:12538716
RGD:7242709 , RGD:7242734
NCBI chr20:3,975,271...3,981,138
Ensembl chr20:3,951,474...3,976,505
G
Cfh
complement factor H
treatment
IEP ISO
protein:decreased expression:serum:
RGD
PMID:20538296 PMID:20538296
RGD:7364948 , RGD:7364948
NCBI chr13:54,063,079...54,164,523
Ensembl chr13:51,511,828...51,613,838
G
Ciita
class II, major histocompatibility complex, transactivator
ISO
RGD
PMID:14569092
RGD:7242896
NCBI chr10:5,646,854...5,694,393
Ensembl chr10:5,140,178...5,187,440
G
Cited1
Cbp/p300-interacting transactivator with Glu/Asp-rich carboxy-terminal domain 1
ISO
mRNA:altered expression:kidney (mouse)
RGD
PMID:18467665
RGD:155631277
NCBI chr X:71,390,328...71,395,023
Ensembl chr X:67,350,373...67,355,162
G
Col1a1
collagen type I alpha 1 chain
ameliorates
ISO
RGD
PMID:24920753
RGD:329845564
NCBI chr10:80,380,458...80,397,461
Ensembl chr10:79,883,622...79,900,624
G
Col3a1
collagen type III alpha 1 chain
ameliorates
ISO
RGD
PMID:24920753
RGD:329845564
NCBI chr 9:54,866,646...54,902,578
Ensembl chr 9:47,374,593...47,410,547
G
Csf1
colony stimulating factor 1
ISO
mRNA:increased expression:kidney
RGD
PMID:23143303 PMID:19196448
RGD:7257565 , RGD:7257570
NCBI chr 2:198,065,400...198,084,774
Ensembl chr 2:195,377,215...195,411,704
G
Csf1r
colony stimulating factor 1 receptor
ISO
RGD
PMID:23143303
RGD:7257565
NCBI chr18:56,834,152...56,860,804
Ensembl chr18:54,546,659...54,590,415
G
Ctla4
cytotoxic T-lymphocyte-associated protein 4
ISO
RGD
PMID:22189844 PMID:9407517
RGD:7204675 , RGD:7204727
NCBI chr 9:69,812,859...69,819,959
Ensembl chr 9:62,319,312...62,324,963
G
Cxcl2
C-X-C motif chemokine ligand 2
ameliorates
ISO
RGD
PMID:24920753
RGD:329845564
NCBI chr14:17,465,210...17,467,255
Ensembl chr14:17,181,062...17,183,075
G
Cxcr2
C-X-C motif chemokine receptor 2
ISO
RGD
PMID:20038794
RGD:7257679
NCBI chr 9:83,178,645...83,185,017
Ensembl chr 9:75,729,115...75,739,425
G
Cxcr4
C-X-C motif chemokine receptor 4
IEP
protein:increased expression:kidney
RGD
PMID:29073721
RGD:13825150
NCBI chr13:42,630,383...42,634,288
Ensembl chr13:40,077,976...40,081,883
G
Cyp19a1
cytochrome P450, family 19, subfamily a, polypeptide 1
treatment
IMP
RGD
PMID:23552495
RGD:7244372
NCBI chr 8:63,449,148...63,476,534
Ensembl chr 8:54,553,165...54,580,758
G
Daxx
death-domain associated protein
ISO
protein:increased expression:kidney:
RGD
PMID:18480747 PMID:18480747
RGD:9587836 , RGD:9587836
NCBI chr20:4,971,973...4,978,062
Ensembl chr20:4,970,092...4,975,843
G
Ddr1
discoidin domain receptor tyrosine kinase 1
ISO
protein:increased expression:kidney (mouse)
RGD
PMID:31383731
RGD:151347540
NCBI chr20:3,047,269...3,069,277
Ensembl chr20:3,044,320...3,064,468
G
Dhfr
dihydrofolate reductase
treatment
IEP
mRNA,protein:decreased expression:kidney:
RGD
PMID:18408363
RGD:11040540
NCBI chr 2:25,320,895...25,346,004
Ensembl chr 2:23,586,031...23,613,713
G
Drd3
dopamine receptor D3
treatment
IDA
RGD
PMID:25989500
RGD:13506961
NCBI chr11:70,385,586...70,437,793
Ensembl chr11:56,879,689...56,940,596
G
Eed
embryonic ectoderm development
ISO
mRNA:altered expression:kidney (mouse)
RGD
PMID:18467665
RGD:155631277
NCBI chr 1:153,280,419...153,307,537
Ensembl chr 1:143,867,875...143,894,974
G
Egln1
egl-9 family hypoxia-inducible factor 1
IEP
mRNA, protein:decreased expression:kidney
RGD
PMID:19349364
RGD:11252083
NCBI chr19:69,765,276...69,804,681
Ensembl chr19:52,869,486...52,907,777
G
Egln3
egl-9 family hypoxia-inducible factor 3
IEP
mRNA, protein:decreased expression:kidney
RGD
PMID:19349364
RGD:11252083
NCBI chr 6:77,385,549...77,411,015
Ensembl chr 6:71,650,297...71,675,766
G
Elane
elastase, neutrophil expressed
treatment
IMP
RGD
PMID:16980042
RGD:10450580
NCBI chr 7:10,467,877...10,469,725
Ensembl chr 7:9,817,252...9,819,100
G
Eng
endoglin
IEP ISO
mRNA, protein:increased expression:kidney (rat)
RGD
PMID:16751653 PMID:16751653
RGD:7248779 , RGD:7248779
NCBI chr 3:36,332,190...36,370,324
Ensembl chr 3:15,934,518...15,973,230
G
Ep300
E1A binding protein p300
IEP
protein:altered localization:kidney (rat)
RGD
PMID:23936185
RGD:7257563
NCBI chr 7:114,987,857...115,058,652
Ensembl chr 7:113,106,247...113,136,088 Ensembl chr 7:113,106,247...113,136,088
G
Epo
erythropoietin
treatment
ISO
RGD
PMID:19961832 PMID:25581532
RGD:10401077 , RGD:11041698
NCBI chr12:24,841,285...24,844,725
Ensembl chr12:19,204,508...19,207,946
G
Ezh2
enhancer of zeste 2 polycomb repressive complex 2 subunit
ISO
mRNA:altered expression:kidney (mouse)
RGD
PMID:18467665
RGD:155631277
NCBI chr 4:77,624,223...77,698,598
Ensembl chr 4:76,624,399...76,687,362
G
F3
coagulation factor III, tissue factor
IEP
protein:decreased expression:lung
RGD
PMID:25883098
RGD:11341735
NCBI chr 2:212,511,675...212,523,375
Ensembl chr 2:209,826,959...209,838,668
G
Fas
Fas cell surface death receptor
treatment
IEP
RGD
PMID:29285062
RGD:13792599
NCBI chr 1:241,212,155...241,245,774
Ensembl chr 1:231,798,960...231,832,591
G
Faslg
Fas ligand
treatment
IEP
RGD
PMID:29285062
RGD:13792599
NCBI chr13:76,680,885...76,706,042
Ensembl chr13:74,154,954...74,162,215
G
Fcgr1a
Fc gamma receptor 1A
treatment
ISO
RGD
PMID:22402584
RGD:9685699
NCBI chr 2:186,539,941...186,548,941
Ensembl chr 2:183,851,077...183,859,994
G
Fga
fibrinogen alpha chain
IEP
mRNA,protein:increased expression:kidney
RGD
PMID:21685370
RGD:7175292
NCBI chr 2:170,672,169...170,679,572
Ensembl chr 2:168,374,120...168,381,528
G
Fgb
fibrinogen beta chain
treatment
IEP ISO
mRNA, protein:increased expression:kidney
RGD
PMID:21685370 PMID:21685370
RGD:7175292 , RGD:7175292
NCBI chr 2:170,693,966...170,700,875
Ensembl chr 2:168,394,916...168,405,979
G
Fgfr2
fibroblast growth factor receptor 2
exacerbates ameliorates
ISO IMP
protein:increased phosphorylation:kidney (mouse)
RGD
PMID:20591940 PMID:22688984 PMID:29344510 PMID:32523960
RGD:155663667 , RGD:155882537 , RGD:155782904 , RGD:155782882
NCBI chr 1:194,175,703...194,280,914
Ensembl chr 1:184,745,420...184,850,626
G
Fgg
fibrinogen gamma chain
IEP
mRNA,protein:increased expression:kidney
RGD
PMID:21685370
RGD:7175292
NCBI chr 2:170,652,929...170,660,372
Ensembl chr 2:168,355,013...168,362,322
G
Fn1
fibronectin 1
IEP
RGD
PMID:11352844
RGD:7205629
NCBI chr 9:80,645,507...80,714,200
Ensembl chr 9:73,196,044...73,264,678
G
Fos
Fos proto-oncogene, AP-1 transcription factor subunit
ISO
RGD
PMID:19095962
RGD:7242184
NCBI chr 6:110,852,188...110,855,054
Ensembl chr 6:105,121,170...105,124,036
G
G6pd
glucose-6-phosphate dehydrogenase
IEP
RGD
PMID:17250641
RGD:2307361
NCBI chr X:157,352,364...157,372,144
Ensembl chr X:152,201,098...152,220,801
G
Gfer
growth factor, augmenter of liver regeneration
treatment
IEP ISO
protein:increased expression:kidney:
RGD
PMID:20332418 PMID:20332418
RGD:9685723 , RGD:9685723
NCBI chr10:14,223,023...14,225,736
Ensembl chr10:13,718,489...13,720,869
G
Glo1
glyoxalase 1
IMP
RGD
PMID:19211689
RGD:7242566
NCBI chr20:8,665,061...8,683,095
Ensembl chr20:8,662,801...8,681,649
G
Gpx3
glutathione peroxidase 3
IEP
protein:decreased expression:kidney mRNA:decreased expression:kidney
RGD
PMID:37033969 PMID:22442209
RGD:401827821 , RGD:401827906
NCBI chr10:39,529,335...39,537,406
Ensembl chr10:39,028,570...39,037,035
G
Gsr
glutathione-disulfide reductase
treatment
IEP
RGD
PMID:24630969
RGD:10401866
NCBI chr16:65,185,574...65,228,742
Ensembl chr16:58,482,505...58,525,661
G
Gstm1
glutathione S-transferase mu 1
IEP
mRNA, protein:decreased expression:kidney
RGD
PMID:29137244
RGD:158014894
NCBI chr 2:198,338,005...198,346,007
Ensembl chr 2:195,649,845...195,655,411
G
Gstt1
glutathione S-transferase theta 1
IEP
protein:decreased expression:kidney
RGD
PMID:37033969
RGD:401827821
NCBI chr20:12,856,068...12,873,020
Ensembl chr20:12,856,669...12,873,585
G
H2ax
H2A.X variant histone
treatment
IEP
RGD
PMID:23726287
RGD:8693706
NCBI chr 8:53,568,718...53,570,072
Ensembl chr 8:44,671,786...44,673,239 Ensembl chr 4:44,671,786...44,673,239
G
Has1
hyaluronan synthase 1
IEP
RGD
PMID:22529164
RGD:9588636
NCBI chr 1:67,366,460...67,378,686
Ensembl chr 1:58,693,411...58,705,397
G
Has2
hyaluronan synthase 2
IEP
RGD
PMID:22529164
RGD:9588636
NCBI chr 7:90,002,929...90,028,933
Ensembl chr 7:88,113,326...88,128,933
G
Havcr1
hepatitis A virus cellular receptor 1
IEP ISO
protein:increased expression:urine:
RGD
PMID:23552495 PMID:23019274 PMID:23085062
RGD:7244372 , RGD:7245495 , RGD:7245489
NCBI chr10:31,619,914...31,652,955
Ensembl chr10:31,119,088...31,151,698
G
Hif1a
hypoxia inducible factor 1 subunit alpha
treatment severity
IDA IMP
RGD
PMID:17519789 PMID:22432008
RGD:1626334 , RGD:9068883
NCBI chr 6:98,357,788...98,405,068
Ensembl chr 6:92,624,390...92,669,261
G
Hmox1
heme oxygenase 1
treatment
IMP
RGD
PMID:21291499
RGD:10755580
NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,467,244...13,474,079
G
Hsf1
heat shock transcription factor 1
IEP
protein:increased expression:kidney (rat)
RGD
PMID:23102208
RGD:10402775
NCBI chr 7:110,076,710...110,103,665
Ensembl chr 7:108,196,056...108,223,011
G
Hspa8
heat shock protein family A (Hsp70) member 8
IEP
RGD
PMID:7569112
RGD:7242788
NCBI chr 8:50,080,514...50,084,376
Ensembl chr 8:41,183,264...41,187,259
G
Hyal1
hyaluronidase 1
IEP
RGD
PMID:22529164
RGD:9588636
NCBI chr 8:117,129,311...117,133,162
Ensembl chr 8:108,250,667...108,260,210
G
Hyal2
hyaluronidase 2
IEP
RGD
PMID:22529164
RGD:9588636
NCBI chr 8:117,121,802...117,125,494
Ensembl chr 8:108,243,133...108,246,850
G
Ifng
interferon gamma
treatment
ISO
RGD
PMID:28355607
RGD:14975115
NCBI chr 7:55,789,180...55,793,216
Ensembl chr 7:53,903,337...53,907,375
G
Igf1r
insulin-like growth factor 1 receptor
IEP
mRNA: increased expression: kidney: 3 and 5 days post ischemia
RGD
PMID:10990448
RGD:7242905
NCBI chr 1:130,959,787...131,248,664
Ensembl chr 1:121,550,743...121,831,777
G
Ikbkb
inhibitor of nuclear factor kappa B kinase subunit beta
treatment
IMP
RGD
PMID:19546526
RGD:7495779
NCBI chr16:76,021,968...76,075,717
Ensembl chr16:69,319,554...69,373,250
G
Il10
interleukin 10
treatment
IDA ISO
RGD
PMID:24079335 PMID:28664613
RGD:7364864 , RGD:14975137
NCBI chr13:45,024,921...45,029,586
Ensembl chr13:42,472,839...42,477,313
G
Il12b
interleukin 12B
ameliorates
ISO
RGD
PMID:24920753
RGD:329845564
NCBI chr10:29,390,300...29,405,194
Ensembl chr10:28,893,008...28,902,903
G
Il18
interleukin 18
treatment
IMP
RGD
PMID:22089199
RGD:8655971
NCBI chr 8:59,802,072...59,829,275
Ensembl chr 8:50,906,960...50,932,887
G
Il1b
interleukin 1 beta
ameliorates
IDA ISO
RGD
PMID:20030532 PMID:24920753
RGD:7175501 , RGD:329845564
NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:116,577,010...116,583,415
G
Il1rn
interleukin 1 receptor antagonist
ISO
rat model treated with human protein mouse model treated with human protein
RGD
PMID:18363573 PMID:9555664 PMID:16849996
RGD:6907101 , RGD:6909149 , RGD:6907359
NCBI chr 3:27,509,836...27,525,738
Ensembl chr 3:7,111,550...7,127,445
G
Il6
interleukin 6
ameliorates
ISO
RGD
PMID:24920753
RGD:329845564
NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,213,394...5,219,178
G
Inhbb
inhibin subunit beta B
IEP
protein:increased expression:serum (rat)
RGD
PMID:27732750
RGD:329322881
NCBI chr13:33,083,671...33,089,373
Ensembl chr13:30,530,860...30,537,832
G
Itgb2
integrin subunit beta 2
ISO IMP
Associated with renal transplant patients
RGD
PMID:20504838 PMID:11007822
RGD:6907049 , RGD:6907073
NCBI chr20:11,061,009...11,097,242
Ensembl chr20:11,061,430...11,097,600
G
Kcnj11
potassium inwardly-rectifying channel, subfamily J, member 11
IEP
protein:decreased expression:kidney
RGD
PMID:21250976
RGD:7297045
NCBI chr 1:105,727,473...105,731,167
Ensembl chr 1:96,591,049...96,594,082
G
Kl
Klotho
treatment
IEP ISO
mRNA,protein:decreased expression:renal tubule:
RGD
PMID:16204278 PMID:16204278
RGD:10403064 , RGD:10403064
NCBI chr12:5,326,003...5,367,016
Ensembl chr12:490,399...530,080
G
Kmt2a
lysine methyltransferase 2A
ISO
protein:increased expression:kidney (mouse)
RGD
PMID:31570196
RGD:155888490
NCBI chr 8:54,013,547...54,089,219
Ensembl chr 8:45,118,814...45,193,181
G
Lcn2
lipocalin 2
IEP ISO
protein:increased expression:urine: mRNA,protein:increased expression:kidney,urine mRNA,protein:increased expression:kidney:
RGD
PMID:23364806 PMID:27800610 PMID:20181666 PMID:23085062
RGD:7245469 , RGD:126790572 , RGD:126779563 , RGD:7245489
NCBI chr 3:36,078,432...36,081,851
Ensembl chr 3:15,680,687...15,684,095
G
Lep
leptin
resistance
IDA
RGD
PMID:22969992
RGD:6909133
NCBI chr 4:58,626,529...58,640,663
Ensembl chr 4:57,661,131...57,675,262
G
Lgals3
galectin 3
IEP
mRNA:increased expression:kidney
RGD
PMID:10980121
RGD:9685228
NCBI chr15:23,099,795...23,111,731
Ensembl chr15:20,607,692...20,632,025
G
Map1lc3a
microtubule-associated protein 1 light chain 3 alpha
treatment
ISO IEP
RGD
PMID:20075199 PMID:26412257
RGD:11561916 , RGD:11561958
NCBI chr 3:164,243,204...164,244,850
Ensembl chr 3:143,783,024...143,784,670
G
Map3k5
mitogen-activated protein kinase kinase kinase 5
treatment
IMP
RGD
PMID:23952292
RGD:10412647
NCBI chr 1:16,505,387...16,723,899
Ensembl chr 1:14,685,492...14,904,800
G
Mc1r
melanocortin 1 receptor
IEP
protein:decreased expression:kidney outer medulla
RGD
PMID:18790174
RGD:5687322
NCBI chr19:68,360,950...68,363,877
Ensembl chr19:51,453,239...51,454,192
G
Mir146a
microRNA 146a
treatment
IEP
RGD
PMID:27760486
RGD:155882556
NCBI chr10:28,349,996...28,350,090
Ensembl chr10:27,848,516...27,848,610
G
Mir320a
microRNA 320a
treatment
IEP
RGD
PMID:31089916 PMID:27760486
RGD:155882543 , RGD:155882556
NCBI chr15:51,926,088...51,926,169
Ensembl chr15:45,516,392...45,516,473
G
Mir381
microRNA 381
IEP
RNA:decreased expression:kidney
RGD
PMID:29073721
RGD:13825150
NCBI chr 6:134,562,381...134,562,441
G
Mir423
microRNA 423
treatment
IMP
RGD
PMID:29137244
RGD:158014894
NCBI chr10:62,412,272...62,412,350
Ensembl chr10:61,914,133...61,914,226
G
Mir494
microRNA 494
ameliorates
ISO
RGD
PMID:23160513
RGD:155883172
NCBI chr 6:134,550,115...134,550,197
Ensembl chr 6:128,728,709...128,728,793
G
Mpo
myeloperoxidase
IEP ISO
protein:increased activity:kidney
RGD
PMID:22950848 PMID:18055546
RGD:6909167 , RGD:7174699
NCBI chr10:73,092,124...73,102,057
Ensembl chr10:72,594,661...72,604,819
G
Muc1
mucin 1, cell surface associated
treatment
IDA
RGD
PMID:22019164
RGD:7245959
NCBI chr 2:176,933,312...176,938,497
Ensembl chr 2:174,635,995...174,640,733
G
Myc
MYC proto-oncogene, bHLH transcription factor
IEP
mRNA:increased expression:kidney (rat)
RGD
PMID:17220792
RGD:7207777
NCBI chr 7:95,483,105...95,488,031
Ensembl chr 7:93,593,705...93,598,630
G
Ndufb8
NADH:ubiquinone oxidoreductase subunit B8
IEP ISO
RGD
PMID:24096033 PMID:22160772
RGD:13801197 , RGD:13801199
NCBI chr 1:253,357,878...253,362,936
Ensembl chr 1:243,408,619...243,413,817
G
Nes
nestin
IEP
RGD
PMID:24503548
RGD:11570523
NCBI chr 2:175,735,715...175,745,631
Ensembl chr 2:173,438,734...173,447,777
G
Nfe2l2
NFE2 like bZIP transcription factor 2
treatment
IEP
RGD
PMID:31089916
RGD:155882543
NCBI chr 3:81,001,529...81,031,165
Ensembl chr 3:60,594,242...60,621,737
G
Nos2
nitric oxide synthase 2
treatment
IEP
RGD
PMID:18408363
RGD:11040540
NCBI chr10:64,313,335...64,349,221
Ensembl chr10:63,815,308...63,851,210
G
Nos3
nitric oxide synthase 3
treatment
IEP
RGD
PMID:29291552 PMID:18408363
RGD:13504682 , RGD:11040540
NCBI chr 4:11,686,088...11,706,604
Ensembl chr 4:10,793,834...10,814,166
G
Nox1
NADPH oxidase 1
treatment
IEP
RGD
PMID:34244746
RGD:329955363
NCBI chr X:101,572,338...101,625,571
Ensembl chr X:97,279,056...97,302,236
G
Nppa
natriuretic peptide A
ISO
RGD
PMID:20471588
RGD:7247717
NCBI chr 5:163,712,184...163,713,493
Ensembl chr 5:158,429,042...158,430,351
G
Nqo1
NAD(P)H quinone dehydrogenase 1
treatment
IEP
RGD
PMID:21545725
RGD:11035217
NCBI chr19:52,205,374...52,220,267
Ensembl chr19:35,295,573...35,310,557
G
Nr4a1
nuclear receptor subfamily 4, group A, member 1
severity
ISO
mRNA:increased expression:kidney
RGD
PMID:22343121 PMID:22343121
RGD:14700869 , RGD:14700869
NCBI chr 7:134,247,153...134,268,044
Ensembl chr 7:132,374,840...132,389,297
G
Ogg1
8-oxoguanine DNA glycosylase
IEP
RGD
PMID:12531391
RGD:2317150
NCBI chr 4:148,030,237...148,037,599
Ensembl chr 4:146,474,750...146,484,766
G
Pax2
paired box 2
IEP
mRNA, protein:increased expression:kidney
RGD
PMID:12444203
RGD:727468
NCBI chr 1:253,555,447...253,646,623
Ensembl chr 1:243,616,606...243,695,321
G
Pdgfb
platelet derived growth factor subunit B
IEP
mRNA,protein:increased expression:tubule, S3 segment:
RGD
PMID:10550325
RGD:8554477
NCBI chr 7:113,419,882...113,438,343
Ensembl chr 7:111,540,345...111,557,984
G
Pdgfra
platelet derived growth factor receptor alpha
IEP
mRNA:increased expression:kidney
RGD
PMID:10550325
RGD:8554477
NCBI chr14:33,360,027...33,408,604
Ensembl chr14:33,005,839...33,054,335
G
Pdgfrb
platelet derived growth factor receptor beta
IMP IEP
mRNA:increased expression:kidney
RGD
PMID:12819032 PMID:10550325
RGD:1580850 , RGD:8554477
NCBI chr18:56,770,348...56,809,228
Ensembl chr18:54,499,964...54,538,843
G
Peg10
paternally expressed 10
ISO
mRNA:increased expression:kidney (mouse)
RGD
PMID:16778176
RGD:401851077
NCBI chr 4:33,809,026...33,822,224
Ensembl chr 4:32,848,493...32,852,621
G
Pkd2
polycystin 2, transient receptor potential cation channel
IEP
protein:increased expression:kidney (rat)
RGD
PMID:12454224
RGD:1580868
NCBI chr14:5,541,821...5,585,140
Ensembl chr14:5,237,135...5,280,825
G
Ppargc1a
PPARG coactivator 1 alpha
treatment
IDA
RGD
PMID:24918615
RGD:10059636
NCBI chr14:63,073,505...63,729,215
Ensembl chr14:58,861,144...59,512,656
G
Ptgis
prostaglandin I2 synthase
ISO
mRNA:increased expression:kidney (mouse)
RGD
PMID:30413885
RGD:401959745
NCBI chr 3:176,347,589...176,383,251
Ensembl chr 3:155,916,412...155,965,451
G
Rnls
renalase, FAD-dependent amine oxidase
ISO
mRNA,protein:decreased expression:kidney,plasma:
RGD
PMID:23393318 PMID:23393318
RGD:7327166 , RGD:7327166
NCBI chr 1:240,450,702...240,723,472
Ensembl chr 1:231,037,486...231,309,823
G
Sell
selectin L
IEP
RGD
PMID:7537789
RGD:597015754
NCBI chr13:78,950,100...78,969,604
Ensembl chr13:76,416,915...76,436,456
G
Serpina1
serpin family A member 1
treatment
ISO
RGD
PMID:28235038
RGD:14695051
NCBI chr 6:128,631,101...128,653,125
Ensembl chr 6:122,866,312...122,888,339
G
Serpinc1
serpin family C member 1
severity
IMP
RGD
PMID:26108065 PMID:26108065
RGD:11354006 , RGD:11354006
NCBI chr13:75,790,558...75,804,826
Ensembl chr13:73,257,179...73,284,293
G
Serpinc1em2Mcwi
serpin family C member 1; ZFN induced mutant 2, Medical College of Wisconsin
IMP
RGD
PMID:26108065
RGD:11354006
G
Serpine1
serpin family E member 1
ameliorates
ISO
RGD
PMID:24920753
RGD:329845564
NCBI chr12:25,237,977...25,248,356
Ensembl chr12:19,601,272...19,611,657
G
Shh
sonic hedgehog signaling molecule
ISO
mRNA, protein:increased expression:kidney
RGD
PMID:24744439
RGD:12859042
NCBI chr 4:7,687,872...7,697,025
Ensembl chr 4:6,954,017...6,963,170
G
Sirt1
sirtuin 1
treatment
IEP
RGD
PMID:22324445
RGD:9495930
NCBI chr20:25,305,953...25,328,000
Ensembl chr20:25,306,917...25,329,260
G
Six2
SIX homeobox 2
ISO
mRNA:altered expression:kidney (mouse)
RGD
PMID:18467665
RGD:155631277
NCBI chr 6:14,727,756...14,734,219
Ensembl chr 6:8,967,157...8,981,193
G
Slc22a1
solute carrier family 22 member 1
IEP
RGD
PMID:21835768
RGD:7243877
NCBI chr 1:50,624,339...50,651,437
Ensembl chr 1:48,076,666...48,103,678
G
Slc22a2
solute carrier family 22 member 2
IEP
RGD
PMID:21835768
RGD:7243877
NCBI chr 1:50,668,817...50,711,019
Ensembl chr 1:48,121,061...48,163,268
G
Slc34a1
solute carrier family 34 member 1
IEP
protein:decreased expression:renal proximal tubule, brush border membrane (rat)
RGD
PMID:15775707
RGD:2311304
NCBI chr17:9,224,010...9,238,983
Ensembl chr17:9,218,876...9,233,852
G
Src
SRC proto-oncogene, non-receptor tyrosine kinase
IEP
RGD
PMID:12819032
RGD:1580850
NCBI chr 3:166,511,616...166,559,463
Ensembl chr 3:146,091,841...146,139,476
G
Stat6
signal transducer and activator of transcription 6
severity
ISO
RGD
PMID:12709397
RGD:7244143
NCBI chr 7:65,365,505...65,382,825
Ensembl chr 7:63,479,642...63,498,495
G
Suz12
SUZ12 polycomb repressive complex 2 subunit
ISO
mRNA:altered expression:kidney (mouse)
RGD
PMID:18467665
RGD:155631277
NCBI chr10:65,464,948...65,510,846
Ensembl chr10:64,966,967...65,012,738
G
Tfpi
tissue factor pathway inhibitor
ISO
RGD
PMID:11796005
RGD:11062062
NCBI chr 3:89,939,862...89,989,253
Ensembl chr 3:69,533,156...69,576,880
G
Tgfb1
transforming growth factor, beta 1
ameliorates
ISO
RGD
PMID:24920753
RGD:329845564
NCBI chr 1:90,324,312...90,340,627
Ensembl chr 1:81,196,532...81,212,847
G
Tlr2
toll-like receptor 2
treatment severity
IDA ISO
RGD
PMID:23239000 PMID:11801667 PMID:20130923 PMID:22750071 PMID:23023072
RGD:7207892 , RGD:7241087 , RGD:7240552 , RGD:7207896 , RGD:7207894
NCBI chr 2:171,499,189...171,504,831
Ensembl chr 2:169,197,419...169,206,630
G
Tlr4
toll-like receptor 4
treatment
IDA ISO
RGD
PMID:23239000 PMID:11801667 PMID:20130923
RGD:7207892 , RGD:7241087 , RGD:7240552
NCBI chr 5:85,161,247...85,174,882
Ensembl chr 5:80,145,826...80,159,628
G
Tnf
tumor necrosis factor
ameliorates
IEP ISO
protein:increased expression:serum
RGD
PMID:19925291 PMID:24920753
RGD:2315112 , RGD:329845564
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,622,011...3,624,629
G
Tnfrsf1a
TNF receptor superfamily member 1A
ISO
mRNA:increased expression:lung
RGD
PMID:22728466
RGD:7245543
NCBI chr 4:159,837,119...159,849,817
Ensembl chr 4:158,150,820...158,163,591
G
Vcam1
vascular cell adhesion molecule 1
IEP
protein:increased expression:kidney
RGD
PMID:20164827
RGD:7240507
NCBI chr 2:206,723,050...206,742,783
Ensembl chr 2:204,038,114...204,057,958
G
Vwf
von Willebrand factor
IEP
protein:increased expression:serum:
RGD
PMID:12684225
RGD:11080744
NCBI chr 4:160,042,900...160,177,757
Ensembl chr 4:158,360,152...158,491,539
G
Wt1
WT1 transcription factor
ISO
mRNA:altered expression:kidney (mouse)
RGD
PMID:18467665
RGD:155631277
NCBI chr 3:112,019,721...112,068,454
Ensembl chr 3:91,567,001...91,613,643
G
Xdh
xanthine dehydrogenase
treatment
IMP
associated with Diabetes Mellitus, Type 2
RGD
PMID:22995295 PMID:20616412
RGD:7247637 , RGD:7247695
NCBI chr 6:27,282,319...27,344,022
Ensembl chr 6:21,530,113...21,592,268
G
Zfp667
zinc finger protein 667
ameliorates
ISO
RGD
PMID:24920753
RGD:329845564
NCBI chr 1:76,634,897...76,655,133
Ensembl chr 1:67,601,807...67,622,041
G
Fshb
follicle stimulating hormone subunit beta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17344003
NCBI chr 3:114,003,262...114,007,072
Ensembl chr 3:93,548,560...93,552,370
G
Agtr1a
angiotensin II receptor, type 1a
ISO
RGD
PMID:11877468
RGD:737810
NCBI chr17:34,383,397...34,435,523
Ensembl chr17:34,174,429...34,226,946
G
Aldh1a2
aldehyde dehydrogenase 1 family, member A2
ISO
RGD
PMID:26315408
RGD:14367880
NCBI chr 8:80,758,641...80,837,891
Ensembl chr 8:71,877,850...71,957,107
G
Cs
citrate synthase
IDA
RGD
PMID:571116
RGD:243049254
NCBI chr 7:1,348,389...1,374,624
Ensembl chr 7:758,345...791,421
G
Csf2
colony stimulating factor 2
ISO
protein:increased expression:plasma:
RGD
PMID:16648859
RGD:10449511
NCBI chr10:38,887,692...38,889,673
Ensembl chr10:38,386,945...38,389,199
G
Csf3
colony stimulating factor 3
treatment
ISO
RGD
PMID:23294128 PMID:16224058
RGD:10400895 , RGD:11039414
NCBI chr10:84,157,485...84,159,860
Ensembl chr10:83,661,207...83,663,603
G
Dll4
delta like canonical Notch ligand 4
exacerbates ameliorates
ISO
RGD
PMID:20508179 PMID:35301145 PMID:22252294
RGD:155641249 , RGD:155663375 , RGD:155663358
NCBI chr 3:126,770,945...126,780,769
Ensembl chr 3:106,316,986...106,326,931
G
Epo
erythropoietin
treatment
ISO
RGD
PMID:23294128
RGD:10400895
NCBI chr12:24,841,285...24,844,725
Ensembl chr12:19,204,508...19,207,946
G
Etv2
ETS variant transcription factor 2
exacerbates ameliorates
ISO
RGD
PMID:26586661 PMID:28466428 PMID:32075417 PMID:28424975 PMID:28424975
RGD:11076207 , RGD:192379484 , RGD:192186227 , RGD:156451664 , RGD:156451664
NCBI chr 1:95,017,980...95,021,582
Ensembl chr 1:85,890,559...85,893,431
G
Fgfr1
Fibroblast growth factor receptor 1
treatment
IEP
RGD
PMID:25388665
RGD:11568031
NCBI chr16:73,194,631...73,249,855
Ensembl chr16:66,494,042...66,547,350
G
Grk2
G protein-coupled receptor kinase 2
treatment
IMP
RGD
PMID:26604244
RGD:13514042
NCBI chr 1:211,010,259...211,031,013
Ensembl chr 1:201,581,480...201,601,582
G
Hgf
hepatocyte growth factor
treatment
ISO
RGD
PMID:15238569
RGD:8548639
NCBI chr 4:19,628,902...19,700,467
Ensembl chr 4:18,677,101...18,745,409
G
Hif1a
hypoxia inducible factor 1 subunit alpha
IEP
protein:increased expression:skeletal muscle
RGD
PMID:17522350
RGD:1626332
NCBI chr 6:98,357,788...98,405,068
Ensembl chr 6:92,624,390...92,669,261
G
Hmox1
heme oxygenase 1
IDA
RGD
PMID:12593860
RGD:1598394
NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,467,244...13,474,079
G
Itgam
integrin subunit alpha M
ISO
protein:increased expression:monocyte (human)
RGD
PMID:20816321
RGD:329901827
NCBI chr 1:192,089,496...192,139,947
Ensembl chr 1:182,659,000...182,709,503
G
Itgav
integrin subunit alpha V
ISO
RGD
PMID:15750161
RGD:1582449
NCBI chr 3:89,245,382...89,333,512
Ensembl chr 3:68,838,189...68,926,639
G
Mir126a
microRNA 126a
ameliorates
ISO
associated with type 1 diabetes mellitus;
RGD
PMID:29242072 PMID:35151721
RGD:401851035 , RGD:401851044
NCBI chr 3:29,813,150...29,813,267
Ensembl chr 3:9,415,063...9,415,180
G
Mir210
microRNA 210
severity
ISO
RGD
PMID:31878120
RGD:155882482
NCBI chr 1:205,755,923...205,756,032
Ensembl chr 1:196,326,337...196,326,454
G
Nos3
nitric oxide synthase 3
treatment
IDA IEP ISO
associated with Diabetes Mellitus, Experimental human gene in rat model
RGD
PMID:19080171 PMID:28979692 PMID:12171788
RGD:7794710 , RGD:13450931 , RGD:7794776
NCBI chr 4:11,686,088...11,706,604
Ensembl chr 4:10,793,834...10,814,166
G
Pecam1
platelet and endothelial cell adhesion molecule 1
ISO
RGD
PMID:22369073 PMID:21940947
RGD:6767285 , RGD:6906905
NCBI chr10:92,090,263...92,152,002
Ensembl chr10:91,590,521...91,652,116
G
Ppbp
pro-platelet basic protein
ISO
protein:increased expression:plasma
RGD
PMID:30638058
RGD:401794451
NCBI chr14:17,586,495...17,587,299
Ensembl chr14:17,302,326...17,303,130
G
Ptgis
prostaglandin I2 synthase
treatment
ISO IMP
human gene in a mouse model rat gene in human cells in a mouse model
RGD
PMID:12586736 PMID:19344900 PMID:14568901
RGD:401959585 , RGD:401960096 , RGD:401960079
NCBI chr 3:176,347,589...176,383,251
Ensembl chr 3:155,916,412...155,965,451
G
Ptpn1
protein tyrosine phosphatase, non-receptor type 1
ISO
protein:increased expression, increased activity:hindlimb muscle (mouse)
RGD
PMID:18451337
RGD:401965417
NCBI chr 3:177,056,588...177,106,424
Ensembl chr 3:156,638,769...156,687,504
G
Vegfa
vascular endothelial growth factor A
treatment
IDA
RGD
PMID:23562340
RGD:7421600
NCBI chr 9:22,452,854...22,468,194
Ensembl chr 9:14,955,300...14,970,641
G
Gpt
glutamic--pyruvic transaminase
treatment
IEP
RGD
PMID:36495512
RGD:401717522
NCBI chr 7:110,295,599...110,300,134
Ensembl chr 7:108,416,642...108,419,494
G
Adipoq
adiponectin, C1Q and collagen domain containing
treatment
IDA
RGD
PMID:23762489
RGD:8695935
NCBI chr11:91,226,524...91,240,244
Ensembl chr11:77,721,912...77,735,564
G
Adm
adrenomedullin
treatment
IEP ISO
mRNA,protein:increased expression:liver,plasma:
RGD
PMID:19212187 PMID:19212187
RGD:7364958 , RGD:7364958
NCBI chr 1:174,164,178...174,182,372
Ensembl chr 1:164,745,466...164,747,654
G
Ager
advanced glycosylation end product-specific receptor
IEP
mRNA:increased expression:liver
RGD
PMID:21431875
RGD:10402078
NCBI chr20:4,152,758...4,155,956
Ensembl chr20:4,147,890...4,151,078
G
Aldh2
aldehyde dehydrogenase 2 family member
treatment
ISO IEP
protein:altered expression:liver (mouse) protein:altered expression:liver (rat)
RGD
PMID:30671488 PMID:29589772
RGD:15036807 , RGD:14975297
NCBI chr12:40,610,244...40,643,220
Ensembl chr12:34,901,219...34,982,521
G
Atf6
activating transcription factor 6
ameliorates
ISO
RGD
PMID:34144219
RGD:329812011
NCBI chr13:85,460,312...85,639,959
Ensembl chr13:82,930,034...83,107,177
G
Atg13
autophagy related 13
ameliorates
ISO
RGD
PMID:34400126
RGD:329902072
NCBI chr 3:98,102,831...98,136,741
Ensembl chr 3:77,645,790...77,681,043
G
Atg16l1
autophagy related 16-like 1
ameliorates
ISO
RGD
PMID:34400126
RGD:329902072
NCBI chr 9:95,869,839...95,905,354
Ensembl chr 9:88,422,038...88,457,529
G
Atg4d
autophagy related 4D, cysteine peptidase
ameliorates
ISO
RGD
PMID:34400126
RGD:329902072
NCBI chr 8:28,083,902...28,093,491
Ensembl chr 8:19,807,766...19,817,321
G
Atg7
autophagy related 7
ameliorates
ISO
RGD
PMID:34400126
RGD:329902072
NCBI chr 4:149,390,000...149,597,534
Ensembl chr 4:147,718,752...147,925,593
G
Bad
BCL2-associated agonist of cell death
treatment
IEP
mRNA:increased expression:liver associated with Non-alcoholic Fatty Liver Disease
RGD
PMID:22647552 PMID:22847887
RGD:10053673 , RGD:10053710
NCBI chr 1:213,562,719...213,572,034
Ensembl chr 1:204,131,501...204,142,823
G
Bax
BCL2 associated X, apoptosis regulator
ameliorates treatment
IEP ISO
mRNA:increased expression:liver associated with Non-alcoholic Fatty Liver Disease
RGD
PMID:22647552 PMID:34144219 PMID:21092002 PMID:22847887
RGD:10053673 , RGD:329812011 , RGD:5134995 , RGD:10053710
NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:95,938,808...95,945,368
G
Bcl2
BCL2, apoptosis regulator
treatment ameliorates
IDA ISO IEP
associated with Non-alcoholic Fatty Liver Disease
RGD
PMID:22847887 PMID:34144219 PMID:21092002
RGD:10053710 , RGD:329812011 , RGD:5134995
NCBI chr13:23,204,464...23,366,900
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
Bcl2l1
Bcl2-like 1
treatment
IEP
associated with Non-alcoholic Fatty Liver Disease
RGD
PMID:22847887
RGD:10053710
NCBI chr 3:161,713,777...161,764,844
Ensembl chr 3:141,253,523...141,303,479 Ensembl chr 1:141,253,523...141,303,479
G
Becn1
beclin 1
ameliorates
ISO
RGD
PMID:34400126
RGD:329902072
NCBI chr10:86,731,649...86,747,002
Ensembl chr10:86,231,388...86,246,742
G
Bid
BH3 interacting domain death agonist
ameliorates
IMP
RGD
PMID:17893612
RGD:408346749
NCBI chr 4:155,785,366...155,808,775
Ensembl chr 4:154,113,198...154,134,720
G
C3
complement C3
treatment
IEP
RGD
PMID:19854450
RGD:11040888
NCBI chr 9:2,174,412...2,201,339
Ensembl chr 9:2,087,437...2,114,429
G
Casp12
caspase 12
treatment
IEP
RGD
PMID:29428101
RGD:13782166
NCBI chr 8:10,927,188...10,954,442
Ensembl chr 8:2,642,434...2,674,037
G
Casp3
caspase 3
ameliorates
ISO
RGD
PMID:34144219
RGD:329812011
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:45,662,910...45,684,648
G
Casp8
caspase 8
treatment
IEP ISO
RGD
PMID:23423194 PMID:15300206
RGD:8661760 , RGD:14695087
NCBI chr 9:67,747,109...67,806,699
Ensembl chr 9:60,264,075...60,312,542
G
Casp9
caspase 9
treatment ameliorates
IEP ISO
RGD
PMID:23364428 PMID:34144219
RGD:13782358 , RGD:329812011
Ensembl chr 5:154,109,046...154,126,626
G
Ccl2
C-C motif chemokine ligand 2
ameliorates treatment severity
IEP ISO
mRNA, protein:increased expression:liver, serum (rat)
RGD
PMID:9500701 PMID:34400126 PMID:10630515 PMID:27229110
RGD:8549627 , RGD:329902072 , RGD:14995929 , RGD:14995460
NCBI chr10:67,503,077...67,504,875
Ensembl chr10:67,005,424...67,007,226
G
Ccl5
C-C motif chemokine ligand 5
treatment severity
ISO
RGD
PMID:28623253 PMID:28623253
RGD:14995305 , RGD:14995305
NCBI chr10:68,820,330...68,824,906
Ensembl chr10:68,322,829...68,327,377
G
Ccl7
C-C motif chemokine ligand 7
ameliorates
ISO
RGD
PMID:34400126
RGD:329902072
NCBI chr10:67,514,095...67,515,945
Ensembl chr10:67,016,446...67,018,303
G
Ccn1
cellular communication network factor 1
ameliorates
ISO
RGD
PMID:34144219
RGD:329812011
NCBI chr 2:237,222,730...237,225,689
Ensembl chr 2:234,562,408...234,565,484
G
Ccr1
C-C motif chemokine receptor 1
ameliorates
ISO
RGD
PMID:34400126
RGD:329902072
NCBI chr 8:132,433,711...132,439,266
G
Ccr2
C-C motif chemokine receptor 2
severity
ISO
RGD
PMID:27229110
RGD:14995460
NCBI chr 8:132,611,883...132,619,106
Ensembl chr 8:123,734,430...123,742,100
G
Cd14
CD14 molecule
IDA
RGD
PMID:22564590
RGD:7183676
NCBI chr18:28,609,558...28,611,409
Ensembl chr18:28,335,340...28,337,261
G
Cd40
CD40 molecule
treatment
IMP
RGD
PMID:14741776
RGD:8547795
NCBI chr 3:174,209,113...174,224,592
Ensembl chr 3:153,790,449...153,805,534
G
Cfh
complement factor H
treatment
IEP ISO
mRNA,protein:decreased expression:liver,plasma:
RGD
PMID:19212187 PMID:19212187
RGD:7364958 , RGD:7364958
NCBI chr13:54,063,079...54,164,523
Ensembl chr13:51,511,828...51,613,838
G
Cs
citrate synthase
IDA
RGD
PMID:25416448
RGD:13504849
NCBI chr 7:1,348,389...1,374,624
Ensembl chr 7:758,345...791,421
G
Cst3
cystatin C
ameliorates
ISO
RGD
PMID:34400126
RGD:329902072
NCBI chr 3:156,790,061...156,794,116
Ensembl chr 3:136,336,920...136,340,822
G
Cxcl1
C-X-C motif chemokine ligand 1
treatment ameliorates
IDA ISO
RGD
PMID:21092002 PMID:34400126
RGD:5134995 , RGD:329902072
NCBI chr14:17,477,542...17,479,321
Ensembl chr14:17,193,365...17,195,215
G
Cxcl10
C-X-C motif chemokine ligand 10
treatment ameliorates
ISO
RGD
PMID:18041715 PMID:34400126
RGD:27095942 , RGD:329902072
NCBI chr14:15,989,066...15,991,263
Ensembl chr14:15,704,758...15,706,975
G
Cxcl2
C-X-C motif chemokine ligand 2
ameliorates
ISO
RGD
PMID:34400126
RGD:329902072
NCBI chr14:17,465,210...17,467,255
Ensembl chr14:17,181,062...17,183,075
G
Cxcl6
C-X-C motif chemokine ligand 6
ameliorates
ISO
RGD
PMID:34400126
RGD:329902072
NCBI chr14:17,594,959...17,596,417
Ensembl chr14:17,310,426...17,313,093
G
Cxcl9
C-X-C motif chemokine ligand 9
ameliorates
ISO
RGD
PMID:34400126
RGD:329902072
NCBI chr14:16,007,166...16,012,077
Ensembl chr14:15,722,908...15,728,435
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
IEP
mRNA:decreased expression:lung
RGD
PMID:19595018
RGD:2314952
NCBI chr 8:66,991,940...66,998,014
Ensembl chr 8:58,096,077...58,102,125
G
Ddit3
DNA-damage inducible transcript 3
ameliorates
ISO
RGD
PMID:34144219
RGD:329812011
NCBI chr 7:65,001,695...65,006,517
Ensembl chr 7:63,116,380...63,121,201
G
Eif2ak3
eukaryotic translation initiation factor 2 alpha kinase 3
ameliorates
ISO
RGD
PMID:34144219
RGD:329812011
NCBI chr 4:104,363,838...104,425,271
Ensembl chr 4:102,805,510...102,866,911
G
Elane
elastase, neutrophil expressed
IMP
RGD
PMID:10588515
RGD:10450560
NCBI chr 7:10,467,877...10,469,725
Ensembl chr 7:9,817,252...9,819,100
G
Epo
erythropoietin
treatment
ISO
RGD
PMID:25769561
RGD:15090809
NCBI chr12:24,841,285...24,844,725
Ensembl chr12:19,204,508...19,207,946
G
Epor
erythropoietin receptor
IEP
protein:increased phosphorylation:liver:
RGD
PMID:25769561
RGD:15090809
NCBI chr 8:28,765,738...28,770,371
Ensembl chr 8:20,489,678...20,494,257
G
F3
coagulation factor III, tissue factor
treatment
IMP
RGD
PMID:11750579
RGD:11341708
NCBI chr 2:212,511,675...212,523,375
Ensembl chr 2:209,826,959...209,838,668
G
Fadd
Fas associated via death domain
treatment
IEP
RGD
PMID:23423194
RGD:8661760
NCBI chr 1:209,169,245...209,175,423
Ensembl chr 1:199,739,994...199,745,653
G
Fas
Fas cell surface death receptor
treatment
IMP IEP
protein:increased expression:liver
RGD
PMID:17235585 PMID:18561025 PMID:16222447
RGD:2290283 , RGD:14700680 , RGD:1600351
NCBI chr 1:241,212,155...241,245,774
Ensembl chr 1:231,798,960...231,832,591
G
Faslg
Fas ligand
treatment
IMP
RGD
PMID:18561025
RGD:14700680
NCBI chr13:76,680,885...76,706,042
Ensembl chr13:74,154,954...74,162,215
G
Fga
fibrinogen alpha chain
IEP
mRNA:increased expression:liver (rat)
RGD
PMID:23503399
RGD:9685021
NCBI chr 2:170,672,169...170,679,572
Ensembl chr 2:168,374,120...168,381,528
G
Fn1
fibronectin 1
IDA
RGD
PMID:12651615
RGD:7205470
NCBI chr 9:80,645,507...80,714,200
Ensembl chr 9:73,196,044...73,264,678
G
Gpt
glutamic--pyruvic transaminase
treatment
IEP
RGD
PMID:22564598 PMID:13678701
RGD:329970282 , RGD:329970285
NCBI chr 7:110,295,599...110,300,134
Ensembl chr 7:108,416,642...108,419,494
G
Gsk3b
glycogen synthase kinase 3 beta
treatment
IDA
associated with nonalcoholic fatty liver disease
RGD
PMID:28807209
RGD:13792730
NCBI chr11:76,004,502...76,154,665
Ensembl chr11:62,504,316...62,648,646
G
Gstm1
glutathione S-transferase mu 1
IEP
mRNA:decreased expression:lung
RGD
PMID:19595018
RGD:2314952
NCBI chr 2:198,338,005...198,346,007
Ensembl chr 2:195,649,845...195,655,411
G
H2ax
H2A.X variant histone
treatment
IEP
RGD
PMID:23792534
RGD:8693718
NCBI chr 8:53,568,718...53,570,072
Ensembl chr 8:44,671,786...44,673,239 Ensembl chr 4:44,671,786...44,673,239
G
Hmgb1
high mobility group box 1
treatment
IMP IEP
protein:increased oxidation:liver mRNA, protein:increased expression, altered localization:serum, hepatocyte, cytoplasm
RGD
PMID:24578610 PMID:22514737 PMID:21431875
RGD:10402068 , RGD:10402175 , RGD:10402078
NCBI chr12:11,009,236...11,015,941
Ensembl chr12:5,901,586...5,978,565 Ensembl chr16:5,901,586...5,978,565
G
Hmox1
heme oxygenase 1
treatment
IEP
RGD
PMID:20446775
RGD:10755725
NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,467,244...13,474,079
G
Hp
haptoglobin
treatment
IEP
RGD
PMID:17187421 PMID:21699906
RGD:1626366 , RGD:11041815
NCBI chr19:54,449,151...54,453,701
Ensembl chr19:37,539,627...37,544,523
G
Icam1
intercellular adhesion molecule 1
treatment
IMP IEP
associated with Intestinal Reperfusion Injury;protein:increased expression:liver
RGD
PMID:7884306 PMID:8780571
RGD:11520784 , RGD:14402044
NCBI chr 8:27,829,688...27,841,618
Ensembl chr 8:19,553,645...19,565,438
G
Idh2
isocitrate dehydrogenase (NADP(+)) 2
severity
ISO
RGD
PMID:28938192
RGD:14985248
NCBI chr 1:143,447,925...143,467,248
Ensembl chr 1:134,029,772...134,058,025
G
Ikbkg
inhibitor of nuclear factor kappa B kinase regulatory subunit gamma
treatment
IDA
RGD
PMID:22381173
RGD:12791280
NCBI chr X:157,358,279...157,397,563
Ensembl chr X:152,216,596...152,239,499
G
Il10
interleukin 10
treatment
IDA
RGD
PMID:21911118
RGD:7364839
NCBI chr13:45,024,921...45,029,586
Ensembl chr13:42,472,839...42,477,313
G
Il18
interleukin 18
treatment
IEP ISO
RGD
PMID:25919765 PMID:14999688
RGD:14696667 , RGD:14696668
NCBI chr 8:59,802,072...59,829,275
Ensembl chr 8:50,906,960...50,932,887
G
Il18bp
interleukin 18 binding protein
IEP
mRNA,protein:increased expression:liver
RGD
PMID:25919765
RGD:14696667
NCBI chr 1:165,784,916...165,787,990
Ensembl chr 1:156,372,883...156,374,963
G
Il1a
interleukin 1 alpha
treatment
IEP IDA
mRNA:increased expression:lung protein:increased expression:serum
RGD
PMID:19595018 PMID:9840148 PMID:19283466
RGD:2314952 , RGD:11059517 , RGD:6907377
NCBI chr 3:136,979,804...136,990,236
Ensembl chr 3:116,526,604...116,536,822
G
Il1b
interleukin 1 beta
ameliorates treatment
IDA ISO
associated with Cholestasis
RGD
PMID:21468628 PMID:34400126 PMID:32155285
RGD:7175318 , RGD:329902072 , RGD:155260323
NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:116,577,010...116,583,415
G
Il1rn
interleukin 1 receptor antagonist
treatment
ISO IMP
rat model treated with human protein
RGD
PMID:9000676 PMID:12451245
RGD:6909138 , RGD:8551710
NCBI chr 3:27,509,836...27,525,738
Ensembl chr 3:7,111,550...7,127,445
G
Il6
interleukin 6
treatment ameliorates
IDA ISO
RGD
PMID:24752458 PMID:34400126 PMID:34144219 PMID:32155285
RGD:11062134 , RGD:329902072 , RGD:329812011 , RGD:155260323
NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,213,394...5,219,178
G
Irf8
interferon regulatory factor 8
ameliorates
ISO
RGD
PMID:34400126
RGD:329902072
NCBI chr19:65,699,284...65,721,066
Ensembl chr19:48,790,588...48,811,829
G
Itgam
integrin subunit alpha M
treatment exacerbates
IMP IEP
protein:increased expression:neutrophil (rat)
RGD
PMID:8387952 PMID:11447039
RGD:329901847 , RGD:329901849
NCBI chr 1:192,089,496...192,139,947
Ensembl chr 1:182,659,000...182,709,503
G
Jak2
Janus kinase 2
treatment
IDA
RGD
PMID:22288937
RGD:10403073
NCBI chr 1:236,408,905...236,468,769
Ensembl chr 1:226,995,334...227,054,189
G
Lamp2
lysosomal-associated membrane protein 2
ameliorates
ISO
RGD
PMID:34400126
RGD:329902072
NCBI chr X:122,038,734...122,087,745
Ensembl chr X:117,057,606...117,260,522
G
Lbp
lipopolysaccharide binding protein
IEP
mRNA, protein:increased expression:liver
RGD
PMID:12134092
RGD:9685192
NCBI chr 3:167,373,786...167,400,941
Ensembl chr 3:146,954,015...146,981,586
G
Map1lc3b
microtubule-associated protein 1 light chain 3 beta
ameliorates
ISO
RGD
PMID:34400126
RGD:329902072
NCBI chr19:66,571,631...66,582,270
Ensembl chr19:49,665,791...49,677,690 Ensembl chr16:49,665,791...49,677,690
G
Map3k7
mitogen activated protein kinase kinase kinase 7
ameliorates exacerbates
ISO
protein:increased phosphorylation:liver (mouse)
RGD
PMID:30076625 PMID:30622220
RGD:155804280 , RGD:155882441
NCBI chr 5:51,149,524...51,212,012
Ensembl chr 5:46,357,931...46,415,597
G
Mapk8
mitogen-activated protein kinase 8
IEP
protein:increased activity:liver:
RGD
PMID:11679968
RGD:10412680
NCBI chr16:8,645,171...8,728,225
Ensembl chr16:8,638,924...8,721,981
G
Mfn2
mitofusin 2
treatment
IEP
mRNA, protein:decreased expression:liver (rat)
RGD
PMID:27363631 PMID:24898700
RGD:12910833 , RGD:13204829
NCBI chr 5:163,587,463...163,617,363
Ensembl chr 5:158,304,287...158,335,342
G
Mir145
microRNA 145
IEP
mRNA:decreased expression:small intestine (rat)
RGD
PMID:23166305
RGD:155230822
NCBI chr18:57,369,983...57,370,070
Ensembl chr18:55,099,640...55,099,727
G
Mir155
microRNA 155
ISO
RGD
PMID:28640790
RGD:21079442
NCBI chr11:37,261,114...37,261,178
Ensembl chr11:23,774,654...23,774,718
G
Mir21
microRNA 21
IEP
RNA:increased expression:liver
RGD
PMID:29187695
RGD:41410824
NCBI chr10:71,902,600...71,902,691
Ensembl chr10:71,405,257...71,405,348
G
Mir210
microRNA 210
treatment
ISO
RGD
PMID:32155285
RGD:155260323
NCBI chr 1:205,755,923...205,756,032
Ensembl chr 1:196,326,337...196,326,454
G
Mir223
microRNA 223
ISO
RNA:increased expression:liver RNA:increased expression:serum,liver
RGD
PMID:19104939 PMID:28646120
RGD:13831297 , RGD:21408574
NCBI chr X:65,151,383...65,151,492
Ensembl chr X:61,141,887...61,141,996
G
Mir34a
microRNA 34a
IEP
miRNA:increased expression:liver
RGD
PMID:28963950
RGD:14695005
NCBI chr 5:165,815,952...165,816,053
Ensembl chr 5:160,533,002...160,533,103
G
Mmp15
matrix metallopeptidase 15
IEP
mRNA:increased expression:lung
RGD
PMID:19595018
RGD:2314952
NCBI chr19:9,669,506...9,691,000
Ensembl chr19:9,663,449...9,684,943
G
Mmp9
matrix metallopeptidase 9
treatment
IEP
associated with Fatty Liver;mRNA, protein:decreased expression, decreased activity:liver
RGD
PMID:17255325
RGD:8547976
NCBI chr 3:174,103,474...174,111,434
Ensembl chr 3:153,683,858...153,692,120
G
Muc1
mucin 1, cell surface associated
IEP
mRNA, protein:decreased expression:bile duct
RGD
PMID:21775928
RGD:7364757
NCBI chr 2:176,933,312...176,938,497
Ensembl chr 2:174,635,995...174,640,733
G
Muc17
mucin 17, cell surface associated
IEP
mRNA, protein:decreased expression:bile duct
RGD
PMID:21775928
RGD:7364757
NCBI chr12:25,139,076...25,175,249
Ensembl chr12:19,527,321...19,538,522
G
Muc4
mucin 4, cell surface associated
IEP
mRNA:decreased expression:bile duct
RGD
PMID:21775928
RGD:7364757
NCBI chr11:81,513,321...81,575,200
G
Nfatc1
nuclear factor of activated T-cells 1
ISO
mRNA,protein:increased expression:liver:
RGD
PMID:36092961
RGD:268357360
NCBI chr18:76,321,386...76,430,997
Ensembl chr18:74,046,904...74,156,028
G
Nfe2l2
NFE2 like bZIP transcription factor 2
treatment
IEP
RGD
PMID:22288937 PMID:31952110
RGD:10403073 , RGD:21201304
NCBI chr 3:81,001,529...81,031,165
Ensembl chr 3:60,594,242...60,621,737
G
Nos3
nitric oxide synthase 3
treatment
IEP
RGD
PMID:28966130
RGD:13450941
NCBI chr 4:11,686,088...11,706,604
Ensembl chr 4:10,793,834...10,814,166
G
Pf4
platelet factor 4
exacerbates
ISO
RGD
PMID:25440775
RGD:329901829
NCBI chr14:17,582,477...17,583,392
Ensembl chr14:17,298,308...17,299,365
G
Proc
protein C, inactivator of coagulation factors Va and VIIIa
treatment
ISO
RGD
PMID:12605111 PMID:18507760
RGD:11100021 , RGD:11100046
NCBI chr18:24,038,596...24,049,061
Ensembl chr18:23,764,368...23,775,133
G
Rab10
RAB10, member RAS oncogene family
ameliorates
ISO
RGD
PMID:34400126
RGD:329902072
NCBI chr 6:31,974,858...32,039,554
Ensembl chr 6:26,266,859...26,320,193
G
Rab8b
RAB8B, member RAS oncogene family
ameliorates
ISO
RGD
PMID:34400126
RGD:329902072
NCBI chr 8:76,340,106...76,417,638
Ensembl chr 8:67,458,923...67,536,384
G
Selplg
selectin P ligand
ameliorates
IMP
RGD
PMID:16365457
RGD:401717523
NCBI chr12:48,457,102...48,470,444
Ensembl chr12:42,796,580...42,812,585
G
Serpinc1
serpin family C member 1
treatment
IEP ISO
RGD
PMID:24726586 PMID:8589354
RGD:10450597 , RGD:11038771
NCBI chr13:75,790,558...75,804,826
Ensembl chr13:73,257,179...73,284,293
G
Serpine1
serpin family E member 1
IEP
protein:increased activity:plasma (rat)
RGD
PMID:12353078
RGD:8547901
NCBI chr12:25,237,977...25,248,356
Ensembl chr12:19,601,272...19,611,657
G
Serping1
serpin family G member 1
treatment
ISO
RGD
PMID:16367929
RGD:1580273
NCBI chr 3:90,249,410...90,259,299
Ensembl chr 3:69,842,739...69,852,034
G
Sirt1
sirtuin 1
treatment
IEP
RGD
PMID:24557422
RGD:9497542
NCBI chr20:25,305,953...25,328,000
Ensembl chr20:25,306,917...25,329,260
G
Slpi
secretory leukocyte peptidase inhibitor
IEP
RGD
PMID:19595018
RGD:2314952
NCBI chr 3:173,501,573...173,503,822
Ensembl chr 3:153,082,369...153,084,453
G
Sod1
superoxide dismutase 1
treatment
ISO
human gene in a rat model
RGD
PMID:16555330 PMID:11779401
RGD:8655889 , RGD:1581095
NCBI chr11:42,942,742...42,948,399
Ensembl chr11:29,456,558...29,462,249
G
Sod3
superoxide dismutase 3
treatment
ISO
human gene in a rat model
RGD
PMID:11779401
RGD:1581095
NCBI chr14:62,822,865...62,828,602
Ensembl chr14:58,609,958...58,615,990
G
Tert
telomerase reverse transcriptase
treatment
ISO
RGD
PMID:19545665
RGD:11038676
NCBI chr 1:31,465,766...31,488,650
Ensembl chr 1:29,637,506...29,659,561
G
Tfpi
tissue factor pathway inhibitor
ISO
RGD
PMID:9921794
RGD:11062061
NCBI chr 3:89,939,862...89,989,253
Ensembl chr 3:69,533,156...69,576,880
G
Tlr2
toll-like receptor 2
treatment
ISO IEP
protein:increased expression:liver
RGD
PMID:16038046 PMID:25780291 PMID:25769561
RGD:15090805 , RGD:597538537 , RGD:15090809
NCBI chr 2:171,499,189...171,504,831
Ensembl chr 2:169,197,419...169,206,630
G
Tlr4
toll-like receptor 4
treatment severity
IEP ISO
mRNA:increased expression:liver protein:increased expression:membrane raft:
RGD
PMID:21431875 PMID:21693218 PMID:22797797 PMID:23395256 PMID:27064547
RGD:10402078 , RGD:5685379 , RGD:14697702 , RGD:14697699 , RGD:14697698
NCBI chr 5:85,161,247...85,174,882
Ensembl chr 5:80,145,826...80,159,628
G
Tnf
tumor necrosis factor
treatment
IEP IMP ISO
protein:increased expression:serum (rat)
RGD
PMID:24726586 PMID:12131680 PMID:32155285 PMID:11592783 PMID:19357028 PMID:11129814 PMID:21125813 PMID:10454827 PMID:15457564 PMID:17164725 More...
RGD:10450597 , RGD:14995454 , RGD:155260323 , RGD:2325259 , RGD:15039406 , RGD:14995473 , RGD:14995447 , RGD:14985258 , RGD:14985257 , RGD:14696803
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,622,011...3,624,629
G
Tnfrsf1a
TNF receptor superfamily member 1A
IEP
protein:increased localization:mitochondrion
RGD
PMID:23423194
RGD:8661760
NCBI chr 4:159,837,119...159,849,817
Ensembl chr 4:158,150,820...158,163,591
G
Tradd
TNFRSF1A-associated via death domain
treatment
IEP
RGD
PMID:23423194
RGD:8661760
NCBI chr19:50,046,057...50,048,158
Ensembl chr19:33,136,138...33,142,638
G
Ucp2
uncoupling protein 2
IEP
mRNA:increased expression:liver
RGD
PMID:22195248
RGD:7175309
NCBI chr 1:164,251,373...164,257,742
Ensembl chr 1:154,839,209...154,845,611
G
Vegfa
vascular endothelial growth factor A
IEP
RGD
PMID:26451003
RGD:15036791
NCBI chr 9:22,452,854...22,468,194
Ensembl chr 9:14,955,300...14,970,641
G
Xdh
xanthine dehydrogenase
treatment
IEP
RGD
PMID:24768926
RGD:13209011
NCBI chr 6:27,282,319...27,344,022
Ensembl chr 6:21,530,113...21,592,268
G
Bax
BCL2 associated X, apoptosis regulator
treatment ameliorates
IEP ISO
RGD
PMID:23953793 PMID:34238924
RGD:10054119 , RGD:153350155
NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:95,938,808...95,945,368
G
Bcl2
BCL2, apoptosis regulator
treatment
IEP
RGD
PMID:23953793
RGD:10054119
NCBI chr13:23,204,464...23,366,900
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
Casp3
caspase 3
treatment
IEP
RGD
PMID:23953793
RGD:10054119
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:45,662,910...45,684,648
G
Col1a1
collagen type I alpha 1 chain
ISO
mRNA:increased expression:lung (mouse)
RGD
PMID:34238924
RGD:153350155
NCBI chr10:80,380,458...80,397,461
Ensembl chr10:79,883,622...79,900,624
G
Col3a1
collagen type III alpha 1 chain
ISO
mRNA:increased expression:lung (mouse)
RGD
PMID:34238924
RGD:153350155
NCBI chr 9:54,866,646...54,902,578
Ensembl chr 9:47,374,593...47,410,547
G
Crebbp
CREB binding protein
ameliorates
ISO
RGD
PMID:34238924
RGD:153350155
NCBI chr10:11,842,307...11,968,266
Ensembl chr10:11,335,953...11,461,888
G
Egr1
early growth response 1
treatment
IMP IEP
RGD
PMID:22878149 PMID:23232597
RGD:10395282 , RGD:10395299
NCBI chr18:26,737,078...26,740,877
Ensembl chr18:26,462,981...26,466,766
G
Elane
elastase, neutrophil expressed
treatment
IMP
RGD
PMID:17888675
RGD:10450582
NCBI chr 7:10,467,877...10,469,725
Ensembl chr 7:9,817,252...9,819,100
G
Fgfr2
fibroblast growth factor receptor 2
ISO
mRNA:increased expression:lung (rat)
RGD
PMID:35600952
RGD:155663563
NCBI chr 1:194,175,703...194,280,914
Ensembl chr 1:184,745,420...184,850,626
G
Hmgb1
high mobility group box 1
IEP
protein:increased expression:lung
RGD
PMID:22115333
RGD:10402095
NCBI chr12:11,009,236...11,015,941
Ensembl chr12:5,901,586...5,978,565 Ensembl chr16:5,901,586...5,978,565
G
Hmox1
heme oxygenase 1
IEP
protein:increased expression:lung
RGD
PMID:21227458
RGD:10755577
NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,467,244...13,474,079
G
Icam1
intercellular adhesion molecule 1
treatment
IEP
RGD
PMID:22503847
RGD:7240537
NCBI chr 8:27,829,688...27,841,618
Ensembl chr 8:19,553,645...19,565,438
G
Il1b
interleukin 1 beta
ameliorates
IDA ISO IEP
protein:increased expression:lung (rat)
RGD
PMID:23142117 PMID:34238924 PMID:23122581
RGD:7183185 , RGD:153350155 , RGD:7204125
NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:116,577,010...116,583,415
G
Il4
interleukin 4
treatment
IDA
RGD
PMID:24365768
RGD:10402797
NCBI chr10:38,272,003...38,277,549
Ensembl chr10:37,771,203...37,776,750
G
Il6
interleukin 6
ameliorates
ISO
RGD
PMID:34238924
RGD:153350155
NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,213,394...5,219,178
G
Kras
KRAS proto-oncogene, GTPase
ameliorates
ISO
RGD
PMID:34238924
RGD:153350155
NCBI chr 4:179,916,255...179,949,613
G
Mmp9
matrix metallopeptidase 9
IEP
protein:increased activity:lung
RGD
PMID:18694576
RGD:5129703
NCBI chr 3:174,103,474...174,111,434
Ensembl chr 3:153,683,858...153,692,120
G
Myc
MYC proto-oncogene, bHLH transcription factor
treatment
IEP
RGD
PMID:22503847
RGD:7240537
NCBI chr 7:95,483,105...95,488,031
Ensembl chr 7:93,593,705...93,598,630
G
Nos3
nitric oxide synthase 3
IMP ISO
mRNA:increased expression:lung (mouse)
RGD
PMID:20815765 PMID:25382268
RGD:4892012 , RGD:11533932
NCBI chr 4:11,686,088...11,706,604
Ensembl chr 4:10,793,834...10,814,166
G
Nqo1
NAD(P)H quinone dehydrogenase 1
treatment
IEP
RGD
PMID:21781312
RGD:6771212
NCBI chr19:52,205,374...52,220,267
Ensembl chr19:35,295,573...35,310,557
G
Pecam1
platelet and endothelial cell adhesion molecule 1
IDA IEP
protein:increased expression:alveolar macrophage (rat)
RGD
PMID:21781312 PMID:16449942
RGD:6771212 , RGD:11541083
NCBI chr10:92,090,263...92,152,002
Ensembl chr10:91,590,521...91,652,116
G
Proc
protein C, inactivator of coagulation factors Va and VIIIa
treatment
ISO
RGD
PMID:19782612
RGD:11100035
NCBI chr18:24,038,596...24,049,061
Ensembl chr18:23,764,368...23,775,133
G
Serpine1
serpin family E member 1
treatment
ISO IDA
protein:increased expression:plasma (human)
RGD
PMID:17846288 PMID:11606484
RGD:8547720 , RGD:11080966
NCBI chr12:25,237,977...25,248,356
Ensembl chr12:19,601,272...19,611,657
G
Tlr4
toll-like receptor 4
treatment
IEP
RGD
PMID:22115333
RGD:10402095
NCBI chr 5:85,161,247...85,174,882
Ensembl chr 5:80,145,826...80,159,628
G
Tnf
tumor necrosis factor
ameliorates
IMP ISO
RGD
PMID:17294835 PMID:34238924
RGD:4143397 , RGD:153350155
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,622,011...3,624,629
G
Zfp36
zinc finger protein 36
exacerbates
ISO
RGD
PMID:34238924
RGD:153350155
NCBI chr 1:92,796,628...92,799,108
Ensembl chr 1:83,669,084...83,671,564
G
Enpp1
ectonucleotide pyrophosphatase/phosphodiesterase 1
ISO
ClinVar Annotator: match by term: Coronary sclerosis, medial, of infancy
ClinVar
PMID:9536098 PMID:15940697 PMID:17576681 PMID:25741868 PMID:28492532
NCBI chr 1:22,518,051...22,583,044
Ensembl chr 1:20,698,764...20,763,715
G
Bdkrb1
bradykinin receptor B1
ISO
mRNA:increased expression:blood, mononuclear cell
RGD
PMID:17852785
RGD:4890450
NCBI chr 6:130,275,631...130,284,968
Ensembl chr 6:124,510,870...124,513,747
G
Bdkrb2
bradykinin receptor B2
ISO
mRNA:increased expression:blood, mononuclear cell
RGD
PMID:17852785
RGD:4890450
NCBI chr 6:130,237,055...130,267,205
Ensembl chr 6:124,472,566...124,502,497
G
Mthfr
methylenetetrahydrofolate reductase
ISO
DNA:transition:cds:g.677C>T (human) CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:17491230 PMID:17491230
RGD:4891159
NCBI chr 5:163,748,346...163,768,141
Ensembl chr 5:158,465,296...158,483,797
G
Tnfrsf11b
TNF receptor superfamily member 11B
ISO
protein:decreased expression:serum
RGD
PMID:15648548
RGD:1620974
NCBI chr 7:87,456,318...87,484,324
Ensembl chr 7:85,566,520...85,594,538
G
Abcc8
ATP binding cassette subfamily C member 8
treatment
IMP
RGD
PMID:23149556 PMID:24602692
RGD:12790979 , RGD:12791996
NCBI chr 1:105,734,992...105,816,272
Ensembl chr 1:96,598,647...96,679,510
G
Ace
angiotensin I converting enzyme
treatment
IMP
RGD
PMID:24471927
RGD:11039026
NCBI chr10:91,410,129...91,430,246
Ensembl chr10:90,910,316...90,931,131
G
Ace2
angiotensin converting enzyme 2
IEP
mRNA, protein:increased expression:brain
RGD
PMID:24090950
RGD:9685436
NCBI chr X:33,925,458...33,972,851
Ensembl chr X:30,293,589...30,340,977
G
Acvr1
activin A receptor type 1
ISO
RGD
PMID:33345977
RGD:329845521
NCBI chr 3:63,387,378...63,506,980
Ensembl chr 3:42,978,561...43,098,241
G
Acvr2b
activin A receptor type 2B
ISO
mRNA:increased expression:brain (mouse)
RGD
PMID:33763412
RGD:329849104
NCBI chr 8:128,016,589...128,056,193
Ensembl chr 8:119,138,812...119,170,458
G
Adora1
adenosine A1 receptor
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:23437309
NCBI chr13:48,210,922...48,247,826
Ensembl chr13:45,658,872...45,695,801
G
Ager
advanced glycosylation end product-specific receptor
IEP ISO
associated with Diabetes Mellitus, Experimental CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:25446913 PMID:24211797
RGD:8696008
NCBI chr20:4,152,758...4,155,956
Ensembl chr20:4,147,890...4,151,078
G
Agt
angiotensinogen
IEP
protein:increased expression:brain, serum
RGD
PMID:24090950
RGD:9685436
NCBI chr19:69,426,540...69,447,017
Ensembl chr19:52,529,185...52,540,977
G
Aifm1
apoptosis inducing factor, mitochondria associated 1
IEP
protein:altered localization: :
RGD
PMID:15181376
RGD:10047403
NCBI chr X:132,528,107...132,567,237
Ensembl chr X:127,650,226...127,689,256
G
Ak1
adenylate kinase 1
IEP
protein:decreased expression:cerebral cortex (rat)
RGD
PMID:16468349
RGD:5508760
NCBI chr 3:36,310,113...36,320,760
Ensembl chr 3:15,912,485...15,923,041
G
Alb
albumin
treatment
ISO
RGD
PMID:22227456
RGD:11036100
NCBI chr14:17,891,564...17,907,043
Ensembl chr14:17,607,381...17,622,836
G
Alox5
arachidonate 5-lipoxygenase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19309543
NCBI chr 4:151,203,948...151,251,126
Ensembl chr 4:149,531,515...149,578,743
G
Ap2b1
adaptor related protein complex 2 subunit beta 1
IEP
protein:increased degradation:brain
RGD
PMID:19240038
RGD:13461853
NCBI chr10:68,596,925...68,702,547
Ensembl chr10:68,099,547...68,205,013
G
Apaf1
apoptotic peptidase activating factor 1
treatment
IEP
RGD
PMID:24012531
RGD:13703113
NCBI chr 7:27,381,392...27,466,772
Ensembl chr 7:25,494,609...25,579,540
G
Apoe
apolipoprotein E
IDA
RGD
PMID:19623195
RGD:6903926
NCBI chr 1:88,481,889...88,485,816
Ensembl chr 1:79,353,916...79,357,932
G
App
amyloid beta precursor protein
treatment
IEP
RGD
PMID:28963051
RGD:13782054
NCBI chr11:37,506,207...37,724,351
Ensembl chr11:24,019,778...24,236,561
G
Aqp4
aquaporin 4
treatment
IEP IMP
RGD
PMID:20815926 PMID:33127515
RGD:8695955 , RGD:155646130
NCBI chr18:6,782,389...6,799,034
Ensembl chr18:6,507,903...6,524,856
G
Arc
activity-regulated cytoskeleton-associated protein
IEP
RGD
PMID:22645329
RGD:10395314
NCBI chr 7:108,444,959...108,448,413
Ensembl chr 7:106,555,785...106,559,378
G
Atf3
activating transcription factor 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12374626
NCBI chr13:105,274,103...105,331,653
Ensembl chr13:102,751,321...102,764,631
G
Bad
BCL2-associated agonist of cell death
treatment
IDA
RGD
PMID:22200499 PMID:21891976
RGD:10053665 , RGD:10053704
NCBI chr 1:213,562,719...213,572,034
Ensembl chr 1:204,131,501...204,142,823
G
Bax
BCL2 associated X, apoptosis regulator
treatment
IEP
RGD
PMID:23143152
RGD:10054501
NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:95,938,808...95,945,368
G
Bcan
brevican
IEP
RGD
PMID:15869933
RGD:9590118
NCBI chr 2:175,752,333...175,765,766
Ensembl chr 2:173,454,482...173,467,460
G
Bcl2
BCL2, apoptosis regulator
treatment
IEP
RGD
PMID:23143152
RGD:10054501
NCBI chr13:23,204,464...23,366,900
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
Bdnf
brain-derived neurotrophic factor
treatment
IEP
RGD
PMID:20417695 PMID:31927682 PMID:28202057 PMID:35218623
RGD:4891138 , RGD:596948420 , RGD:405878057 , RGD:401960864
NCBI chr 3:116,619,633...116,670,212
Ensembl chr 3:96,165,042...96,215,615
G
Becn1
beclin 1
treatment
IMP
RGD
PMID:22108007
RGD:11561900
NCBI chr10:86,731,649...86,747,002
Ensembl chr10:86,231,388...86,246,742
G
Bnip3
BCL2 interacting protein 3
IEP
protein:increased expression:brain
RGD
PMID:17379825
RGD:9685412
NCBI chr 1:203,137,778...203,154,962
Ensembl chr 1:193,708,167...193,725,359
G
Bnip3l
BCL2 interacting protein 3 like
IEP
RGD
PMID:15902200 PMID:21029239
RGD:2314138 , RGD:9068917
NCBI chr15:45,350,081...45,373,213
Ensembl chr15:41,174,594...41,197,803
G
C1qtnf6
C1q and TNF related 6
ameliorates
IEP
RGD
PMID:35322553
RGD:242905190
NCBI chr 7:111,958,348...111,964,948
Ensembl chr 7:110,077,878...110,084,412
G
C3
complement C3
IEP ISO
protein:increased expression:plasma CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:23199288 PMID:22103620
RGD:7175514
NCBI chr 9:2,174,412...2,201,339
Ensembl chr 9:2,087,437...2,114,429
G
Calca
calcitonin-related polypeptide alpha
treatment
IEP
RGD
PMID:30531687
RGD:329849008
NCBI chr 1:178,312,636...178,317,588
Ensembl chr 1:168,878,214...168,883,105
G
Camk2a
calcium/calmodulin-dependent protein kinase II alpha
IEP
RGD
PMID:14688616
RGD:1358416
NCBI chr18:56,648,779...56,711,505
Ensembl chr18:54,378,784...54,438,994
G
Casp3
caspase 3
treatment
IDA IEP
RGD
PMID:21891976 PMID:26868427 PMID:23143152
RGD:10053704 , RGD:13782346 , RGD:10054501
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:45,662,910...45,684,648
G
Casp6
caspase 6
IEP
RGD
PMID:26868427
RGD:13782346
NCBI chr 2:221,140,287...221,152,727
Ensembl chr 2:218,466,076...218,478,502
G
Casp9
caspase 9
treatment
IEP
RGD
PMID:26868427
RGD:13782346
Ensembl chr 5:154,109,046...154,126,626
G
Ccl2
C-C motif chemokine ligand 2
ISO
CTD Direct Evidence: marker/mechanism|therapeutic
CTD
PMID:12374626 PMID:23043544 PMID:25257527
NCBI chr10:67,503,077...67,504,875
Ensembl chr10:67,005,424...67,007,226
G
Ccl7
C-C motif chemokine ligand 7
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12374626
NCBI chr10:67,514,095...67,515,945
Ensembl chr10:67,016,446...67,018,303
G
Cd36
CD36 molecule
treatment
ISO
RGD
PMID:25216018
RGD:11041113
NCBI chr 4:18,209,088...18,302,142
Ensembl chr 4:17,354,466...17,513,903
G
Cd86
CD86 molecule
IEP
protein:increased expression:brain subventricular zone, microglial cell (rat)
RGD
PMID:19053043
RGD:2313025
NCBI chr11:77,647,565...77,706,178
Ensembl chr11:64,163,828...64,200,818
G
Cdk5
cyclin-dependent kinase 5
ISO
RGD
PMID:24920629
RGD:13782375
NCBI chr 4:11,647,098...11,651,606
Ensembl chr 4:10,754,687...10,760,112
G
Cldn5
claudin 5
treatment
IEP
RGD
PMID:24842554
RGD:13204729
NCBI chr11:95,717,172...95,718,598
Ensembl chr11:82,211,475...82,214,992
G
Creb1
cAMP responsive element binding protein 1
treatment
IDA
RGD
PMID:35218623
RGD:401960864
NCBI chr 9:73,397,333...73,466,339
Ensembl chr 9:65,903,547...65,970,816
G
Crh
corticotropin releasing hormone
IEP
protein:decreased expression:median eminence of hypothalamus (rat)
RGD
PMID:21741032
RGD:5490538
NCBI chr 2:104,059,184...104,061,048
Ensembl chr 2:102,143,055...102,144,919
G
Crp
C-reactive protein
ISO
RGD
PMID:15545914
RGD:9585995
NCBI chr13:87,694,062...87,695,978
Ensembl chr13:85,124,977...85,175,178
G
Crtc1
CREB regulated transcription coactivator 1
treatment
IEP
RGD
PMID:20417695
RGD:4891138
NCBI chr16:19,022,171...19,080,880
Ensembl chr16:18,988,250...19,043,381
G
Csf3
colony stimulating factor 3
treatment
ISO IEP
mRNA, protein:increased expression:brain:
RGD
PMID:19298757 PMID:15530654
RGD:11039420 , RGD:11039425
NCBI chr10:84,157,485...84,159,860
Ensembl chr10:83,661,207...83,663,603
G
Cxcl10
C-X-C motif chemokine ligand 10
ISO
RGD
PMID:10825390
RGD:632989
NCBI chr14:15,989,066...15,991,263
Ensembl chr14:15,704,758...15,706,975
G
Cxcl2
C-X-C motif chemokine ligand 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12374626
NCBI chr14:17,465,210...17,467,255
Ensembl chr14:17,181,062...17,183,075
G
Cxcr2
C-X-C motif chemokine receptor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25257527
NCBI chr 9:83,178,645...83,185,017
Ensembl chr 9:75,729,115...75,739,425
G
Cxcr3
C-X-C motif chemokine receptor 3
IEP
mRNA:increased expression:cerebral cortex
RGD
PMID:10825390
RGD:632989
NCBI chr X:70,884,293...70,886,944
Ensembl chr X:66,844,318...66,846,969
G
Cyp2e1
cytochrome P450, family 2, subfamily e, polypeptide 1
IEP
RGD
PMID:23002367
RGD:14700877
NCBI chr 1:205,269,967...205,280,365
Ensembl chr 1:195,840,058...195,864,023
G
Dicer1
dicer 1 ribonuclease III
IEP
mRNA:decreased expression:brain:
RGD
PMID:26294080
RGD:11553310
NCBI chr 6:129,392,298...129,457,252
Ensembl chr 6:123,631,250...123,693,965
G
Dnmt1
DNA methyltransferase 1
ISO
RGD
PMID:11726790
RGD:9588643
NCBI chr 8:27,716,797...27,763,405
Ensembl chr 8:19,440,611...19,486,659
G
Dnmt3a
DNA methyltransferase 3 alpha
IMP
RGD
PMID:23516428
RGD:9589049
NCBI chr 6:32,507,316...32,621,678
Ensembl chr 6:26,822,609...26,896,687
G
Dynll1
dynein light chain LC8-type 1
IEP
RGD
PMID:9522364
RGD:13208524
NCBI chr12:46,945,291...46,976,867
Ensembl chr12:41,312,367...41,314,741
G
Edn1
endothelin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17197033
NCBI chr17:22,660,799...22,666,687
Ensembl chr17:22,454,420...22,460,885
G
Egr1
early growth response 1
IEP
RGD
PMID:22645329
RGD:10395314
NCBI chr18:26,737,078...26,740,877
Ensembl chr18:26,462,981...26,466,766
G
Egr2
early growth response 2
IEP
RGD
PMID:22645329
RGD:10395314
NCBI chr20:21,050,149...21,055,201
Ensembl chr20:21,051,277...21,055,562
G
Egr4
early growth response 4
IEP
RGD
PMID:22645329
RGD:10395314
NCBI chr 4:119,605,358...119,607,817
Ensembl chr 4:118,047,869...118,050,328
G
Eif2s1
eukaryotic translation initiation factor 2 subunit alpha
treatment
IDA IMP
RGD
PMID:23669639 PMID:19763736
RGD:10395346 , RGD:10755569
NCBI chr 6:103,405,880...103,430,549
Ensembl chr 6:97,672,766...97,706,225
G
Elane
elastase, neutrophil expressed
treatment
IMP
RGD
PMID:10700596
RGD:10450546
NCBI chr 7:10,467,877...10,469,725
Ensembl chr 7:9,817,252...9,819,100
G
Eng
endoglin
ISO
RGD
PMID:24876084
RGD:11041171
NCBI chr 3:36,332,190...36,370,324
Ensembl chr 3:15,934,518...15,973,230
G
Epcam
epithelial cell adhesion molecule
IEP
RGD
PMID:15950761
RGD:11038820
NCBI chr 6:12,633,715...12,649,678
Ensembl chr 6:6,878,237...6,896,127
G
Ephb2
Eph receptor B2
treatment
IEP ISO
mRNA,protein:increased expression: cortex, cerebral cortex subventricular zone
RGD
PMID:16321245 PMID:16321245
RGD:1642069 , RGD:1642069
NCBI chr 5:154,179,065...154,360,459
Ensembl chr 5:148,897,246...149,077,059
G
Epn1
Epsin 1
IEP
protein:increased degradation:brain
RGD
PMID:19240038
RGD:13461853
NCBI chr 1:77,771,335...77,789,411
Ensembl chr 1:68,742,789...68,758,874
G
Epo
erythropoietin
treatment
ISO
RGD
PMID:20833153 PMID:20547143
RGD:10400898 , RGD:10401066
NCBI chr12:24,841,285...24,844,725
Ensembl chr12:19,204,508...19,207,946
G
Ercc6
ERCC excision repair 6, chromatin remodeling factor
IEP
RGD
PMID:9974119
RGD:10401103
NCBI chr16:7,771,311...7,841,895
Ensembl chr16:7,765,013...7,835,587
G
F11
coagulation factor XI
ISO
RGD
PMID:16533887
RGD:11041786
NCBI chr16:53,720,502...53,741,547
Ensembl chr16:46,986,107...47,008,437
G
F12
coagulation factor XII
treatment
ISO
RGD
PMID:16533887 PMID:16533887
RGD:11041786 , RGD:11041786
NCBI chr17:9,212,819...9,220,664
Ensembl chr17:9,207,683...9,215,530
G
F2
coagulation factor II, thrombin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29651748
NCBI chr 3:98,051,958...98,065,246
Ensembl chr 3:77,596,198...77,609,486
G
Fadd
Fas associated via death domain
treatment
ISO IEP
RGD
PMID:18950622 PMID:23378241
RGD:11341807 , RGD:11344885
NCBI chr 1:209,169,245...209,175,423
Ensembl chr 1:199,739,994...199,745,653
G
Fgf2
fibroblast growth factor 2
treatment
IEP
RGD
PMID:30531687
RGD:329849008
NCBI chr 2:122,164,454...122,218,796
Ensembl chr 2:120,236,328...120,291,221
G
Fgf21
fibroblast growth factor 21
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25257527
NCBI chr 1:105,219,825...105,221,376
Ensembl chr 1:96,083,441...96,090,454
G
Fos
Fos proto-oncogene, AP-1 transcription factor subunit
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12374626
NCBI chr 6:110,852,188...110,855,054
Ensembl chr 6:105,121,170...105,124,036
G
Gabra6
gamma-aminobutyric acid type A receptor subunit alpha6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25257527
NCBI chr10:27,311,965...27,327,337
Ensembl chr10:26,810,423...26,825,769
G
Gap43
growth associated protein 43
treatment
IEP
RGD
PMID:30531687
RGD:329849008
NCBI chr11:71,882,131...71,975,799
Ensembl chr11:58,376,371...58,470,045
G
Gapdh
glyceraldehyde-3-phosphate dehydrogenase
IDA
RGD
PMID:25882840
RGD:13792686
NCBI chr 4:159,648,592...159,653,436
Ensembl chr 4:157,962,343...157,966,235
G
Gch1
GTP cyclohydrolase 1
treatment
IEP
RGD
PMID:24956890
RGD:401717568
NCBI chr15:22,884,006...22,917,412
Ensembl chr15:20,402,527...20,437,698
G
Gdnf
glial cell derived neurotrophic factor
treatment
IMP IEP IDA
RGD
PMID:29497380 PMID:28202057 PMID:20468049 PMID:21347705
RGD:40925919 , RGD:405878057 , RGD:405866363 , RGD:405866359
NCBI chr 2:58,621,327...58,647,242
Ensembl chr 2:56,895,010...56,917,209
G
Ghrl
ghrelin and obestatin prepropeptide
treatment
IDA
RGD
PMID:19352052
RGD:9850083
NCBI chr 4:148,421,315...148,431,128
Ensembl chr 4:146,865,712...146,869,621
G
Ghsr
growth hormone secretagogue receptor
IMP
RGD
PMID:19352052
RGD:9850083
NCBI chr 2:112,196,158...112,201,666
Ensembl chr 2:110,268,489...110,271,865
G
Glul
glutamate-ammonia ligase
treatment
IEP
protein:increased expression:eye protein:increased expression:cerebrum, astrocyte
RGD
PMID:24518488 PMID:23595285 PMID:26024074 PMID:26093193
RGD:401794420 , RGD:401794586 , RGD:401794592 , RGD:401794587
NCBI chr13:68,519,500...68,585,554
Ensembl chr13:66,025,630...66,035,108
G
Grin1
glutamate ionotropic receptor NMDA type subunit 1
treatment
IEP
RGD
PMID:26674869
RGD:11068571
NCBI chr 3:28,501,836...28,528,754
Ensembl chr 3:8,103,680...8,130,603
G
Grn
granulin precursor
treatment
ISO
RGD
PMID:23972823
RGD:10401661
NCBI chr10:87,887,834...87,893,938
Ensembl chr10:87,387,638...87,393,775
G
Grpel1
GrpE-like 1, mitochondrial
IEP
mRNA:increased expression:cerebral cortex
RGD
PMID:12505684
RGD:632868
NCBI chr14:78,517,049...78,522,868
Ensembl chr14:74,292,023...74,298,200
G
Gsk3b
glycogen synthase kinase 3 beta
treatment
IDA
RGD
PMID:28440874
RGD:13792734
NCBI chr11:76,004,502...76,154,665
Ensembl chr11:62,504,316...62,648,646
G
Gsn
gelsolin
ameliorates
ISO
RGD
PMID:18234195 PMID:9927495
RGD:329333031 , RGD:329333033
NCBI chr 3:38,982,605...39,035,849
Ensembl chr 3:18,585,172...18,638,402
G
H19
H19 imprinted maternally expressed transcript
ameliorates
IEP ISO IMP
RNA:increased expression:brain (rat) RNA:increased expression:brain (mouse)
RGD
PMID:28203482 PMID:28630232 PMID:35322553 PMID:31170091 PMID:32335212
RGD:155900760 , RGD:242905192 , RGD:242905190 , RGD:242905188 , RGD:156451661
NCBI chr 1:207,160,175...207,162,851
Ensembl chr 1:197,730,698...197,733,134
G
Hamp
hepcidin antimicrobial peptide
IEP
mRNA, protein:increased expression:cerebral cortex, hippocampus, corpus striatum
RGD
PMID:21957487
RGD:11041635
NCBI chr 1:95,298,332...95,300,271
Ensembl chr 1:86,170,901...86,172,891
G
Has2
hyaluronan synthase 2
IEP
mRNA:increased expression:brain
RGD
PMID:11283406
RGD:9588631
NCBI chr 7:90,002,929...90,028,933
Ensembl chr 7:88,113,326...88,128,933
G
Hdac2
histone deacetylase 2
exacerbates
ISO
RGD
PMID:32239566
RGD:155883173
NCBI chr20:42,101,815...42,126,486
Ensembl chr20:40,548,250...40,571,609
G
Hdac4
histone deacetylase 4
treatment
IEP
mRNA,protein:decreased expression:brain:
RGD
PMID:23480850
RGD:9681449
NCBI chr 9:99,950,972...100,200,994
Ensembl chr 9:92,507,611...92,750,164
G
Hdac5
histone deacetylase 5
treatment
IEP
mRNA,protein:decreased expression:brain:
RGD
PMID:23480850
RGD:9681449
NCBI chr10:87,653,139...87,688,078
Ensembl chr10:87,152,978...87,188,235
G
Hdac9
histone deacetylase 9
IEP
mRNA:increased expression:brain:
RGD
PMID:23480850
RGD:9681449
NCBI chr 6:56,489,472...57,351,654
Ensembl chr 6:50,763,590...51,625,333
G
Hif1a
hypoxia inducible factor 1 subunit alpha
treatment
IDA
RGD
PMID:21029239
RGD:9068917
NCBI chr 6:98,357,788...98,405,068
Ensembl chr 6:92,624,390...92,669,261
G
Hmgb1
high mobility group box 1
treatment
IEP
RGD
PMID:23480850
RGD:9681449
NCBI chr12:11,009,236...11,015,941
Ensembl chr12:5,901,586...5,978,565 Ensembl chr16:5,901,586...5,978,565
G
Hmox1
heme oxygenase 1
treatment
IEP IDA ISO
RGD
PMID:24252362 PMID:23870531 PMID:20888632
RGD:10755587 , RGD:10755755 , RGD:10755588
NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,467,244...13,474,079
G
Hp
haptoglobin
IEP
RGD
PMID:22103620
RGD:7175514
NCBI chr19:54,449,151...54,453,701
Ensembl chr19:37,539,627...37,544,523
G
Hspa4
heat shock protein family A (Hsp70) member 4
IMP ISO
rat gene in mouse model
RGD
PMID:17473852 PMID:21709150
RGD:5688754 , RGD:6218961
NCBI chr10:37,908,866...37,951,994
Ensembl chr10:37,408,025...37,449,001
G
Hspd1
heat shock protein family D (Hsp60) member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12374626
NCBI chr 9:64,073,610...64,084,332
Ensembl chr 9:56,579,201...56,589,662
G
Htra2
HtrA serine peptidase 2
IEP ISO
protein:increased expression:brain, cytosol (rat) protein:increased expression:brain, cytosol (mouse)
RGD
PMID:16978742 PMID:15306124
RGD:2314385 , RGD:5688372
NCBI chr 4:117,114,631...117,117,793
Ensembl chr 4:115,556,916...115,560,095
G
Hvcn1
hydrogen voltage-gated channel 1
IMP
RGD
PMID:31250553
RGD:14985213
NCBI chr12:40,001,205...40,030,671
Ensembl chr12:34,335,190...34,370,141
G
Hvcn1em2Mcwi
hydrogen voltage-gated channel 1; zinc finger nuclease induced mutant 2, Medical College of Wisconsin
IMP
RGD
PMID:31250553
RGD:14985213
G
Icam1
intercellular adhesion molecule 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12374626
NCBI chr 8:27,829,688...27,841,618
Ensembl chr 8:19,553,645...19,565,438
G
Igf1
insulin-like growth factor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25257527
NCBI chr 7:24,169,608...24,249,446
Ensembl chr 7:22,282,930...22,359,296
G
Ikbkb
inhibitor of nuclear factor kappa B kinase subunit beta
treatment
ISO
RGD
PMID:16286924
RGD:10045955
NCBI chr16:76,021,968...76,075,717
Ensembl chr16:69,319,554...69,373,250
G
Il10
interleukin 10
ameliorates
ISO
RGD
PMID:28630232
RGD:242905192
NCBI chr13:45,024,921...45,029,586
Ensembl chr13:42,472,839...42,477,313
G
Il11
interleukin 11
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25257527
NCBI chr 1:78,098,622...78,104,915
Ensembl chr 1:69,068,137...69,076,129
G
Il13
interleukin 13
IEP
protein:increased expression:cerebral cortex
RGD
PMID:23028794
RGD:7204480
NCBI chr10:38,290,926...38,293,483
Ensembl chr10:37,790,130...37,792,737
G
Il1b
interleukin 1 beta
ameliorates treatment
IEP ISO
protein:increased expression:cerebral cortex (rat) CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:25257527 PMID:23028794 PMID:35322553 PMID:29498696 PMID:24916922
RGD:7204480 , RGD:242905190 , RGD:13792833 , RGD:10450594
NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:116,577,010...116,583,415
G
Il1rn
interleukin 1 receptor antagonist
treatment
ISO
human gene in a rat model
RGD
PMID:7790404
RGD:8551708
NCBI chr 3:27,509,836...27,525,738
Ensembl chr 3:7,111,550...7,127,445
G
Il22
interleukin 22
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25257527
NCBI chr 7:55,687,061...55,691,526
Ensembl chr 7:53,801,206...53,806,186
G
Il4
interleukin 4
IEP
protein:increased expression:cerebral cortex
RGD
PMID:23028794
RGD:7204480
NCBI chr10:38,272,003...38,277,549
Ensembl chr10:37,771,203...37,776,750
G
Il5
interleukin 5
IEP
RGD
PMID:23028794
RGD:7204480
NCBI chr10:38,375,132...38,378,003
Ensembl chr10:37,874,342...37,877,213
G
Il6
interleukin 6
treatment
ISO IEP
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:12374626 PMID:21940958 PMID:25257527 PMID:29498696
RGD:13792833
NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,213,394...5,219,178
G
Il6r
interleukin 6 receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21940958
NCBI chr 2:177,582,020...177,646,705
Ensembl chr 2:175,298,686...175,347,536
G
Il6st
interleukin 6 cytokine family signal transducer
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21940958
NCBI chr 2:45,798,872...45,839,501
Ensembl chr 2:44,066,130...44,109,936
G
Il7r
interleukin 7 receptor
IEP
protein:increased expression:brain:
RGD
PMID:30676545
RGD:151347693
NCBI chr 2:60,179,561...60,204,937
Ensembl chr 2:58,454,217...58,477,757
G
Ina
internexin neuronal intermediate filament protein, alpha
ISO
RGD
PMID:29967576
RGD:27226878
NCBI chr 1:255,838,129...255,849,680
Ensembl chr 1:245,896,775...245,908,330
G
Inhba
inhibin subunit beta A
ISO
RGD
PMID:33345977
RGD:329845521
NCBI chr17:53,787,159...53,810,942
Ensembl chr17:49,095,920...49,108,982
G
Irf4
interferon regulatory factor 4
IEP
RGD
PMID:25652434
RGD:11530061
NCBI chr17:33,930,460...33,948,842
Ensembl chr17:33,721,811...33,740,070
G
Junb
JunB proto-oncogene, AP-1 transcription factor subunit
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12374626
NCBI chr19:40,081,126...40,082,910
Ensembl chr19:23,176,294...23,178,035
G
Kcnn4
potassium calcium-activated channel subfamily N member 4
ameliorates
ISO IMP
RGD
PMID:26661208 PMID:25477223 PMID:21750563
RGD:329955572 , RGD:401700383 , RGD:329955444
NCBI chr 1:89,084,306...89,102,279
Ensembl chr 1:79,959,322...79,974,340
G
Lig3
DNA ligase 3
IEP
associated with transient cerebral ischemia;protein:increased expression:brain
RGD
PMID:17412650
RGD:2302580
NCBI chr10:68,215,371...68,238,705
Ensembl chr10:67,717,812...67,798,414
G
Mag
myelin-associated glycoprotein
treatment
IMP
RGD
PMID:15678116
RGD:9685232
NCBI chr 1:95,275,728...95,291,133
Ensembl chr 1:86,148,228...86,163,656
G
Mapk1
mitogen activated protein kinase 1
treatment
IDA
RGD
PMID:27152455 PMID:35218623
RGD:13800881 , RGD:401960864
NCBI chr11:97,462,025...97,529,193
Ensembl chr11:83,957,813...84,023,616
G
Mapk3
mitogen activated protein kinase 3
treatment
IDA
RGD
PMID:27152455 PMID:35218623
RGD:13800881 , RGD:401960864
NCBI chr 1:190,797,189...190,803,411
Ensembl chr 1:181,366,637...181,372,863
G
Mapt
microtubule-associated protein tau
treatment
IEP IDA ISO
RGD
PMID:28886009 PMID:25903928 PMID:28886009
RGD:13800886 , RGD:13800913 , RGD:13800886
NCBI chr10:89,638,618...89,736,108
Ensembl chr10:89,138,627...89,236,129
G
Mir107
microRNA 107
IEP
RNA:increased expression:brain
RGD
PMID:26294080
RGD:11553310
NCBI chr 1:241,750,418...241,750,504
Ensembl chr 1:232,337,767...232,337,853
G
Mir132
microRNA 132
treatment
ISO
mRNA:decreased expression:brain (mouse)
RGD
PMID:33763412 PMID:33763412
RGD:329849104 , RGD:329849104
NCBI chr10:60,522,033...60,522,133
Ensembl chr10:60,023,696...60,023,796
G
Mir140
microRNA 140
ameliorates
ISO IEP
miRNA:decreased expression:cerebral cortex (rat)
RGD
PMID:33246036 PMID:27035554
RGD:329337375 , RGD:329337377
NCBI chr19:52,375,293...52,375,391
Ensembl chr19:35,465,577...35,465,675
G
Mir19a
microRNA 19a
ISO
RNA:decreased expression:brain (mouse)
RGD
PMID:32335212
RGD:156451661
NCBI chr15:98,588,131...98,588,212
Ensembl chr15:92,180,912...92,180,993
G
Mir210
microRNA 210
treatment
IEP
RGD
PMID:34337881
RGD:155269103
NCBI chr 1:205,755,923...205,756,032
Ensembl chr 1:196,326,337...196,326,454
G
Mir29b1
microRNA 29b-1
exacerbates
IMP
RGD
PMID:35322553
RGD:242905190
NCBI chr 4:60,618,334...60,618,414
Ensembl chr 4:59,650,986...59,651,067
G
Mir494
microRNA 494
ameliorates
ISO
RGD
PMID:32239566 PMID:31465536
RGD:155883173 , RGD:156430320
NCBI chr 6:134,550,115...134,550,197
Ensembl chr 6:128,728,709...128,728,793
G
Mmp9
matrix metallopeptidase 9
treatment
ISO IEP
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:19309543 PMID:24842554
RGD:13204729
NCBI chr 3:174,103,474...174,111,434
Ensembl chr 3:153,683,858...153,692,120
G
Mt3
metallothionein 3
IEP
protein:decreased expression:brain
RGD
PMID:8869568
RGD:9685807
NCBI chr19:10,854,676...10,856,080
Ensembl chr19:10,848,755...10,850,158
G
Mtor
mechanistic target of rapamycin kinase
treatment
IEP IDA
RGD
PMID:24583056 PMID:21185267 PMID:23777415
RGD:10040971 , RGD:10041016 , RGD:10040974
NCBI chr 5:164,167,985...164,277,438
Ensembl chr 5:158,884,804...158,994,311
G
Nae1
NEDD8 activating enzyme E1 subunit 1
IEP
RGD
PMID:21386696
RGD:13801046
NCBI chr19:452,462...478,591
Ensembl chr19:446,000...472,371
G
Nampt
nicotinamide phosphoribosyltransferase
treatment
IMP
RGD
PMID:28495827
RGD:13781880
NCBI chr 6:55,152,756...55,189,547
Ensembl chr 6:49,424,332...49,462,100
G
Ncam1
neural cell adhesion molecule 1
treatment
ISO IMP
RGD
PMID:32962079 PMID:29497380
RGD:40924633 , RGD:40925919
NCBI chr 8:58,762,088...59,062,131
Ensembl chr 8:49,865,633...50,166,014
G
Nefh
neurofilament heavy chain
ISO
RGD
PMID:29967576
RGD:27226878
NCBI chr14:84,044,428...84,054,413
Ensembl chr14:79,830,362...79,840,351
G
Nefl
neurofilament light chain
ISO
protein:increased expression:brain
RGD
PMID:29967576
RGD:27226878
NCBI chr15:46,477,330...46,481,203
Ensembl chr15:42,301,916...42,305,793
G
Nefm
neurofilament medium chain
ISO
protein:altered expression:brain
RGD
PMID:29967576
RGD:27226878
NCBI chr15:46,535,857...46,541,161
Ensembl chr15:42,360,454...42,365,755
G
Nfe2l2
NFE2 like bZIP transcription factor 2
treatment
IDA
RGD
PMID:23880501 PMID:24466583
RGD:10412696 , RGD:10412714
NCBI chr 3:81,001,529...81,031,165
Ensembl chr 3:60,594,242...60,621,737
G
Nfkbia
NFKB inhibitor alpha
treatment
IEP
RGD
PMID:21122797
RGD:10413868
NCBI chr 6:78,593,844...78,597,307
Ensembl chr 6:72,858,712...72,861,941
G
Ngf
nerve growth factor
treatment
ISO IMP
CTD Direct Evidence: therapeutic
CTD RGD
PMID:10408807 PMID:29409115
RGD:402463967
NCBI chr 2:192,589,580...192,642,971
Ensembl chr 2:189,901,058...189,954,452
G
Ngfr
nerve growth factor receptor
treatment
IDA
RGD
PMID:22678884
RGD:10413900
NCBI chr10:81,012,077...81,030,305
Ensembl chr10:80,515,299...80,533,518
G
Nod2
nucleotide-binding oligomerization domain containing 2
treatment
IEP
RGD
PMID:24842554
RGD:13204729
NCBI chr19:34,555,832...34,596,281
Ensembl chr19:18,382,439...18,417,177
G
Nos2
nitric oxide synthase 2
IEP ISO
protein:increased expression:brain (rat) mRNA:increased expression:brain (mouse)
RGD
PMID:21959178 PMID:22020035
RGD:5508751 , RGD:5509037
NCBI chr10:64,313,335...64,349,221
Ensembl chr10:63,815,308...63,851,210
G
Nox1
NADPH oxidase 1
treatment
IEP
RGD
PMID:30816157
RGD:329955567
NCBI chr X:101,572,338...101,625,571
Ensembl chr X:97,279,056...97,302,236
G
Nqo1
NAD(P)H quinone dehydrogenase 1
treatment
IEP
protein:increased expression:brain
RGD
PMID:21120604 PMID:25069640
RGD:5133239 , RGD:11035212
NCBI chr19:52,205,374...52,220,267
Ensembl chr19:35,295,573...35,310,557
G
Nrg1
neuregulin 1
treatment ameliorates
ISO
RGD
PMID:20691195 PMID:30206770
RGD:10449015 , RGD:405650589
NCBI chr16:65,954,084...67,007,484
Ensembl chr16:59,250,854...60,296,884
G
Ntrk2
neurotrophic receptor tyrosine kinase 2
treatment
IEP IDA
mRNA:increased exprerssion:hippocampus
RGD
PMID:31927682 PMID:30981830 PMID:32992173
RGD:596948420 , RGD:597538459 , RGD:597015758
NCBI chr17:5,560,558...5,875,899
Ensembl chr17:5,559,043...5,869,136
G
Ogg1
8-oxoguanine DNA glycosylase
treatment
IEP
associated with Hypertension
RGD
PMID:17920569
RGD:8657395
NCBI chr 4:148,030,237...148,037,599
Ensembl chr 4:146,474,750...146,484,766
G
Park7
Parkinsonism associated deglycase
treatment
ISO
RGD
PMID:17882163
RGD:13463450
NCBI chr 5:166,636,551...166,659,825
Ensembl chr 5:161,353,719...161,376,970
G
Parp1
poly (ADP-ribose) polymerase 1
treatment
ISO IDA IEP
RGD
PMID:21311064 PMID:25882840 PMID:23143152 PMID:23801245
RGD:5683909 , RGD:13792686 , RGD:10054501 , RGD:11073732
NCBI chr13:94,839,484...94,871,295
Ensembl chr13:92,307,586...92,339,404
G
Pawr
pro-apoptotic WT1 regulator
treatment
ISO IEP
protein:increased expression:brain:
RGD
PMID:16403464 PMID:19352052 PMID:11323519
RGD:9835380 , RGD:9850083 , RGD:9835381
NCBI chr 7:45,531,480...45,611,492
Ensembl chr 7:43,645,084...43,725,028
G
Pdgfra
platelet derived growth factor receptor alpha
treatment
IDA
RGD
PMID:16917016
RGD:11084934
NCBI chr14:33,360,027...33,408,604
Ensembl chr14:33,005,839...33,054,335
G
Pdgfrb
platelet derived growth factor receptor beta
treatment
IDA
RGD
PMID:16917016
RGD:11084934
NCBI chr18:56,770,348...56,809,228
Ensembl chr18:54,499,964...54,538,843
G
Plat
plasminogen activator, tissue type
IEP ISO
CTD Direct Evidence: therapeutic
CTD RGD
PMID:12297567 PMID:17690543 PMID:18453163 PMID:20547619 PMID:29651748 PMID:14512838 More...
RGD:1580876
NCBI chr16:75,943,061...76,022,037
Ensembl chr16:69,240,585...69,268,223
G
Plau
plasminogen activator, urokinase
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:11677890 PMID:15181847 PMID:17702958
NCBI chr15:3,505,485...3,511,987
Ensembl chr15:3,456,232...3,462,775
G
Pld1
phospholipase D1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12374626
NCBI chr 2:112,777,820...112,975,857
Ensembl chr 2:110,893,608...111,047,692
G
Polb
DNA polymerase beta
IEP
associated with transient cerebral ischemia;protein:increased expression:brain
RGD
PMID:17412650
RGD:2302580
NCBI chr16:76,081,903...76,105,174
Ensembl chr16:69,379,400...69,404,812
G
Prkcg
protein kinase C, gamma
ISO
RGD
PMID:14688616
RGD:1358416
NCBI chr 1:74,748,272...74,777,611
Ensembl chr 1:65,832,855...65,859,384
G
Proc
protein C, inactivator of coagulation factors Va and VIIIa
treatment
ISO
RGD
PMID:24159062
RGD:11100027
NCBI chr18:24,038,596...24,049,061
Ensembl chr18:23,764,368...23,775,133
G
Ptprz1
protein tyrosine phosphatase, receptor type Z1
IEP
mRNA:increased expression:cerebral cortex
RGD
PMID:15869933
RGD:9590118
NCBI chr 4:52,363,006...52,560,905
Ensembl chr 4:51,397,601...51,595,218
G
Rbfox3
RNA binding fox-1 homolog 3
treatment
IEP
RGD
PMID:30531687
RGD:329849008
NCBI chr10:104,218,940...104,655,863
Ensembl chr10:103,720,636...104,156,935
G
Reln
reelin
severity
ISO
RGD
PMID:16438965
RGD:13207538
NCBI chr 4:13,628,440...14,055,201
Ensembl chr 4:12,736,130...13,162,211
G
Rgma
repulsive guidance molecule BMP co-receptor a
treatment
IEP IMP
RGD
PMID:21840379 PMID:23275173
RGD:9850121 , RGD:9850122
NCBI chr 1:136,538,782...136,582,763
Ensembl chr 1:127,128,934...127,172,918
G
Rpl28
ribosomal protein L28
IEP
RGD
PMID:16805800
RGD:6480229
NCBI chr 1:78,080,945...78,083,532
Ensembl chr 1:69,053,203...69,055,032
G
Runx1
RUNX family transcription factor 1
IAGP
mRNA:increased expression:brain
RGD
PMID:24672479
RGD:11251714
NCBI chr11:45,325,778...45,560,300
Ensembl chr11:31,843,764...32,074,542
G
S100a5
S100 calcium binding protein A5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25257527
NCBI chr 2:178,392,922...178,397,128
Ensembl chr 2:176,097,539...176,099,546
G
S100b
S100 calcium binding protein B
IEP
protein:increased expression:cerebrum, astrocyte
RGD
PMID:23595285
RGD:401794586
NCBI chr20:12,372,345...12,381,159
Ensembl chr20:12,372,881...12,394,743
G
Serpine1
serpin family E member 1
IEP
RGD
PMID:14512838
RGD:1580876
NCBI chr12:25,237,977...25,248,356
Ensembl chr12:19,601,272...19,611,657
G
Serpinf1
serpin family F member 1
treatment
IDA
RGD
PMID:22714093
RGD:8655545
NCBI chr10:60,748,504...60,760,898
Ensembl chr10:60,249,708...60,262,646
G
Serpinh1
serpin family H member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12374626
NCBI chr 1:163,055,630...163,063,177
Ensembl chr 1:153,643,510...153,650,801
G
Shh
sonic hedgehog signaling molecule
treatment
ISO
RGD
PMID:22324418
RGD:12879461
NCBI chr 4:7,687,872...7,697,025
Ensembl chr 4:6,954,017...6,963,170
G
Sirt1
sirtuin 1
treatment
IMP ISO
RGD
PMID:23600725 PMID:23600725
RGD:9585664 , RGD:9585664
NCBI chr20:25,305,953...25,328,000
Ensembl chr20:25,306,917...25,329,260
G
Slc12a2
solute carrier family 12 member 2
treatment
IMP ISO
protein:increased expression:brain:
RGD
PMID:12535773 PMID:27798271
RGD:1580583 , RGD:14398833
NCBI chr18:53,546,263...53,614,478
Ensembl chr18:51,348,302...51,416,440
G
Slc1a2
solute carrier family 1 member 2
treatment
IEP
RGD
PMID:20423712
RGD:401794585
NCBI chr 3:109,460,109...109,590,445
Ensembl chr 3:89,005,129...89,126,498
G
Slc2a1
solute carrier family 2 member 1
treatment
IEP
RGD
PMID:9419067
RGD:12879855
NCBI chr 5:138,002,522...138,030,742
Ensembl chr 5:132,717,196...132,745,416
G
Slc9a1
solute carrier family 9 member A1
treatment
IMP
RGD
PMID:31250553
RGD:14985213
NCBI chr 5:150,859,412...150,913,525
Ensembl chr 5:145,576,334...145,629,624
G
Slpi
secretory leukocyte peptidase inhibitor
treatment
IEP
RGD
PMID:14500739
RGD:9999390
NCBI chr 3:173,501,573...173,503,822
Ensembl chr 3:153,082,369...153,084,453
G
Smo
smoothened, frizzled class receptor
treatment
IMP
RGD
PMID:23696546 PMID:23499832
RGD:12832759 , RGD:12879404
NCBI chr 4:59,311,084...59,341,280
Ensembl chr 4:58,343,529...58,373,829
G
Smox
spermine oxidase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30576531
NCBI chr 3:139,184,793...139,220,174
Ensembl chr 3:118,731,900...118,765,710 Ensembl chr X:118,731,900...118,765,710
G
Snap91
synaptosome associated protein 91
IEP
protein:increased degradation:brain
RGD
PMID:19240038
RGD:13461853
NCBI chr 8:96,618,039...96,732,763
Ensembl chr 8:87,738,824...87,852,367
G
Sod1
superoxide dismutase 1
treatment
IDA IEP
mRNA, protein:increased expression:cerebral cortex (rat)
RGD
PMID:22001340 PMID:22133807
RGD:8657021 , RGD:8657023
NCBI chr11:42,942,742...42,948,399
Ensembl chr11:29,456,558...29,462,249
G
Sod2
superoxide dismutase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21940958
NCBI chr 1:50,043,323...50,050,168
Ensembl chr 1:47,636,528...47,645,189
G
Sphk2
sphingosine kinase 2
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:23043544
NCBI chr 1:105,317,332...105,324,985
Ensembl chr 1:96,180,887...96,188,391
G
Stat3
signal transducer and activator of transcription 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21940958
NCBI chr10:86,311,528...86,363,513
Ensembl chr10:85,811,218...85,863,057
G
Tgfb1
transforming growth factor, beta 1
ameliorates
IEP ISO
RGD
PMID:31409163 PMID:28630232
RGD:14995477 , RGD:242905192
NCBI chr 1:90,324,312...90,340,627
Ensembl chr 1:81,196,532...81,212,847
G
Th
tyrosine hydroxylase
IEP
protein:decreased expression:substantia nigra pars compacta, neuron (rat)
RGD
PMID:21366664
RGD:5128609
NCBI chr 1:207,500,959...207,508,276
Ensembl chr 1:198,071,503...198,109,767
G
Tlr2
toll-like receptor 2
treatment
ISO IEP
mRNA:increased expression:microglial cell
RGD
PMID:29039449 PMID:20859668 PMID:24723245
RGD:597538462 , RGD:597538540 , RGD:597538520
NCBI chr 2:171,499,189...171,504,831
Ensembl chr 2:169,197,419...169,206,630
G
Tlr4
toll-like receptor 4
treatment
IEP
RGD
PMID:24723245 PMID:20859668
RGD:597538520 , RGD:597538540
NCBI chr 5:85,161,247...85,174,882
Ensembl chr 5:80,145,826...80,159,628
G
Tnf
tumor necrosis factor
treatment ameliorates
IEP ISO IMP
RGD
PMID:24916922 PMID:28630232 PMID:35322553 PMID:15647744 PMID:29498696
RGD:10450594 , RGD:242905192 , RGD:242905190 , RGD:13825261 , RGD:13792833
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,622,011...3,624,629
G
Tnfaip6
TNF alpha induced protein 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12374626
NCBI chr 3:56,911,398...56,930,797
Ensembl chr 3:36,502,188...36,521,649
G
Tnfrsf1a
TNF receptor superfamily member 1A
IMP
RGD
PMID:15647744
RGD:13825261
NCBI chr 4:159,837,119...159,849,817
Ensembl chr 4:158,150,820...158,163,591
G
Trem1
triggering receptor expressed on myeloid cells 1
ameliorates
IDA
RGD
PMID:32736673
RGD:127284860
NCBI chr 9:20,259,227...20,276,879
Ensembl chr 9:12,763,819...12,779,203
G
Upp1
uridine phosphorylase 1
IEP
mRNA, protein:increased expression:brain (rat)
RGD
PMID:18457515
RGD:2317094
NCBI chr14:88,023,155...88,043,036
Ensembl chr14:83,809,960...83,829,462
G
Vegfa
vascular endothelial growth factor A
treatment
IMP IEP
mRNA,protein:increased expression:cerebral cortex (rat)
RGD
PMID:29497380 PMID:30531687 PMID:27035554
RGD:40925919 , RGD:329849008 , RGD:329337377
NCBI chr 9:22,452,854...22,468,194
Ensembl chr 9:14,955,300...14,970,641
G
Xdh
xanthine dehydrogenase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12374626
NCBI chr 6:27,282,319...27,344,022
Ensembl chr 6:21,530,113...21,592,268
G
Xrcc1
X-ray repair cross complementing 1
IEP
associated with transient cerebral ischemia;protein:increased expression:brain
RGD
PMID:17412650
RGD:2302580
NCBI chr 1:89,268,721...89,296,619
Ensembl chr 1:80,141,207...80,168,701
G
App
amyloid beta precursor protein
ISO
protein:decreased expression:cerebrospinal fluid:
RGD
PMID:1677459
RGD:10054257
NCBI chr11:37,506,207...37,724,351
Ensembl chr11:24,019,778...24,236,561
G
Bax
BCL2 associated X, apoptosis regulator
treatment
IEP
RGD
PMID:18938189
RGD:10054050
NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:95,938,808...95,945,368
G
Bcl2
BCL2, apoptosis regulator
treatment
IEP
RGD
PMID:18938189
RGD:10054050
NCBI chr13:23,204,464...23,366,900
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
G6pd
glucose-6-phosphate dehydrogenase
treatment
IEP
RGD
PMID:21279683
RGD:10449132
NCBI chr X:157,352,364...157,372,144
Ensembl chr X:152,201,098...152,220,801
G
Il2
interleukin 2
severity
ISO
protein:increased secretion:mononuclear cell:
RGD
PMID:8586980
RGD:10047081
NCBI chr 2:121,932,968...121,937,672
Ensembl chr 2:120,004,862...120,009,566
G
Abcc9
ATP binding cassette subfamily C member 9
ISO
ClinVar Annotator: match by term: Myocardial infarction
ClinVar
PMID:16563363 PMID:18239147 PMID:20474083 PMID:21846889 PMID:23739550 PMID:23861362 PMID:24033266 PMID:24439875 PMID:25333069 PMID:25741868 PMID:26636822 PMID:26656175 PMID:26764160 PMID:28492532 More...
NCBI chr 4:177,262,848...177,386,837
Ensembl chr 4:175,532,547...175,655,356
G
Ace
angiotensin I converting enzyme
treatment susceptibility
ISO IEP IMP
ClinVar Annotator: match by term: Myocardial infarction, susceptibility to CTD Direct Evidence: marker/mechanism associated with Diabetes Mellitus, Type 1;DNA:deletion:intron:IVS16+1464-1751del (human) associated with Myocardial Reperfusion Injury
ClinVar CTD RGD
PMID:1313972 PMID:1319114 PMID:1328889 PMID:1386652 PMID:1976655 PMID:2847529 PMID:2849100 PMID:7593601 PMID:7729604 PMID:7783416 PMID:7854377 PMID:7909524 PMID:8131299 PMID:8131300 PMID:8136829 PMID:8170965 PMID:8208911 PMID:8298638 PMID:8314010 PMID:8541160 PMID:8644984 PMID:8675669 PMID:9120002 PMID:9236417 PMID:9259580 PMID:9699903 PMID:9737775 PMID:9916793 PMID:10099885 PMID:10636736 PMID:10643899 PMID:10841123 PMID:11687636 PMID:11956052 PMID:12220450 PMID:12666117 PMID:14657821 PMID:14872014 PMID:15110771 PMID:15277638 PMID:15381116 PMID:15531537 PMID:15534175 PMID:15635071 PMID:19221299 PMID:25741868 PMID:28492532 PMID:15118671 PMID:23959549 PMID:15671045 PMID:7555560 PMID:21975128 More...
RGD:1331525 , RGD:9685449 , RGD:1558664 , RGD:7829785 , RGD:6893480
NCBI chr10:91,410,129...91,430,246
Ensembl chr10:90,910,316...90,931,131
G
Ace2
angiotensin converting enzyme 2
treatment
IEP IDA
mRNA:increased expression:myocardium
RGD
PMID:15671045 PMID:23959549
RGD:1558664 , RGD:9685449
NCBI chr X:33,925,458...33,972,851
Ensembl chr X:30,293,589...30,340,977
G
Acta2
actin alpha 2, smooth muscle
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24358288
NCBI chr 1:241,159,723...241,172,503
Ensembl chr 1:231,746,548...231,759,554
G
Acvr2a
activin A receptor type 2A
ISO
mRNA:decreased expression:myocardium (mouse)
RGD
PMID:32427381
RGD:329849118
NCBI chr 3:53,614,143...53,701,933
Ensembl chr 3:33,205,523...33,289,968
G
Acvr2b
activin A receptor type 2B
ISO
mRNA:decreased expression:myocardium (mouse)
RGD
PMID:32427381
RGD:329849118
NCBI chr 8:128,016,589...128,056,193
Ensembl chr 8:119,138,812...119,170,458
G
Adamts1
ADAM metallopeptidase with thrombospondin type 1 motif, 1
IEP
RGD
PMID:15625312
RGD:9681751
NCBI chr11:38,418,565...38,427,384
Ensembl chr11:24,931,761...24,941,103
G
Add1
adducin 1
no_association
ISO
DNA:missense mutation:cds:p.G460W (human)
RGD
PMID:17082469 PMID:16420563
RGD:5147995 , RGD:5148001
NCBI chr14:80,333,242...80,401,641
Ensembl chr14:76,108,654...76,167,182
G
Adipoq
adiponectin, C1Q and collagen domain containing
disease_progression
IEP
RGD
PMID:21326342
RGD:5686351
NCBI chr11:91,226,524...91,240,244
Ensembl chr11:77,721,912...77,735,564
G
Adipor1
adiponectin receptor 1
ISO
mRNA, protein:decreased expression:heart left ventricle
RGD
PMID:16415076
RGD:1625764
NCBI chr13:48,411,438...48,431,251
Ensembl chr13:45,859,533...45,879,241
G
Adipor2
adiponectin receptor 2
ISO
mRNA, protein:decreased expression:heart left ventricle
RGD
PMID:16415076
RGD:1625764
NCBI chr 4:154,195,440...154,261,141
Ensembl chr 4:152,524,623...152,559,355
G
Adora1
adenosine A1 receptor
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:12160945
NCBI chr13:48,210,922...48,247,826
Ensembl chr13:45,658,872...45,695,801
G
Adora3
adenosine A3 receptor
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:12160945 PMID:20132822
NCBI chr 2:196,077,042...196,080,686
Ensembl chr 2:193,388,713...193,392,357
G
Adra2b
adrenoceptor alpha 2B
ISO
RGD
PMID:12535806
RGD:1559314
NCBI chr 3:135,038,481...135,042,527
Ensembl chr 3:114,585,169...114,589,355
G
Adrb1
adrenoceptor beta 1
ISO IMP
GAD RGD
PMID:15118671 PMID:17143192
RGD:1331525 , RGD:7241557
NCBI chr 1:265,777,103...265,780,114
Ensembl chr 1:255,771,597...255,807,259
G
Adrb2
adrenoceptor beta 2
susceptibility
ISO IEP
DNA:polymorphisms: :p.G16R, p.Q27E, p.T164I mRNA:decreased expression:heart
RGD
PMID:15520258 PMID:12400771
RGD:1601126 , RGD:8548519
NCBI chr18:57,912,760...57,914,802
Ensembl chr18:55,502,903...55,644,512
G
Ager
advanced glycosylation end product-specific receptor
susceptibility
IEP ISO
mRNA:increased expression:left ventricle myocardium (rat) DNA:polymorphism:promoter:-429T>C (human)
RGD
PMID:19910580 PMID:16728681
RGD:2325647 , RGD:1625333
NCBI chr20:4,152,758...4,155,956
Ensembl chr20:4,147,890...4,151,078
G
Agt
angiotensinogen
susceptibility
IDA ISO
CTD Direct Evidence: marker/mechanism associated with Coronary Artery Disease;DNA:polymorphism: :p.M235T (human) associated with hypertension;DNA:polymorphism: :p.M235T
CTD RGD
PMID:1668233 PMID:16413583 PMID:21167013 PMID:15118671 PMID:11393670 PMID:17299437 More...
RGD:5129191 , RGD:1331525 , RGD:1566452 , RGD:1601132
NCBI chr19:69,426,540...69,447,017
Ensembl chr19:52,529,185...52,540,977
G
Agtr1a
angiotensin II receptor, type 1a
susceptibility no_association
ISO IEP
DNA:polymorphism:3' utr:1166A>C DNA:polymorphism:3' utr:1166A>C (human)
RGD GAD
PMID:16061119 PMID:9652322 PMID:15118671 PMID:9857918
RGD:1601150 , RGD:10047101 , RGD:1331525 , RGD:1566499
NCBI chr17:34,383,397...34,435,523
Ensembl chr17:34,174,429...34,226,946
G
Ahsg
alpha-2-HS-glycoprotein
ISO
protein:increased expression:plasma
RGD
PMID:19029462
RGD:2313810
NCBI chr11:91,625,975...91,632,583
Ensembl chr11:78,117,918...78,145,999
G
Aimp1
aminoacyl tRNA synthetase complex-interacting multifunctional protein 1
IEP
RGD
PMID:14732363
RGD:1580021
NCBI chr 2:223,825,930...223,849,477
Ensembl chr 2:221,151,904...221,175,728
G
Ak1
adenylate kinase 1
treatment
IEP
RGD
PMID:22229508
RGD:11100025
NCBI chr 3:36,310,113...36,320,760
Ensembl chr 3:15,912,485...15,923,041
G
Akt1
AKT serine/threonine kinase 1
ISO IDA
protein:increased serine phosphorylation:platelet protein:decreased serine phosphorylation:heart
RGD
PMID:20467748 PMID:20352476
RGD:5509094 , RGD:10041035
NCBI chr 6:137,534,810...137,555,131
Ensembl chr 6:131,713,720...131,733,921
G
Aldh2
aldehyde dehydrogenase 2 family member
ISO
DNA:missense mutation: :p.E487K (human)
RGD
PMID:12452318
RGD:2311152
NCBI chr12:40,610,244...40,643,220
Ensembl chr12:34,901,219...34,982,521
G
Alox5ap
arachidonate 5-lipoxygenase activating protein
no_association
ISO
DNA:snps:multiple (human)
RGD GAD
PMID:14770184 PMID:15118671 PMID:19046748
RGD:1578317 , RGD:1331525 , RGD:2313891
NCBI chr12:10,785,254...10,809,295
Ensembl chr12:5,748,944...5,772,986
G
Ang
angiogenin
ISO
RGD
PMID:18462761
RGD:2325719
NCBI chr15:26,786,233...26,796,883
G
Angpt1
angiopoietin 1
IEP
mRNA, protein:decreased expression:myocardium
RGD
PMID:15364619
RGD:1626168
NCBI chr 7:75,415,959...75,668,696
Ensembl chr 7:73,531,486...73,784,067
G
Angpt2
angiopoietin 2
IEP
protein:increased expression:left ventricular wall, heart septum (rat)
RGD
PMID:16714360
RGD:1601493
NCBI chr16:77,790,760...77,841,241
Ensembl chr16:71,088,364...71,138,804
G
Anxa5
annexin A5
susceptibility no_association
ISO IEP
DNA:polymorphism: :-1C>T (human) protein:altered localization:cardiac muscle cell, sarcolemma protein:increased expression:plasma
RGD
PMID:12200370 PMID:16501019 PMID:8814351 PMID:16025836
RGD:2317542 , RGD:2317541 , RGD:2317543 , RGD:1578384
NCBI chr 2:121,242,133...121,272,935
Ensembl chr 2:119,314,007...119,353,369
G
Apex1
apurinic/apyrimidinic endodeoxyribonuclease 1
susceptibility
ISO
DNA:polymorphism:exon 5: G>A (human)
RGD
PMID:18712175
RGD:401827276
NCBI chr15:26,618,146...26,620,330
Ensembl chr15:24,144,362...24,146,785
G
Apoa1
apolipoprotein A1
treatment no_association
ISO IEP
DNA:polymorphisms
RGD GAD
PMID:20176799 PMID:31734577 PMID:15118671 PMID:10428310
RGD:2325759 , RGD:408418726 , RGD:1331525 , RGD:1578442
NCBI chr 8:55,423,945...55,425,729
Ensembl chr 8:46,527,144...46,529,035
G
Apoa4
apolipoprotein A4
no_association susceptibility
ISO
DNA:mutation:intron:IVS2 (human) associated with Diabetes Mellitus, Type 2; DNA:missense mutation:cds:p.Q360H (human)
RGD GAD
PMID:10428310 PMID:7958503 PMID:15118671
RGD:1578442 , RGD:5685678 , RGD:1331525
NCBI chr 8:55,435,779...55,438,160
Ensembl chr 8:46,539,082...46,541,469
G
Apob
apolipoprotein B
ISO
GAD
PMID:15118671
RGD:1331525
NCBI chr 6:36,563,704...36,603,300
Ensembl chr 6:30,844,368...30,892,497
G
Apoc3
apolipoprotein C3
no_association
ISO
ClinVar Annotator: match by term: Myocardial infarction, susceptibility to
ClinVar RGD
PMID:25741868 PMID:10428310 PMID:15118671
RGD:1578442 , RGD:1331525
NCBI chr 8:55,428,172...55,430,352
Ensembl chr 8:46,531,478...46,533,583
G
Apoe
apolipoprotein E
susceptibility
ISO
DNA:missense mutations, haplotypes:cds:p.C112R, p.R158C (human) CTD Direct Evidence: marker/mechanism DNA:missense mutations, haplotype:cds:p.C112R, p.C158R (human)
CTD RGD
PMID:10587578 PMID:17217375 PMID:10090925 PMID:15118671
RGD:1601229 , RGD:10449412 , RGD:1331525
NCBI chr 1:88,481,889...88,485,816
Ensembl chr 1:79,353,916...79,357,932
G
Apoh
apolipoprotein H
ISO IDA
RGD
PMID:15322656 PMID:12826288
RGD:2313985 , RGD:10054111
NCBI chr10:93,841,992...93,855,897
Ensembl chr10:93,310,977...93,356,329
G
Atg7
autophagy related 7
IEP
mRNA:increased expression:plantaris
RGD
PMID:24427319
RGD:11557988
NCBI chr 4:149,390,000...149,597,534
Ensembl chr 4:147,718,752...147,925,593
G
Atm
ATM serine/threonine kinase
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:24358288 PMID:24358288
RGD:10053570
NCBI chr 8:62,724,939...62,829,040
Ensembl chr 8:53,831,093...53,932,437
G
Atp1a1
ATPase Na+/K+ transporting subunit alpha 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:29702141
NCBI chr 2:191,709,311...191,737,414
Ensembl chr 2:189,020,722...189,048,837
G
Atp5f1d
ATP synthase F1 subunit delta
treatment
IEP
protein:decreased expression:myocardium (rat)
RGD
PMID:29300489 PMID:23809007
RGD:13792656 , RGD:13792681
NCBI chr 7:10,211,260...10,218,989
Ensembl chr 7:9,560,608...9,565,929
G
Atp5po
ATP synthase peripheral stalk subunit OSCP
treatment
ISO
RGD
PMID:24692845
RGD:13801194
NCBI chr11:44,651,171...44,657,483
Ensembl chr11:31,165,217...31,171,592
G
Avpr1a
arginine vasopressin receptor 1A
IMP
RGD
PMID:16423716
RGD:2300376
NCBI chr 7:59,999,743...60,003,667
Ensembl chr 7:58,114,284...58,122,215
G
Bak1
BCL2-antagonist/killer 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29122578
NCBI chr20:5,102,334...5,111,615
Ensembl chr20:5,100,480...5,109,264
G
Bax
BCL2 associated X, apoptosis regulator
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20079142 PMID:25450231
NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:95,938,808...95,945,368
G
Bcl2
BCL2, apoptosis regulator
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19027736
NCBI chr13:23,204,464...23,366,900
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
Bcl2l1
Bcl2-like 1
IMP ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:20079142 PMID:17467744
RGD:1643494
NCBI chr 3:161,713,777...161,764,844
Ensembl chr 3:141,253,523...141,303,479 Ensembl chr 1:141,253,523...141,303,479
G
Bdkrb1
bradykinin receptor B1
IEP
mRNA:increased expression:heart
RGD
PMID:12489796
RGD:704379
NCBI chr 6:130,275,631...130,284,968
Ensembl chr 6:124,510,870...124,513,747
G
Bdkrb2
bradykinin receptor B2
IEP
mRNA:increased expression:heart
RGD
PMID:12489796
RGD:704379
NCBI chr 6:130,237,055...130,267,205
Ensembl chr 6:124,472,566...124,502,497
G
Becn1
beclin 1
treatment
ISO IEP
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:20079142 PMID:20079142
RGD:11561913
NCBI chr10:86,731,649...86,747,002
Ensembl chr10:86,231,388...86,246,742
G
Birc5
baculoviral IAP repeat-containing 5
IEP
RGD
PMID:15081314
RGD:2293137
NCBI chr10:103,567,369...103,580,069
Ensembl chr10:103,073,408...103,081,380
G
Bnip3
BCL2 interacting protein 3
IEP
mRNA:increased expression:plantaris
RGD
PMID:24427319
RGD:11557988
NCBI chr 1:203,137,778...203,154,962
Ensembl chr 1:193,708,167...193,725,359
G
Brap
BRCA1 associated protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19198608
NCBI chr12:40,535,232...40,561,726
Ensembl chr12:34,874,533...34,901,030
G
Brinp3
BMP/retinoic acid inducible neural specific 3
susceptibility
ISO
DNA:SNPs:3' end:
RGD
PMID:18430236
RGD:14398488
NCBI chr13:60,964,127...61,397,044
Ensembl chr13:58,413,883...58,846,770
G
C1qtnf6
C1q and TNF related 6
IEP
protein:decreased expression:heart
RGD
PMID:25962701
RGD:529435444
NCBI chr 7:111,958,348...111,964,948
Ensembl chr 7:110,077,878...110,084,412
G
C3
complement C3
treatment
IEP
mRNA, protein:increased expression:myocardium
RGD
PMID:16996480 PMID:31734577
RGD:1600605 , RGD:408418726
NCBI chr 9:2,174,412...2,201,339
Ensembl chr 9:2,087,437...2,114,429
G
C7
complement C7
IEP
Protein:increased activity:serum, myocardium
RGD
PMID:15724448
RGD:1599522
NCBI chr 2:55,815,687...55,892,605
Ensembl chr 2:54,088,116...54,158,535
G
C8a
complement C8 alpha chain
IEP
RGD
PMID:7515561
RGD:1600501
NCBI chr 5:124,812,131...124,866,631
Ensembl chr 5:119,583,174...119,637,754
G
C8b
complement C8 beta chain
IEP
RGD
PMID:7515561
RGD:1600501
NCBI chr 5:124,763,974...124,801,522
Ensembl chr 5:119,535,146...119,572,565
G
Cacybp
calcyclin binding protein
IEP
mRNA:increased expression:heart
RGD
PMID:16440310
RGD:2326117
NCBI chr13:74,970,917...74,981,298
Ensembl chr13:72,437,490...72,450,177
G
Camk2d
calcium/calmodulin-dependent protein kinase II delta
treatment
IEP
mRNA, protein:splice variants, increased expression:heart left ventricle (rat)
RGD
PMID:26067684
RGD:11097969
NCBI chr 2:217,698,324...217,961,898
Ensembl chr 2:215,024,004...215,286,178
G
Casp1
caspase 1
severity ameliorates
ISO IEP
RGD
PMID:17303764 PMID:33389498
RGD:2315913 , RGD:242905187
NCBI chr 8:10,746,338...10,882,295
Ensembl chr 8:2,587,831...2,597,383
G
Casp3
caspase 3
ameliorates treatment
ISO IEP
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:25450231 PMID:28622474 PMID:27904666
RGD:329333030 , RGD:13782309
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:45,662,910...45,684,648
G
Casr
calcium-sensing receptor
IEP
protein:increased expression:myocardium (rat)
RGD
PMID:22527939
RGD:7205672
NCBI chr11:77,738,398...77,813,639
Ensembl chr11:64,235,251...64,304,811
G
Cat
catalase
IEP ISO
CTD Direct Evidence: therapeutic
CTD RGD
PMID:21600015 PMID:14575298
RGD:1581148
NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:89,842,399...89,874,478
G
Cav3
caveolin 3
IEP
Protein:increased expression:cytosol mRNA, protein; increased expression; myocardium (rat)
RGD
PMID:12566108 PMID:29438664
RGD:1599542 , RGD:126925221
NCBI chr 4:147,137,993...147,153,967
Ensembl chr 4:145,582,060...145,598,137
G
Ccl2
C-C motif chemokine ligand 2
treatment
IEP IDA ISO
protein:increased expression:serum DNA:snp:promoter:g.-2518A>G (human)
RGD
PMID:18459941 PMID:18753699 PMID:16116069
RGD:2307033 , RGD:8549616 , RGD:1581161
NCBI chr10:67,503,077...67,504,875
Ensembl chr10:67,005,424...67,007,226
G
Ccl5
C-C motif chemokine ligand 5
IEP
mRNA:increased expression:heart (rat)
RGD
PMID:18954648
RGD:4890013
NCBI chr10:68,820,330...68,824,906
Ensembl chr10:68,322,829...68,327,377
G
Ccn1
cellular communication network factor 1
ISO
mRNA,protein:increased expression:myocardium (mouse)
RGD
PMID:15117851
RGD:329845570
NCBI chr 2:237,222,730...237,225,689
Ensembl chr 2:234,562,408...234,565,484
G
Ccn2
cellular communication network factor 2
treatment
IEP
mRNA:increased expression:left ventricle (rat)
RGD
PMID:18167060 PMID:29849775
RGD:2314623 , RGD:35673318
NCBI chr 1:22,621,498...22,624,614
Ensembl chr 1:20,802,199...20,805,734
G
Ccna2
cyclin A2
IEP
protein:increased expression:cardiomyocyte:
RGD
PMID:23634243
RGD:10054471
NCBI chr 2:121,355,363...121,361,762
Ensembl chr 2:119,426,089...119,433,577
G
Ccr2
C-C motif chemokine receptor 2
ISO
RGD
PMID:12719858 PMID:12853162
RGD:1581177 , RGD:1581174
NCBI chr 8:132,611,883...132,619,106
Ensembl chr 8:123,734,430...123,742,100
G
Ccr3
C-C motif chemokine receptor 3
IDA
RGD
PMID:18954648
RGD:4890013
NCBI chr 8:132,463,533...132,511,601
Ensembl chr 8:123,616,236...123,634,990
G
Cct7
chaperonin containing TCP1 subunit 7
ISO
ClinVar Annotator: match by term: Myocardial infarction, susceptibility to, 1
ClinVar
PMID:24213632
NCBI chr 4:119,546,730...119,563,973
Ensembl chr 4:117,989,232...118,006,580
G
Cd14
CD14 molecule
no_association
ISO
associated with Coronary Artery Disease;DNA:SNP:promoter
RGD
PMID:10195920 PMID:14587643 PMID:17436151
RGD:1580252 , RGD:1580255 , RGD:2314155
NCBI chr18:28,609,558...28,611,409
Ensembl chr18:28,335,340...28,337,261
G
Cd36
CD36 molecule
severity
IMP
RGD
PMID:22128087
RGD:6893560
NCBI chr 4:18,209,088...18,302,142
Ensembl chr 4:17,354,466...17,513,903
G
Cd40lg
CD40 ligand
ISO
protein:increased expression:serum
RGD
PMID:17635572
RGD:2314209
NCBI chr X:140,164,341...140,176,057
Ensembl chr X:135,126,969...135,138,306
G
Cd59b
CD59b molecule
IEP
protein:decreased expression:myocardium
RGD
PMID:7515561
RGD:1600501
NCBI chr 3:110,914,008...110,932,489
Ensembl chr 3:90,459,162...90,478,847
G
Cdkn1b
cyclin-dependent kinase inhibitor 1B
treatment
IMP ISO
RGD
PMID:22492676 PMID:22492676
RGD:10045366 , RGD:10045366
NCBI chr 4:169,491,273...169,496,500
Ensembl chr 4:167,760,181...167,764,982
G
Cfl1
cofilin 1
treatment
IDA
RGD
PMID:24292258
RGD:11570534
NCBI chr 1:212,227,124...212,230,656
Ensembl chr 1:202,786,627...202,817,587
G
Cftr
CF transmembrane conductance regulator
ISO
associated with Myocardial Reperfusion Injury
RGD
PMID:23221371
RGD:11566046
NCBI chr 4:47,422,084...47,694,646
Ensembl chr 4:46,560,885...46,728,756
G
Chi3l1
chitinase 3 like 1
ISO
protein:increased secretion:serum (human)
RGD
PMID:18480670
RGD:4892633
NCBI chr13:48,193,839...48,201,822
Ensembl chr13:45,641,802...45,649,787
G
Ciita
class II, major histocompatibility complex, transactivator
susceptibility no_association
ISO
DNA:polymorphism:promoter:-168A>G (human)
RGD
PMID:15821736 PMID:17183695
RGD:1358146 , RGD:5491201
NCBI chr10:5,646,854...5,694,393
Ensembl chr10:5,140,178...5,187,440
G
Ckb
creatine kinase B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12359538
NCBI chr 6:136,550,583...136,553,464
Ensembl chr 6:130,729,423...130,732,315
G
Ckm
creatine kinase, M-type
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:3279722 PMID:12359538
NCBI chr 1:88,189,382...88,199,717
Ensembl chr 1:79,061,456...79,071,720
G
Clu
clusterin
treatment
ISO
RGD
PMID:20854280
RGD:9068409
NCBI chr15:44,336,619...44,375,861
Ensembl chr15:40,174,617...40,200,315
G
Col1a1
collagen type I alpha 1 chain
treatment
IEP
RGD
PMID:25636075
RGD:11041598
NCBI chr10:80,380,458...80,397,461
Ensembl chr10:79,883,622...79,900,624
G
Col3a1
collagen type III alpha 1 chain
treatment
IEP
RGD
PMID:25636075
RGD:11041598
NCBI chr 9:54,866,646...54,902,578
Ensembl chr 9:47,374,593...47,410,547
G
Col4a1
collagen type IV alpha 1 chain
susceptibility
ISO
DNA:polymorphism: :p.Q1334H (human)
RGD
PMID:18077766
RGD:2311341
NCBI chr16:84,885,597...84,996,482
Ensembl chr16:78,183,533...78,294,412
G
Col6a3
collagen type VI alpha 3 chain
ISO
DNA:SNP:CDS:E1386K (rs146092501) (human)
RGD
PMID:30226566
RGD:401851058
NCBI chr 9:98,809,171...98,887,060
Ensembl chr 9:91,361,583...91,439,471
G
Creb1
cAMP responsive element binding protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19027736
NCBI chr 9:73,397,333...73,466,339
Ensembl chr 9:65,903,547...65,970,816
G
Crem
cAMP responsive element modulator
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19027736
NCBI chr17:58,932,011...59,001,160
Ensembl chr17:54,239,030...54,305,989
G
Crp
C-reactive protein
IEP ISO
protein:increased expression:serum associated with Angina, Unstable;
RGD
PMID:21046814 PMID:9761079 PMID:22446866
RGD:5131456 , RGD:9491780 , RGD:6482304
NCBI chr13:87,694,062...87,695,978
Ensembl chr13:85,124,977...85,175,178
G
Cs
citrate synthase
severity
IDA ISO
protein:decreased expression:diaphragm, mitochondrion
RGD
PMID:1877670 PMID:34416105
RGD:243048469 , RGD:243048471
NCBI chr 7:1,348,389...1,374,624
Ensembl chr 7:758,345...791,421
G
Csf2
colony stimulating factor 2
IMP
RGD
PMID:21326109
RGD:5131507
NCBI chr10:38,887,692...38,889,673
Ensembl chr10:38,386,945...38,389,199
G
Csf3
colony stimulating factor 3
treatment
ISO
RGD
PMID:15639484
RGD:11039417
NCBI chr10:84,157,485...84,159,860
Ensembl chr10:83,661,207...83,663,603
G
Csnk2a1
casein kinase 2 alpha 1
IEP
RGD
PMID:15090263
RGD:11565830
NCBI chr 3:161,170,295...161,217,073
Ensembl chr 3:140,709,991...140,756,696
G
Csnk2b
casein kinase 2 beta
IEP
RGD
PMID:15090263
RGD:11565830
NCBI chr20:3,704,833...3,709,999
Ensembl chr20:3,698,733...3,707,133
G
Ctla4
cytotoxic T-lymphocyte-associated protein 4
ISO
DNA:SNP:CDS:49A>G (human)
RGD
PMID:17652883
RGD:2301976
NCBI chr 9:69,812,859...69,819,959
Ensembl chr 9:62,319,312...62,324,963
G
Ctsb
cathepsin B
IEP
protein:increased activity:serum, heart (rat)
RGD
PMID:19958779
RGD:2315501
NCBI chr15:41,565,607...41,586,479
Ensembl chr15:37,389,629...37,410,500
G
Cxcl12
C-X-C motif chemokine ligand 12
IEP IMP
mRNA:increased expression:heart left ventricle
RGD
PMID:11820456 PMID:19187644
RGD:632503 , RGD:2306567
NCBI chr 4:152,060,781...152,073,628
Ensembl chr 4:150,388,325...150,401,168
G
Cyba
cytochrome b-245 alpha chain
IEP
mRNA:increased expression:myocardium mRNA:increase expression:ventricle myocardium:
RGD
PMID:18762777 PMID:11243862
RGD:2317860 , RGD:1599690
NCBI chr19:67,396,143...67,404,214
Ensembl chr19:50,487,597...50,495,721
G
Cybb
cytochrome b-245 beta chain
IEP
mRNA:increase expression:ventricle myocardium
RGD
PMID:11243862
RGD:1599690
NCBI chr X:16,030,596...16,065,065
Ensembl chr X:13,359,430...13,392,586
G
Cyp11b2
cytochrome P450, family 11, subfamily b, polypeptide 2
IMP
RGD
PMID:18689429
RGD:2307303
NCBI chr 7:108,719,349...108,726,024
Ensembl chr 7:106,838,590...106,845,004
G
Cyp1b1
cytochrome P450, family 1, subfamily b, polypeptide 1
ameliorates
IMP
RGD
PMID:33389498
RGD:242905187
NCBI chr 6:21,093,927...21,103,091
Ensembl chr 6:15,342,344...15,350,917
G
Cyp2j4
cytochrome P450, family 2, subfamily j, polypeptide 4
susceptibility
ISO
DNA:polymorphism
RGD
PMID:17126841
RGD:1625380
NCBI chr 5:116,295,691...116,323,219
Ensembl chr 5:111,178,703...111,244,794
G
Cyp2r1
cytochrome P450, family 2, subfamily r, polypeptide 1
ISO
DNA:SNP:CDS:rs2060793, rs1993116, rs10766197 (human)
RGD
PMID:29804528
RGD:401901167
NCBI chr 1:178,166,984...178,232,191
Ensembl chr 1:168,751,038...168,797,759
G
Dab2
DAB adaptor protein 2
IEP IMP
protein:increased expression:cardiomyocyte
RGD
PMID:21762377 PMID:20666606
RGD:7243156 , RGD:7243158
NCBI chr 2:57,241,947...57,294,893
Ensembl chr 2:55,514,700...55,567,476
G
Dab2ip
DAB2 interacting protein
onset
ISO
CTD Direct Evidence: marker/mechanism DNA:SNP:CDS:intron 1 (rs7025486) (human)
CTD RGD
PMID:20622881 PMID:20622881
RGD:401901599
NCBI chr 3:39,312,745...39,483,730
Ensembl chr 3:18,915,290...19,086,280
G
Dag1
dystroglycan 1
treatment
IDA
RGD
PMID:12034665
RGD:11541047
NCBI chr 8:117,769,517...117,834,347
Ensembl chr 8:108,890,929...108,952,325
G
Dcn
decorin
IEP
RGD
PMID:16311904
RGD:1598497
NCBI chr 7:34,167,973...34,208,004
Ensembl chr 7:32,281,252...32,321,270
G
Ddit3
DNA-damage inducible transcript 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25450231
NCBI chr 7:65,001,695...65,006,517
Ensembl chr 7:63,116,380...63,121,201
G
Dgkz
diacylglycerol kinase zeta
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:17071729
NCBI chr 3:98,359,804...98,401,847
Ensembl chr 3:77,904,150...77,946,099
G
Dvl1
dishevelled segment polarity protein 1
IEP
RGD
PMID:15256074
RGD:1580899
NCBI chr 5:171,738,911...171,750,967
Ensembl chr 5:166,456,686...166,468,664
G
Dyrk1a
dual specificity tyrosine phosphorylation regulated kinase 1A
treatment
IEP
associated with heart failure; protein:increased expression, increased activity:heart left ventricle (rat)
RGD
PMID:26067684
RGD:11097969
NCBI chr11:47,360,824...47,479,033
Ensembl chr11:33,890,490...34,009,420
G
Ece1
endothelin converting enzyme 1
ISO
RGD
PMID:9607404
RGD:1580912
NCBI chr 5:155,361,031...155,462,723
Ensembl chr 5:150,077,644...150,179,371
G
Edn1
endothelin 1
severity
ISO IEP
protein:increased secretion:plasma (human) mRNA:increased expression:heart left ventricle (rat)
RGD
PMID:17893002 PMID:10573185
RGD:4144880 , RGD:1580921
NCBI chr17:22,660,799...22,666,687
Ensembl chr17:22,454,420...22,460,885
G
Edn2
endothelin 2
IEP
RGD
PMID:10573185
RGD:1580921
NCBI chr 5:139,036,576...139,042,074
Ensembl chr 5:133,751,217...133,756,814
G
Ednra
endothelin receptor type A
IDA
RGD
PMID:12524016
RGD:1580948
NCBI chr19:47,137,360...47,207,961
Ensembl chr19:30,233,571...30,297,049
G
Ednrb
endothelin receptor type B
IDA
RGD
PMID:12524016
RGD:1580948
NCBI chr15:87,055,490...87,086,765
Ensembl chr15:80,643,043...80,672,115
G
Egln1
egl-9 family hypoxia-inducible factor 1
IEP
RGD
PMID:16765982
RGD:11252084
NCBI chr19:69,765,276...69,804,681
Ensembl chr19:52,869,486...52,907,777
G
Egln3
egl-9 family hypoxia-inducible factor 3
IEP
RGD
PMID:16765982
RGD:11252084
NCBI chr 6:77,385,549...77,411,015
Ensembl chr 6:71,650,297...71,675,766
G
Epas1
endothelial PAS domain protein 1
IEP
RGD
PMID:15247145 PMID:18484163
RGD:1580977 , RGD:5147886
NCBI chr 6:13,543,252...13,626,147
Ensembl chr 6:7,790,647...7,871,228
G
Ephb1
Eph receptor B1
ameliorates
IEP
RGD
PMID:28622474
RGD:329333030
NCBI chr 8:111,386,432...111,823,759
Ensembl chr 8:102,507,549...102,944,839
G
Ephx2
epoxide hydrolase 2
ISO
RGD
PMID:19716829
RGD:5688358
NCBI chr15:44,465,447...44,503,157
Ensembl chr15:40,289,902...40,327,615
G
Epo
erythropoietin
treatment
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:19337937 PMID:21415704
RGD:10400907
NCBI chr12:24,841,285...24,844,725
Ensembl chr12:19,204,508...19,207,946
G
Epor
erythropoietin receptor
IEP
RGD
PMID:21415704
RGD:10400907
NCBI chr 8:28,765,738...28,770,371
Ensembl chr 8:20,489,678...20,494,257
G
Erbb2
erb-b2 receptor tyrosine kinase 2
treatment
IEP
RGD
PMID:26892146
RGD:11522702
NCBI chr10:83,907,491...83,931,365
Ensembl chr10:83,411,313...83,435,078
G
Erbb4
erb-b2 receptor tyrosine kinase 4
treatment
IEP
RGD
PMID:26892146
RGD:11522702
NCBI chr 9:76,973,386...78,045,633
Ensembl chr 9:69,531,481...70,596,595
G
Esr1
estrogen receptor 1
susceptibility
ISO
ClinVar Annotator: match by term: Myocardial infarction, susceptibility to CTD Direct Evidence: marker/mechanism
OMIM ClinVar CTD
PMID:11894143 PMID:11919305 PMID:14600184 PMID:15133719 PMID:25741868 PMID:15118671 More...
RGD:1331525
NCBI chr 1:43,511,685...43,904,454
Ensembl chr 1:41,210,475...41,495,002
G
F10
coagulation factor X
ISO
ClinVar Annotator: match by term: Myocardial infarction, decreased susceptibility to
ClinVar
PMID:10984565 PMID:12181036 PMID:25741868
NCBI chr16:83,170,973...83,190,280
Ensembl chr16:76,468,838...76,488,141
G
F12
coagulation factor XII
susceptibility
ISO
DNA:polymorphism:promoter:-46C>T(human)
RGD
PMID:16411408
RGD:11041803
NCBI chr17:9,212,819...9,220,664
Ensembl chr17:9,207,683...9,215,530
G
F13a1
coagulation factor XIII A1 chain
ISO
ClinVar Annotator: match by term: Myocardial infarction, protection against | ClinVar Annotator: match by term: Myocardial infarction, susceptibility to CTD Direct Evidence: marker/mechanism
OMIM ClinVar CTD RGD
PMID:8025280 PMID:9459313 PMID:9550516 PMID:10365735 PMID:10910914 PMID:12072871 PMID:12456499 PMID:17393027 PMID:25741868 PMID:12480694 More...
RGD:1581022
NCBI chr17:28,021,197...28,197,960
Ensembl chr17:27,815,702...27,992,700
G
F2
coagulation factor II, thrombin
susceptibility
ISO
CTD Direct Evidence: marker/mechanism DNA:polymorphism::20210G>A(human)
CTD RGD
PMID:9292507 PMID:9531249 PMID:10027711 PMID:12480694
RGD:1581022
NCBI chr 3:98,051,958...98,065,246
Ensembl chr 3:77,596,198...77,609,486
G
F3
coagulation factor III, tissue factor
treatment
IEP
RGD
PMID:21229253
RGD:11062083
NCBI chr 2:212,511,675...212,523,375
Ensembl chr 2:209,826,959...209,838,668
G
F5
coagulation factor V
no_association susceptibility
ISO
CTD Direct Evidence: marker/mechanism DNA:mutation:cds:1691G>A (human)
CTD RGD
PMID:9531249 PMID:10590188 PMID:15131548
RGD:11564337 , RGD:11564335
NCBI chr13:79,046,657...79,116,247
Ensembl chr13:76,513,255...76,582,317
G
F7
coagulation factor VII
susceptibility
ISO
protein:increased activity:plasma (human) ClinVar Annotator: match by term: F7-related condition | ClinVar Annotator: match by term: Myocardial infarction, decreased susceptibility to | ClinVar Annotator: match by term: Myocardial infarction, susceptibility to CTD Direct Evidence: marker/mechanism DNA:missense mutation, repeat:cds, intron:p.R353Q, (human)
OMIM ClinVar CTD RGD
PMID:627745 PMID:1634227 PMID:2070047 PMID:6812354 PMID:7919338 PMID:7974346 PMID:7981691 PMID:8043443 PMID:8242057 PMID:8448207 PMID:8844208 PMID:8883260 PMID:9657438 PMID:9949166 PMID:10554827 PMID:10862079 PMID:10959697 PMID:10984565 PMID:11091194 PMID:11092214 PMID:11129332 PMID:11225604 PMID:11313743 PMID:11918550 PMID:11931672 PMID:12181036 PMID:12632035 PMID:12695753 PMID:12903033 PMID:12935978 PMID:14521598 PMID:15142120 PMID:15194538 PMID:15456489 PMID:15590402 PMID:15735798 PMID:15741795 PMID:15907525 PMID:16732384 PMID:16753603 PMID:16807660 PMID:18282149 PMID:18669152 PMID:18976247 PMID:19601987 PMID:19751712 PMID:19780835 PMID:20040857 PMID:20735728 PMID:20958793 PMID:21206266 PMID:21902896 PMID:22180436 PMID:22327826 PMID:22353194 PMID:23731332 PMID:24533960 PMID:24711753 PMID:25275492 PMID:25582404 PMID:25741868 PMID:25828579 PMID:25952977 PMID:26105150 PMID:27227566 PMID:27848944 PMID:28447100 PMID:28492532 PMID:29104756 PMID:29246447 PMID:29318701 PMID:29618153 PMID:31064749 PMID:31273093 PMID:31467667 PMID:31589614 PMID:32333443 PMID:33477601 PMID:34342048 PMID:34355501 PMID:35356632 PMID:35552711 PMID:35802509 PMID:36571800 PMID:36696193 PMID:36719811 PMID:36760778 PMID:37055848 PMID:37091489 PMID:37312209 PMID:37521340 PMID:37761907 PMID:38202056 PMID:38387429 PMID:38397060 PMID:7495060 PMID:9420338 PMID:16116695 More...
RGD:2312409 , RGD:11049521 , RGD:1580374
NCBI chr16:83,191,896...83,202,775
Ensembl chr16:76,489,717...76,500,610
G
Fabp3
fatty acid binding protein 3
ISO
RGD
PMID:8326460
RGD:1582401
NCBI chr 5:147,936,027...147,942,870
Ensembl chr 5:142,651,956...142,658,718
G
Fga
fibrinogen alpha chain
treatment
IEP
RGD
PMID:31734577
RGD:408418726
NCBI chr 2:170,672,169...170,679,572
Ensembl chr 2:168,374,120...168,381,528
G
Fgb
fibrinogen beta chain
ISO
GAD RGD
PMID:15118671 PMID:9437197
RGD:1331525 , RGD:1580381
NCBI chr 2:170,693,966...170,700,875
Ensembl chr 2:168,394,916...168,405,979
G
Fgf1
fibroblast growth factor 1
treatment
ISO
RGD
PMID:24200746
RGD:10449026
NCBI chr18:30,937,670...31,023,786
Ensembl chr18:30,686,581...30,772,357
G
Fgfr1
Fibroblast growth factor receptor 1
ISO
RGD
PMID:17439742
RGD:10402087
NCBI chr16:73,194,631...73,249,855
Ensembl chr16:66,494,042...66,547,350
G
Fgfr2
fibroblast growth factor receptor 2
ameliorates
ISO
RGD
PMID:19358330
RGD:155663664
NCBI chr 1:194,175,703...194,280,914
Ensembl chr 1:184,745,420...184,850,626
G
Fgg
fibrinogen gamma chain
treatment
IEP
RGD
PMID:31734577
RGD:408418726
NCBI chr 2:170,652,929...170,660,372
Ensembl chr 2:168,355,013...168,362,322
G
Fis1
fission, mitochondrial 1
IEP
protein:increased expression:plantaris (rat)
RGD
PMID:24427319
RGD:11557988
NCBI chr12:25,345,239...25,360,135
Ensembl chr12:19,708,558...19,723,377
G
Flt1
Fms related receptor tyrosine kinase 1
IEP
RGD
PMID:16714360
RGD:1601493
NCBI chr12:12,333,050...12,504,750
Ensembl chr12:7,297,292...7,468,626
G
Flt3lg
Fms related receptor tyrosine kinase 3 ligand
treatment
ISO
RGD
PMID:24184252
RGD:11049498
NCBI chr 1:104,751,518...104,756,925
Ensembl chr 1:95,609,370...95,620,463
G
Fn1
fibronectin 1
IEP
protein:decreased expression:heart
RGD
PMID:19695229
RGD:2325720
NCBI chr 9:80,645,507...80,714,200
Ensembl chr 9:73,196,044...73,264,678
G
Fos
Fos proto-oncogene, AP-1 transcription factor subunit
IEP
protein:increased expression:paraventricular nucleus hypothalamus, paraventricular nucleus thalamus
RGD
PMID:27601012
RGD:405649741
NCBI chr 6:110,852,188...110,855,054
Ensembl chr 6:105,121,170...105,124,036
G
Fto
FTO, alpha-ketoglutarate dependent dioxygenase
treatment
ISO
mRNA, protein:decreased expression:heart DNA:SNP: :rs17817449 (human) associated with type 2 diabetes mellitus;DNA:SNP:intron:rs9939609 (human)
RGD
PMID:29997116 PMID:26772723 PMID:20031593 PMID:29997116
RGD:329812009 , RGD:11555187 , RGD:329901766 , RGD:329812009
NCBI chr19:31,456,749...31,865,011
Ensembl chr19:15,349,696...15,692,083
G
Fzd2
frizzled class receptor 2
IEP
mRNA:increased expression:heart left ventricle
RGD
PMID:9142123
RGD:4107058
NCBI chr10:88,061,988...88,063,898
Ensembl chr10:87,561,326...87,565,334
G
G6pd
glucose-6-phosphate dehydrogenase
treatment
IEP
RGD
PMID:20462747
RGD:10449173
NCBI chr X:157,352,364...157,372,144
Ensembl chr X:152,201,098...152,220,801
G
Gata4
GATA binding protein 4
treatment
IMP ISO
CTD Direct Evidence: therapeutic
CTD RGD
PMID:20200331 PMID:23948075
RGD:7327215
NCBI chr15:41,635,572...41,707,252
Ensembl chr15:37,459,601...37,505,636
G
Gatm
glycine amidinotransferase
ISO
RGD
PMID:31972362
RGD:329961305
NCBI chr 3:130,112,508...130,137,664
Ensembl chr 3:109,658,951...109,684,129
G
Gch1
GTP cyclohydrolase 1
treatment
IDA IEP
RGD
PMID:32782412 PMID:26192027
RGD:329961570 , RGD:329970290
NCBI chr15:22,884,006...22,917,412
Ensembl chr15:20,402,527...20,437,698
G
Gclc
glutamate-cysteine ligase, catalytic subunit
susceptibility
ISO
DNA:snp:promoter:c.-129C>T (human) ClinVar Annotator: match by term: GCLC-related condition | ClinVar Annotator: match by term: Myocardial infarction, susceptibility to CTD Direct Evidence: marker/mechanism
OMIM ClinVar CTD RGD
PMID:12598062 PMID:25741868 PMID:28492532 PMID:12598062
RGD:1302515
NCBI chr 8:87,510,251...87,548,896
Ensembl chr 8:78,630,127...78,668,544
G
Gclm
glutamate cysteine ligase, modifier subunit
susceptibility
ISO
ClinVar Annotator: match by term: Myocardial infarction, susceptibility to CTD Direct Evidence: marker/mechanism
ClinVar OMIM CTD
PMID:12081989 PMID:12975258
NCBI chr 2:213,032,135...213,052,192
Ensembl chr 2:210,347,482...210,367,535
G
Ggt1
gamma-glutamyltransferase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19419996
NCBI chr20:13,074,141...13,103,551
Ensembl chr20:13,074,700...13,108,442
G
Gh1
growth hormone 1
treatment
ISO
RGD
PMID:12500159
RGD:11352745
NCBI chr10:91,727,883...91,729,860
Ensembl chr10:91,228,103...91,230,078
G
Ghrh
growth hormone releasing hormone
treatment
IDA
RGD
PMID:24373935
RGD:10401242
NCBI chr 3:166,412,763...166,432,519
Ensembl chr 3:145,992,763...146,011,889
G
Gja1
gap junction protein, alpha 1
treatment
IEP IMP
protein:decreased phosphorylation
RGD
PMID:22969867 PMID:29428663 PMID:22841862
RGD:7207261 , RGD:13592597 , RGD:7207262
NCBI chr20:36,302,490...36,315,010
Ensembl chr20:35,755,991...35,768,582
G
Gja4
gap junction protein, alpha 4
ISO
RGD
PMID:15982495
RGD:1580400
NCBI chr 5:144,917,791...144,920,324
Ensembl chr 5:139,633,287...139,635,925
G
Gja5
gap junction protein, alpha 5
treatment
IEP
RGD
PMID:29428663
RGD:13592597
NCBI chr 2:187,291,227...187,310,770
Ensembl chr 2:184,564,475...184,621,952
G
Gp1ba
glycoprotein Ib platelet subunit alpha
ISO
RGD
PMID:15269835
RGD:1580432
NCBI chr10:55,831,901...55,856,729
Ensembl chr10:55,352,899...55,356,774
G
Gp6
glycoprotein VI
sexual_dimorphism treatment no_association susceptibility onset
ISO
DNA:missense mutation:CDS:c.13254T>C (p.S219P) (human) human protein in a mouse model DNA:missense mutation:CDS:c.13254T>C (p.S219P) (rs1613662) (human) DNA:missense mutation:exon 7:c.645213C>T (p.T249A) (human) DNA:SNP, missense mutation:promoter, CDS:c.-148C>T, c.13254T>C (p.S219P) (human)
RGD
PMID:11571236 PMID:22814400 PMID:20723028 PMID:12417295 PMID:11571236 PMID:11571236 More...
RGD:401793749 , RGD:401824647 , RGD:401794407 , RGD:401793754 , RGD:401793749 , RGD:401793749
NCBI chr 1:78,471,900...78,535,374
Ensembl chr 1:69,465,789...69,491,326
G
Gpt
glutamic--pyruvic transaminase
treatment
IEP
RGD
PMID:32026788
RGD:401793703
NCBI chr 7:110,295,599...110,300,134
Ensembl chr 7:108,416,642...108,419,494
G
Gpx1
glutathione peroxidase 1
susceptibility
ISO
RGD
PMID:14573732
RGD:1600662
NCBI chr 8:117,905,462...117,906,588
Ensembl chr 8:109,026,905...109,028,024
G
Gsk3b
glycogen synthase kinase 3 beta
treatment
IMP ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:16716347 PMID:16565311
RGD:10045368
NCBI chr11:76,004,502...76,154,665
Ensembl chr11:62,504,316...62,648,646
G
Gsn
gelsolin
ameliorates
ISO IEP
protein:decreased expression:blood serum (human)
RGD
PMID:9142022 PMID:28622474
RGD:329333022 , RGD:329333030
NCBI chr 3:38,982,605...39,035,849
Ensembl chr 3:18,585,172...18,638,402
G
Gsr
glutathione-disulfide reductase
treatment
IEP
RGD
PMID:25119867
RGD:10401898
NCBI chr16:65,185,574...65,228,742
Ensembl chr16:58,482,505...58,525,661
G
Gucy1a1
guanylate cyclase 1 soluble subunit alpha 1
ISO
ClinVar Annotator: match by term: Myocardial infarction, susceptibility to, 1
ClinVar
PMID:24213632
NCBI chr 2:169,716,684...169,780,360
Ensembl chr 2:167,418,640...167,481,671
G
H19
H19 imprinted maternally expressed transcript
ameliorates
IMP
RGD
PMID:33389498
RGD:242905187
NCBI chr 1:207,160,175...207,162,851
Ensembl chr 1:197,730,698...197,733,134
G
Hadh
hydroxyacyl-CoA dehydrogenase
IEP
RGD
PMID:11481570
RGD:2302229
NCBI chr 2:222,462,049...222,504,446
Ensembl chr 2:219,787,927...219,830,353
G
Hamp
hepcidin antimicrobial peptide
IEP
mRNA:increased expression:heart
RGD
PMID:19615879
RGD:11041636
NCBI chr 1:95,298,332...95,300,271
Ensembl chr 1:86,170,901...86,172,891
G
Hfe
homeostatic iron regulator
no_association susceptibility
ISO
RGD
PMID:12850485 PMID:10491370
RGD:1582672 , RGD:1582697
NCBI chr17:41,841,302...41,849,359
Ensembl chr17:41,413,451...41,421,502
G
Hgf
hepatocyte growth factor
treatment
ISO
protein:increased expression:serum:
RGD
PMID:12419930 PMID:16570015
RGD:8548609 , RGD:8548632
NCBI chr 4:19,628,902...19,700,467
Ensembl chr 4:18,677,101...18,745,409
G
Hif1a
hypoxia inducible factor 1 subunit alpha
ameliorates treatment
IEP ISO
mRNA:increased expression:heart left ventricle human gene in a rat model
RGD
PMID:18484163 PMID:28622474 PMID:15247145 PMID:15999059
RGD:5147886 , RGD:329333030 , RGD:1580977 , RGD:9068466
NCBI chr 6:98,357,788...98,405,068
Ensembl chr 6:92,624,390...92,669,261
G
Hmgb1
high mobility group box 1
treatment
IDA ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:21113057 PMID:23188125
RGD:10402174
NCBI chr12:11,009,236...11,015,941
Ensembl chr12:5,901,586...5,978,565 Ensembl chr16:5,901,586...5,978,565
G
Hmox1
heme oxygenase 1
IEP IDA
RGD
PMID:12392996 PMID:20925964
RGD:1598393 , RGD:4145134
NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,467,244...13,474,079
G
Hp
haptoglobin
susceptibility
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:16597321 PMID:17068284 PMID:17207726 PMID:3990081 PMID:2613263
RGD:1626360 , RGD:1626354
NCBI chr19:54,449,151...54,453,701
Ensembl chr19:37,539,627...37,544,523
G
Hsd11b1
hydroxysteroid 11-beta dehydrogenase 1
ameliorates
ISO
RGD
PMID:28522730 PMID:26465199
RGD:329902054 , RGD:11087531
NCBI chr13:107,277,526...107,327,462
Ensembl chr13:104,728,539...104,788,687
G
Hsd11b2
hydroxysteroid 11-beta dehydrogenase 2
IEP ISO
mRNA:increased expression:heart CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:17587755 PMID:17587755
RGD:2308939
NCBI chr19:50,307,569...50,312,812
Ensembl chr19:33,397,656...33,402,899
G
Hspa5
heat shock protein family A (Hsp70) member 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25450231
NCBI chr 3:38,453,016...38,457,475
Ensembl chr 3:18,055,405...18,059,891
G
Hspd1
heat shock protein family D (Hsp60) member 1
IEP
RGD
PMID:17202668
RGD:1624230
NCBI chr 9:64,073,610...64,084,332
Ensembl chr 9:56,579,201...56,589,662
G
Icam1
intercellular adhesion molecule 1
treatment
IEP ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:10070497 PMID:23139358
RGD:8547733
NCBI chr 8:27,829,688...27,841,618
Ensembl chr 8:19,553,645...19,565,438
G
Igf1
insulin-like growth factor 1
severity
IEP ISO
mRNA, protein:increased expression:myocardium
RGD
PMID:19295919 PMID:16635594
RGD:2306696 , RGD:1598421
NCBI chr 7:24,169,608...24,249,446
Ensembl chr 7:22,282,930...22,359,296
G
Igf1r
insulin-like growth factor 1 receptor
IEP
mRNA,protein:increased expression:myocyte:
RGD
PMID:8682060
RGD:10046050
NCBI chr 1:130,959,787...131,248,664
Ensembl chr 1:121,550,743...121,831,777
G
Il10
interleukin 10
susceptibility
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:15883752 PMID:16310260 PMID:15466015
RGD:1598480
NCBI chr13:45,024,921...45,029,586
Ensembl chr13:42,472,839...42,477,313
G
Il17a
interleukin 17A
IEP
mRNA, protein:increased expression:heart left ventricle (rat)
RGD
PMID:23096364
RGD:9095344
NCBI chr 9:30,640,844...30,644,331
Ensembl chr 9:23,144,402...23,147,889
G
Il18
interleukin 18
ameliorates
IEP
RGD
PMID:33389498
RGD:242905187
NCBI chr 8:59,802,072...59,829,275
Ensembl chr 8:50,906,960...50,932,887
G
Il18bp
interleukin 18 binding protein
ISO
RGD
PMID:19805173
RGD:4889400
NCBI chr 1:165,784,916...165,787,990
Ensembl chr 1:156,372,883...156,374,963
G
Il1b
interleukin 1 beta
ameliorates
IDA IEP ISO
CTD Direct Evidence: marker/mechanism protein:increased expression:serum (rat)
CTD RGD
PMID:11743230 PMID:15883752 PMID:16310260 PMID:23143013 PMID:33389498 PMID:23237935 More...
RGD:7175553 , RGD:242905187 , RGD:7204425
NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:116,577,010...116,583,415
G
Il1rn
interleukin 1 receptor antagonist
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:18474815 PMID:19005744
NCBI chr 3:27,509,836...27,525,738
Ensembl chr 3:7,111,550...7,127,445
G
Il4r
interleukin 4 receptor
IEP
mRNA:increased expression:heart
RGD
PMID:10807530
RGD:4889985
NCBI chr 1:189,545,739...189,570,639
Ensembl chr 1:180,115,120...180,139,980
G
Il6
interleukin 6
treatment
ISO IEP
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:15883752 PMID:16310260 PMID:31734577
RGD:408418726
NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,213,394...5,219,178
G
Il6r
interleukin 6 receptor
IEP
RGD
PMID:12123772
RGD:1625444
NCBI chr 2:177,582,020...177,646,705
Ensembl chr 2:175,298,686...175,347,536
G
Inhba
inhibin subunit beta A
IEP ISO
mRNA:increased expression:heart (rat) mRNA:increased expression:myocardium (mouse)
RGD
PMID:14993131 PMID:32427381
RGD:1580888 , RGD:329849118
NCBI chr17:53,787,159...53,810,942
Ensembl chr17:49,095,920...49,108,982
G
Inhbb
inhibin subunit beta B
ISO
mRNA:increased expression:myocardium (mouse)
RGD
PMID:32427381
RGD:329849118
NCBI chr13:33,083,671...33,089,373
Ensembl chr13:30,530,860...30,537,832
G
Isl1
ISL LIM homeobox 1
ameliorates
ISO
RGD
PMID:29482621 PMID:22727192
RGD:243048463 , RGD:243048464
NCBI chr 2:49,813,618...49,823,442
Ensembl chr 2:48,080,522...48,095,584
G
Itga2
integrin subunit alpha 2
susceptibility no_association
ISO
RGD
PMID:16697311 PMID:10194421 PMID:15227729
RGD:1582296 , RGD:1581029 , RGD:1582294
NCBI chr 2:48,253,412...48,354,509
Ensembl chr 2:46,523,948...46,621,481
G
Itga3
integrin subunit alpha 3
IEP
protein:increased expression:myocardium (rat)
RGD
PMID:19041328
RGD:2325287
NCBI chr10:80,486,998...80,522,548
Ensembl chr10:79,990,161...80,022,118
G
Itgam
integrin subunit alpha M
treatment
ISO
RGD
PMID:29933226
RGD:329853753
NCBI chr 1:192,089,496...192,139,947
Ensembl chr 1:182,659,000...182,709,503
G
Itgb1
integrin subunit beta 1
treatment
IMP
RGD
PMID:28367125
RGD:13602094
NCBI chr19:73,602,277...73,650,271
Ensembl chr19:56,705,171...56,753,195
G
Itgb3
integrin subunit beta 3
no_association susceptibility
ISO IEP
DNA:polymorphism:exon: ClinVar Annotator: match by term: Myocardial infarction, susceptibility to mRNA, protein:increased expression:myocardium CTD Direct Evidence: marker/mechanism associated with arteriosclerosis; DNA:polymorphism:exon
ClinVar OMIM CTD RGD
PMID:1371279 PMID:2014236 PMID:7570918 PMID:8598867 PMID:8667943 PMID:8838346 PMID:9215749 PMID:9351872 PMID:9376589 PMID:9450787 PMID:9536098 PMID:9700201 PMID:9790984 PMID:10583927 PMID:10727448 PMID:11723016 PMID:11806996 PMID:14629479 PMID:16199547 PMID:16463284 PMID:17264806 PMID:17576681 PMID:19691478 PMID:20020534 PMID:20106508 PMID:21781244 PMID:21917754 PMID:22250950 PMID:24236036 PMID:25373348 PMID:25539746 PMID:25728920 PMID:25741868 PMID:26096001 PMID:27469266 PMID:28492532 PMID:28748566 PMID:28983057 PMID:31565851 PMID:32237906 PMID:32581362 PMID:32757236 PMID:33718801 PMID:34066320 PMID:36122578 PMID:9716140 PMID:12600920 PMID:10531147 PMID:20846430 More...
RGD:5128498 , RGD:633129 , RGD:5128481 , RGD:5128476
NCBI chr10:90,009,927...90,067,787
Ensembl chr10:89,509,989...89,564,679
G
Itih4
inter-alpha-trypsin inhibitor heavy chain 4
ISO
RGD
PMID:10486281
RGD:1582334
NCBI chr16:6,086,985...6,102,162
Ensembl chr16:6,080,539...6,095,708
G
Jak2
Janus kinase 2
susceptibility
IMP
associated with Myocardial Reperfusion Injury
RGD
PMID:22749532
RGD:10403083
NCBI chr 1:236,408,905...236,468,769
Ensembl chr 1:226,995,334...227,054,189
G
Kcnj2
potassium inwardly-rectifying channel, subfamily J, member 2
treatment
IDA
RGD
PMID:23647964
RGD:7247426
NCBI chr10:96,560,225...96,570,788
Ensembl chr10:96,060,821...96,071,445
G
Kcnk2
potassium two pore domain channel subfamily K member 2
IEP
mRNA:decreased expression:heart left ventricle, epicardium, endocardium (rat)
RGD
PMID:21683547
RGD:9831182
NCBI chr13:103,297,387...103,494,686
Ensembl chr13:100,766,113...100,963,435
G
Kcnn4
potassium calcium-activated channel subfamily N member 4
susceptibility
ISO
DNA:SNPs,haplotypes:introns:multiple
RGD
PMID:19644414
RGD:329969896
NCBI chr 1:89,084,306...89,102,279
Ensembl chr 1:79,959,322...79,974,340
G
Kdm5b
lysine demethylase 5B
ameliorates
ISO
RGD
PMID:36481938
RGD:329901769
NCBI chr13:48,554,367...48,625,721
Ensembl chr13:46,002,542...46,073,872
G
Kdm6a
lysine demethylase 6A
IEP
mRNA:increased expression:myocardium (rat)
RGD
PMID:30887465
RGD:151665136
NCBI chr X:6,920,374...7,060,027
Ensembl chr X:4,337,750...4,477,062
G
Kdr
kinase insert domain receptor
treatment
ISO IDA
RGD
PMID:16698275 PMID:25936512
RGD:1581717 , RGD:126925214
NCBI chr14:32,572,031...32,615,204
Ensembl chr14:32,217,871...32,261,018
G
Kif6
kinesin family member 6
no_association treatment
ISO
DNA:SNP: :rs20455 (human) CTD Direct Evidence: marker/mechanism DNA:SNP: :p.W719R (rs20455) (human)
CTD RGD
PMID:21943003 PMID:18222354 PMID:20927332 PMID:26997531 PMID:19371834 PMID:20403483 More...
RGD:243048446 , RGD:243048450 , RGD:243048449 , RGD:243048447 , RGD:11097528
NCBI chr 9:18,573,925...18,870,789
Ensembl chr 9:11,072,824...11,373,006
G
Klf13
KLF transcription factor 13
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29122578
NCBI chr 1:126,917,671...126,948,436
Ensembl chr 1:117,503,602...117,551,227
G
Klk1
kallikrein 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:12411458
NCBI chr 1:103,779,152...103,783,270
Ensembl chr 1:94,642,687...94,646,754
G
Klk1c12
kallikrein 1-related peptidase C12
ISO
RGD
PMID:17022964
RGD:1641799
NCBI chr 1:103,514,639...103,518,676
Ensembl chr 1:94,378,054...94,382,176
G
Lamp2
lysosomal-associated membrane protein 2
IEP
mRNA:increased expression:plantaris
RGD
PMID:24427319
RGD:11557988
NCBI chr X:122,038,734...122,087,745
Ensembl chr X:117,057,606...117,260,522
G
Lcat
lecithin cholesterol acyltransferase
IDA
RGD
PMID:16640830
RGD:1581773
NCBI chr19:50,744,598...50,748,064
Ensembl chr19:33,834,403...33,838,231
G
Lcn2
lipocalin 2
ameliorates
ISO
RGD
PMID:27800610
RGD:126790572
NCBI chr 3:36,078,432...36,081,851
Ensembl chr 3:15,680,687...15,684,095
G
Ldha
lactate dehydrogenase A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:3279722
NCBI chr 1:106,508,092...106,517,512
Ensembl chr 1:97,366,021...97,433,472
G
Ldlr
low density lipoprotein receptor
ISO
GAD
PMID:15118671
RGD:1331525
NCBI chr 8:28,546,191...28,569,075
Ensembl chr 8:20,270,041...20,294,580
G
Lefty1
left right determination factor 1
ameliorates
ISO
RGD
PMID:33409963
RGD:401794430
NCBI chr13:95,188,091...95,191,488
Ensembl chr13:92,656,323...92,659,720
G
Lgals2
galectin 2
susceptibility
ISO
CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Myocardial infarction, susceptibility to
OMIM CTD ClinVar RGD
PMID:15129282 PMID:15129282
RGD:1581852
NCBI chr 7:112,283,630...112,290,228
Ensembl chr 7:110,403,173...110,404,802
G
Lgals3
galectin 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29769800
NCBI chr15:23,099,795...23,111,731
Ensembl chr15:20,607,692...20,632,025
G
Lipg
lipase G, endothelial type
susceptibility
ISO
DNA:polymorphism: :584C>T
RGD
PMID:17526978
RGD:1641818
NCBI chr18:70,790,077...70,811,259
Ensembl chr18:68,514,923...68,536,260
G
Lox
lysyl oxidase
ISO
RGD
PMID:14553832
RGD:1581883
NCBI chr18:48,162,889...48,175,640
Ensembl chr18:45,967,343...46,041,477
G
Lpl
lipoprotein lipase
susceptibility
ISO
associated with Diabetes Mellitus, Non-Insulin-Dependent;DNA:SNP: :p.D9N (rs1801177) (human)
RGD
PMID:18823627
RGD:2313302
NCBI chr16:25,596,205...25,621,928
Ensembl chr16:20,829,465...20,855,249
G
Lrp1
LDL receptor related protein 1
susceptibility
ISO
RGD
PMID:12402342
RGD:1581913
NCBI chr 7:65,265,639...65,346,196
Ensembl chr 7:63,380,356...63,460,910
G
Lrp8
LDL receptor related protein 8
no_association susceptibility onset
ISO
DNA:missense mutation:cds:p.R952Q (human) ClinVar Annotator: match by term: LRP8-related condition | ClinVar Annotator: match by term: Myocardial infarction, susceptibility to, 1 CTD Direct Evidence: marker/mechanism
ClinVar CTD OMIM RGD
PMID:17847002 PMID:25741868 PMID:28492532 PMID:18592168 PMID:17847002
RGD:2306125 , RGD:2306124
NCBI chr 5:127,792,236...127,864,207
Ensembl chr 5:122,563,453...122,631,352
G
Lrpap1
LDL receptor related protein associated protein 1
susceptibility
ISO
RGD
PMID:12394648
RGD:1581922
NCBI chr14:79,876,002...79,888,011
Ensembl chr14:75,651,376...75,665,414
G
Lta
lymphotoxin alpha
no_association susceptibility severity
ISO
ClinVar Annotator: match by term: Myocardial infarction, susceptibility to CTD Direct Evidence: marker/mechanism DNA:SNP:exon:804C>A (p.T26N) (human)
ClinVar OMIM CTD RGD
PMID:12426569 PMID:12746914 PMID:14681301 PMID:15129282 PMID:15266304 PMID:15175864 PMID:23398946 PMID:12426569 More...
RGD:1581940 , RGD:8548841 , RGD:1580417
NCBI chr20:3,622,291...3,625,852
Ensembl chr20:3,618,853...3,620,859
G
Map1lc3a
microtubule-associated protein 1 light chain 3 alpha
treatment
IEP
RGD
PMID:20079142
RGD:11561913
NCBI chr 3:164,243,204...164,244,850
Ensembl chr 3:143,783,024...143,784,670
G
Map3k5
mitogen-activated protein kinase kinase kinase 5
treatment
IMP
RGD
PMID:22635076
RGD:10412335
NCBI chr 1:16,505,387...16,723,899
Ensembl chr 1:14,685,492...14,904,800
G
Map3k7
mitogen activated protein kinase kinase kinase 7
treatment
IEP
mRNA, protein:increased expression:myocardium (rat)
RGD
PMID:16183734 PMID:27121011
RGD:2298758 , RGD:11073666
NCBI chr 5:51,149,524...51,212,012
Ensembl chr 5:46,357,931...46,415,597
G
Mapk1
mitogen activated protein kinase 1
IDA
RGD
PMID:15653762
RGD:1582282
NCBI chr11:97,462,025...97,529,193
Ensembl chr11:83,957,813...84,023,616
G
Mapk14
mitogen activated protein kinase 14
ameliorates
ISO
RGD
PMID:33409963
RGD:401794430
NCBI chr20:6,751,288...6,812,294
Ensembl chr20:6,749,670...6,810,589
G
Mapk8
mitogen-activated protein kinase 8
ameliorates
IEP
RGD
PMID:28622474
RGD:329333030
NCBI chr16:8,645,171...8,728,225
Ensembl chr16:8,638,924...8,721,981
G
Mdh2
malate dehydrogenase 2
IDA
RGD
PMID:9753871
RGD:1582468
NCBI chr12:26,530,886...26,543,841
Ensembl chr12:20,894,262...20,907,271
G
Mdk
midkine
IEP
RGD
PMID:9568069
RGD:1582488
NCBI chr 3:98,356,789...98,358,960
Ensembl chr 3:77,901,158...77,903,130
G
Mef2a
myocyte enhancer factor 2a
ISO
RGD
PMID:15811259
RGD:1580548
NCBI chr 1:130,258,083...130,392,819
Ensembl chr 1:120,850,080...120,981,948
G
Mef2c
myocyte enhancer factor 2C
treatment
IMP
RGD
PMID:23948075
RGD:7327215
NCBI chr 2:15,708,732...15,871,639
Ensembl chr 2:13,993,438...14,132,880
G
Meox2
mesenchyme homeobox 2
IEP
protein:decreased expression:heart (rat)
RGD
PMID:24155330
RGD:155882536
NCBI chr 6:59,584,025...59,644,722
Ensembl chr 6:53,856,758...53,917,467
G
Mesp1
mesoderm posterior bHLH transcription factor 1
treatment
ISO
human gene and cell line in a rat model
RGD
PMID:32550911
RGD:242905196
NCBI chr 1:143,147,671...143,149,189
Ensembl chr 1:133,738,357...133,739,875
G
Mff
mitochondrial fission factor
treatment
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:23867156 PMID:23867156
RGD:12879458
NCBI chr 9:91,455,931...91,484,171
Ensembl chr 9:84,007,798...84,036,039
G
Mfn2
mitofusin 2
treatment
IEP
RGD
PMID:20886221
RGD:12738232
NCBI chr 5:163,587,463...163,617,363
Ensembl chr 5:158,304,287...158,335,342
G
Mgp
matrix Gla protein
susceptibility
ISO
RGD
PMID:11073842
RGD:1582503
NCBI chr 4:171,497,472...171,500,888
Ensembl chr 4:169,766,279...169,769,667
G
Mia3
MIA SH3 domain ER export factor 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19198609
NCBI chr13:97,502,040...97,547,155
Ensembl chr13:94,970,424...95,011,972
G
Miat
myocardial infarction associated transcript
susceptibility
ISO
CTD Direct Evidence: marker/mechanism
CTD OMIM
PMID:17066261
NCBI chr12:44,414,620...44,429,852
G
Mif
macrophage migration inhibitory factor
ISO IEP
protein:increased expression:plasma mRNA, protein:increased expression:myocardium
RGD
PMID:11589847 PMID:12704210
RGD:1642008 , RGD:1642003
NCBI chr20:12,767,138...12,791,222
Ensembl chr20:12,790,902...12,799,504 Ensembl chr 4:12,790,902...12,799,504
G
Mir125b2
microRNA 125b-2
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:29122578
NCBI chr11:29,732,572...29,732,659
G
Mir143
microRNA 143
ISO IEP
RNA:increased expression:myocardium: RNA:increased expression:plasma, left ventricle:
RGD
PMID:28887629 PMID:29728596
RGD:155882580 , RGD:155882581
NCBI chr18:57,371,349...57,371,453
Ensembl chr18:55,101,006...55,101,110
G
Mir145
microRNA 145
treatment ameliorates
ISO IMP
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:29956747 PMID:30146700 PMID:32890431
RGD:155260296 , RGD:155260294
NCBI chr18:57,369,983...57,370,070
Ensembl chr18:55,099,640...55,099,727
G
Mir155
microRNA 155
treatment
ISO
RGD
PMID:31207208
RGD:21066347
NCBI chr11:37,261,114...37,261,178
Ensembl chr11:23,774,654...23,774,718
G
Mir208a
microRNA 208a
treatment
ISO IEP
miRNA:increased expression:heart
RGD
PMID:26688617 PMID:26861724
RGD:11536862 , RGD:242905213
NCBI chr15:32,395,552...32,395,634
G
Mir223
microRNA 223
IEP
RNA:increased expression:heart
RGD
PMID:29608885
RGD:21408565
NCBI chr X:65,151,383...65,151,492
Ensembl chr X:61,141,887...61,141,996
G
Mir25
microRNA 25
ISO
RNA:increased expression:myocardium:
RGD
PMID:28887629
RGD:155882580
NCBI chr12:22,156,641...22,156,724
Ensembl chr12:17,042,932...17,043,015
G
Mir30a
microRNA 30a
treatment
IDA
RGD
PMID:29849775
RGD:35673318
NCBI chr 9:33,233,941...33,234,011
Ensembl chr 9:25,737,600...25,737,670
G
Mir30c1
microRNA 30c-1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:34217758
NCBI chr 5:139,634,455...139,634,543
Ensembl chr 5:134,349,237...134,349,325
G
Mir30e
microRNA 30e
IEP
miRNA:decreased expression:heart (rat)
RGD
PMID:25950484
RGD:11541106
NCBI chr 5:139,637,450...139,637,541
Ensembl chr 5:134,352,232...134,352,323
G
Mir320a
microRNA 320a
treatment
ISO
RGD
PMID:19380620
RGD:155882541
NCBI chr15:51,926,088...51,926,169
Ensembl chr15:45,516,392...45,516,473
G
Mir423
microRNA 423
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24253456
NCBI chr10:62,412,272...62,412,350
Ensembl chr10:61,914,133...61,914,226
G
Mir761
microRNA 761
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:23867156
NCBI chr 5:123,776,534...123,776,609
Ensembl chr 5:123,776,534...123,776,609
G
Mlxipl
MLX interacting protein-like
susceptibility
ISO
DNA:SNP:cd: C771G, p.Q241H (rs3812316) (human)
RGD
PMID:24448738
RGD:401799621
NCBI chr12:27,178,158...27,213,675
Ensembl chr12:21,543,576...21,577,112
G
Mmp1
matrix metallopeptidase 1
susceptibility
ISO IEP IDA
protein:increased expression, increased activity:heart left ventricle (rat) human gene in rat model associated with Coronary Artery Disease; DNA:snps, haplotype:promoter:g.-519A>G, g.-340T>C (human)
RGD
PMID:15009768 PMID:8531210 PMID:11179039 PMID:19797822 PMID:16210545
RGD:1582535 , RGD:7207198 , RGD:7207136 , RGD:7207135 , RGD:1582520
NCBI chr 8:12,943,453...12,963,966
Ensembl chr 8:4,658,588...4,679,097
G
Mmp13
matrix metallopeptidase 13
IDA
RGD
PMID:15782494
RGD:1582556
NCBI chr 8:12,782,829...12,793,108
Ensembl chr 8:4,497,960...4,508,239
G
Mmp14
matrix metallopeptidase 14
IEP ISO
RGD
PMID:10773235 PMID:16461815
RGD:1582587 , RGD:1582569
NCBI chr15:31,857,824...31,867,049
Ensembl chr15:27,887,727...27,899,864
G
Mmp2
matrix metallopeptidase 2
IEP ISO IDA
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:16310260 PMID:24358288 PMID:10773235 PMID:11179039
RGD:1582587 , RGD:7207136
NCBI chr19:30,327,643...30,355,856
Ensembl chr19:14,154,657...14,182,870
G
Mmp3
matrix metallopeptidase 3
ISO
RGD
PMID:15467919
RGD:1580551
NCBI chr 8:12,925,267...12,938,828
Ensembl chr 8:4,640,416...4,653,961
G
Mmp7
matrix metallopeptidase 7
ISO
RGD
PMID:16769909
RGD:1582373
NCBI chr 8:13,133,043...13,140,761
Ensembl chr 8:4,848,186...4,855,902
G
Mmp9
matrix metallopeptidase 9
susceptibility
ISO IEP IDA
protein:increased expression:coronary artery, plasma (human) protein:increased expression:heart left ventricle CTD Direct Evidence: marker/mechanism protein:increased expression, increased activity:heart left ventricle (rat) DNA:snps:promoter, exon:g.-1562C>T, p.R279Q (rs3918242, rs2664538) (human)
CTD RGD
PMID:16310260 PMID:24358288 PMID:15118287 PMID:25520329 PMID:8531210 PMID:17893005 PMID:14729404 PMID:16845718 More...
RGD:1582645 , RGD:13204799 , RGD:7207198 , RGD:7207049 , RGD:1582639 , RGD:1582653
NCBI chr 3:174,103,474...174,111,434
Ensembl chr 3:153,683,858...153,692,120
G
Mstn
myostatin
ISO
mRNA:decreased expression:myocardium (mouse)
RGD
PMID:32427381
RGD:329849118
NCBI chr 9:55,944,513...55,950,913
Ensembl chr 9:48,452,533...48,458,933
G
Mt-nd2
mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 2
ISO
DNA:missense mutation: :m.5178C>A (p.L237M) (human)
RGD
PMID:15262184
RGD:1581054
NCBI chr MT:3,904...4,942
Ensembl chr MT:3,904...4,942
G
Mthfr
methylenetetrahydrofolate reductase
susceptibility
ISO
associated with Kidney Failure, Chronic; DNA:transition:cds:g.677C>T rs1801133 (human) DNA:SNP: :677C>T (human)
RGD
PMID:19272686 PMID:10090925
RGD:6893548 , RGD:10449412
NCBI chr 5:163,748,346...163,768,141
Ensembl chr 5:158,465,296...158,483,797
G
Mtor
mechanistic target of rapamycin kinase
treatment
IDA
protein:decreased serine phosphorylation:heart associated with Diabetes Mellitus, Experimental
RGD
PMID:20352476 PMID:23773982
RGD:10041035 , RGD:10041040
NCBI chr 5:164,167,985...164,277,438
Ensembl chr 5:158,884,804...158,994,311
G
Myh6
myosin heavy chain 6
IEP
RGD
PMID:15090263
RGD:11565830
NCBI chr15:32,388,102...32,413,663
Ensembl chr15:28,417,616...28,441,720
G
Myh7
myosin heavy chain 7
ISO IEP
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:11743230 PMID:15090263
RGD:11565830
NCBI chr15:32,416,525...32,439,851
Ensembl chr15:28,446,550...28,468,217
G
Ncam1
neural cell adhesion molecule 1
ISO IEP
mRNA, protein:increased expression:heart protein:alternative form, increased expression:myocardium
RGD
PMID:19853610 PMID:23462508
RGD:2325979 , RGD:40924663
NCBI chr 8:58,762,088...59,062,131
Ensembl chr 8:49,865,633...50,166,014
G
Ndufb5
NADH:ubiquinone oxidoreductase subunit B5
treatment
ISO
RGD
PMID:24692845
RGD:13801194
NCBI chr 2:117,447,605...117,461,943
Ensembl chr 2:115,519,154...115,533,589
G
Nfe2l2
NFE2 like bZIP transcription factor 2
treatment
IDA ISO
RGD
PMID:23290949 PMID:24915518
RGD:10412734 , RGD:10412738
NCBI chr 3:81,001,529...81,031,165
Ensembl chr 3:60,594,242...60,621,737
G
Nfkbia
NFKB inhibitor alpha
treatment
IEP
RGD
PMID:19616538
RGD:10413879
NCBI chr 6:78,593,844...78,597,307
Ensembl chr 6:72,858,712...72,861,941
G
Ngf
nerve growth factor
treatment
ISO
protein:increased expression:myocardium
RGD
PMID:20360245 PMID:20360245
RGD:405100231 , RGD:405100231
NCBI chr 2:192,589,580...192,642,971
Ensembl chr 2:189,901,058...189,954,452
G
Nlk
nemo like kinase
IEP
mRNA, protein:decreased expression:heart
RGD
PMID:26861724
RGD:242905213
NCBI chr10:63,965,432...64,089,006
Ensembl chr10:63,438,222...63,589,730
G
Nlrp3
NLR family, pyrin domain containing 3
ameliorates
IEP
RGD
PMID:33389498
RGD:242905187
NCBI chr10:44,826,299...44,853,373
Ensembl chr10:44,328,566...44,352,811
G
Nono
non-POU domain containing, octamer-binding
ameliorates
ISO
RGD
PMID:35247074
RGD:155882458
NCBI chr X:70,594,116...70,611,976
Ensembl chr X:66,554,098...66,571,952
G
Nos2
nitric oxide synthase 2
treatment
ISO IEP
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:10090345 PMID:11489778 PMID:26192027
RGD:329970290
NCBI chr10:64,313,335...64,349,221
Ensembl chr10:63,815,308...63,851,210
G
Nos3
nitric oxide synthase 3
susceptibility treatment
ISO IEP IDA
DNA:repeats:intron protein:decreased expression:aorta (rat) CTD Direct Evidence: marker/mechanism human gene in rat model DNA:duplication:intron:IVS4?-?+27 (human)
CTD RGD
PMID:10510054 PMID:16337503 PMID:10531147 PMID:29311930 PMID:28980197 PMID:22012955 PMID:17637430 PMID:11903359 PMID:12362496 More...
RGD:5128481 , RGD:13503346 , RGD:13450930 , RGD:7771563 , RGD:7771561 , RGD:1580284 , RGD:1580283
NCBI chr 4:11,686,088...11,706,604
Ensembl chr 4:10,793,834...10,814,166
G
Npm1
nucleophosmin 1
ISO
protein:increased expression:cardiomyocyte:
RGD
PMID:21444791
RGD:11535018
NCBI chr10:18,245,739...18,255,913
Ensembl chr10:17,739,941...17,751,645 Ensembl chr X:17,739,941...17,751,645
G
Nppa
natriuretic peptide A
ISO IEP
DNA:snp:cds:c.2238T>C (human) CTD Direct Evidence: marker/mechanism|therapeutic
CTD RGD
PMID:9527094 PMID:11743230 PMID:12514664 PMID:16087130
RGD:1579982 , RGD:1580000
NCBI chr 5:163,712,184...163,713,493
Ensembl chr 5:158,429,042...158,430,351
G
Nppb
natriuretic peptide B
IMP ISO IEP
RGD
PMID:19858735 PMID:17639095 PMID:17256064
RGD:2324680 , RGD:7247724 , RGD:1642266
NCBI chr 5:163,699,955...163,701,314
Ensembl chr 5:158,416,866...158,418,168
G
Npr1
natriuretic peptide receptor 1
susceptibility
ISO
DNA:missense mutation:cds:p.M341I (human)
RGD
PMID:14646971
RGD:1580174
NCBI chr 2:178,231,766...178,247,591
Ensembl chr 2:175,934,181...175,949,505
G
Nr1h3
nuclear receptor subfamily 1, group H, member 3
susceptibility
ISO
DNA:SNPs, haplotype:promoter:c.-115G>A, c.-840C>A (rs12221497, rs61896015) (human)
RGD
PMID:21903943
RGD:401842365
NCBI chr 3:97,614,616...97,632,053
Ensembl chr 3:77,158,808...77,168,722
G
Nr3c2
nuclear receptor subfamily 3, group C, member 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16413583 PMID:17587755
NCBI chr19:47,619,853...47,964,089
Ensembl chr19:30,715,648...31,059,885
G
Nrg1
neuregulin 1
treatment
ISO IEP
RGD
PMID:24200746 PMID:26892146 PMID:27993643
RGD:10449026 , RGD:11522702 , RGD:405145704
NCBI chr16:65,954,084...67,007,484
Ensembl chr16:59,250,854...60,296,884
G
Nrip1
nuclear receptor interacting protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22503866
NCBI chr11:28,382,835...28,466,483
Ensembl chr11:14,895,553...14,981,761
G
Olr1
oxidized low density lipoprotein receptor 1
susceptibility
ISO
DNA:missense mutation:cds:p.K167N (human) ClinVar Annotator: match by term: Myocardial infarction, susceptibility to | ClinVar Annotator: match by term: OLR1-related condition CTD Direct Evidence: marker/mechanism
ClinVar OMIM CTD RGD
PMID:12646194 PMID:12810610 PMID:14684693 PMID:12646194
RGD:1580996
NCBI chr 4:164,612,460...164,635,082
Ensembl chr 4:162,926,439...162,948,523
G
Opa1
OPA1, mitochondrial dynamin like GTPase
treatment
IEP
RGD
PMID:20886221
RGD:12738232
NCBI chr11:84,612,943...84,690,025
Ensembl chr11:71,109,873...71,185,109
G
Oprd1
opioid receptor, delta 1
IDA IMP
RGD
PMID:12798419 PMID:15076225
RGD:2316587 , RGD:9831425
NCBI chr 5:149,590,244...149,624,999
Ensembl chr 5:144,306,188...144,340,960
G
Oprk1
opioid receptor, kappa 1
IMP
RGD
PMID:15076225
RGD:9831425
NCBI chr 5:18,657,866...18,675,671
Ensembl chr 5:13,860,021...13,877,823
G
P2ry12
purinergic receptor P2Y12
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19334620
NCBI chr 2:145,631,487...145,673,194
Ensembl chr 2:143,481,430...143,523,361
G
Pappa
pappalysin
susceptibility
ISO
DNA:polymorphism:intron CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:11586954 PMID:17700210
RGD:1642324
NCBI chr 5:83,513,358...83,751,364
Ensembl chr 5:78,498,300...78,730,666
G
Parp1
poly (ADP-ribose) polymerase 1
ISO
protein:altered processing:left ventricle (mouse)
RGD
PMID:21282286
RGD:5684012
NCBI chr13:94,839,484...94,871,295
Ensembl chr13:92,307,586...92,339,404
G
Pcsk2
proprotein convertase subtilisin/kexin type 2
ISO
DNA:SNP:intron: (rs6080699) (human)
RGD
PMID:20036365
RGD:6483554
NCBI chr 3:151,333,938...151,636,628
Ensembl chr 3:130,880,422...131,183,127
G
Pde3a
phosphodiesterase 3A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19027736
NCBI chr 4:175,904,276...176,170,531
Ensembl chr 4:174,172,868...174,438,274
G
Pde5a
phosphodiesterase 5A
IMP
RGD
PMID:17339532
RGD:2314468
NCBI chr 2:213,542,822...213,687,638
Ensembl chr 2:210,858,063...210,999,701
G
Pdgfd
platelet derived growth factor D
IEP
mRNA,protein:altered expression:myocardium:
RGD
PMID:21767547
RGD:9854703
NCBI chr 8:11,773,335...12,007,277
Ensembl chr 8:3,488,423...3,722,395
G
Pebp1
phosphatidylethanolamine binding protein 1
IEP
protein:decreased expression:right heart ventricle, ventricular septum
RGD
PMID:17089028
RGD:2302667
NCBI chr12:44,946,307...44,967,890
Ensembl chr12:39,302,840...39,307,862
G
Pecam1
platelet and endothelial cell adhesion molecule 1
onset no_association
ISO
DNA:polymorphisms: :p.N563S, p.G670R (human) DNA:missense mutation:cds:p.R643G (human) DNA:missense mutations:cds:p.L125V, p.S563N (human)
RGD
PMID:11795274 PMID:15488875 PMID:15265022
RGD:2311656 , RGD:6771224 , RGD:1581009
NCBI chr10:92,090,263...92,152,002
Ensembl chr10:91,590,521...91,652,116
G
Pgf
placental growth factor
ISO IMP
RGD
PMID:20649603 PMID:21329947 PMID:22114497
RGD:6483584 , RGD:6483777 , RGD:6483773
NCBI chr 6:110,547,165...110,557,747
Ensembl chr 6:104,816,104...104,826,685
G
Phactr1
phosphatase and actin regulator 1
susceptibility severity no_association
ISO IEP
CTD Direct Evidence: marker/mechanism DNA:SNP:intron: (rs9369640) (human) DNA:SNPs:multiple (human) DNA:SNP:intron:(rs12526453) (human) mRNA:increased expression:peripheral blood mononuclear cells (human) DNA:SNPs:intron 3: (rs9349379, rs2026458, rs2876300) (human) DNA:SNP:intron:g.13035530G>C (rs12526453) (human) mRNA, protein:decreased expression:heart left ventricle (rat)
CTD RGD
PMID:19198609 PMID:26098115 PMID:25738804 PMID:25838425 PMID:26086777 PMID:33460763 PMID:33460763 PMID:19198609 PMID:26098115 More...
RGD:11052994 , RGD:11052493 , RGD:11056926 , RGD:401900171 , RGD:401900171 , RGD:401851907 , RGD:11053274
NCBI chr17:21,769,006...22,246,227
Ensembl chr17:21,562,721...22,039,831
G
Phlda3
pleckstrin homology-like domain, family A, member 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:34351043
NCBI chr13:49,745,003...49,748,088
Ensembl chr13:47,193,086...47,196,335
G
Pik3cg
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma
ISO
RGD
PMID:20056919
RGD:6482688
NCBI chr 6:54,494,247...54,529,563
Ensembl chr 6:48,766,864...48,802,043
G
Pla2g7
phospholipase A2 group VII
ISO
protein:decreased expression:serum
RGD
PMID:19644070
RGD:6482786
NCBI chr 9:24,859,491...24,901,747
Ensembl chr 9:17,362,225...17,404,476
G
Plat
plasminogen activator, tissue type
treatment
ISO
DNA:snp:enhancer:g.-7351C>T (human) CTD Direct Evidence: therapeutic
CTD RGD
PMID:1430592 PMID:1492007 PMID:1898952 PMID:1899364 PMID:1900011 PMID:2104561 PMID:2105625 PMID:2494454 PMID:2505604 PMID:2521976 PMID:3089627 PMID:3121335 PMID:7488445 PMID:7723950 PMID:7775709 PMID:7902905 PMID:8328192 PMID:8554022 PMID:8598594 PMID:9183334 PMID:10171637 PMID:10505926 PMID:10645301 PMID:10914357 PMID:11382373 PMID:11489769 PMID:12074692 PMID:12227717 PMID:12848087 PMID:15215796 PMID:15301905 PMID:18195371 PMID:19341228 PMID:20122609 PMID:11848437 PMID:7994806 More...
RGD:1580881 , RGD:11541077
NCBI chr16:75,943,061...76,022,037
Ensembl chr16:69,240,585...69,268,223
G
Plau
plasminogen activator, urokinase
ISO IEP
DNA:SNP:3' utr:c.*141C>T (rs4065) (human) CTD Direct Evidence: marker/mechanism|therapeutic mRNA, protein:increased expression:myocardium
CTD RGD
PMID:1908371 PMID:2174952 PMID:2382605 PMID:3068399 PMID:3984876 PMID:8416330 PMID:20518747 PMID:17653104 PMID:20952728 More...
RGD:6484126 , RGD:6484145 , RGD:6484133
NCBI chr15:3,505,485...3,511,987
Ensembl chr15:3,456,232...3,462,775
G
Plaur
plasminogen activator, urokinase receptor
ISO IEP
mRNA, protein:increased expression:myocardium
RGD
PMID:12393744 PMID:20952728
RGD:1580897 , RGD:6484133
NCBI chr 1:89,181,363...89,196,308
Ensembl chr 1:80,050,324...80,068,595
G
Plcb1
phospholipase C beta 1
IEP
protein:increased expression:heart
RGD
PMID:9521338
RGD:2314514
NCBI chr 3:142,512,765...143,224,042
Ensembl chr 3:122,060,031...122,772,869
G
Plcb3
phospholipase C beta 3
IEP
protein:increased expression:heart
RGD
PMID:9521338
RGD:2314514
NCBI chr 1:213,572,499...213,589,585
Ensembl chr 1:204,144,956...204,160,228
G
Pln
phospholamban
treatment
IDA IEP ISO
protein:decreased expression:heart left ventricle (rat) CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:16026515 PMID:16162791 PMID:23781262 PMID:26067684
RGD:7327176 , RGD:11097969
NCBI chr20:33,166,512...33,182,241
G
Pon1
paraoxonase 1
ISO
RGD
PMID:10978258 PMID:10610741
RGD:1580202 , RGD:1580198
NCBI chr 4:34,261,312...34,292,327
Ensembl chr 4:33,294,722...33,321,360
G
Postn
periostin
IEP
protein:increased expression:heart:
RGD
PMID:24212842
RGD:10041024
NCBI chr 2:140,677,774...140,709,304
Ensembl chr 2:138,527,696...138,559,099
G
Ppara
peroxisome proliferator activated receptor alpha
ISO
DNA:SNP:intron:rs4253623, minor allele associated with increased risk (human)
RGD
PMID:18549840
RGD:5562819
NCBI chr 7:118,712,261...118,780,723
Ensembl chr 7:116,832,756...116,895,346
G
Ppargc1a
PPARG coactivator 1 alpha
IEP ISO
protein:decreased expression:heart (rat) CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:22503866 PMID:22503866 PMID:22087236
RGD:7242181 , RGD:6484266
NCBI chr14:63,073,505...63,729,215
Ensembl chr14:58,861,144...59,512,656
G
Prkce
protein kinase C, epsilon
ISO
CTD Direct Evidence: therapeutic RNA:decreased expression:myocardium:
CTD RGD
PMID:16782078 PMID:28887629
RGD:155882580
NCBI chr 6:13,718,050...14,204,931
Ensembl chr 6:7,965,048...8,451,719
G
Prkd1
protein kinase D1
treatment
IEP
RGD
PMID:26064267
RGD:289474908
NCBI chr 6:73,460,640...73,774,433
Ensembl chr 6:67,725,905...68,039,042
G
Proc
protein C, inactivator of coagulation factors Va and VIIIa
ISO
RGD
PMID:10936861
RGD:11100014
NCBI chr18:24,038,596...24,049,061
Ensembl chr18:23,764,368...23,775,133
G
Psma6
proteasome 20S subunit alpha 6
susceptibility
ISO
CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: PSMA6-related condition
CTD ClinVar OMIM
PMID:16845397 PMID:19282875
NCBI chr 6:78,500,676...78,531,693
Ensembl chr 6:72,765,473...72,796,554
G
Ptgis
prostaglandin I2 synthase
susceptibility
ISO
DNA:SNP::1117C>A (human) DNA:silent mutation:exon 8:1117C>A (human) DNA:SNP:CDS: (rs5629) (human)
RGD
PMID:19040046 PMID:12040339 PMID:19327107 PMID:19046748
RGD:401901147 , RGD:401901268 , RGD:401901155 , RGD:2313891
NCBI chr 3:176,347,589...176,383,251
Ensembl chr 3:155,916,412...155,965,451
G
Ptgs2
prostaglandin-endoperoxide synthase 2
ISO
RGD
PMID:15138244
RGD:1581289
NCBI chr13:64,714,063...64,722,320
Ensembl chr13:62,163,932...62,172,188
G
Ptn
pleiotrophin
IEP
protein:increased expression:myocardium (rat)
RGD
PMID:17925408
RGD:10044023
NCBI chr 4:66,260,764...66,342,614
Ensembl chr 4:65,293,734...65,375,456
G
Rad50
RAD50 double strand break repair protein
treatment
IDA
RGD
PMID:15623426
RGD:9831390
NCBI chr10:38,310,147...38,362,100
Ensembl chr10:37,808,726...37,861,396
G
Ranbp1
RAN binding protein 1
IEP
protein:decreased expression:heart ventricle, cytoplasm (rat)
RGD
PMID:25341891
RGD:9835001
NCBI chr11:96,246,912...96,255,145
Ensembl chr11:82,742,600...82,750,838
G
Rbp4
retinol binding protein 4
ISO
protein:increased expression:blood serum (human)
RGD
PMID:25142320
RGD:329845867
NCBI chr 1:245,306,349...245,313,551
Ensembl chr 1:235,893,917...235,901,399
G
Reg1a
regenerating family member 1 alpha
IEP
mRNA:increased expression:heart left ventricle (rat)
RGD
PMID:15778284
RGD:9850130
NCBI chr 4:112,450,466...112,453,130
Ensembl chr 4:110,892,453...110,895,570
G
Ren
renin
susceptibility
ISO
associated with Hypertension; protein:increased activity:plasma (human) CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:1668233 PMID:1759997
RGD:6892687
NCBI chr13:47,348,312...47,359,539
Ensembl chr13:44,796,091...44,807,489
G
Retn
resistin
ISO
protein:increased expression:plasma
RGD
PMID:18997620
RGD:7207152
NCBI chr12:6,508,653...6,511,115
Ensembl chr12:1,710,881...1,712,620
G
Rps6kb1
ribosomal protein S6 kinase B1
IEP
protein:increased threonine phosphorylation:heart left ventricle
RGD
PMID:16540832
RGD:1642998
NCBI chr10:71,817,794...71,865,211
Ensembl chr10:71,323,777...71,367,908
G
Ryr1
ryanodine receptor 1
IDA
protein:hyperphosphorylation:extensor digitorum longus:
RGD
PMID:12824280
RGD:329813076
NCBI chr 1:93,420,078...93,551,305
Ensembl chr 1:84,292,578...84,423,812
G
S100b
S100 calcium binding protein B
IEP ISO
mRNA, protein:increased expression:left ventricle myocardium, plasma CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:9788975 PMID:19910580
RGD:2325647
NCBI chr20:12,372,345...12,381,159
Ensembl chr20:12,372,881...12,394,743
G
Sdc1
syndecan 1
IEP
mRNA:increased expression:myocardium
RGD
PMID:9237025
RGD:2311712
NCBI chr 6:37,282,041...37,304,503
Ensembl chr 6:31,562,739...31,585,264
G
Sdc4
syndecan 4
ISO
protein:increased expression:plasma
RGD
PMID:11372670
RGD:2312328
NCBI chr 3:173,574,239...173,592,923
Ensembl chr 3:153,154,896...153,173,580
G
Sell
selectin L
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:10070497
NCBI chr13:78,950,100...78,969,604
Ensembl chr13:76,416,915...76,436,456
G
Selp
selectin P
susceptibility
ISO IEP
associated with Hypertension;protein:increased expression:plasma protein:increased expression:serum DNA:polymorphisms, haplotypes:cds:p.S290N, p.N562D, p.T715P (human)
RGD
PMID:17391113 PMID:21162967 PMID:21567088 PMID:12165563
RGD:2312304 , RGD:6219003 , RGD:6218991 , RGD:1580075
NCBI chr13:79,009,379...79,044,994
Ensembl chr13:76,476,295...76,511,845
G
Serpine1
serpin family E member 1
susceptibility
ISO IMP
DNA:deletion:promoter:g.-676_-674delG (human)
RGD
PMID:12477941 PMID:16053971
RGD:1626626 , RGD:8547882
NCBI chr12:25,237,977...25,248,356
Ensembl chr12:19,601,272...19,611,657
G
Sfrp2
secreted frizzled-related protein 2
IEP ISO
RGD
PMID:19109969 PMID:19079247
RGD:4107088 , RGD:155883169
NCBI chr 2:171,387,536...171,395,081
Ensembl chr 2:169,089,517...169,097,063
G
Sh2b3
SH2B adaptor protein 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19198610
NCBI chr12:40,391,755...40,414,336
Ensembl chr12:34,731,911...34,753,616
G
Shh
sonic hedgehog signaling molecule
treatment
IMP
RGD
PMID:20052412
RGD:12879408
NCBI chr 4:7,687,872...7,697,025
Ensembl chr 4:6,954,017...6,963,170
G
Sirt1
sirtuin 1
IEP
protein:altered localization:nucleus
RGD
PMID:20089851
RGD:2316169
NCBI chr20:25,305,953...25,328,000
Ensembl chr20:25,306,917...25,329,260
G
Sirt3
sirtuin 3
treatment
IEP
RGD
PMID:24471974
RGD:9586050
NCBI chr 1:205,371,703...205,394,145
Ensembl chr 1:195,942,073...195,964,808
G
Slc27a1
solute carrier family 27 member 1
IEP
protein:decreased expression:infarcted heart
RGD
PMID:17034771
RGD:1642800
NCBI chr16:18,311,859...18,337,024
Ensembl chr16:18,278,984...18,296,063
G
Slc27a6
solute carrier family 27 member 6
IEP
protein:decreased expression:heart
RGD
PMID:17034771
RGD:1642800
NCBI chr18:54,238,697...54,297,595
Ensembl chr18:52,041,074...52,099,414
G
Slpi
secretory leukocyte peptidase inhibitor
treatment
IEP
RGD
PMID:23361363
RGD:9999400
NCBI chr 3:173,501,573...173,503,822
Ensembl chr 3:153,082,369...153,084,453
G
Smad2
SMAD family member 2
treatment ameliorates
IEP ISO
RGD
PMID:11087260 PMID:33409963
RGD:12903276 , RGD:401794430
NCBI chr18:72,124,792...72,193,345
Ensembl chr18:69,850,377...69,912,323
G
Smad3
SMAD family member 3
ameliorates
ISO
RGD
PMID:33409963
RGD:401794430
NCBI chr 8:73,022,204...73,132,324
Ensembl chr 8:64,110,039...64,236,960
G
Smad4
SMAD family member 4
treatment
IEP
RGD
PMID:11087260
RGD:12903276
NCBI chr18:69,518,988...69,549,684
Ensembl chr18:67,243,742...67,274,438
G
Socs1
suppressor of cytokine signaling 1
IEP
protein:increased expression:heart
RGD
PMID:16377761
RGD:2298918
NCBI chr10:5,389,574...5,391,265
Ensembl chr10:4,882,560...4,884,383
G
Sod1
superoxide dismutase 1
treatment
ISO
CTD Direct Evidence: therapeutic human gene in a rat model
CTD RGD
PMID:21600015 PMID:11864929 PMID:22006090
RGD:1581222 , RGD:8655953
NCBI chr11:42,942,742...42,948,399
Ensembl chr11:29,456,558...29,462,249
G
Sod2
superoxide dismutase 2
IDA ISO IEP
CTD Direct Evidence: therapeutic
CTD RGD
PMID:12160945 PMID:14575298 PMID:9250167
RGD:1581148 , RGD:1580839
NCBI chr 1:50,043,323...50,050,168
Ensembl chr 1:47,636,528...47,645,189
G
Sod3
superoxide dismutase 3
ISO
RGD
PMID:14592844
RGD:1580841
NCBI chr14:62,822,865...62,828,602
Ensembl chr14:58,609,958...58,615,990
G
Sparc
secreted protein acidic and cysteine rich
IEP
mRNA:increased expression:heart
RGD
PMID:12826287
RGD:2300056
NCBI chr10:40,017,065...40,038,816
Ensembl chr10:39,516,406...39,538,396
G
Spp1
secreted phosphoprotein 1
ISO
RGD
PMID:12939547 PMID:14500723
RGD:1581386 , RGD:1581325
NCBI chr14:5,613,569...5,620,695
Ensembl chr14:5,308,885...5,315,162
G
Srsf1
serine and arginine rich splicing factor 1
treatment
IDA
protein:increased phosphorylation:heart left ventricle(rat)
RGD
PMID:26067684
RGD:11097969
NCBI chr10:73,335,519...73,342,549
Ensembl chr10:72,839,274...72,845,336
G
Tbx3
T-box transcription factor 3
IEP
RGD
PMID:19341743
RGD:5132891
NCBI chr12:42,540,378...42,555,490
Ensembl chr12:36,881,445...36,893,708
G
Tbx5
T-box transcription factor 5
treatment
IMP
RGD
PMID:23948075
RGD:7327215
NCBI chr12:42,342,926...42,399,723
Ensembl chr12:36,688,014...36,734,885
G
Tek
TEK receptor tyrosine kinase
IEP
protein:increased expression:ventricle myocardium
RGD
PMID:16714360
RGD:1601493
NCBI chr 5:114,722,815...114,849,535
Ensembl chr 5:109,607,077...109,733,804
G
Tfpi
tissue factor pathway inhibitor
treatment
ISO IEP
mRNA,protein:increased expression:heart:
RGD
PMID:15630488 PMID:21229253 PMID:14656922
RGD:11060131 , RGD:11062083 , RGD:11060139
NCBI chr 3:89,939,862...89,989,253
Ensembl chr 3:69,533,156...69,576,880
G
Tgfb1
transforming growth factor, beta 1
susceptibility
ISO IEP
associated with Coronary Disease;DNA:polymorphism:promoter:-509C>T (human) CTD Direct Evidence: marker/mechanism mRNA,protein:increased expression:heart:
CTD RGD
PMID:16310260 PMID:16543493 PMID:27121011 PMID:15118671
RGD:1601560 , RGD:11073666 , RGD:1331525
NCBI chr 1:90,324,312...90,340,627
Ensembl chr 1:81,196,532...81,212,847
G
Tgfb2
transforming growth factor, beta 2
IEP
RGD
PMID:14575314
RGD:2302107
NCBI chr13:100,691,540...100,793,227
Ensembl chr13:98,160,087...98,261,405
G
Tgfbr1
transforming growth factor, beta receptor 1
IEP
RGD
PMID:10198196
RGD:1601617
NCBI chr 5:66,449,348...66,506,371
Ensembl chr 5:61,653,233...61,710,777
G
Tgfbr2
transforming growth factor, beta receptor 2
IEP
protein:increased expression:myocardium
RGD
PMID:10198196
RGD:1601617
NCBI chr 8:124,672,677...124,761,741
Ensembl chr 8:115,794,537...115,883,228
G
Th
tyrosine hydroxylase
no_association
ISO
DNA:polymorphism:intron:g.1170_1173dupTCAT (human)
RGD
PMID:16139102
RGD:1580048
NCBI chr 1:207,500,959...207,508,276
Ensembl chr 1:198,071,503...198,109,767
G
Thbd
thrombomodulin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:9843165 PMID:10627464
NCBI chr 3:156,316,526...156,320,178
Ensembl chr 3:135,862,835...135,867,193
G
Thbs1
thrombospondin 1
IEP
mRNA, protein:increased expression:myocardium
RGD
PMID:16179730
RGD:2317960
NCBI chr 3:125,510,250...125,525,402
Ensembl chr 3:105,056,292...105,071,440
G
Timp2
TIMP metallopeptidase inhibitor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24358288
NCBI chr10:104,041,604...104,089,214
Ensembl chr10:103,531,505...103,590,611
G
Tlr4
toll-like receptor 4
ISO
DNA:SNP:intron:rs1927911, minor allele associated with decreased risk (human)
RGD
PMID:15864121 PMID:18549840
RGD:1580734 , RGD:5562819
NCBI chr 5:85,161,247...85,174,882
Ensembl chr 5:80,145,826...80,159,628
G
Tm6sf2
transmembrane 6 superfamily member 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24633158
NCBI chr16:19,378,148...19,385,360
Ensembl chr16:19,344,222...19,351,431
G
Tnc
tenascin C
IEP
protein:increased expression:heart, fibroblast
RGD
PMID:11454990
RGD:4889618
NCBI chr 5:82,391,340...82,476,197
Ensembl chr 5:77,375,851...77,460,624
G
Tnf
tumor necrosis factor
IEP ISO
mRNA, protein:increased expression:left ventricle myocardium, plasma CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:15883752 PMID:16310260 PMID:21362018
RGD:5130892
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,622,011...3,624,629
G
Tnfrsf11b
TNF receptor superfamily member 11B
ISO
RGD
PMID:15926884
RGD:1620893
NCBI chr 7:87,456,318...87,484,324
Ensembl chr 7:85,566,520...85,594,538
G
Tnfrsf12a
TNF receptor superfamily member 12A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20082609
NCBI chr10:13,211,670...13,213,666
Ensembl chr10:12,689,890...12,709,045
G
Tnfrsf14
TNF receptor superfamily member 14
IEP
protein:increased expression:heart, cardiomyocyte, endothelial cell (rat)
RGD
PMID:18353719
RGD:2317281
NCBI chr 5:170,768,413...170,776,749
Ensembl chr 5:165,484,262...165,493,703
G
Tnfrsf1a
TNF receptor superfamily member 1A
IEP IMP IDA
mRNA, protein:increased expression:left ventricle myocardium (rat)
RGD
PMID:21362018 PMID:20651834 PMID:15117889
RGD:5130892 , RGD:5130975 , RGD:1624194
NCBI chr 4:159,837,119...159,849,817
Ensembl chr 4:158,150,820...158,163,591
G
Tnfrsf1b
TNF receptor superfamily member 1B
IEP
mRNA, protein:decreased expression:left ventricle myocardium (rat)
RGD
PMID:21362018
RGD:5130892
NCBI chr 5:162,356,250...162,387,411
Ensembl chr 5:157,070,642...157,104,206
G
Tnfsf11
TNF superfamily member 11
ISO
protein:increased expression:serum
RGD
PMID:18298349
RGD:2302363
NCBI chr15:60,083,008...60,114,479
Ensembl chr15:53,673,877...53,705,445
G
Tnfsf4
TNF superfamily member 4
susceptibility
ISO
CTD Direct Evidence: marker/mechanism
CTD OMIM RGD
PMID:15750594
RGD:1580396
NCBI chr13:76,256,654...76,280,133
Ensembl chr13:73,723,329...73,746,788
G
Tnni3
troponin I3, cardiac type
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12359538
NCBI chr 1:78,342,571...78,346,255
Ensembl chr 1:69,299,900...69,303,580
G
Tnnt2
troponin T2, cardiac type
ISO
RGD
PMID:15226628
RGD:1580441
NCBI chr13:49,819,123...49,837,125
Ensembl chr13:47,267,204...47,285,388
G
Tp53
tumor protein p53
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24358288
NCBI chr10:54,798,871...54,810,300
Ensembl chr10:54,300,048...54,311,524
G
Trem1
triggering receptor expressed on myeloid cells 1
ameliorates disease_progression
ISO IMP
RGD
PMID:25840803 PMID:25840803 PMID:25840803
RGD:127284842 , RGD:127284842 , RGD:127284842
NCBI chr 9:20,259,227...20,276,879
Ensembl chr 9:12,763,819...12,779,203
G
Trpv1
transient receptor potential cation channel, subfamily V, member 1
IMP
RGD
PMID:27671317
RGD:13792689
NCBI chr10:58,349,936...58,375,021
Ensembl chr10:57,851,428...57,876,513
G
Trpv1em1Sage
transient receptor potential cation channel, subfamily V, member 1; ZFN induced mutant 1, Sage
IMP
RGD
PMID:27671317
RGD:13792689
G
Ttn
titin
IEP
RGD
PMID:12221049
RGD:1580780
NCBI chr 3:82,059,648...82,332,130
Ensembl chr 3:61,652,439...61,924,741
G
Txn1
thioredoxin 1
ISO
RGD
PMID:14677813
RGD:1580785
NCBI chr 5:77,507,455...77,519,685
Ensembl chr 5:72,711,933...72,724,629
G
Txnrd1
thioredoxin reductase 1
IEP
mRNA:decreased expression:heart left ventricle (rat)
RGD
PMID:18515646
RGD:5134341
NCBI chr 7:22,717,620...22,802,553
Ensembl chr 7:20,830,045...20,907,863
G
Ubd
ubiquitin D
IEP IMP
mRNA, protein; increased expression; myocardium (rat) associated with induced myocardial infarction
RGD
PMID:29438664 PMID:29438664
RGD:126925221 , RGD:126925221
NCBI chr20:1,390,734...1,392,685
Ensembl chr20:1,385,864...1,408,639 Ensembl chr20:1,385,864...1,408,639
G
Ubdem1
ubiquitin D; CRISPR/Cas9 induced mutant1
IMP
associated with induced myocardial infarction
RGD
PMID:29438664
RGD:126925221
G
Uts2
urotensin 2
IEP
associated with Heart Failure, Congestive;mRNA:increased expression:heart ventricle
RGD
PMID:15549273
RGD:2306846
NCBI chr 5:166,725,471...166,739,063
Ensembl chr 5:161,450,846...161,456,237
G
Uts2r
urotensin 2 receptor
IEP
associated with Heart Failure, Congestive;mRNA:increased expression:heart ventricle
RGD
PMID:15549273
RGD:2306846
NCBI chr10:106,936,398...106,937,558
Ensembl chr10:106,438,092...106,439,252
G
Vcan
versican
IEP
RGD
PMID:16311904
RGD:1598497
NCBI chr 2:22,497,035...22,595,955
Ensembl chr 2:20,761,718...20,860,637
G
Vdac1
voltage-dependent anion channel 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25488258
NCBI chr10:37,029,377...37,060,542
Ensembl chr10:36,532,244...36,559,640
G
Vdac2
voltage-dependent anion channel 2
treatment
IDA
RGD
PMID:20601275
RGD:10003049
NCBI chr15:2,512,214...2,526,105
Ensembl chr15:2,463,056...2,476,553
G
Vegfa
vascular endothelial growth factor A
treatment
ISO IDA
protein:increased expression:serum,platelet:
RGD
PMID:10652191 PMID:25936512
RGD:7483604 , RGD:126925214
NCBI chr 9:22,452,854...22,468,194
Ensembl chr 9:14,955,300...14,970,641
G
Vegfb
vascular endothelial growth factor B
ISO
RGD
PMID:17975666
RGD:2314324
NCBI chr 1:213,601,570...213,607,254
Ensembl chr 1:204,172,225...204,177,944
G
Vwf
von Willebrand factor
IEP
protein:increased expression:heart:
RGD
PMID:19435557
RGD:11080745
NCBI chr 4:160,042,900...160,177,757
Ensembl chr 4:158,360,152...158,491,539
G
Wdr12
WD repeat domain 12
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19198609 PMID:25915632
NCBI chr 9:68,969,547...68,996,811
Ensembl chr 9:61,475,517...61,502,469
G
Wrn
WRN RecQ like helicase
ISO
RGD
PMID:9021029
RGD:1580821
NCBI chr16:65,466,552...65,602,951
Ensembl chr16:58,763,504...58,895,450
G
Xrcc3
X-ray repair cross complementing 3
susceptibility
ISO
DNA:polymorphism:: (human)
RGD
PMID:18712175
RGD:401827276
NCBI chr 6:136,684,558...136,694,822
Ensembl chr 6:130,863,959...130,872,444
G
Ybx1
Y box binding protein 1
IEP
RGD
PMID:16002047
RGD:1580630
NCBI chr 5:138,167,444...138,188,155
Ensembl chr 5:132,882,145...132,898,862
G
Zeb2
zinc finger E-box binding homeobox 2
IEP
protein:increased expression:heart (rat)
RGD
PMID:24155330
RGD:155882536
NCBI chr 3:49,624,028...49,754,323
Ensembl chr 3:29,218,301...29,345,157
G
Acot2
acyl-CoA thioesterase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16214533
NCBI chr 6:109,341,426...109,352,818
Ensembl chr 6:103,611,544...103,619,245
G
Actb
actin, beta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16214533
NCBI chr12:16,776,664...16,779,634
Ensembl chr12:11,663,109...11,672,877
G
Acvr1b
activin A receptor type 1B
IEP
RGD
PMID:14993131
RGD:1580888
NCBI chr 7:134,164,987...134,208,389
Ensembl chr 7:132,286,275...132,329,673
G
Adipoq
adiponectin, C1Q and collagen domain containing
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:16155579
NCBI chr11:91,226,524...91,240,244
Ensembl chr11:77,721,912...77,735,564
G
Adm
adrenomedullin
ISO
protein:increased expression:plasma
RGD
PMID:15350700
RGD:1625302
NCBI chr 1:174,164,178...174,182,372
Ensembl chr 1:164,745,466...164,747,654
G
Adm2
adrenomedullin 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16987513
NCBI chr 7:122,272,808...122,274,594
Ensembl chr 7:120,393,179...120,396,331
G
Adrb1
adrenoceptor beta 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:9554809
NCBI chr 1:265,777,103...265,780,114
Ensembl chr 1:255,771,597...255,807,259
G
Adrb2
adrenoceptor beta 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:9554809
NCBI chr18:57,912,760...57,914,802
Ensembl chr18:55,502,903...55,644,512
G
Ager
advanced glycosylation end product-specific receptor
ISO
associated with Diabetes Mellitus, Type 2;DNA:SNP:promoter:-374T>A (human)
RGD
PMID:15896660
RGD:8695969
NCBI chr20:4,152,758...4,155,956
Ensembl chr20:4,147,890...4,151,078
G
Agt
angiotensinogen
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16775501
NCBI chr19:69,426,540...69,447,017
Ensembl chr19:52,529,185...52,540,977
G
Ak1
adenylate kinase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16214533
NCBI chr 3:36,310,113...36,320,760
Ensembl chr 3:15,912,485...15,923,041
G
Akr1b1
aldo-keto reductase family 1 member B1
IDA
protein:increased activity:heart
RGD
PMID:16567803
RGD:1626092
NCBI chr 4:63,899,222...63,913,315
Ensembl chr 4:62,932,031...62,946,157
G
Aldh2
aldehyde dehydrogenase 2 family member
IDA
RGD
PMID:18787169
RGD:7241592
NCBI chr12:40,610,244...40,643,220
Ensembl chr12:34,901,219...34,982,521
G
Aldh6a1
aldehyde dehydrogenase 6 family, member A1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16214533
NCBI chr 6:109,809,092...109,829,725
Ensembl chr 6:104,077,979...104,098,656
G
Aldoa
aldolase, fructose-bisphosphate A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16214533
NCBI chr 1:190,832,820...190,838,021
Ensembl chr 1:181,402,275...181,406,182
G
Ampd1
adenosine monophosphate deaminase 1
susceptibility
ISO
associated with congestive heart failure; DNA:SNP:exon 2:34C>T (human)
RGD
PMID:16875916
RGD:329412475
NCBI chr 2:193,287,219...193,308,446
Ensembl chr 2:190,598,700...190,619,938
G
Anxa5
annexin A5
IEP
RGD
PMID:8056721
RGD:7241858
NCBI chr 2:121,242,133...121,272,935
Ensembl chr 2:119,314,007...119,353,369
G
Aplp2
amyloid beta precursor like protein 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16214533
NCBI chr 8:37,857,407...37,920,487
Ensembl chr 8:29,599,230...29,661,855
G
Apob
apolipoprotein B
ISO
RGD
PMID:9603795
RGD:1578415
NCBI chr 6:36,563,704...36,603,300
Ensembl chr 6:30,844,368...30,892,497
G
Apoe
apolipoprotein E
susceptibility
ISO
DNA:polymorphism:promoter:-219G>T (human)
RGD
PMID:17006673
RGD:1601238
NCBI chr 1:88,481,889...88,485,816
Ensembl chr 1:79,353,916...79,357,932
G
Areg
amphiregulin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16214533
NCBI chr14:17,256,384...17,265,641
Ensembl chr14:16,972,187...16,981,535
G
Atp1a1
ATPase Na+/K+ transporting subunit alpha 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16214533
NCBI chr 2:191,709,311...191,737,414
Ensembl chr 2:189,020,722...189,048,837
G
Axin2
axin 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29394407
NCBI chr10:94,393,379...94,426,579
Ensembl chr10:93,899,245...93,926,231
G
Bax
BCL2 associated X, apoptosis regulator
treatment
IEP
RGD
PMID:22014268
RGD:10054500
NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:95,938,808...95,945,368
G
Bcl2
BCL2, apoptosis regulator
treatment
IEP
RGD
PMID:22014268
RGD:10054500
NCBI chr13:23,204,464...23,366,900
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
Bhlhe40
basic helix-loop-helix family, member e40
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16214533
NCBI chr 4:143,174,450...143,180,150
Ensembl chr 4:141,618,476...141,624,774
G
Bmal1
basic helix-loop-helix ARNT like 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16214533
NCBI chr 1:176,766,222...176,864,741
Ensembl chr 1:167,331,633...167,430,231
G
C1qb
complement C1q B chain
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16214533
NCBI chr 5:154,402,276...154,407,827
Ensembl chr 5:149,118,846...149,124,407
G
Cacna2d2
calcium voltage-gated channel auxiliary subunit alpha2delta 2
IEP
protein:decreased expression:heart
RGD
PMID:28469787
RGD:13513983
NCBI chr 8:116,950,860...117,082,159
Ensembl chr 8:108,072,454...108,203,173
G
Calr
calreticulin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16214533
NCBI chr19:40,213,367...40,218,262
Ensembl chr19:23,308,351...23,313,414
G
Camk2d
calcium/calmodulin-dependent protein kinase II delta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16214533
NCBI chr 2:217,698,324...217,961,898
Ensembl chr 2:215,024,004...215,286,178
G
Canx
calnexin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16214533
NCBI chr10:35,124,941...35,157,954
Ensembl chr10:34,625,191...34,656,821
G
Ccl2
C-C motif chemokine ligand 2
IEP ISO
protein:increased expression:plasma, heart (rat) CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:16214533 PMID:10068207
RGD:8549542
NCBI chr10:67,503,077...67,504,875
Ensembl chr10:67,005,424...67,007,226
G
Ccl3
C-C motif chemokine ligand 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16214533
NCBI chr10:68,948,889...68,950,439
Ensembl chr10:68,451,388...68,452,938
G
Ccl4
C-C motif chemokine ligand 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16214533
NCBI chr10:68,963,893...68,965,728
Ensembl chr10:68,452,052...68,468,231
G
Ccna2
cyclin A2
ISO
RGD
PMID:17382628
RGD:10054468
NCBI chr 2:121,355,363...121,361,762
Ensembl chr 2:119,426,089...119,433,577
G
Ccnd1
cyclin D1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16214533
NCBI chr 1:209,518,288...209,527,986
Ensembl chr 1:200,089,002...200,098,602
G
Ccnd2
cyclin D2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16214533
NCBI chr 4:161,653,048...161,675,422
Ensembl chr 4:159,962,363...159,989,495
G
Cd36
CD36 molecule
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16214533
NCBI chr 4:18,209,088...18,302,142
Ensembl chr 4:17,354,466...17,513,903
G
Cd38
CD38 molecule
IDA ISO
protein:increased activity:ventricle myocardium CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:16214533 PMID:12111041
RGD:2307243
NCBI chr14:71,384,532...71,424,794
Ensembl chr14:67,172,063...67,211,986
G
Cd40
CD40 molecule
treatment
IDA
RGD
PMID:19565716
RGD:11352677
NCBI chr 3:174,209,113...174,224,592
Ensembl chr 3:153,790,449...153,805,534
G
Cd40lg
CD40 ligand
treatment
IDA IEP
protein:increased expression:myocardium (rat)
RGD
PMID:19565716 PMID:19204010
RGD:11352677 , RGD:11352684
NCBI chr X:140,164,341...140,176,057
Ensembl chr X:135,126,969...135,138,306
G
Cdh2
cadherin 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16214533
NCBI chr18:8,051,097...8,265,288
Ensembl chr18:7,776,704...7,990,167
G
Cebpd
CCAAT/enhancer binding protein delta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16214533
NCBI chr11:98,268,856...98,269,994
Ensembl chr11:84,764,565...84,765,829
G
Ces3a
carboxylesterase 3a
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16214533
NCBI chr19:49,902,312...49,910,484
G
Cirbp
cold inducible RNA binding protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16214533
NCBI chr 7:10,184,515...10,189,623
Ensembl chr 7:9,424,178...9,538,818
G
Clec10a
C-type lectin domain containing 10A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16214533
NCBI chr10:55,374,914...55,379,110
Ensembl chr10:54,876,260...54,880,435
G
Cox5b
cytochrome c oxidase subunit 5B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16214533
NCBI chr 9:46,417,735...46,419,664
Ensembl chr 9:38,921,967...38,925,052
G
Cpt1b
carnitine palmitoyltransferase 1B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16214533
NCBI chr 7:122,370,974...122,380,473
Ensembl chr 7:120,491,354...120,500,404
G
Crk
CRK proto-oncogene, adaptor protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16214533
NCBI chr10:61,028,736...61,054,971
Ensembl chr10:60,530,464...60,553,406
G
Crp
C-reactive protein
IEP ISO
protein:increased expression:serum CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:11840375 PMID:21122204
RGD:5128547
NCBI chr13:87,694,062...87,695,978
Ensembl chr13:85,124,977...85,175,178
G
Cryab
crystallin, alpha B
IDA
RGD
PMID:11945023
RGD:704398
NCBI chr 8:59,989,885...59,995,532
Ensembl chr 8:51,093,441...51,099,157
G
Ctnnb1
catenin beta 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29394407
NCBI chr 8:129,517,576...129,544,661
Ensembl chr 8:120,639,995...120,667,111
G
Ctsc
cathepsin C
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16214533
NCBI chr 1:151,440,860...151,472,430
Ensembl chr 1:142,028,392...142,060,387
G
Cttnbp2
cortactin binding protein 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16214533
NCBI chr 4:47,766,867...47,930,598
Ensembl chr 4:46,800,981...46,964,631
G
Cx3cl1
C-X3-C motif chemokine ligand 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16214533
NCBI chr19:10,233,326...10,244,856
Ensembl chr19:10,227,340...10,236,833
G
Cxcl10
C-X-C motif chemokine ligand 10
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16214533
NCBI chr14:15,989,066...15,991,263
Ensembl chr14:15,704,758...15,706,975
G
Cxcl2
C-X-C motif chemokine ligand 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16214533
NCBI chr14:17,465,210...17,467,255
Ensembl chr14:17,181,062...17,183,075
G
Dcn
decorin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16214533
NCBI chr 7:34,167,973...34,208,004
Ensembl chr 7:32,281,252...32,321,270
G
Dlat
dihydrolipoamide S-acetyltransferase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16214533
NCBI chr 8:59,875,537...59,900,947
Ensembl chr 8:50,978,051...51,004,479 Ensembl chr 1:50,978,051...51,004,479
G
Dll4
delta like canonical Notch ligand 4
treatment
IEP
RGD
PMID:32089723
RGD:155641250
NCBI chr 3:126,770,945...126,780,769
Ensembl chr 3:106,316,986...106,326,931
G
Dnm1l
dynamin 1-like
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16214533
NCBI chr11:98,084,049...98,135,663
Ensembl chr11:84,581,216...84,631,482
G
Dusp1
dual specificity phosphatase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16214533
NCBI chr10:17,184,853...17,187,646
G
Dusp6
dual specificity phosphatase 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16214533
NCBI chr 7:35,979,502...35,983,834
Ensembl chr 7:34,092,943...34,097,185
G
Edn1
endothelin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:10462014 PMID:11707688 PMID:16306806
NCBI chr17:22,660,799...22,666,687
Ensembl chr17:22,454,420...22,460,885
G
Ednra
endothelin receptor type A
ISO
RGD
PMID:14729387
RGD:1580946
NCBI chr19:47,137,360...47,207,961
Ensembl chr19:30,233,571...30,297,049
G
Ednrb
endothelin receptor type B
ISO
RGD
PMID:14729387
RGD:1580946
NCBI chr15:87,055,490...87,086,765
Ensembl chr15:80,643,043...80,672,115
G
Egr2
early growth response 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16214533
NCBI chr20:21,050,149...21,055,201
Ensembl chr20:21,051,277...21,055,562
G
Eif2a
eukaryotic translation initiation factor 2A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19041636
NCBI chr 2:144,911,247...144,944,705
Ensembl chr 2:142,761,416...142,795,068
G
Eif2ak3
eukaryotic translation initiation factor 2 alpha kinase 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19041636
NCBI chr 4:104,363,838...104,425,271
Ensembl chr 4:102,805,510...102,866,911
G
Eif4e
eukaryotic translation initiation factor 4E
IDA
RGD
PMID:16439989
RGD:10401145
NCBI chr 2:229,736,309...229,772,628
Ensembl chr 2:227,066,673...227,098,683
G
Eif4ebp1
eukaryotic translation initiation factor 4E binding protein 1
IDA
RGD
PMID:16439989
RGD:10401145
NCBI chr16:71,495,457...71,508,845
Ensembl chr16:64,790,226...64,805,984
G
Eif4g1
eukaryotic translation initiation factor 4 gamma 1
IEP
RGD
PMID:16439989
RGD:10401145
NCBI chr11:93,726,322...93,746,387
Ensembl chr11:80,221,919...80,241,941
G
Eln
elastin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16214533
NCBI chr12:27,604,983...27,648,413
Ensembl chr12:21,968,544...22,011,928
G
Ensa
endosulfine alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16214533
NCBI chr 2:185,874,500...185,881,838
Ensembl chr 2:183,185,552...183,194,847
G
Ephx1
epoxide hydrolase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29298899
NCBI chr13:95,246,079...95,275,852
Ensembl chr13:92,714,315...92,790,235
G
Ephx2
epoxide hydrolase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29298899
NCBI chr15:44,465,447...44,503,157
Ensembl chr15:40,289,902...40,327,615
G
Erbb2
erb-b2 receptor tyrosine kinase 2
ISO
RGD
PMID:15685397
RGD:1580988
NCBI chr10:83,907,491...83,931,365
Ensembl chr10:83,411,313...83,435,078
G
F2rl1
F2R like trypsin receptor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16214533
NCBI chr 2:28,507,003...28,519,954
Ensembl chr 2:26,772,278...26,785,226
G
F3
coagulation factor III, tissue factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16286589
NCBI chr 2:212,511,675...212,523,375
Ensembl chr 2:209,826,959...209,838,668
G
F5
coagulation factor V
ISO
DNA:mutation, haplotype: :1691G>A (human)
RGD
PMID:19524925
RGD:4892673
NCBI chr13:79,046,657...79,116,247
Ensembl chr13:76,513,255...76,582,317
G
Fabp5
fatty acid binding protein 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16214533
NCBI chr 2:93,672,451...93,676,186
Ensembl chr 2:91,765,056...91,853,773
G
Fev
FEV transcription factor, ETS family member
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16214533
NCBI chr 9:83,887,844...83,891,718
Ensembl chr 9:76,439,172...76,443,065
G
Fez2
fasciculation and elongation protein zeta 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16214533
NCBI chr 6:22,406,685...22,446,745
Ensembl chr 6:16,654,614...16,694,626
G
Fgf1
fibroblast growth factor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16214533
NCBI chr18:30,937,670...31,023,786
Ensembl chr18:30,686,581...30,772,357
G
Fgf2
fibroblast growth factor 2
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:12173832 PMID:14583313
NCBI chr 2:122,164,454...122,218,796
Ensembl chr 2:120,236,328...120,291,221
G
Fxyd1
FXYD domain-containing ion transport regulator 1
IDA
RGD
PMID:14597563
RGD:9685466
NCBI chr 1:95,414,556...95,418,645
Ensembl chr 1:86,287,165...86,291,278
G
Gas5
growth arrest specific 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16214533
NCBI chr13:75,836,963...75,840,284
G
Gatm
glycine amidinotransferase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16214533
NCBI chr 3:130,112,508...130,137,664
Ensembl chr 3:109,658,951...109,684,129
G
Gbp2
guanylate binding protein 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16214533
NCBI chr 2:234,005,727...234,021,812
Ensembl chr 2:231,332,284...231,348,571
G
Gch1
GTP cyclohydrolase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16214533
NCBI chr15:22,884,006...22,917,412
Ensembl chr15:20,402,527...20,437,698
G
Gclc
glutamate-cysteine ligase, catalytic subunit
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16214533
NCBI chr 8:87,510,251...87,548,896
Ensembl chr 8:78,630,127...78,668,544
G
Gdf1
growth differentiation factor 1
ISO
protein:increased expression:Left ventricle (human)
RGD
PMID:25726944
RGD:11252030
NCBI chr16:19,131,271...19,146,480
Ensembl chr16:19,097,314...19,112,519
G
Gdf15
growth differentiation factor 15
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16214533
NCBI chr16:18,838,436...18,842,022
Ensembl chr16:18,805,239...18,808,055
G
Ghr
growth hormone receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16214533
NCBI chr 2:54,269,066...54,532,595
Ensembl chr 2:52,542,594...52,804,735
G
Ghrl
ghrelin and obestatin prepropeptide
disease_progression treatment
IEP ISO
mRNA,protein:increased expression:plasma,myocardia:
RGD
PMID:16626506 PMID:16626506
RGD:12907503 , RGD:12907503
NCBI chr 4:148,421,315...148,431,128
Ensembl chr 4:146,865,712...146,869,621
G
Ghsr
growth hormone secretagogue receptor
IEP
mRNA,protein:increased expression,increased activity:myocardia:
RGD
PMID:16626506
RGD:12907503
NCBI chr 2:112,196,158...112,201,666
Ensembl chr 2:110,268,489...110,271,865
G
Gk
glycerol kinase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16214533
NCBI chr X:54,106,708...54,189,940
Ensembl chr X:50,163,123...50,238,631
G
Gna12
G protein subunit alpha 12
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16214533
NCBI chr12:18,919,629...19,000,185
Ensembl chr12:13,805,698...13,886,255
G
Gpt
glutamic--pyruvic transaminase
IEP
RGD
PMID:30841448
RGD:401717562
NCBI chr 7:110,295,599...110,300,134
Ensembl chr 7:108,416,642...108,419,494
G
Gsta1
glutathione S-transferase alpha 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16214533
NCBI chr 9:31,199,887...31,216,606
Ensembl chr 9:23,703,477...23,720,121
G
Gstm2
glutathione S-transferase mu 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16214533
NCBI chr 2:198,312,179...198,316,962
Ensembl chr 2:195,544,426...195,628,961
G
Gstp1
glutathione S-transferase pi 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16214533
NCBI chr 1:210,767,237...210,770,242
Ensembl chr 1:201,321,672...201,340,226
G
Gyg1
glycogenin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16214533
NCBI chr 2:104,540,927...104,583,038
Ensembl chr 2:102,598,496...102,653,797
G
Hadha
hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16214533
NCBI chr 6:31,907,801...31,947,434
Ensembl chr 6:26,187,956...26,227,869
G
Hfe
homeostatic iron regulator
susceptibility
ISO
RGD
PMID:11545759
RGD:1582695
NCBI chr17:41,841,302...41,849,359
Ensembl chr17:41,413,451...41,421,502
G
Hgf
hepatocyte growth factor
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:12447174
NCBI chr 4:19,628,902...19,700,467
Ensembl chr 4:18,677,101...18,745,409
G
Hif1a
hypoxia inducible factor 1 subunit alpha
IEP
mRNA, protein:increased expression:myocardium (rat)
RGD
PMID:17335664
RGD:9068465
NCBI chr 6:98,357,788...98,405,068
Ensembl chr 6:92,624,390...92,669,261
G
Hivep2
HIVEP zinc finger 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16214533
NCBI chr 1:10,176,880...10,376,089
Ensembl chr 1:8,359,289...8,555,993
G
Hk1
hexokinase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16214533
NCBI chr20:30,773,222...30,874,814
Ensembl chr20:30,230,486...30,332,131
G
Hk2
hexokinase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16214533
NCBI chr 4:116,792,258...116,841,275
Ensembl chr 4:115,234,509...115,283,530
G
Hmgb1
high mobility group box 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16214533
NCBI chr12:11,009,236...11,015,941
Ensembl chr12:5,901,586...5,978,565 Ensembl chr16:5,901,586...5,978,565
G
Hmgcs2
3-hydroxy-3-methylglutaryl-CoA synthase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16214533
NCBI chr 2:188,564,348...188,590,872
Ensembl chr 2:185,875,616...185,902,130
G
Hmox1
heme oxygenase 1
susceptibility
ISO IEP
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:16214533 PMID:15064108 PMID:15734859
RGD:1598399 , RGD:1582713
NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,467,244...13,474,079
G
Hspa1a
heat shock protein family A (Hsp70) member 1A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16214533
NCBI chr20:3,875,411...3,877,866
Ensembl chr20:3,856,006...3,873,227
G
Hspa2
heat shock protein family A (Hsp70) member 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16214533
NCBI chr 6:100,864,172...100,866,946
Ensembl chr 6:95,128,350...95,131,287
G
Hspa9
heat shock protein family A (Hsp70) member 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16214533
NCBI chr18:26,810,004...26,832,958
Ensembl chr18:26,535,798...26,554,292
G
Hspd1
heat shock protein family D (Hsp60) member 1
IEP
protein:increased expression:heart
RGD
PMID:12872233
RGD:1624250
NCBI chr 9:64,073,610...64,084,332
Ensembl chr 9:56,579,201...56,589,662
G
Icam1
intercellular adhesion molecule 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16214533
NCBI chr 8:27,829,688...27,841,618
Ensembl chr 8:19,553,645...19,565,438
G
Id1
inhibitor of DNA binding 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16214533
NCBI chr 3:161,671,525...161,672,691
Ensembl chr 3:141,211,267...141,212,419
G
Id3
inhibitor of DNA binding 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16214533
NCBI chr 5:153,656,253...153,657,860
Ensembl chr 5:148,372,762...148,374,349
G
Ifngr1
interferon gamma receptor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16214533
NCBI chr 1:16,152,811...16,171,439
Ensembl chr 1:14,333,187...14,351,785
G
Igf1
insulin-like growth factor 1
severity
ISO IDA
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:16214533 PMID:16793032 PMID:16698918
RGD:1598425 , RGD:1598426
NCBI chr 7:24,169,608...24,249,446
Ensembl chr 7:22,282,930...22,359,296
G
Igfbp3
insulin-like growth factor binding protein 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16214533
NCBI chr14:86,270,208...86,277,944
Ensembl chr14:82,056,347...82,064,083
G
Il1a
interleukin 1 alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16214533
NCBI chr 3:136,979,804...136,990,236
Ensembl chr 3:116,526,604...116,536,822
G
Il1b
interleukin 1 beta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16214533
NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:116,577,010...116,583,415
G
Il6
interleukin 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16286589
NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,213,394...5,219,178
G
Il6st
interleukin 6 cytokine family signal transducer
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16214533
NCBI chr 2:45,798,872...45,839,501
Ensembl chr 2:44,066,130...44,109,936
G
Irf1
interferon regulatory factor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16214533
NCBI chr10:38,417,935...38,424,946
Ensembl chr10:37,916,670...37,924,166
G
Itgav
integrin subunit alpha V
ISO
RGD
PMID:11997283
RGD:1582453
NCBI chr 3:89,245,382...89,333,512
Ensembl chr 3:68,838,189...68,926,639
G
Jak2
Janus kinase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15746188 PMID:16214533
NCBI chr 1:236,408,905...236,468,769
Ensembl chr 1:226,995,334...227,054,189
G
Junb
JunB proto-oncogene, AP-1 transcription factor subunit
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16214533
NCBI chr19:40,081,126...40,082,910
Ensembl chr19:23,176,294...23,178,035
G
Kcnj11
potassium inwardly-rectifying channel, subfamily J, member 11
IEP
RGD
PMID:26591689
RGD:12790977
NCBI chr 1:105,727,473...105,731,167
Ensembl chr 1:96,591,049...96,594,082
G
Kcnj8
potassium inwardly-rectifying channel, subfamily J, member 8
IEP ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:16214533 PMID:9399952 PMID:26591689
RGD:1598652 , RGD:12790977
NCBI chr 4:177,240,692...177,246,548
Ensembl chr 4:175,508,912...175,515,603
G
Kcnk2
potassium two pore domain channel subfamily K member 2
IEP
mRNA:increased expression:heart left ventricle, epicardium, endocardium (rat)
RGD
PMID:24705172
RGD:9831164
NCBI chr13:103,297,387...103,494,686
Ensembl chr13:100,766,113...100,963,435
G
Kcnmb1
potassium calcium-activated channel subfamily M regulatory beta subunit 1
no_association
ISO
RGD
PMID:16155733
RGD:1581719
NCBI chr10:19,062,014...19,119,005
Ensembl chr10:18,557,904...18,565,798
G
Kdr
kinase insert domain receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16214533
NCBI chr14:32,572,031...32,615,204
Ensembl chr14:32,217,871...32,261,018
G
Kitlg
KIT ligand
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16214533
NCBI chr 7:36,782,621...36,863,796
Ensembl chr 7:34,896,053...34,977,214
G
Klf4
KLF transcription factor 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16214533
NCBI chr 5:75,074,107...75,079,182
Ensembl chr 5:70,278,972...70,283,602
G
Lepr
leptin receptor
susceptibility
ISO
DNA:polymorphism: :p.Q223R (human)
RGD
PMID:19337797
RGD:2311129
NCBI chr 5:121,409,735...121,593,201
Ensembl chr 5:116,289,823...116,475,908
G
Ltbp2
latent transforming growth factor beta binding protein 2
ISO
mRNA:increased expression:myocardium (human)
RGD
PMID:17343875
RGD:156451374
NCBI chr 6:110,161,029...110,261,586
Ensembl chr 6:104,429,947...104,526,208
G
Map1lc3b
microtubule-associated protein 1 light chain 3 beta
IDA
RGD
PMID:12371906
RGD:629541
NCBI chr19:66,571,631...66,582,270
Ensembl chr19:49,665,791...49,677,690 Ensembl chr16:49,665,791...49,677,690
G
Map2k3
mitogen activated protein kinase kinase 3
IDA
RGD
PMID:20550965
RGD:7243113
NCBI chr10:46,107,639...46,128,986
Ensembl chr10:45,607,163...45,629,492
G
Map3k8
mitogen-activated protein kinase kinase kinase 8
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16214533
NCBI chr17:58,078,175...58,098,455
Ensembl chr17:53,383,131...53,403,216
G
Mapk14
mitogen activated protein kinase 14
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16214533
NCBI chr20:6,751,288...6,812,294
Ensembl chr20:6,749,670...6,810,589
G
Mapre1
microtubule-associated protein, RP/EB family, member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16214533
NCBI chr 3:162,679,020...162,707,167
Ensembl chr 3:142,212,955...142,246,983
G
Mb
myoglobin
susceptibility
IDA IEP ISO
protein:decreased expression:subendocardium
RGD
PMID:12935692 PMID:3315739 PMID:15762290
RGD:1582426 , RGD:485874381 , RGD:1582393
NCBI chr 7:110,640,511...110,647,742
Ensembl chr 7:108,759,904...108,767,383
G
Meox2
mesenchyme homeobox 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16214533
NCBI chr 6:59,584,025...59,644,722
Ensembl chr 6:53,856,758...53,917,467
G
Mfn1
mitofusin 1
treatment
IEP
RGD
PMID:27491814
RGD:12910831
NCBI chr 2:117,240,525...117,288,017
Ensembl chr 2:115,313,401...115,359,640
G
Mfn2
mitofusin 2
treatment
IEP
RGD
PMID:27491814
RGD:12910831
NCBI chr 5:163,587,463...163,617,363
Ensembl chr 5:158,304,287...158,335,342
G
Mir145
microRNA 145
ISO
miRNA:decreased expression:myocardium (mouse)
RGD
PMID:23028672
RGD:10047368
NCBI chr18:57,369,983...57,370,070
Ensembl chr18:55,099,640...55,099,727
G
Mpo
myeloperoxidase
ISO
Acute Coronary Syndrome; protein:increased expression:plasma
RGD
PMID:21226709
RGD:5130961
NCBI chr10:73,092,124...73,102,057
Ensembl chr10:72,594,661...72,604,819
G
Msn
moesin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16214533
NCBI chr X:65,005,546...65,073,512
Ensembl chr X:60,995,951...61,065,628
G
Msr1
macrophage scavenger receptor 1
disease_progression
ISO
mRNA:increased expression:blood, mononuclear cell
RGD
PMID:17945237
RGD:2306126
NCBI chr16:59,421,250...59,507,070
Ensembl chr16:52,717,732...52,799,676
G
Mx1
MX dynamin like GTPase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16214533
NCBI chr11:50,269,056...50,294,699
Ensembl chr11:36,799,660...36,823,507
G
Ncl
nucleolin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16214533
NCBI chr 9:94,447,559...94,456,083
Ensembl chr 9:86,998,019...87,008,136
G
Nedd4
NEDD4 E3 ubiquitin protein ligase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16214533
NCBI chr 8:82,264,751...82,349,642
Ensembl chr 8:73,383,695...73,468,951
G
Nfkbia
NFKB inhibitor alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16214533
NCBI chr 6:78,593,844...78,597,307
Ensembl chr 6:72,858,712...72,861,941
G
Nos3
nitric oxide synthase 3
susceptibility
ISO
DNA:duplication, snp:intron, cds:g.IVS4?-?+27, p.E298D (human) ClinVar Annotator: match by term: Ischemic heart disease, susceptibility to CTD Direct Evidence: therapeutic
ClinVar CTD RGD
PMID:9737779 PMID:9894802 PMID:10475066 PMID:10510054 PMID:10514107 PMID:11026457 PMID:11354626 PMID:11394896 PMID:11745998 PMID:12354446 PMID:15007011 PMID:16059745 PMID:16813604 PMID:17165044 PMID:24033266 PMID:25741868 PMID:15007011 More...
RGD:7777100
NCBI chr 4:11,686,088...11,706,604
Ensembl chr 4:10,793,834...10,814,166
G
Notch1
notch receptor 1
treatment
IEP
RGD
PMID:32089723
RGD:155641250
NCBI chr 3:29,676,040...29,721,613
Ensembl chr 3:9,278,086...9,323,531
G
Nppa
natriuretic peptide A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:1830552
NCBI chr 5:163,712,184...163,713,493
Ensembl chr 5:158,429,042...158,430,351
G
Nptn
neuroplastin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16214533
NCBI chr 8:67,892,678...67,959,231
Ensembl chr 8:58,996,887...59,063,401
G
Nr1h3
nuclear receptor subfamily 1, group H, member 3
susceptibility
ISO
DNA:SNPs, haplotype:promoter:c.-115G>A, c.-840C>A (rs12221497, rs61896015) (human)
RGD
PMID:21903943
RGD:401842365
NCBI chr 3:97,614,616...97,632,053
Ensembl chr 3:77,158,808...77,168,722
G
Nr4a1
nuclear receptor subfamily 4, group A, member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16214533
NCBI chr 7:134,247,153...134,268,044
Ensembl chr 7:132,374,840...132,389,297
G
Opa1
OPA1, mitochondrial dynamin like GTPase
treatment
IEP
RGD
PMID:27491814
RGD:12910831
NCBI chr11:84,612,943...84,690,025
Ensembl chr11:71,109,873...71,185,109
G
P4hb
prolyl 4-hydroxylase subunit beta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16214533
NCBI chr10:106,335,300...106,346,911
Ensembl chr10:105,836,982...105,848,500
G
Pde4b
phosphodiesterase 4B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16214533
NCBI chr 5:122,028,956...122,598,267
Ensembl chr 5:116,799,971...117,367,696
G
Pdha1
pyruvate dehydrogenase E1 subunit alpha 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16214533
NCBI chr X:38,509,158...38,522,986
Ensembl chr X:34,700,409...34,714,311
G
Pdk4
pyruvate dehydrogenase kinase 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16214533
NCBI chr 4:34,558,327...34,568,329
Ensembl chr 4:33,589,799...33,601,850
G
Pdlim5
PDZ and LIM domain 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16214533
NCBI chr 2:233,625,478...233,793,582
Ensembl chr 2:230,952,248...231,120,275
G
Pebp1
phosphatidylethanolamine binding protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16214533
NCBI chr12:44,946,307...44,967,890
Ensembl chr12:39,302,840...39,307,862
G
Penk
proenkephalin
treatment
IEP
RGD
PMID:21247719
RGD:10003103
NCBI chr 5:21,981,381...21,987,074
Ensembl chr 5:17,183,806...17,189,129
G
Pfkfb3
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16214533
NCBI chr17:71,893,320...71,974,526
Ensembl chr17:66,983,686...67,063,125
G
Pfkm
phosphofructokinase, muscle
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16214533
NCBI chr 7:131,100,684...131,138,250
Ensembl chr 7:129,221,653...129,259,192
G
Pgf
placental growth factor
ISO
RGD
PMID:18192038
RGD:6483613
NCBI chr 6:110,547,165...110,557,747
Ensembl chr 6:104,816,104...104,826,685
G
Pgm1
phosphoglucomutase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16214533
NCBI chr 5:119,710,734...119,770,159
Ensembl chr 5:114,595,293...114,654,728
G
Pla2g2a
phospholipase A2 group IIA
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16214533
NCBI chr 5:156,359,725...156,362,302
Ensembl chr 5:151,076,442...151,079,014
G
Plcd1
phospholipase C, delta 1
IEP
protein:decreased expression:heart
RGD
PMID:15276620
RGD:2300429
NCBI chr 8:127,672,955...127,695,939
Ensembl chr 8:118,795,201...118,818,186
G
Pomc
proopiomelanocortin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:10908253
NCBI chr 6:32,659,137...32,665,175
Ensembl chr 6:26,939,837...26,945,664
G
Ppat
phosphoribosyl pyrophosphate amidotransferase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16214533
NCBI chr14:31,570,010...31,604,410
Ensembl chr14:31,216,165...31,250,144
G
Ppm1b
protein phosphatase, Mg2+/Mn2+ dependent, 1B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16214533
NCBI chr 6:15,399,559...15,460,301
Ensembl chr 6:9,655,765...9,707,974
G
Ppp2ca
protein phosphatase 2 catalytic subunit alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16214533
NCBI chr10:36,856,534...36,878,789
Ensembl chr10:36,358,101...36,377,862
G
Ppp3r1
protein phosphatase 3, regulatory subunit B, alpha
IDA ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:16214533 PMID:16214533
RGD:1580707
NCBI chr14:95,758,333...95,808,015
Ensembl chr14:91,604,121...91,606,907
G
Prdx6
peroxiredoxin 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16214533
NCBI chr13:76,062,082...76,072,631
Ensembl chr13:73,528,210...73,539,355
G
Prkcd
protein kinase C, delta
IEP
mRNA, protein:increased expression, altered phosphorylation:heart
RGD
PMID:16924416
RGD:1642550
NCBI chr16:5,775,681...5,806,122
Ensembl chr16:5,769,215...5,799,352
G
Prkce
protein kinase C, epsilon
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16214533
NCBI chr 6:13,718,050...14,204,931
Ensembl chr 6:7,965,048...8,451,719
G
Psmb5
proteasome 20S subunit beta 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16214533
NCBI chr15:32,042,784...32,047,379
Ensembl chr15:28,072,781...28,077,440
G
Ptpra
protein tyrosine phosphatase, receptor type, A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16214533
NCBI chr 3:138,103,261...138,212,835
Ensembl chr 3:117,650,183...117,759,728
G
Pygb
glycogen phosphorylase B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16214533
NCBI chr 3:160,072,141...160,118,930
Ensembl chr 3:139,611,749...139,663,553
G
Pygm
glycogen phosphorylase, muscle associated
IDA
RGD
PMID:10498852
RGD:1599991
NCBI chr 1:213,119,805...213,134,622
Ensembl chr 1:203,690,533...203,705,368
G
Rab12
RAB12, member RAS oncogene family
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16214533
NCBI chr 9:113,927,119...113,953,722
Ensembl chr 9:106,480,301...106,506,910
G
Rab1b
RAB1B, member RAS oncogene family
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16214533
NCBI chr 1:211,835,133...211,843,408
Ensembl chr 1:202,405,759...202,413,868 Ensembl chr X:202,405,759...202,413,868
G
Rab5a
RAB5A, member RAS oncogene family
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16214533
NCBI chr 9:6,720,057...6,749,456
Ensembl chr 9:6,484,469...6,512,873
G
Rab7a
RAB7A, member RAS oncogene family
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16214533
NCBI chr 4:122,019,281...122,068,067
Ensembl chr 4:120,461,963...120,506,889
G
Ralbp1
ralA binding protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16214533
NCBI chr 9:112,903,289...112,940,093
Ensembl chr 9:105,456,425...105,492,707
G
Ramp2
receptor activity modifying protein 2
IEP
mRNA:increased expression:ventricle myocardium
RGD
PMID:16987513
RGD:1642684
NCBI chr10:86,689,148...86,690,956
Ensembl chr10:86,188,812...86,231,829
G
Rgcc
regulator of cell cycle
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16214533
NCBI chr15:61,071,574...61,084,408
Ensembl chr15:54,662,483...54,681,141
G
Rhoc
ras homolog family member C
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16214533
NCBI chr 2:194,975,586...194,981,637
Ensembl chr 2:192,287,130...192,295,306
G
Rln3
relaxin 3
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:16112403
NCBI chr19:24,107,401...24,109,432
Ensembl chr19:24,107,401...24,109,886
G
Rpl17
ribosomal protein L17
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16214533
NCBI chr18:70,856,275...70,859,388
Ensembl chr18:68,581,098...68,584,253 Ensembl chr 3:68,581,098...68,584,253
G
Rsad2
radical S-adenosyl methionine domain containing 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16214533
NCBI chr 6:48,774,985...48,788,245
Ensembl chr 6:43,047,658...43,059,699
G
RT1-A2
RT1 class Ia, locus A2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16214533
NCBI chr20:4,872,720...4,876,425
G
RT1-N3
RT1 class Ib, locus N3
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:16214533
NCBI chr20:2,666,469...2,670,355
Ensembl chr20:2,661,584...2,665,530
G
Rtn1
reticulon 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16214533
NCBI chr 6:90,763,212...90,983,436
Ensembl chr 6:90,763,216...90,983,436
G
Rxrg
retinoid X receptor gamma
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16214533
NCBI chr13:82,276,330...82,318,097
Ensembl chr13:79,743,563...79,785,167
G
Ryr2
ryanodine receptor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16214533
NCBI chr17:63,081,527...63,667,141
Ensembl chr17:58,389,925...58,975,142
G
S100a1
S100 calcium binding protein A1
ISO
protein:increased expression:serum (human)
RGD
PMID:10924368
RGD:1579977
NCBI chr 2:178,291,503...178,296,346
Ensembl chr 2:175,993,922...175,999,544
G
Sele
selectin E
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16214533
NCBI chr13:78,935,997...78,945,905
Ensembl chr13:76,403,304...76,412,741
G
Selp
selectin P
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16214533
NCBI chr13:79,009,379...79,044,994
Ensembl chr13:76,476,295...76,511,845
G
Serpina1
serpin family A member 1
ISO
associated with Aortic Aneurysm, Abdominal;DNA:polymorphism: :p.E342K (human)
RGD
PMID:10063411
RGD:1643148
NCBI chr 6:128,631,101...128,653,125
Ensembl chr 6:122,866,312...122,888,339
G
Serpinf1
serpin family F member 1
ISO
associated with chronic kidney disease;protein:increased expression:blood (human)
RGD
PMID:11045282
RGD:30296653
NCBI chr10:60,748,504...60,760,898
Ensembl chr10:60,249,708...60,262,646
G
Sfrp4
secreted frizzled-related protein 4
IEP
RGD
PMID:20528676
RGD:4107721
NCBI chr17:49,974,532...50,026,448
Ensembl chr17:45,234,097...45,330,736
G
Slc6a6
solute carrier family 6 member 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16214533
NCBI chr 4:125,752,340...125,826,033
Ensembl chr 4:124,195,218...124,268,875
G
Slc8a1
solute carrier family 8 member A1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16214533
NCBI chr 6:18,975,498...19,299,704
Ensembl chr 6:13,194,662...13,535,628
G
Slc9a1
solute carrier family 9 member A1
IDA
RGD
PMID:17356886
RGD:1625560
NCBI chr 5:150,859,412...150,913,525
Ensembl chr 5:145,576,334...145,629,624
G
Snap23
synaptosome associated protein 23
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16214533
NCBI chr 3:127,966,184...127,999,929
Ensembl chr 3:107,514,131...107,544,320
G
Socs3
suppressor of cytokine signaling 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16214533
NCBI chr10:103,692,579...103,695,975
Ensembl chr10:103,193,537...103,197,787
G
Sod2
superoxide dismutase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:16214533 PMID:15681709
RGD:1581233
NCBI chr 1:50,043,323...50,050,168
Ensembl chr 1:47,636,528...47,645,189
G
Sod3
superoxide dismutase 3
IDA ISO
ClinVar Annotator: match by term: Superoxide dismutase, elevated extracellular
ClinVar RGD
PMID:7662997 PMID:8034674 PMID:14662715 PMID:16840738
RGD:1580843
NCBI chr14:62,822,865...62,828,602
Ensembl chr14:58,609,958...58,615,990
G
Sox2
SRY-box transcription factor 2
IMP
RGD
PMID:34321385
RGD:155882552
NCBI chr 2:119,465,131...119,467,542
Ensembl chr 2:117,536,929...117,539,338
G
Sparc
secreted protein acidic and cysteine rich
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16214533
NCBI chr10:40,017,065...40,038,816
Ensembl chr10:39,516,406...39,538,396
G
Stat5a
signal transducer and activator of transcription 5A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15746188
NCBI chr10:86,285,859...86,310,187
Ensembl chr10:85,785,537...85,809,866
G
Sult1a1
sulfotransferase family 1A member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16214533
NCBI chr 1:190,702,592...190,706,112
Ensembl chr 1:181,272,023...181,275,562
G
Tap1
transporter 1, ATP binding cassette subfamily B member
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16214533
NCBI chr20:4,658,171...4,668,543
Ensembl chr20:4,656,263...4,666,901
G
Tcf7l2
transcription factor 7 like 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29394407
NCBI chr 1:264,791,335...264,984,225
Ensembl chr 1:254,786,091...254,978,967
G
Tfrc
transferrin receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16214533
NCBI chr11:81,668,478...81,690,318
Ensembl chr11:68,163,413...68,185,257
G
Tgoln2
trans-golgi network protein 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16214533
NCBI chr 4:106,221,503...106,229,360
Ensembl chr 4:104,663,353...104,671,164
G
Tle4
TLE family member 4, transcriptional corepressor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16214533
NCBI chr 1:211,661,738...211,798,458
Ensembl chr 1:211,661,746...211,797,862
G
Tle5
TLE family member 5, transcriptional modulator
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16214533
NCBI chr 7:8,794,123...8,801,056
Ensembl chr 7:8,143,357...8,150,113
G
Tmed2
transmembrane p24 trafficking protein 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16214533
NCBI chr12:37,713,522...37,722,606
Ensembl chr12:32,052,543...32,071,903
G
Tmpo
thymopoietin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16214533
NCBI chr 7:27,529,977...27,554,980
Ensembl chr 7:25,586,725...25,667,727
G
Tnf
tumor necrosis factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16214533 PMID:16775501
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,622,011...3,624,629
G
Tnnt2
troponin T2, cardiac type
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:10789933
NCBI chr13:49,819,123...49,837,125
Ensembl chr13:47,267,204...47,285,388
G
Ttn
titin
IDA
RGD
PMID:12221049
RGD:1580780
NCBI chr 3:82,059,648...82,332,130
Ensembl chr 3:61,652,439...61,924,741
G
Tuba1a
tubulin, alpha 1A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16214533
NCBI chr 7:131,992,151...131,996,850
Ensembl chr 7:130,081,032...130,196,186
G
Txnip
thioredoxin interacting protein
IDA
RGD
PMID:16172122
RGD:1580789
NCBI chr 2:186,781,933...186,785,736
Ensembl chr 2:184,092,991...184,096,886
G
Txnrd1
thioredoxin reductase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16214533
NCBI chr 7:22,717,620...22,802,553
Ensembl chr 7:20,830,045...20,907,863
G
Ugcg
UDP-glucose ceramide glucosyltransferase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16214533
NCBI chr 5:78,828,006...78,860,725
Ensembl chr 5:74,032,978...74,065,393
G
Uqcrfs1
ubiquinol-cytochrome c reductase, Rieske iron-sulfur polypeptide 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16214533
NCBI chr17:34,173,787...34,190,952
Ensembl chr17:33,977,921...33,982,479
G
Vcam1
vascular cell adhesion molecule 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16214533
NCBI chr 2:206,723,050...206,742,783
Ensembl chr 2:204,038,114...204,057,958
G
Vegfa
vascular endothelial growth factor A
ISO
CTD Direct Evidence: marker/mechanism|therapeutic
CTD
PMID:9860779 PMID:14503966 PMID:14583313 PMID:15347709 PMID:16214533
NCBI chr 9:22,452,854...22,468,194
Ensembl chr 9:14,955,300...14,970,641
G
Zeb1
zinc finger E-box binding homeobox 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16214533
NCBI chr17:56,644,397...56,811,155
Ensembl chr17:51,948,948...52,115,214
G
Zfp36
zinc finger protein 36
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16214533
NCBI chr 1:92,796,628...92,799,108
Ensembl chr 1:83,669,084...83,671,564
G
Abcc8
ATP binding cassette subfamily C member 8
ISO
RGD
PMID:18316485
RGD:2301903
NCBI chr 1:105,734,992...105,816,272
Ensembl chr 1:96,598,647...96,679,510
G
Acvr2b
activin A receptor type 2B
treatment
ISO
human construct in mouse model mRNA, protein:decreased expression:heart (mouse)
RGD
PMID:30765322 PMID:30765322
RGD:329849112 , RGD:329849112
NCBI chr 8:128,016,589...128,056,193
Ensembl chr 8:119,138,812...119,170,458
G
Ada
adenosine deaminase
IDA
protein:increased expression
RGD
PMID:16641873
RGD:1624305
NCBI chr 3:172,818,174...172,842,283
Ensembl chr 3:152,398,747...152,447,088
G
Adipoq
adiponectin, C1Q and collagen domain containing
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:16155579
NCBI chr11:91,226,524...91,240,244
Ensembl chr11:77,721,912...77,735,564
G
Adrb1
adrenoceptor beta 1
IMP ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:10900253 PMID:17201736
RGD:5129149
NCBI chr 1:265,777,103...265,780,114
Ensembl chr 1:255,771,597...255,807,259
G
Adrb2
adrenoceptor beta 2
IDA
RGD
PMID:16269402
RGD:1598746
NCBI chr18:57,912,760...57,914,802
Ensembl chr18:55,502,903...55,644,512
G
Ager
advanced glycosylation end product-specific receptor
IEP
protein:increased expression:heart (rat)
RGD
PMID:16505177
RGD:1625342
NCBI chr20:4,152,758...4,155,956
Ensembl chr20:4,147,890...4,151,078
G
Agl
amylo-alpha-1,6-glucosidase and 4-alpha-glucanotransferase
IMP
RGD
PMID:9281456
RGD:1598779
NCBI chr 2:207,389,949...207,445,959
Ensembl chr 2:204,705,053...204,760,828
G
Agt
angiotensinogen
ISO
CTD Direct Evidence: marker/mechanism|therapeutic
CTD
PMID:2535056 PMID:19166939
NCBI chr19:69,426,540...69,447,017
Ensembl chr19:52,529,185...52,540,977
G
Agtr1a
angiotensin II receptor, type 1a
IEP
protein:increased expression:myocardium
RGD
PMID:21078800
RGD:5129194
NCBI chr17:34,383,397...34,435,523
Ensembl chr17:34,174,429...34,226,946
G
Ahr
aryl hydrocarbon receptor
treatment
IMP
RGD
PMID:35788946
RGD:401793705
NCBI chr 6:57,961,423...57,998,901
Ensembl chr 6:52,234,089...52,271,568
G
Aifm1
apoptosis inducing factor, mitochondria associated 1
IEP ISO
protein:decreased expression:mitochondrion:
RGD
PMID:23685150 PMID:23685150
RGD:10053560 , RGD:10053560
NCBI chr X:132,528,107...132,567,237
Ensembl chr X:127,650,226...127,689,256
G
Akt1
AKT serine/threonine kinase 1
IDA
protein:increased phosphorylation:heart left ventricle
RGD
PMID:20217242
RGD:5509104
NCBI chr 6:137,534,810...137,555,131
Ensembl chr 6:131,713,720...131,733,921
G
Akt2
AKT serine/threonine kinase 2
IDA
RGD
PMID:16418318
RGD:2313347
NCBI chr 1:92,004,705...92,061,420
Ensembl chr 1:82,883,547...82,933,817
G
Alb
albumin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:9572063
NCBI chr14:17,891,564...17,907,043
Ensembl chr14:17,607,381...17,622,836
G
Aldh2
aldehyde dehydrogenase 2 family member
IDA
RGD
PMID:23468836
RGD:7241598
NCBI chr12:40,610,244...40,643,220
Ensembl chr12:34,901,219...34,982,521
G
Alox5
arachidonate 5-lipoxygenase
IMP
RGD
PMID:20011686
RGD:2317527
NCBI chr 4:151,203,948...151,251,126
Ensembl chr 4:149,531,515...149,578,743
G
Angpt2
angiopoietin 2
IEP
mRNA, protein:increased expression:myocardium (rat)
RGD
PMID:12737621
RGD:1601505
NCBI chr16:77,790,760...77,841,241
Ensembl chr16:71,088,364...71,138,804
G
Ank1
ankyrin 1
IDA
RGD
PMID:9378703
RGD:1599110
NCBI chr16:75,578,824...75,757,464
Ensembl chr16:68,877,504...69,054,759
G
Ank2
ankyrin 2
IDA
RGD
PMID:9378703
RGD:1599110
NCBI chr 2:218,052,555...218,628,414
Ensembl chr 2:215,379,680...215,862,923
G
Ankrd1
ankyrin repeat domain 1
IEP
protein:decreased expression:myocardium
RGD
PMID:19299913
RGD:5133278
NCBI chr 1:243,228,460...243,237,014
Ensembl chr 1:233,815,851...233,834,919
G
Anxa1
annexin A1
treatment
IEP ISO
protein:increased expression:heart, leukocyte
RGD
PMID:11641252 PMID:22924634 PMID:22924634
RGD:2306910 , RGD:7421655 , RGD:7421655
NCBI chr 1:227,287,713...227,306,739
Ensembl chr 1:217,861,175...217,877,343
G
Apex1
apurinic/apyrimidinic endodeoxyribonuclease 1
IEP
protein:altered localization:cytoplasm
RGD
PMID:17602955
RGD:2315672
NCBI chr15:26,618,146...26,620,330
Ensembl chr15:24,144,362...24,146,785
G
Arrb2
arrestin, beta 2
IEP
RGD
PMID:29016703
RGD:13506827
NCBI chr10:55,645,539...55,653,485
Ensembl chr10:55,146,818...55,154,850
G
Atf3
activating transcription factor 3
IEP
RGD
PMID:11485922
RGD:7327201
NCBI chr13:105,274,103...105,331,653
Ensembl chr13:102,751,321...102,764,631
G
Atp1a1
ATPase Na+/K+ transporting subunit alpha 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:29702141
NCBI chr 2:191,709,311...191,737,414
Ensembl chr 2:189,020,722...189,048,837
G
Atp2a1
ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 1
IMP
RGD
PMID:17630344
RGD:13782075
NCBI chr 1:190,457,198...190,475,410
Ensembl chr 1:181,026,608...181,044,838
G
Atp2a2
ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2
treatment
ISO IEP
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:10734148 PMID:28637456
RGD:13782080
NCBI chr12:39,733,519...39,782,942
Ensembl chr12:34,072,683...34,122,101
G
Atp5f1d
ATP synthase F1 subunit delta
treatment
IEP
protein:decreased expression:myocardium (rat)
RGD
PMID:26109848 PMID:25305180
RGD:13792666 , RGD:13792676
NCBI chr 7:10,211,260...10,218,989
Ensembl chr 7:9,560,608...9,565,929
G
Bad
BCL2-associated agonist of cell death
treatment
IEP IDA
protein:increased expression, decreased serine phosphorylation:heart
RGD
PMID:15339931 PMID:23364609
RGD:2292700 , RGD:10053674
NCBI chr 1:213,562,719...213,572,034
Ensembl chr 1:204,131,501...204,142,823
G
Bax
BCL2 associated X, apoptosis regulator
treatment
IEP ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:20026869 PMID:21223820 PMID:31583047 PMID:25547710
RGD:10054103 , RGD:155230831 , RGD:13782178
NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:95,938,808...95,945,368
G
Bcl2
BCL2, apoptosis regulator
treatment
IEP IDA
RGD
PMID:16289365 PMID:31583047 PMID:20821058 PMID:23364609
RGD:1599484 , RGD:155230831 , RGD:11561911 , RGD:10053674
NCBI chr13:23,204,464...23,366,900
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
Bcl2l1
Bcl2-like 1
treatment
IDA
RGD
PMID:12668130
RGD:11035287
NCBI chr 3:161,713,777...161,764,844
Ensembl chr 3:141,253,523...141,303,479 Ensembl chr 1:141,253,523...141,303,479
G
Becn1
beclin 1
treatment
IDA ISO
RGD
PMID:20821058 PMID:20812860
RGD:11561911 , RGD:11561944
NCBI chr10:86,731,649...86,747,002
Ensembl chr10:86,231,388...86,246,742
G
Bid
BH3 interacting domain death agonist
IDA IEP
protein:increased cleavage:heart:
RGD
PMID:19940077 PMID:11934844
RGD:2317561 , RGD:13782263
NCBI chr 4:155,785,366...155,808,775
Ensembl chr 4:154,113,198...154,134,720
G
Blk
BLK proto-oncogene, Src family tyrosine kinase
IEP
mRNA:increased expression:left ventricle (rat)
RGD
PMID:17562528
RGD:1642307
NCBI chr15:41,802,701...41,841,004
Ensembl chr15:37,627,039...37,665,031
G
Bnip3
BCL2 interacting protein 3
treatment
IMP IEP
protein:decreased expression:myocardium (human)
RGD
PMID:16645637 PMID:28661226
RGD:11561983 , RGD:155260328
NCBI chr 1:203,137,778...203,154,962
Ensembl chr 1:193,708,167...193,725,359
G
Brd4
bromodomain containing 4
ISO
mRNA,protein:increased expression:heart
RGD
PMID:33982231
RGD:155883171
NCBI chr 7:11,866,997...11,946,575
Ensembl chr 7:11,216,446...11,295,539
G
Btg2
BTG anti-proliferation factor 2
IEP
mRNA:increased expression:heart
RGD
PMID:12909328
RGD:2289075
NCBI chr13:48,083,931...48,087,690
Ensembl chr13:45,531,925...45,535,628
G
C3
complement C3
IEP
protein:increased expression:myocardium
RGD
PMID:11560858
RGD:1582136
NCBI chr 9:2,174,412...2,201,339
Ensembl chr 9:2,087,437...2,114,429
G
C5
complement C5
treatment
IDA IMP
RGD
PMID:9631876 PMID:23067403
RGD:1600666 , RGD:7411626
NCBI chr 3:38,668,174...38,759,468
Ensembl chr 3:18,270,696...18,361,994
G
Casp1
caspase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:14998631
NCBI chr 8:10,746,338...10,882,295
Ensembl chr 8:2,587,831...2,597,383
G
Casp12
caspase 12
treatment
IEP ISO
protein:increased activity:myocardium CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:14998631 PMID:19406177 PMID:25547710
RGD:2311458 , RGD:13782178
NCBI chr 8:10,927,188...10,954,442
Ensembl chr 8:2,642,434...2,674,037
G
Casp3
caspase 3
ameliorates treatment
IMP ISO IEP
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:14998631 PMID:18470603 PMID:30259997 PMID:29538428
RGD:2293314 , RGD:329337366 , RGD:13782276
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:45,662,910...45,684,648
G
Casp7
caspase 7
treatment
ISO IEP
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:14998631 PMID:29538428
RGD:13782276
NCBI chr 1:265,442,647...265,481,938
Ensembl chr 1:255,437,172...255,476,729
G
Casp8
caspase 8
ISO IEP
CTD Direct Evidence: marker/mechanism protein:increased activity:cardiomyocyte
CTD RGD
PMID:14998631 PMID:11934844
RGD:13782263
NCBI chr 9:67,747,109...67,806,699
Ensembl chr 9:60,264,075...60,312,542
G
Casp9
caspase 9
ameliorates treatment
ISO IEP
CTD Direct Evidence: marker/mechanism protein:increased activity:cardiomyocyte,endothelial cell
CTD RGD
PMID:14998631 PMID:30259997 PMID:29538428 PMID:11934844
RGD:329337366 , RGD:13782276 , RGD:13782263
Ensembl chr 5:154,109,046...154,126,626
G
Casr
calcium-sensing receptor
IEP
protein:increased expression:ventricular myocardium (rat)
RGD
PMID:21766206
RGD:7205698
NCBI chr11:77,738,398...77,813,639
Ensembl chr11:64,235,251...64,304,811
G
Cast
calpastatin
ameliorates
IEP ISO
human transcript overexpression in rat model
RGD
PMID:12482022 PMID:14519437
RGD:5683872 , RGD:405101692
NCBI chr 2:5,707,633...5,817,213
Ensembl chr 2:3,973,112...4,082,659
G
Cat
catalase
IEP ISO
CTD Direct Evidence: therapeutic
CTD RGD
PMID:21600015 PMID:11510883
RGD:1581149
NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:89,842,399...89,874,478
G
Cbl
Cbl proto-oncogene
severity
ISO
RGD
PMID:24583314
RGD:11251947
NCBI chr 8:53,384,656...53,468,067
Ensembl chr 8:44,489,410...44,571,176
G
Ccl2
C-C motif chemokine ligand 2
IEP ISO
mRNA:increased expression:heart (rat) CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:12087064 PMID:10908159
RGD:8549625
NCBI chr10:67,503,077...67,504,875
Ensembl chr10:67,005,424...67,007,226
G
Ccr2
C-C motif chemokine receptor 2
ISO
protein:decreased expression:monocyte:
RGD
PMID:15786508
RGD:4892017
NCBI chr 8:132,611,883...132,619,106
Ensembl chr 8:123,734,430...123,742,100
G
Ccr5
C-C motif chemokine receptor 5
treatment
ISO IEP
protein:decreased expression:blood, monocyte (human)
RGD
PMID:15786508 PMID:23456481
RGD:4892017 , RGD:8552227
NCBI chr 8:132,629,097...132,660,980
Ensembl chr 8:123,752,325...123,759,260
G
Cflar
CASP8 and FADD-like apoptosis regulator
treatment
IEP
RGD
PMID:18466417
RGD:11341714
NCBI chr 9:67,679,502...67,747,226
Ensembl chr 9:60,185,452...60,237,034
G
Cnr1
cannabinoid receptor 1
IMP
RGD
PMID:18771032
RGD:2316217
NCBI chr 5:53,204,867...53,230,396
Ensembl chr 5:48,408,574...48,435,099
G
Cnr2
cannabinoid receptor 2
IMP
RGD
PMID:17950273
RGD:2316224
NCBI chr 5:153,408,968...153,435,092
Ensembl chr 5:148,125,604...148,151,548
G
Cobll1
cordon-bleu WH2 repeat protein-like 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:34355838
NCBI chr 3:70,161,369...70,324,844
Ensembl chr 3:49,753,262...49,915,194
G
Crebbp
CREB binding protein
treatment
IEP
RGD
PMID:24338162
RGD:153352322
NCBI chr10:11,842,307...11,968,266
Ensembl chr10:11,335,953...11,461,888
G
Crp
C-reactive protein
IEP
protein:increased expression:serum
RGD
PMID:21122204
RGD:5128547
NCBI chr13:87,694,062...87,695,978
Ensembl chr13:85,124,977...85,175,178
G
Cx3cr1
C-X3-C motif chemokine receptor 1
ISO
protein:decreased expression:blood, monocyte
RGD
PMID:15786508
RGD:4892017
NCBI chr 8:128,661,294...128,679,048
Ensembl chr 8:119,782,595...119,800,014
G
Cxcl1
C-X-C motif chemokine ligand 1
IMP
RGD
PMID:11342480
RGD:5135269
NCBI chr14:17,477,542...17,479,321
Ensembl chr14:17,193,365...17,195,215
G
Cxcl2
C-X-C motif chemokine ligand 2
IMP
RGD
PMID:11342480
RGD:5135269
NCBI chr14:17,465,210...17,467,255
Ensembl chr14:17,181,062...17,183,075
G
Cxcl6
C-X-C motif chemokine ligand 6
IMP
RGD
PMID:11342480
RGD:5135269
NCBI chr14:17,594,959...17,596,417
Ensembl chr14:17,310,426...17,313,093
G
Cybb
cytochrome b-245 beta chain
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19207477
NCBI chr X:16,030,596...16,065,065
Ensembl chr X:13,359,430...13,392,586
G
Diablo
diablo, IAP-binding mitochondrial protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:14998631
NCBI chr12:38,716,668...38,731,285
Ensembl chr12:33,055,263...33,070,387
G
Dnm1l
dynamin 1-like
ameliorates
ISO
RGD
PMID:30259997
RGD:329337366
NCBI chr11:98,084,049...98,135,663
Ensembl chr11:84,581,216...84,631,482
G
Ece1
endothelin converting enzyme 1
IMP IEP
RGD
PMID:18586023 PMID:12193087
RGD:4892580 , RGD:7244160
NCBI chr 5:155,361,031...155,462,723
Ensembl chr 5:150,077,644...150,179,371
G
Edn1
endothelin 1
IEP ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:15642760 PMID:16700825 PMID:18586023
RGD:4892580
NCBI chr17:22,660,799...22,666,687
Ensembl chr17:22,454,420...22,460,885
G
Ednra
endothelin receptor type A
IMP
RGD
PMID:18586023
RGD:4892580
NCBI chr19:47,137,360...47,207,961
Ensembl chr19:30,233,571...30,297,049
G
Ednrb
endothelin receptor type B
IMP
RGD
PMID:21048781
RGD:4892332
NCBI chr15:87,055,490...87,086,765
Ensembl chr15:80,643,043...80,672,115
G
Egln1
egl-9 family hypoxia-inducible factor 1
susceptibility
ISO
RGD
PMID:20185832
RGD:11251775
NCBI chr19:69,765,276...69,804,681
Ensembl chr19:52,869,486...52,907,777
G
Ephx2
epoxide hydrolase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19834332
NCBI chr15:44,465,447...44,503,157
Ensembl chr15:40,289,902...40,327,615
G
Esr1
estrogen receptor 1
IMP
RGD
PMID:18314151
RGD:4892299
NCBI chr 1:43,511,685...43,904,454
Ensembl chr 1:41,210,475...41,495,002
G
Esr2
estrogen receptor 2
ISO
RGD
PMID:18656630
RGD:5508820
NCBI chr 6:100,589,553...100,645,240
Ensembl chr 6:94,809,547...94,908,919
G
Fadd
Fas associated via death domain
treatment
ISO IEP
RGD
PMID:26038570 PMID:26948086
RGD:11341801 , RGD:13792504
NCBI chr 1:209,169,245...209,175,423
Ensembl chr 1:199,739,994...199,745,653
G
Fas
Fas cell surface death receptor
treatment
IDA
RGD
PMID:21316771
RGD:8686424
NCBI chr 1:241,212,155...241,245,774
Ensembl chr 1:231,798,960...231,832,591
G
Fis1
fission, mitochondrial 1
ameliorates
ISO
RGD
PMID:30259997
RGD:329337366
NCBI chr12:25,345,239...25,360,135
Ensembl chr12:19,708,558...19,723,377
G
Gapdh
glyceraldehyde-3-phosphate dehydrogenase
treatment
IEP
RGD
PMID:27129213
RGD:11574725
NCBI chr 4:159,648,592...159,653,436
Ensembl chr 4:157,962,343...157,966,235
G
Gcg
glucagon
treatment
ISO
RGD
PMID:24125539
RGD:10402369
NCBI chr 3:67,522,489...67,531,533
Ensembl chr 3:47,113,914...47,122,929
G
Gdf11
growth differentiation factor 11
ISO
mRNA, protein:decreased expression:heart (mouse)
RGD
PMID:30765322
RGD:329849112
NCBI chr 7:1,896,229...1,909,147
Ensembl chr 7:1,311,732...1,320,725
G
Gja1
gap junction protein, alpha 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17445419
NCBI chr20:36,302,490...36,315,010
Ensembl chr20:35,755,991...35,768,582
G
Glrx
glutaredoxin
IEP
mRNA:decreased expression:heart:
RGD
PMID:18163565
RGD:2306160
NCBI chr 2:7,073,737...7,083,548
Ensembl chr 2:5,341,885...5,351,680
G
Gpx3
glutathione peroxidase 3
ISO
RGD
PMID:11043918
RGD:401827843
NCBI chr10:39,529,335...39,537,406
Ensembl chr10:39,028,570...39,037,035
G
Grk2
G protein-coupled receptor kinase 2
treatment severity susceptibility
IMP ISO IDA
associated with Diabetes Mellitus, Experimental protein:increased expression:heart, mitochondrion (mouse) associated with Hypertension
RGD
PMID:27865836 PMID:23467820 PMID:24170934 PMID:27296507 PMID:27601479
RGD:13513990 , RGD:13792779 , RGD:13792704 , RGD:13513995 , RGD:13513993
NCBI chr 1:211,010,259...211,031,013
Ensembl chr 1:201,581,480...201,601,582
G
Gsk3b
glycogen synthase kinase 3 beta
treatment
IDA IEP
RGD
PMID:20217242 PMID:26918336 PMID:29978610
RGD:5509104 , RGD:13792772 , RGD:13792725
NCBI chr11:76,004,502...76,154,665
Ensembl chr11:62,504,316...62,648,646
G
Gsr
glutathione-disulfide reductase
treatment
IEP
RGD
PMID:24769323
RGD:10401892
NCBI chr16:65,185,574...65,228,742
Ensembl chr16:58,482,505...58,525,661
G
H19
H19 imprinted maternally expressed transcript
ameliorates
ISO
RGD
PMID:31284127
RGD:158013771
NCBI chr 1:207,160,175...207,162,851
Ensembl chr 1:197,730,698...197,733,134
G
H2ax
H2A.X variant histone
treatment
IDA
RGD
PMID:23108649
RGD:8693739
NCBI chr 8:53,568,718...53,570,072
Ensembl chr 8:44,671,786...44,673,239 Ensembl chr 4:44,671,786...44,673,239
G
Hdac3
histone deacetylase 3
ameliorates
ISO
RGD
PMID:33982231
RGD:155883171
NCBI chr18:30,021,847...30,041,061
Ensembl chr18:29,770,636...29,793,856
G
Hif1a
hypoxia inducible factor 1 subunit alpha
treatment
IEP ISO IDA
mRNA:increased expression:heart CTD Direct Evidence: marker/mechanism protein:increased expression:myocardium
CTD RGD
PMID:18549825 PMID:22050707 PMID:12189448 PMID:20170615 PMID:19727523
RGD:1626327 , RGD:9068872 , RGD:5147885
NCBI chr 6:98,357,788...98,405,068
Ensembl chr 6:92,624,390...92,669,261
G
Hmgb1
high mobility group box 1
treatment
IEP ISO IDA
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:21113057 PMID:23531454 PMID:19540007
RGD:10402066 , RGD:10402170
NCBI chr12:11,009,236...11,015,941
Ensembl chr12:5,901,586...5,978,565 Ensembl chr16:5,901,586...5,978,565
G
Hmox1
heme oxygenase 1
treatment
IDA ISO IEP
RGD
PMID:12709584 PMID:23921302 PMID:22179023
RGD:1598392 , RGD:10755585 , RGD:10755573
NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,467,244...13,474,079
G
Hrh2
histamine receptor H 2
susceptibility
ISO
RGD
PMID:23467745
RGD:9685524
NCBI chr17:10,371,083...10,412,979
Ensembl chr17:10,368,298...10,407,631
G
Hrh3
histamine receptor H3
IDA
RGD
PMID:15076218
RGD:1626433
NCBI chr 3:187,569,174...187,575,263
Ensembl chr 3:167,191,558...167,196,642
G
Hsf1
heat shock transcription factor 1
ISO
RGD
PMID:22426029
RGD:10402789
NCBI chr 7:110,076,710...110,103,665
Ensembl chr 7:108,196,056...108,223,011
G
Hspa1a
heat shock protein family A (Hsp70) member 1A
treatment
IEP
RGD
PMID:20501665
RGD:10003160
NCBI chr20:3,875,411...3,877,866
Ensembl chr20:3,856,006...3,873,227
G
Hspa5
heat shock protein family A (Hsp70) member 5
treatment
IEP
RGD
PMID:24129401 PMID:25547710
RGD:11354962 , RGD:13782178
NCBI chr 3:38,453,016...38,457,475
Ensembl chr 3:18,055,405...18,059,891
G
Htra2
HtrA serine peptidase 2
ISO
protein:increased expression:myocardium, cytosol (mouse)
RGD
PMID:15611365
RGD:5688376
NCBI chr 4:117,114,631...117,117,793
Ensembl chr 4:115,556,916...115,560,095
G
Icam1
intercellular adhesion molecule 1
IEP ISO
protein:increased expression:heart (rat) CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:12087064 PMID:20851484
RGD:4145348
NCBI chr 8:27,829,688...27,841,618
Ensembl chr 8:19,553,645...19,565,438
G
Il10
interleukin 10
treatment
IEP IDA
protein:increased expression:plasma
RGD
PMID:19275881 PMID:23840272
RGD:2311056 , RGD:7365001
NCBI chr13:45,024,921...45,029,586
Ensembl chr13:42,472,839...42,477,313
G
Il17a
interleukin 17A
treatment
IMP
RGD
PMID:22030025
RGD:9068944
NCBI chr 9:30,640,844...30,644,331
Ensembl chr 9:23,144,402...23,147,889
G
Il18
interleukin 18
ISO IDA
RGD
PMID:19164288 PMID:19805173
RGD:4889578 , RGD:4889400
NCBI chr 8:59,802,072...59,829,275
Ensembl chr 8:50,906,960...50,932,887
G
Il18bp
interleukin 18 binding protein
ISO
mRNA:increased expression:heart
RGD
PMID:19164288 PMID:19805173
RGD:4889578 , RGD:4889400
NCBI chr 1:165,784,916...165,787,990
Ensembl chr 1:156,372,883...156,374,963
G
Il18rap
interleukin 18 receptor accessory protein
ISO
RGD
PMID:19164288
RGD:4889578
NCBI chr 9:50,263,723...50,296,583
Ensembl chr 9:42,768,220...42,800,959
G
Il1a
interleukin 1 alpha
treatment
ISO IEP
RGD
PMID:8576926 PMID:7622355
RGD:7794741 , RGD:7794764
NCBI chr 3:136,979,804...136,990,236
Ensembl chr 3:116,526,604...116,536,822
G
Il1b
interleukin 1 beta
treatment
IEP
mRNA:increased expression:heart
RGD
PMID:17134725 PMID:31583047
RGD:1626628 , RGD:155230831
NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:116,577,010...116,583,415
G
Il1rl2
interleukin 1 receptor-like 2
IMP
compared to Wild Type in cardiopulmonary bypass model
RGD
PMID:32048631
RGD:126925167
NCBI chr 9:50,087,271...50,134,225
Ensembl chr 9:42,591,934...42,636,667
G
Il1rl2tm1(Myh6-cre)Mhzh
interleukin 1 receptor-like 2; tm1 (Myh6-cre), Mhzh
IMP
compared to Wild Type in cardiopulmonary bypass model
RGD
PMID:32048631
RGD:126925167
G
Il1rn
interleukin 1 receptor antagonist
ISO
rat model treated with human protein
RGD
PMID:22649318
RGD:7174360
NCBI chr 3:27,509,836...27,525,738
Ensembl chr 3:7,111,550...7,127,445
G
Il36rn
interleukin 36 receptor antagonist
IMP
RGD
PMID:32048631
RGD:126925167
NCBI chr 3:27,442,679...27,449,306
Ensembl chr 3:7,044,406...7,051,016
G
Il36rntm1(Myh6-cre)Mhzh
interleukin 36 receptor antagonist; tm1, Mhzh
IMP
RGD
PMID:32048631
RGD:126925167
G
Il6
interleukin 6
treatment
IDA IEP
RGD
PMID:27087891 PMID:31583047
RGD:11062149 , RGD:155230831
NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,213,394...5,219,178
G
Il6r
interleukin 6 receptor
ISO
RGD
PMID:16056242
RGD:1625435
NCBI chr 2:177,582,020...177,646,705
Ensembl chr 2:175,298,686...175,347,536
G
Inhba
inhibin subunit beta A
ISO
mRNA, protein:increased expression:heart (mouse)
RGD
PMID:30765322
RGD:329849112
NCBI chr17:53,787,159...53,810,942
Ensembl chr17:49,095,920...49,108,982
G
Irak1
interleukin-1 receptor-associated kinase 1
IEP
protein:increased activity:ventricle myocardium (rat)
RGD
PMID:15793310
RGD:1579809
NCBI chr X:156,919,927...156,929,825
Ensembl chr X:151,768,777...151,778,521
G
Irf9
interferon regulatory factor 9
exacerbates ameliorates
ISO
protein:increased expression:left ventricular free wall
RGD
PMID:25150882 PMID:25150882 PMID:25150882
RGD:125093742 , RGD:125093742 , RGD:125093742
NCBI chr15:33,065,422...33,071,881
Ensembl chr15:29,095,789...29,101,236
G
Jak2
Janus kinase 2
treatment
IMP
associated with Diabetes Mellitus, Experimental
RGD
PMID:23796350 PMID:23747931
RGD:8694332 , RGD:10403071
NCBI chr 1:236,408,905...236,468,769
Ensembl chr 1:226,995,334...227,054,189
G
Kcnj11
potassium inwardly-rectifying channel, subfamily J, member 11
ISO
RGD
PMID:17906066
RGD:7297046
NCBI chr 1:105,727,473...105,731,167
Ensembl chr 1:96,591,049...96,594,082
G
Kcnj8
potassium inwardly-rectifying channel, subfamily J, member 8
IDA
RGD
PMID:12234964
RGD:729109
NCBI chr 4:177,240,692...177,246,548
Ensembl chr 4:175,508,912...175,515,603
G
Klrk1
killer cell lectin like receptor K1
treatment
IMP
RGD
PMID:23953572
RGD:9685183
NCBI chr 4:164,767,377...164,778,453
Ensembl chr 4:163,081,927...163,092,459
G
Kng1
kininogen 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:2535056 PMID:7856280
NCBI chr11:91,317,354...91,340,148
Ensembl chr11:77,812,752...77,835,555
G
Lep
leptin
IEP
RGD
PMID:21122204
RGD:5128547
NCBI chr 4:58,626,529...58,640,663
Ensembl chr 4:57,661,131...57,675,262
G
Lepr
leptin receptor
IEP
mRNA:decreased expression:heart mRNA:altered expression:heart
RGD
PMID:15284063 PMID:17134725
RGD:5129123 , RGD:1626628
NCBI chr 5:121,409,735...121,593,201
Ensembl chr 5:116,289,823...116,475,908
G
Lum
lumican
IDA
RGD
PMID:11348051
RGD:1582122
NCBI chr 7:34,245,323...34,252,510
Ensembl chr 7:32,358,614...32,365,793
G
Map1lc3a
microtubule-associated protein 1 light chain 3 alpha
treatment
IEP ISO
protein:increased expression:heart
RGD
PMID:20821058 PMID:20812860
RGD:11561911 , RGD:11561944
NCBI chr 3:164,243,204...164,244,850
Ensembl chr 3:143,783,024...143,784,670
G
Map2k6
mitogen-activated protein kinase kinase 6
ISO
RGD
PMID:14749328 PMID:15492008
RGD:7495840 , RGD:1582277
NCBI chr10:95,872,747...95,987,747
Ensembl chr10:95,373,204...95,488,293
G
Map3k5
mitogen-activated protein kinase kinase kinase 5
treatment
IEP
RGD
PMID:31583047
RGD:155230831
NCBI chr 1:16,505,387...16,723,899
Ensembl chr 1:14,685,492...14,904,800
G
Mapk1
mitogen activated protein kinase 1
treatment
IDA
RGD
PMID:15653762 PMID:25345742
RGD:1582282 , RGD:13800900
NCBI chr11:97,462,025...97,529,193
Ensembl chr11:83,957,813...84,023,616
G
Mapk14
mitogen activated protein kinase 14
ISO
RGD
PMID:14749328
RGD:7495840
NCBI chr20:6,751,288...6,812,294
Ensembl chr20:6,749,670...6,810,589
G
Mapk3
mitogen activated protein kinase 3
treatment
IEP IDA
RGD
PMID:29741915 PMID:25345742 PMID:28814571
RGD:13800564 , RGD:13800900 , RGD:13800874
NCBI chr 1:190,797,189...190,803,411
Ensembl chr 1:181,366,637...181,372,863
G
Mapk8
mitogen-activated protein kinase 8
treatment
IDA IEP
RGD
PMID:15309413 PMID:31583047 PMID:12883833
RGD:1582311 , RGD:155230831 , RGD:1582312
NCBI chr16:8,645,171...8,728,225
Ensembl chr16:8,638,924...8,721,981
G
Mb
myoglobin
treatment
ISO IEP IDA
RGD
PMID:15132981 PMID:31455109 PMID:11972171
RGD:1582385 , RGD:487982219 , RGD:1582431
NCBI chr 7:110,640,511...110,647,742
Ensembl chr 7:108,759,904...108,767,383
G
Mbl1
mannose binding lectin 1
IDA IMP ISO
RGD
PMID:11560858 PMID:20216929 PMID:15972690
RGD:1582136 , RGD:4889154 , RGD:1582131
NCBI chr16:17,063,232...17,069,271
Ensembl chr16:17,029,118...17,035,174
G
Mbl2
mannose binding lectin 2
treatment
ISO
RGD
PMID:25482922
RGD:11530049
NCBI chr 1:237,429,873...237,465,567
G
Mdm2
MDM2 proto-oncogene
IEP
protein:increased serine phosphorylation:heart ventricle (rat)
RGD
PMID:14644432
RGD:2317401
NCBI chr 7:55,176,558...55,201,757
Ensembl chr 7:53,290,664...53,314,915
G
Mfn2
mitofusin 2
treatment
IEP
RGD
PMID:24721408
RGD:13204835
NCBI chr 5:163,587,463...163,617,363
Ensembl chr 5:158,304,287...158,335,342
G
Mir1
microRNA 1
treatment
IMP
RGD
PMID:29741915
RGD:13800564
NCBI chr18:2,160,327...2,160,413
G
Mir10a
microRNA 10a
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22050707
NCBI chr10:81,779,709...81,779,818
Ensembl chr10:81,283,171...81,283,280
G
Mir10b
microRNA 10b
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22050707
NCBI chr 3:80,035,859...80,035,967
Ensembl chr 3:59,628,438...59,628,546
G
Mir126a
microRNA 126a
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22050707
NCBI chr 3:29,813,150...29,813,267
Ensembl chr 3:9,415,063...9,415,180
G
Mir134
microRNA 134
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22050707
NCBI chr 6:134,570,313...134,570,385
G
Mir137
microRNA 137
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22050707
NCBI chr 2:209,165,709...209,165,810
Ensembl chr 2:206,480,884...206,480,985
G
Mir140
microRNA 140
exacerbates
ISO
miRNA:increased expression:heart, endothelial cells (mouse)
RGD
PMID:30259997 PMID:31792649
RGD:329337366 , RGD:329337374
NCBI chr19:52,375,293...52,375,391
Ensembl chr19:35,465,577...35,465,675
G
Mir142
microRNA 142
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22050707
NCBI chr10:73,055,104...73,055,190
Ensembl chr10:72,557,857...72,557,967
G
Mir145
microRNA 145
treatment
IEP
RNA:decreased expression:heart
RGD
PMID:31583047 PMID:33658472
RGD:155230831 , RGD:329955358
NCBI chr18:57,369,983...57,370,070
Ensembl chr18:55,099,640...55,099,727
G
Mir146b
microRNA 146b
IEP
miRNA:increased expression:heart (rat)
RGD
PMID:19380620
RGD:155882541
NCBI chr 1:255,144,860...255,144,947
Ensembl chr 1:245,203,438...245,203,525
G
Mir181c
microRNA 181c
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22050707
NCBI chr19:40,888,291...40,888,396
Ensembl chr19:23,983,523...23,983,628
G
Mir183
microRNA 183
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22050707
NCBI chr 4:59,756,044...59,756,153
Ensembl chr 4:58,788,614...58,788,723
G
Mir186
microRNA 186
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22050707
NCBI chr 2:249,241,650...249,241,735
Ensembl chr 2:246,582,806...246,582,891
G
Mir188
microRNA 188
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22050707
NCBI chr X:17,919,585...17,919,664
Ensembl chr X:15,247,715...15,247,794
G
Mir193a
microRNA 193a
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22050707
NCBI chr10:65,170,306...65,170,417
Ensembl chr10:64,672,343...64,672,454
G
Mir196b
microRNA 196b
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22050707
NCBI chr 4:82,661,101...82,661,185
Ensembl chr 4:81,330,487...81,330,571
G
Mir206
microRNA 206
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22050707
NCBI chr 9:30,590,697...30,590,780
Ensembl chr 9:23,094,249...23,094,332
G
Mir20b
microRNA 20b
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22050707
NCBI chr X:137,343,197...137,343,268
Ensembl chr X:132,422,211...132,422,282
G
Mir21
microRNA 21
exacerbates
ISO IEP
CTD Direct Evidence: marker/mechanism miRNA:increased expression:heart (rat)
CTD RGD
PMID:22050707 PMID:19380620 PMID:24825878
RGD:155882541 , RGD:41404665
NCBI chr10:71,902,600...71,902,691
Ensembl chr10:71,405,257...71,405,348
G
Mir210
microRNA 210
sexual_dimorphism
IEP ISO
miRNA:increased expression:myocardium (human)
RGD
PMID:28661226 PMID:35296158
RGD:155260328 , RGD:155663666
NCBI chr 1:205,755,923...205,756,032
Ensembl chr 1:196,326,337...196,326,454
G
Mir222
microRNA 222
ameliorates
ISO
RGD
PMID:25863248
RGD:152025190
NCBI chr X:6,022,621...6,022,723
Ensembl chr X:3,428,904...3,429,006
G
Mir23b
microRNA 23b
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22050707
NCBI chr17:1,819,386...1,819,482
Ensembl chr17:1,813,667...1,813,763
G
Mir26a
microRNA 26a
treatment
IEP
RGD
PMID:29978610
RGD:13792725
NCBI chr 8:127,633,048...127,633,137
Ensembl chr 8:118,755,289...118,755,378
G
Mir27a
microRNA 27a
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22050707
NCBI chr19:40,859,603...40,859,689
Ensembl chr19:23,954,831...23,954,917
G
Mir27b
microRNA 27b
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22050707
NCBI chr17:1,819,147...1,819,243
Ensembl chr17:1,813,426...1,813,529
G
Mir28
microRNA 28
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22050707
NCBI chr11:89,480,252...89,480,337
Ensembl chr11:75,975,523...75,975,608
G
Mir296
microRNA 296
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22050707
NCBI chr 3:183,470,069...183,470,146
Ensembl chr 3:163,051,838...163,051,915
G
Mir301b
microRNA 301b
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22050707
NCBI chr11:97,384,033...97,384,110
Ensembl chr11:83,879,816...83,879,893
G
Mir30a
microRNA 30a
treatment
IEP
RGD
PMID:25137026
RGD:35673319
NCBI chr 9:33,233,941...33,234,011
Ensembl chr 9:25,737,600...25,737,670
G
Mir30c1
microRNA 30c-1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:34217758
NCBI chr 5:139,634,455...139,634,543
Ensembl chr 5:134,349,237...134,349,325
G
Mir320a
microRNA 320a
treatment ameliorates
IMP ISO
RGD
PMID:27175593 PMID:25268616 PMID:30840298 PMID:19380620
RGD:155882540 , RGD:155882578 , RGD:155882546 , RGD:155882541
NCBI chr15:51,926,088...51,926,169
Ensembl chr15:45,516,392...45,516,473
G
Mir330
microRNA 330
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22050707
NCBI chr 1:87,961,207...87,961,303
Ensembl chr 1:78,833,178...78,833,274
G
Mir331
microRNA 331
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22050707
NCBI chr 7:30,414,386...30,414,481
Ensembl chr 7:28,527,390...28,527,485
G
Mir337
microRNA 337
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22050707
NCBI chr 6:134,321,142...134,321,238
Ensembl chr 6:128,538,902...128,538,998
G
Mir346
microRNA 346
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22050707
NCBI chr16:10,224,300...10,224,397
Ensembl chr16:10,218,118...10,218,215
G
Mir34c
microRNA 34c
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22050707
NCBI chr 8:60,306,091...60,306,167
Ensembl chr 8:51,409,726...51,409,802
G
Mir361
microRNA 361
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22050707
NCBI chr X:82,438,463...82,438,532
Ensembl chr X:78,246,206...78,246,275
G
Mir375
microRNA 375
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22050707
NCBI chr 9:83,906,582...83,906,656
Ensembl chr 9:76,457,911...76,457,985
G
Mir411
microRNA 411
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22050707
NCBI chr 6:134,544,594...134,544,669
Ensembl chr 6:128,723,184...128,723,279
G
Mir429
microRNA 429
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22050707
NCBI chr 5:171,929,682...171,929,766
Ensembl chr 5:166,647,459...166,647,543
G
Mir433
microRNA 433
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22050707
NCBI chr 6:134,327,358...134,327,450
Ensembl chr 6:128,545,112...128,545,217
G
Mir451a
microRNA 451a
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22050707
NCBI chr10:63,459,569...63,459,640
Ensembl chr10:62,961,520...62,961,591
G
Mir494
microRNA 494
ameliorates
ISO
RGD
PMID:33982231 PMID:20837890 PMID:20837890
RGD:155883171 , RGD:155883174 , RGD:155883174
NCBI chr 6:134,550,115...134,550,197
Ensembl chr 6:128,728,709...128,728,793
G
Mir500
microRNA 500
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22050707
NCBI chr X:17,930,647...17,930,726
Ensembl chr X:15,258,768...15,258,859
G
Mir503
microRNA 503
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22050707
NCBI chr X:137,725,856...137,725,926
Ensembl chr X:132,806,303...132,806,373
G
Mir532
microRNA 532
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22050707
NCBI chr X:17,919,185...17,919,263
Ensembl chr X:15,247,315...15,247,393
G
Mir542
microRNA 542
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22050707
NCBI chr X:137,722,176...137,722,254
Ensembl chr X:132,802,623...132,802,701
G
Mir582
microRNA 582
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22050707
NCBI chr 2:42,661,954...42,662,034
Ensembl chr 2:40,928,571...40,928,651
G
Mir598
microRNA 598
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22050707
NCBI chr15:42,138,609...42,138,687
Ensembl chr15:37,962,692...37,962,771
G
Mir743a
microRNA 743a
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:22050707
NCBI chr X:150,444,088...150,444,163
Ensembl chr X:145,402,692...145,402,767
G
Mirlet7i
microRNA let-7i
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22050707
NCBI chr 7:60,527,877...60,527,961
Ensembl chr 7:58,642,480...58,642,571
G
Mki67
marker of proliferation Ki-67
IDA
RGD
PMID:22405128
RGD:6483543
NCBI chr 1:199,926,150...199,952,847
Ensembl chr 1:190,496,319...190,522,762
G
Mmp1
matrix metallopeptidase 1
ISO IEP
RGD
PMID:12892382 PMID:17996137
RGD:1582539 , RGD:7207397
NCBI chr 8:12,943,453...12,963,966
Ensembl chr 8:4,658,588...4,679,097
G
Mmp2
matrix metallopeptidase 2
treatment
ISO IEP
RGD
PMID:16699069 PMID:23889688
RGD:1582614 , RGD:8657084
NCBI chr19:30,327,643...30,355,856
Ensembl chr19:14,154,657...14,182,870
G
Mstn
myostatin
ISO
mRNA, protein:increased expression:heart (mouse)
RGD
PMID:30765322
RGD:329849112
NCBI chr 9:55,944,513...55,950,913
Ensembl chr 9:48,452,533...48,458,933
G
Myd88
MYD88, innate immune signal transduction adaptor
IDA
RGD
PMID:14962484
RGD:1302746
NCBI chr 8:127,952,161...127,956,230
Ensembl chr 8:119,074,437...119,079,415
G
Ncl
nucleolin
IEP
protein:decreased expression:heart
RGD
PMID:23594402
RGD:9686384
NCBI chr 9:94,447,559...94,456,083
Ensembl chr 9:86,998,019...87,008,136
G
Ndufs1
NADH:ubiquinone oxidoreductase core subunit S1
treatment
IDA
RGD
PMID:21700931
RGD:13801200
NCBI chr 9:72,040,286...72,073,605
Ensembl chr 9:64,546,225...64,579,893
G
Nfe2l1
NFE2 like bZIP transcription factor 1
treatment
IEP
RGD
PMID:20501665
RGD:10003160
NCBI chr10:82,296,824...82,309,472
Ensembl chr10:81,800,366...81,832,318
G
Nfe2l2
NFE2 like bZIP transcription factor 2
ISO
RGD
PMID:24915518
RGD:10412738
NCBI chr 3:81,001,529...81,031,165
Ensembl chr 3:60,594,242...60,621,737
G
Nfkbia
NFKB inhibitor alpha
treatment
IDA
RGD
PMID:19304943
RGD:10413871
NCBI chr 6:78,593,844...78,597,307
Ensembl chr 6:72,858,712...72,861,941
G
Nos2
nitric oxide synthase 2
IEP ISO
mRNA:decreased expression:heart (rat) CTD Direct Evidence: marker/mechanism|therapeutic
CTD RGD
PMID:12003803 PMID:12087064 PMID:14990356 PMID:19207477 PMID:20828608 PMID:21844074 More...
RGD:5509098
NCBI chr10:64,313,335...64,349,221
Ensembl chr10:63,815,308...63,851,210
G
Nos3
nitric oxide synthase 3
treatment
IEP IDA ISO IMP
CTD Direct Evidence: therapeutic
CTD RGD
PMID:12354446 PMID:20828747 PMID:29274587 PMID:29299201 PMID:18390819
RGD:4891991 , RGD:13504684 , RGD:13503347 , RGD:2292091
NCBI chr 4:11,686,088...11,706,604
Ensembl chr 4:10,793,834...10,814,166
G
Nox1
NADPH oxidase 1
IEP
mRNA:increased expression:heart
RGD
PMID:33658472
RGD:329955358
NCBI chr X:101,572,338...101,625,571
Ensembl chr X:97,279,056...97,302,236
G
Nppb
natriuretic peptide B
IDA
RGD
PMID:21168723
RGD:5685663
NCBI chr 5:163,699,955...163,701,314
Ensembl chr 5:158,416,866...158,418,168
G
Nppc
natriuretic peptide C
IDA
RGD
PMID:15337698
RGD:1580149
NCBI chr 9:94,767,986...94,772,186
Ensembl chr 9:87,320,051...87,324,251
G
Npr3
natriuretic peptide receptor 3
IDA
RGD
PMID:15337698
RGD:1580149
NCBI chr 2:62,592,557...62,660,497
Ensembl chr 2:60,870,594...60,932,955
G
Npy1r
neuropeptide Y receptor Y1
IEP
mRNA:decreased expression:heart left ventricle
RGD
PMID:17562528
RGD:1642307
NCBI chr16:27,804,416...27,814,070
Ensembl chr16:23,037,789...23,046,759
G
Olr1
oxidized low density lipoprotein receptor 1
treatment
IMP
RGD
PMID:12384456
RGD:628368
NCBI chr 4:164,612,460...164,635,082
Ensembl chr 4:162,926,439...162,948,523
G
Oprd1
opioid receptor, delta 1
IDA
RGD
PMID:12136724
RGD:2316590
NCBI chr 5:149,590,244...149,624,999
Ensembl chr 5:144,306,188...144,340,960
G
Oxt
oxytocin/neurophysin I prepropeptide
IMP
RGD
PMID:19234577
RGD:2304087
NCBI chr 3:138,235,754...138,236,594
Ensembl chr 3:117,782,650...117,783,490
G
P2ry12
purinergic receptor P2Y12
ISO
RGD
PMID:20431845
RGD:6480645
NCBI chr 2:145,631,487...145,673,194
Ensembl chr 2:143,481,430...143,523,361
G
Parp1
poly (ADP-ribose) polymerase 1
ISO
RGD
PMID:9670921 PMID:23598272
RGD:5683917 , RGD:11073735
NCBI chr13:94,839,484...94,871,295
Ensembl chr13:92,307,586...92,339,404
G
Pawr
pro-apoptotic WT1 regulator
treatment
IMP
RGD
PMID:18055876
RGD:9835369
NCBI chr 7:45,531,480...45,611,492
Ensembl chr 7:43,645,084...43,725,028
G
Pdia3
protein disulfide isomerase family A, member 3
IEP
RGD
PMID:12872233
RGD:1624250
NCBI chr 3:128,841,781...128,865,733
Ensembl chr 3:108,388,245...108,413,236
G
Pecam1
platelet and endothelial cell adhesion molecule 1
IMP
RGD
PMID:8989147
RGD:2311662
NCBI chr10:92,090,263...92,152,002
Ensembl chr10:91,590,521...91,652,116
G
Phlda3
pleckstrin homology-like domain, family A, member 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:34351043
NCBI chr13:49,745,003...49,748,088
Ensembl chr13:47,193,086...47,196,335
G
Pik3cg
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma
ISO
RGD
PMID:20179753
RGD:6482687
NCBI chr 6:54,494,247...54,529,563
Ensembl chr 6:48,766,864...48,802,043
G
Plcd1
phospholipase C, delta 1
IDA
protein:altered activity
RGD
PMID:12623065
RGD:1304368
NCBI chr 8:127,672,955...127,695,939
Ensembl chr 8:118,795,201...118,818,186
G
Pld2
phospholipase D2
IDA
protein:altered activity:sarcolemma, sarcoplasmic reticulum, heart left ventricle
RGD
PMID:15752718
RGD:2299906
NCBI chr10:55,754,957...55,772,819
Ensembl chr10:55,256,359...55,272,808
G
Pln
phospholamban
treatment
IDA ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:10734148 PMID:21934351
RGD:7327186
NCBI chr20:33,166,512...33,182,241
G
Ppara
peroxisome proliferator activated receptor alpha
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:16411023
NCBI chr 7:118,712,261...118,780,723
Ensembl chr 7:116,832,756...116,895,346
G
Ppard
peroxisome proliferator-activated receptor delta
IDA
RGD
PMID:19997057
RGD:2324876
NCBI chr20:6,300,527...6,365,707
Ensembl chr20:6,298,785...6,363,968
G
Pparg
peroxisome proliferator-activated receptor gamma
ISO
RGD
PMID:18562925
RGD:2301853
NCBI chr 4:150,095,743...150,221,104
Ensembl chr 4:148,423,194...148,548,468
G
Ppargc1a
PPARG coactivator 1 alpha
treatment
ISO
RGD
PMID:19096023
RGD:10059669
NCBI chr14:63,073,505...63,729,215
Ensembl chr14:58,861,144...59,512,656
G
Prkaa2
protein kinase AMP-activated catalytic subunit alpha 2
treatment
IEP
RGD
PMID:20501665
RGD:10003160
NCBI chr 5:125,036,945...125,109,010
Ensembl chr 5:119,813,226...119,879,543
G
Prkcb
protein kinase C, beta
IDA
RGD
PMID:15878997
RGD:1625520
NCBI chr 1:186,263,397...186,594,743
Ensembl chr 1:176,832,226...177,163,536
G
Prkcd
protein kinase C, delta
IEP
protein:decreased expression:heart
RGD
PMID:17322024
RGD:1642542
NCBI chr16:5,775,681...5,806,122
Ensembl chr16:5,769,215...5,799,352
G
Prkd1
protein kinase D1
ameliorates
ISO
RGD
PMID:24345679
RGD:307727199
NCBI chr 6:73,460,640...73,774,433
Ensembl chr 6:67,725,905...68,039,042
G
Prkg1
protein kinase cGMP-dependent 1
treatment
IMP
RGD
PMID:18332860 PMID:19845676
RGD:7777120 , RGD:7777130
NCBI chr 1:237,818,950...239,052,184
Ensembl chr 1:228,408,947...229,639,080
G
Procr
protein C receptor
treatment
IDA
RGD
PMID:26994471
RGD:13515126
NCBI chr 3:164,714,727...164,718,994
Ensembl chr 3:144,254,380...144,258,903
G
Pten
phosphatase and tensin homolog
treatment
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:19038262 PMID:20951693
RGD:127285611
NCBI chr 1:240,043,707...240,110,330
Ensembl chr 1:230,630,338...230,696,838
G
Ptger3
prostaglandin E receptor 3
treatment
IMP
RGD
PMID:10193764
RGD:10043342
NCBI chr 2:249,264,985...249,409,966
Ensembl chr 2:246,606,183...246,684,434
G
Ptgs2
prostaglandin-endoperoxide synthase 2
IMP
RGD
PMID:17660401
RGD:2300261
NCBI chr13:64,714,063...64,722,320
Ensembl chr13:62,163,932...62,172,188
G
Rap1a
RAP1A, member of RAS oncogene family
treatment
IDA
RGD
PMID:20501665
RGD:10003160
NCBI chr 2:195,896,967...195,974,851
Ensembl chr 2:193,208,635...193,286,501
G
Rela
RELA proto-oncogene, NF-kB subunit
treatment
IDA IEP
protein:altered localization:nucleus
RGD
PMID:18636044 PMID:31583047
RGD:2298773 , RGD:155230831
NCBI chr 1:212,354,336...212,364,815
Ensembl chr 1:202,924,945...202,935,484
G
Rhoa
ras homolog family member A
IEP
protein:altered localization:heart
RGD
PMID:17322412
RGD:1642967
NCBI chr 8:117,870,548...117,904,303
Ensembl chr 8:108,991,954...109,025,746
G
Rnf41
ring finger protein 41
severity
ISO
RGD
PMID:21312039
RGD:401827146
NCBI chr 7:1,422,651...1,461,700
Ensembl chr 7:838,203...865,511
G
Rnls
renalase, FAD-dependent amine oxidase
ISO
RGD
PMID:21178975 PMID:21178975
RGD:7327174 , RGD:7327174
NCBI chr 1:240,450,702...240,723,472
Ensembl chr 1:231,037,486...231,309,823
G
S100b
S100 calcium binding protein B
IEP
mRNA, protein:increased expression:myocardium
RGD
PMID:21663912
RGD:5508825
NCBI chr20:12,372,345...12,381,159
Ensembl chr20:12,372,881...12,394,743
G
Selp
selectin P
IEP ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:12087064 PMID:21146547
RGD:6480105
NCBI chr13:79,009,379...79,044,994
Ensembl chr13:76,476,295...76,511,845
G
Serpina3n
serpin family A member 3N
ISO
RGD
PMID:7562495
RGD:5147423
NCBI chr 6:129,088,392...129,095,950
Ensembl chr 6:123,323,629...123,332,433
G
Serpine1
serpin family E member 1
treatment
IDA
RGD
PMID:26958805
RGD:11073621
NCBI chr12:25,237,977...25,248,356
Ensembl chr12:19,601,272...19,611,657
G
Serping1
serpin family G member 1
treatment
ISO
RGD
PMID:16942749
RGD:8661647
NCBI chr 3:90,249,410...90,259,299
Ensembl chr 3:69,842,739...69,852,034
G
Sfrp2
secreted frizzled-related protein 2
IEP
RGD
PMID:19109969
RGD:4107088
NCBI chr 2:171,387,536...171,395,081
Ensembl chr 2:169,089,517...169,097,063
G
Sh2b3
SH2B adaptor protein 3
IMP
RGD
PMID:25628389
RGD:12904914
NCBI chr12:40,391,755...40,414,336
Ensembl chr12:34,731,911...34,753,616
G
Sh2b3em2Mcwi
SH2B adaptor protein 3; zinc finger nuclease induced mutant 2, Medical College of Wisconsin
IMP
RGD
PMID:25628389
RGD:12904914
G
Shh
sonic hedgehog signaling molecule
IEP
protein:increased expression:heart
RGD
PMID:18228117
RGD:2306299
NCBI chr 4:7,687,872...7,697,025
Ensembl chr 4:6,954,017...6,963,170
G
Sirt1
sirtuin 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:21060073
NCBI chr20:25,305,953...25,328,000
Ensembl chr20:25,306,917...25,329,260
G
Slc25a4
solute carrier family 25 member 4
treatment
IEP
RGD
PMID:24126566
RGD:9681554
NCBI chr16:52,805,521...52,809,316
Ensembl chr16:46,072,939...46,076,733
G
Slc2a1
solute carrier family 2 member 1
IEP
RGD
PMID:10336852
RGD:12879857
NCBI chr 5:138,002,522...138,030,742
Ensembl chr 5:132,717,196...132,745,416
G
Slc2a4
solute carrier family 2 member 4
IEP
RGD
PMID:10336852
RGD:12879857
NCBI chr10:55,164,721...55,170,289
Ensembl chr10:54,666,015...54,671,565
G
Slc8a1
solute carrier family 8 member A1
IDA ISO IMP
CTD Direct Evidence: marker/mechanism protein:increased activity:cardiac muscle cell
CTD RGD
PMID:15215644 PMID:17267548 PMID:17822695
RGD:1642729 , RGD:1642716
NCBI chr 6:18,975,498...19,299,704
Ensembl chr 6:13,194,662...13,535,628
G
Slc9a1
solute carrier family 9 member A1
IMP
RGD
PMID:22803959
RGD:6771238
NCBI chr 5:150,859,412...150,913,525
Ensembl chr 5:145,576,334...145,629,624
G
Smad1
SMAD family member 1
ISO
RGD
PMID:15911698
RGD:1643233
NCBI chr19:45,417,430...45,477,962
Ensembl chr19:28,513,131...28,573,651
G
Smad3
SMAD family member 3
treatment
IDA
RGD
PMID:22913380
RGD:12903950
NCBI chr 8:73,022,204...73,132,324
Ensembl chr 8:64,110,039...64,236,960
G
Smad4
SMAD family member 4
treatment
IEP
RGD
PMID:22913380
RGD:12903950
NCBI chr18:69,518,988...69,549,684
Ensembl chr18:67,243,742...67,274,438
G
Sod1
superoxide dismutase 1
treatment
ISO IDA
human protein in a rat model
RGD
PMID:19277497 PMID:12668130 PMID:23629152
RGD:8655884 , RGD:11035287 , RGD:8655965
NCBI chr11:42,942,742...42,948,399
Ensembl chr11:29,456,558...29,462,249
G
Sod2
superoxide dismutase 2
treatment
ISO
RGD
PMID:11864929 PMID:12668130
RGD:1581222 , RGD:11035287
NCBI chr 1:50,043,323...50,050,168
Ensembl chr 1:47,636,528...47,645,189
G
Sord
sorbitol dehydrogenase
IEP ISO
protein:increased activity:heart CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:18549825 PMID:14525943
RGD:1601364
NCBI chr 3:129,638,282...129,669,727
Ensembl chr 3:109,184,676...109,216,133
G
Spp1
secreted phosphoprotein 1
ISO
RGD
PMID:15165989
RGD:1581342
NCBI chr14:5,613,569...5,620,695
Ensembl chr14:5,308,885...5,315,162
G
Stat1
signal transducer and activator of transcription 1
IDA
protein:increased phosphorylation:heart
RGD
PMID:16935931
RGD:1600091
NCBI chr 9:56,911,522...56,951,926
Ensembl chr 9:49,419,340...49,588,540
G
Stat3
signal transducer and activator of transcription 3
treatment
IDA
RGD
PMID:23796350
RGD:8694332
NCBI chr10:86,311,528...86,363,513
Ensembl chr10:85,811,218...85,863,057
G
Suv39h1
SUV39H1 histone lysine methyltransferase
treatment
IDA
associated with Diabetes Mellitus, Experimental
RGD
PMID:24752040
RGD:9586740
NCBI chr X:17,093,059...17,105,942
Ensembl chr X:14,421,109...14,433,982
G
Tek
TEK receptor tyrosine kinase
IEP
mRNA, protein:increased expression:ventricle myocardium
RGD
PMID:12737621
RGD:1601505
NCBI chr 5:114,722,815...114,849,535
Ensembl chr 5:109,607,077...109,733,804
G
Tfrc
transferrin receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18549825
NCBI chr11:81,668,478...81,690,318
Ensembl chr11:68,163,413...68,185,257
G
Tgfb1
transforming growth factor, beta 1
treatment
IEP
RGD
PMID:22913380
RGD:12903950
NCBI chr 1:90,324,312...90,340,627
Ensembl chr 1:81,196,532...81,212,847
G
Thbs1
thrombospondin 1
IEP
mRNA:increased expression:heart
RGD
PMID:16179730
RGD:2317960
NCBI chr 3:125,510,250...125,525,402
Ensembl chr 3:105,056,292...105,071,440
G
Timp4
TIMP metallopeptidase inhibitor 4
IEP
protein:increased expression:blood
RGD
PMID:12707244
RGD:2290461
NCBI chr 4:149,978,667...149,985,350
Ensembl chr 4:148,304,490...148,312,558
G
Tlr2
toll-like receptor 2
treatment
IEP
protein:increased expression:serum
RGD
PMID:19274437 PMID:32377693 PMID:32626996 PMID:22402367
RGD:2312688 , RGD:597621678 , RGD:597621676 , RGD:597538502
NCBI chr 2:171,499,189...171,504,831
Ensembl chr 2:169,197,419...169,206,630
G
Tlr4
toll-like receptor 4
IDA IEP
protein:increased expression:serum
RGD
PMID:14962484 PMID:32626996
RGD:1302746 , RGD:597621676
NCBI chr 5:85,161,247...85,174,882
Ensembl chr 5:80,145,826...80,159,628
G
Tnc
tenascin C
IEP
RGD
PMID:20554738
RGD:4889599
NCBI chr 5:82,391,340...82,476,197
Ensembl chr 5:77,375,851...77,460,624
G
Tnf
tumor necrosis factor
treatment
IEP
protein:increased expression:serum, heart:
RGD
PMID:24157164 PMID:31583047
RGD:7387274 , RGD:155230831
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,622,011...3,624,629
G
Tnni3
troponin I3, cardiac type
ameliorates
ISO
RGD
PMID:30259997
RGD:329337366
NCBI chr 1:78,342,571...78,346,255
Ensembl chr 1:69,299,900...69,303,580
G
Tp53
tumor protein p53
IEP
protein:increased expression:heart
RGD
PMID:18317410
RGD:2290554
NCBI chr10:54,798,871...54,810,300
Ensembl chr10:54,300,048...54,311,524
G
Txn1
thioredoxin 1
IEP
mRNA:decreased expression:heart
RGD
PMID:18045550
RGD:2306159
NCBI chr 5:77,507,455...77,519,685
Ensembl chr 5:72,711,933...72,724,629
G
Txn2
thioredoxin 2
IEP
mRNA, protein:decreased expression:heart
RGD
PMID:18045550
RGD:2306159
NCBI chr 7:111,377,338...111,390,940
Ensembl chr 7:109,496,761...109,510,359
G
Ucn
urocortin
IDA
RGD
PMID:15806110
RGD:1642783
NCBI chr 6:30,958,086...30,958,916
Ensembl chr 6:25,238,120...25,238,950
G
Ucp2
uncoupling protein 2
IEP
mRNA:increased expression:myocardium
RGD
PMID:19526854
RGD:2313528
NCBI chr 1:164,251,373...164,257,742
Ensembl chr 1:154,839,209...154,845,611
G
Ucp3
uncoupling protein 3
IEP
mRNA:increased expression:myocardium
RGD
PMID:19526854
RGD:2313528
NCBI chr 1:164,227,910...164,240,893
Ensembl chr 1:154,815,777...154,828,762
G
Uts2
urotensin 2
IDA
RGD
PMID:17900760
RGD:2306836
NCBI chr 5:166,725,471...166,739,063
Ensembl chr 5:161,450,846...161,456,237
G
Uts2r
urotensin 2 receptor
IMP
RGD
PMID:17900760
RGD:2306836
NCBI chr10:106,936,398...106,937,558
Ensembl chr10:106,438,092...106,439,252
G
Vcam1
vascular cell adhesion molecule 1
IEP
protein:increased expression:heart
RGD
PMID:23052973
RGD:7207792
NCBI chr 2:206,723,050...206,742,783
Ensembl chr 2:204,038,114...204,057,958
G
Vcan
versican
IEP
mRNA:increased expression:heart
RGD
PMID:16311904
RGD:1598497
NCBI chr 2:22,497,035...22,595,955
Ensembl chr 2:20,761,718...20,860,637
G
Vdac1
voltage-dependent anion channel 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25488258
NCBI chr10:37,029,377...37,060,542
Ensembl chr10:36,532,244...36,559,640
G
Vdr
vitamin D receptor
ISO
mRNA,protein:increased expression, activity:heart:
RGD
PMID:25365634
RGD:13432076
NCBI chr 7:130,864,764...130,916,757
Ensembl chr 7:128,987,981...129,037,677
G
Vegfa
vascular endothelial growth factor A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22050707
NCBI chr 9:22,452,854...22,468,194
Ensembl chr 9:14,955,300...14,970,641
G
Xdh
xanthine dehydrogenase
IEP
RGD
PMID:3162724
RGD:13209131
NCBI chr 6:27,282,319...27,344,022
Ensembl chr 6:21,530,113...21,592,268
G
Xiap
X-linked inhibitor of apoptosis
treatment
ISO IEP
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:14998631 PMID:20501665
RGD:10003160
NCBI chr X:125,756,107...125,803,979
Ensembl chr X:120,897,907...120,934,700
G
Yes1
YES proto-oncogene 1, Src family tyrosine kinase
ISO
mRNA,protein:increased expression:myocardium (mouse)
RGD
PMID:30259997
RGD:329337366
NCBI chr 9:120,646,657...120,753,880
Ensembl chr 9:113,200,256...113,299,837
G
Atp2a2
ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16317512
NCBI chr12:39,733,519...39,782,942
Ensembl chr12:34,072,683...34,122,101
G
Nos2
nitric oxide synthase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11927517
NCBI chr10:64,313,335...64,349,221
Ensembl chr10:63,815,308...63,851,210
G
Pln
phospholamban
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16317512
NCBI chr20:33,166,512...33,182,241
G
Tnf
tumor necrosis factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11927517
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,622,011...3,624,629
G
Cdh5
cadherin 5
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:16824628
NCBI chr19:821,875...860,931
Ensembl chr19:815,411...854,368
G
Ctnnb1
catenin beta 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:16824628
NCBI chr 8:129,517,576...129,544,661
Ensembl chr 8:120,639,995...120,667,111
G
Jup
junction plakoglobin
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:16824628
NCBI chr10:85,800,812...85,827,881
Ensembl chr10:85,300,440...85,327,057
G
F3
coagulation factor III, tissue factor
treatment
IEP
RGD
PMID:26370456
RGD:11341710
NCBI chr 2:212,511,675...212,523,375
Ensembl chr 2:209,826,959...209,838,668
G
Ccn2
cellular communication network factor 2
exacerbates
IEP
protein:increased expression:urine (rat)
RGD
PMID:19921985
RGD:150517553
NCBI chr 1:22,621,498...22,624,614
Ensembl chr 1:20,802,199...20,805,734
G
Cd40lg
CD40 ligand
treatment
ISO
RGD
PMID:12244161
RGD:7248713
NCBI chr X:140,164,341...140,176,057
Ensembl chr X:135,126,969...135,138,306
G
Gata2
GATA binding protein 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28569748
NCBI chr 4:122,211,501...122,225,058
Ensembl chr 4:120,658,986...120,667,761
G
Gpx3
glutathione peroxidase 3
treatment
ISO
RGD
PMID:29290803
RGD:401827126
NCBI chr10:39,529,335...39,537,406
Ensembl chr10:39,028,570...39,037,035
G
Icam1
intercellular adhesion molecule 1
treatment
IMP
RGD
PMID:22617707 PMID:10666412
RGD:8547722 , RGD:11520779
NCBI chr 8:27,829,688...27,841,618
Ensembl chr 8:19,553,645...19,565,438
G
Il10
interleukin 10
treatment
IDA
RGD
PMID:21911153
RGD:11049478
NCBI chr13:45,024,921...45,029,586
Ensembl chr13:42,472,839...42,477,313
G
Npy
neuropeptide Y
IEP
mRNA, protein:decreased expression:blood, mononuclear cell
RGD
PMID:18981110
RGD:10448956
NCBI chr 4:80,212,111...80,219,310
Ensembl chr 4:78,881,264...78,888,495
G
Pf4
platelet factor 4
ameliorates
IDA
RGD
PMID:24986443
RGD:329901907
NCBI chr14:17,582,477...17,583,392
Ensembl chr14:17,298,308...17,299,365
G
Selp
selectin P
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28569748
NCBI chr13:79,009,379...79,044,994
Ensembl chr13:76,476,295...76,511,845
G
Senp1
SUMO specific peptidase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28569748
NCBI chr 7:131,042,237...131,105,826
Ensembl chr 7:129,165,774...129,221,598
G
Tnf
tumor necrosis factor
treatment
IEP
liver
RGD
PMID:18972563
RGD:15023490
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,622,011...3,624,629
G
Vcam1
vascular cell adhesion molecule 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28569748
NCBI chr 2:206,723,050...206,742,783
Ensembl chr 2:204,038,114...204,057,958
G
Icam1
intercellular adhesion molecule 1
ISO
protein:increased expression:plasma
RGD
PMID:9415270
RGD:8547713
NCBI chr 8:27,829,688...27,841,618
Ensembl chr 8:19,553,645...19,565,438
G
Kcnj8
potassium inwardly-rectifying channel, subfamily J, member 8
ISO
RGD
PMID:11984590
RGD:1581700
NCBI chr 4:177,240,692...177,246,548
Ensembl chr 4:175,508,912...175,515,603
G
Pnpo
pyridoxamine 5'-phosphate oxidase
ISO
ClinVar Annotator: match by term: Pyridoxal phosphate-responsive seizures CTD Direct Evidence: marker/mechanism
OMIM ClinVar CTD
PMID:9536098 PMID:15182361 PMID:15772097 PMID:16199547 PMID:17216302 PMID:17576681 PMID:18296573 PMID:18485777 PMID:19759001 PMID:20370816 PMID:21292558 PMID:22858719 PMID:23419474 PMID:23430561 PMID:23708187 PMID:24266778 PMID:24297574 PMID:24645144 PMID:24658933 PMID:24781210 PMID:25256445 PMID:25741868 PMID:25762494 PMID:25979913 PMID:26077850 PMID:26467025 PMID:27014579 PMID:27419045 PMID:27781031 PMID:28133863 PMID:28349276 PMID:28492532 PMID:28929476 PMID:28985901 PMID:29588952 PMID:29610166 PMID:30398534 PMID:31440721 PMID:32395712 PMID:32788630 PMID:32888189 PMID:33087887 PMID:33981986 PMID:34177756 PMID:34769443 PMID:35217610 PMID:35495162 PMID:35636100 PMID:35715422 PMID:36007526 PMID:36106796 PMID:36801247 More...
NCBI chr10:82,421,027...82,427,288
Ensembl chr10:81,924,569...81,930,871
G
Apaf1
apoptotic peptidase activating factor 1
treatment
IMP
RGD
PMID:25330150
RGD:13703111
NCBI chr 7:27,381,392...27,466,772
Ensembl chr 7:25,494,609...25,579,540
G
Lcn2
lipocalin 2
ISO
protein:increased expression:urine
RGD
PMID:27800610
RGD:126790572
NCBI chr 3:36,078,432...36,081,851
Ensembl chr 3:15,680,687...15,684,095
G
Xdh
xanthine dehydrogenase
IEP
protein:decreased expression:kidney
RGD
PMID:2253787
RGD:13209019
NCBI chr 6:27,282,319...27,344,022
Ensembl chr 6:21,530,113...21,592,268
G
Abcb1a
ATP binding cassette subfamily B member 1A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22749977
NCBI chr 4:26,312,403...26,488,456
Ensembl chr 4:25,158,362...25,442,709
G
Abcc5
ATP binding cassette subfamily C member 5
IEP
mRNA, protein:increased expression:brain, neuron
RGD
PMID:16997484
RGD:2301088
NCBI chr11:93,975,579...94,071,659
Ensembl chr11:80,473,872...80,567,253
G
Abcg2
ATP binding cassette subfamily G member 2
IEP
mRNA, protein:increased expression, altered localization:small intestine
RGD
PMID:18451542
RGD:2315580
NCBI chr 4:89,006,056...89,132,915
Ensembl chr 4:87,745,319...87,802,409
G
Ace
angiotensin I converting enzyme
IMP
RGD
PMID:20436217
RGD:2325213
NCBI chr10:91,410,129...91,430,246
Ensembl chr10:90,910,316...90,931,131
G
Adcyap1
adenylate cyclase activating polypeptide 1
IEP
mRNA:increased expression:hippocampal granule cell
RGD
PMID:19647005
RGD:2315956
NCBI chr 9:120,550,236...120,569,096
Ensembl chr 9:113,103,718...113,109,773
G
Adcyap1r1
ADCYAP receptor type I
IEP
mRNA:decreased expression:dentate gyrus (rat)
RGD
PMID:19647005
RGD:2315956
NCBI chr 4:85,924,171...85,972,973
Ensembl chr 4:84,593,892...84,642,700
G
Adgrl1
adhesion G protein-coupled receptor L1
IEP
RGD
PMID:12225880
RGD:2314400
NCBI chr19:41,107,162...41,148,752
Ensembl chr19:24,204,360...24,244,139
G
Adgrl3
adhesion G protein-coupled receptor L3
IEP
RGD
PMID:12225880
RGD:2314400
NCBI chr14:26,690,891...27,458,132
Ensembl chr14:26,368,277...27,105,860
G
Adipoq
adiponectin, C1Q and collagen domain containing
IMP
associated with Non-alcoholic Fatty Liver Disease;
RGD
PMID:18098300
RGD:5686804
NCBI chr11:91,226,524...91,240,244
Ensembl chr11:77,721,912...77,735,564
G
Adm
adrenomedullin
IEP
protein:increased expression:plasma:
RGD
PMID:17263982
RGD:7364988
NCBI chr 1:174,164,178...174,182,372
Ensembl chr 1:164,745,466...164,747,654
G
Adora2a
adenosine A2a receptor
IDA ISO
CTD Direct Evidence: therapeutic
CTD RGD
PMID:27757725 PMID:17937935
RGD:4890367
NCBI chr20:13,315,270...13,332,802
Ensembl chr20:13,315,853...13,333,386
G
Adora2b
adenosine A2B receptor
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:27757725
NCBI chr10:47,439,712...47,456,092
Ensembl chr10:46,940,384...46,956,772
G
Adrb1
adrenoceptor beta 1
IMP
RGD
PMID:20451506
RGD:5129116
NCBI chr 1:265,777,103...265,780,114
Ensembl chr 1:255,771,597...255,807,259
G
Adrb2
adrenoceptor beta 2
IDA
RGD
PMID:14630341 PMID:18336819
RGD:1598754 , RGD:4145097
NCBI chr18:57,912,760...57,914,802
Ensembl chr18:55,502,903...55,644,512
G
Agt
angiotensinogen
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23875703
NCBI chr19:69,426,540...69,447,017
Ensembl chr19:52,529,185...52,540,977
G
Agtr2
angiotensin II receptor, type 2
IDA
RGD
PMID:22920387
RGD:6903870
NCBI chr X:116,914,320...116,918,504
Ensembl chr X:112,120,228...112,124,057
G
Aif1
allograft inflammatory factor 1
IEP
protein:increased expression:Kupffer cell (rat)
RGD
PMID:16500929
RGD:2313040
NCBI chr20:3,651,435...3,657,341
Ensembl chr20:3,646,777...3,652,668
G
Akt1
AKT serine/threonine kinase 1
ISO
RGD
PMID:21351045
RGD:5509067
NCBI chr 6:137,534,810...137,555,131
Ensembl chr 6:131,713,720...131,733,921
G
Akt1s1
AKT1 substrate 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16397181
NCBI chr 1:104,469,823...104,476,168
Ensembl chr 1:95,332,898...95,339,677
G
Alb
albumin
IEP
mRNA, protein:increased expression:brain
RGD
PMID:20193666
RGD:2325686
NCBI chr14:17,891,564...17,907,043
Ensembl chr14:17,607,381...17,622,836
G
Aldoa
aldolase, fructose-bisphosphate A
IEP
RGD
PMID:10395295
RGD:1599061
NCBI chr 1:190,832,820...190,838,021
Ensembl chr 1:181,402,275...181,406,182
G
Alox12
arachidonate 12-lipoxygenase, 12S type
IEP
RGD
PMID:15518705
RGD:5509617
NCBI chr10:55,456,923...55,469,239
Ensembl chr10:54,958,271...54,970,542
G
Alox15
arachidonate 15-lipoxygenase
ISO
RGD
PMID:18635843
RGD:5509608
NCBI chr10:55,559,060...55,567,535
Ensembl chr10:55,060,412...55,068,874
G
Alox5
arachidonate 5-lipoxygenase
IEP ISO IMP
protein:increased expression:cerebral hemisphere CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:15266012 PMID:14769366 PMID:19816089
RGD:1626152 , RGD:2317531
NCBI chr 4:151,203,948...151,251,126
Ensembl chr 4:149,531,515...149,578,743
G
Ang
angiogenin
IEP
protein:increased expression:brain
RGD
PMID:19666176
RGD:2325717
NCBI chr15:26,786,233...26,796,883
G
Angpt1
angiopoietin 1
ISO
RGD
PMID:19885826
RGD:2316041
NCBI chr 7:75,415,959...75,668,696
Ensembl chr 7:73,531,486...73,784,067
G
Aoc3
amine oxidase, copper containing 3
IMP
RGD
PMID:16339390
RGD:2313821
NCBI chr10:86,773,018...86,780,961
G
Apaf1
apoptotic peptidase activating factor 1
IEP
RGD
PMID:18205898
RGD:2292105
NCBI chr 7:27,381,392...27,466,772
Ensembl chr 7:25,494,609...25,579,540
G
Apex1
apurinic/apyrimidinic endodeoxyribonuclease 1
IEP
protein:increased expression:placenta
RGD
PMID:18373555
RGD:2315671
NCBI chr15:26,618,146...26,620,330
Ensembl chr15:24,144,362...24,146,785
G
Aqp4
aquaporin 4
IEP ISO
protein:increased expression:cerebral cortex mRNA, protein:increased expression:parietal cortex
RGD
PMID:20979759 PMID:21718723 PMID:19806476 PMID:20924629
RGD:5148016 , RGD:5684013 , RGD:5148037 , RGD:5148022
NCBI chr18:6,782,389...6,799,034
Ensembl chr18:6,507,903...6,524,856
G
Arg1
arginase 1
IEP
protein:increased expression:serum (rat)
RGD
PMID:17023552
RGD:4143185
NCBI chr 1:22,295,093...22,307,720
Ensembl chr 1:20,475,968...20,488,422
G
Asl
argininosuccinate lyase
resistance
IEP
protein:increased expression:brain, neuron (rat)
RGD
PMID:17198704
RGD:1599263
NCBI chr12:32,295,779...32,313,257
Ensembl chr12:26,659,565...26,679,662
G
Ass1
argininosuccinate synthase 1
resistance
IEP
protein:increased expression:brain, neuron (rat)
RGD
PMID:17198704
RGD:1599263
NCBI chr 3:35,144,765...35,194,632
Ensembl chr 3:14,747,368...14,796,903
G
Bad
BCL2-associated agonist of cell death
IEP
protein:altered localization:brain, mitochondria
RGD
PMID:18347331
RGD:2292679
NCBI chr 1:213,562,719...213,572,034
Ensembl chr 1:204,131,501...204,142,823
G
Bag1
BAG cochaperone 1
IMP
RGD
PMID:12215270
RGD:2296021
NCBI chr 5:60,864,476...60,877,059
Ensembl chr 5:56,068,494...56,081,075
G
Bag3
BAG cochaperone 3
IEP
protein:increased expression:hippocampus, astrocyte
RGD
PMID:12061864
RGD:2325848
NCBI chr 1:192,533,460...192,557,281
Ensembl chr 1:183,102,871...183,126,858
G
Bax
BCL2 associated X, apoptosis regulator
IEP
protein:increased expression:brain
RGD
PMID:18083315 PMID:18221257
RGD:2290557 , RGD:2293026
NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:95,938,808...95,945,368
G
Bcl2
BCL2, apoptosis regulator
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:15449323
NCBI chr13:23,204,464...23,366,900
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
Bdnf
brain-derived neurotrophic factor
IEP
mRNA:increased expression:retina
RGD
PMID:20554625
RGD:4891135
NCBI chr 3:116,619,633...116,670,212
Ensembl chr 3:96,165,042...96,215,615
G
Becn1
beclin 1
IEP
protein:increased expression:brain
RGD
PMID:22306244
RGD:6483054
NCBI chr10:86,731,649...86,747,002
Ensembl chr10:86,231,388...86,246,742
G
Bid
BH3 interacting domain death agonist
IDA
RGD
PMID:19888517
RGD:2317562
NCBI chr 4:155,785,366...155,808,775
Ensembl chr 4:154,113,198...154,134,720
G
Birc5
baculoviral IAP repeat-containing 5
IEP IMP
protein:increased expression:brain
RGD
PMID:18159002 PMID:18053646
RGD:2293126 , RGD:2293127
NCBI chr10:103,567,369...103,580,069
Ensembl chr10:103,073,408...103,081,380
G
Bmp6
bone morphogenetic protein 6
IEP
RGD
PMID:11245809
RGD:2289024
NCBI chr17:26,523,704...26,785,558
Ensembl chr17:26,318,569...26,470,365
G
Bmpr2
bone morphogenetic protein receptor type 2
IEP
mRNA:increased expression:dentate gyrus, granule cell
RGD
PMID:10996456
RGD:5129486
NCBI chr 9:68,685,942...68,801,353
Ensembl chr 9:61,190,566...61,301,809
G
Bsg
basigin
IEP
protein:increased expression:basal ganglia
RGD
PMID:16029217
RGD:2289063
NCBI chr 7:10,643,788...10,651,005
Ensembl chr 7:9,993,170...10,000,387
G
Btg2
BTG anti-proliferation factor 2
IEP
mRNA:increased expression:kidney
RGD
PMID:9712737
RGD:2289078
NCBI chr13:48,083,931...48,087,690
Ensembl chr13:45,531,925...45,535,628
G
C3
complement C3
IEP
protein:increased expression:intestine
RGD
PMID:17981193
RGD:5129536
NCBI chr 9:2,174,412...2,201,339
Ensembl chr 9:2,087,437...2,114,429
G
C3ar1
complement C3a receptor 1
IMP
RGD
PMID:15159277
RGD:5129702
NCBI chr 4:157,747,419...157,756,609
Ensembl chr 4:156,075,389...156,084,701
G
C5
complement C5
IDA
RGD
PMID:15158333
RGD:1600597
NCBI chr 3:38,668,174...38,759,468
Ensembl chr 3:18,270,696...18,361,994
G
C5ar1
complement C5a receptor 1
IMP
RGD
PMID:15158333 PMID:15159277
RGD:1600597 , RGD:5129702
NCBI chr 1:86,077,309...86,088,001
G
Casp1
caspase 1
IMP
RGD
PMID:17845807
RGD:2315890
NCBI chr 8:10,746,338...10,882,295
Ensembl chr 8:2,587,831...2,597,383
G
Casp12
caspase 12
IEP
RGD
PMID:18273070
RGD:2311461
NCBI chr 8:10,927,188...10,954,442
Ensembl chr 8:2,642,434...2,674,037
G
Casp3
caspase 3
treatment
IMP IDA ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:23875703 PMID:18490106 PMID:29568770
RGD:2293311 , RGD:13792595
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:45,662,910...45,684,648
G
Casp6
caspase 6
IEP
protein:increased expression, increased activity:small intestine mucosa
RGD
PMID:15010362
RGD:2301320
NCBI chr 2:221,140,287...221,152,727
Ensembl chr 2:218,466,076...218,478,502
G
Casp8
caspase 8
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23875703
NCBI chr 9:67,747,109...67,806,699
Ensembl chr 9:60,264,075...60,312,542
G
Casp9
caspase 9
treatment
IDA
RGD
PMID:29568770
RGD:13792595
Ensembl chr 5:154,109,046...154,126,626
G
Cast
calpastatin
IEP
RGD
PMID:11035539
RGD:5509823
NCBI chr 2:5,707,633...5,817,213
Ensembl chr 2:3,973,112...4,082,659
G
Cat
catalase
IDA ISO IEP
CTD Direct Evidence: marker/mechanism|therapeutic
CTD RGD
PMID:8215636 PMID:16682413 PMID:23743330 PMID:23875703 PMID:19196076 PMID:20888583 More...
RGD:5130760 , RGD:5130200
NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:89,842,399...89,874,478
G
Cav1
caveolin 1
IEP
protein:increased expression:brain
RGD
PMID:17293479
RGD:2289123
NCBI chr 4:46,606,538...46,639,616
Ensembl chr 4:45,634,918...45,673,705
G
Ccl11
C-C motif chemokine ligand 11
IEP
mRNA:increased expression:aorta
RGD
PMID:9665468
RGD:4145482
NCBI chr10:67,525,975...67,530,576
Ensembl chr10:67,028,328...67,032,926
G
Ccl2
C-C motif chemokine ligand 2
treatment
IDA ISO
Gastric Reperfusion Injury CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:12468449 PMID:15829914 PMID:22611311
RGD:8549744
NCBI chr10:67,503,077...67,504,875
Ensembl chr10:67,005,424...67,007,226
G
Ccl3
C-C motif chemokine ligand 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15829914
NCBI chr10:68,948,889...68,950,439
Ensembl chr10:68,451,388...68,452,938
G
Ccl5
C-C motif chemokine ligand 5
ISO IEP
protein:increased secretion:lung, secretion (mouse) protein:increased expression:gut
RGD
PMID:19558673 PMID:15542513
RGD:4891479 , RGD:2307184
NCBI chr10:68,820,330...68,824,906
Ensembl chr10:68,322,829...68,327,377
G
Ccnb1
cyclin B1
IEP
protein;altered expression:cerebral cortex, hippocampus CA1, neuron
RGD
PMID:18278459
RGD:2315990
NCBI chr 2:33,646,252...33,655,225
Ensembl chr 2:31,912,193...31,921,172
G
Ccnd1
cyclin D1
IEP
RGD
PMID:16718823
RGD:2289145
NCBI chr 1:209,518,288...209,527,986
Ensembl chr 1:200,089,002...200,098,602
G
Ccne1
cyclin E1
IEP
protein:decreased expression:liver
RGD
PMID:17584601
RGD:2289275
NCBI chr 1:99,918,672...99,927,986
Ensembl chr 1:90,781,949...90,791,101
G
Ccng1
cyclin G1
IEP
mRNA, protein:increased expression:brain
RGD
PMID:9698156
RGD:2316027
NCBI chr10:25,678,503...25,684,876
Ensembl chr10:25,176,234...25,181,641
G
Ccr1
C-C motif chemokine receptor 1
ISO
mRNA:increased expression:kidney
RGD
PMID:20410256
RGD:5688141
NCBI chr 8:132,433,711...132,439,266
G
Cd2ap
CD2-associated protein
IEP
RGD
PMID:16088078
RGD:1581187
NCBI chr 9:25,580,071...25,679,968
Ensembl chr 9:18,086,984...18,182,199
G
Cd36
CD36 molecule
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16526316
NCBI chr 4:18,209,088...18,302,142
Ensembl chr 4:17,354,466...17,513,903
G
Cd40
CD40 molecule
IMP
RGD
PMID:12388354
RGD:5508171
NCBI chr 3:174,209,113...174,224,592
Ensembl chr 3:153,790,449...153,805,534
G
Cd40lg
CD40 ligand
ISO IMP
RGD
PMID:20659085 PMID:12388354
RGD:5490531 , RGD:5508171
NCBI chr X:140,164,341...140,176,057
Ensembl chr X:135,126,969...135,138,306
G
Cd44
CD44 molecule
IEP
protein:increased expression:kidney protein:increased expression:testis, macrophage
RGD
PMID:16786159 PMID:16891795
RGD:2289354 , RGD:2289369
NCBI chr 3:109,610,824...109,699,776
Ensembl chr 3:89,157,058...89,244,620
G
Cd55
CD55 molecule (Cromer blood group)
IEP
RGD
PMID:20403613
RGD:2326175
NCBI chr13:44,409,574...44,438,913
Ensembl chr13:41,857,395...41,885,831
G
Cd59b
CD59b molecule
IDA
RGD
PMID:10530491
RGD:1600493
NCBI chr 3:110,914,008...110,932,489
Ensembl chr 3:90,459,162...90,478,847
G
Cdc42
cell division cycle 42
IDA
protein:increased activation:hippocampus CA1
RGD
PMID:17161586
RGD:2298583
NCBI chr 5:154,838,478...154,876,629
Ensembl chr 5:149,553,724...149,593,111
G
Cdkn1a
cyclin-dependent kinase inhibitor 1A
IEP ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:16968891 PMID:10451498
RGD:10043817
NCBI chr20:7,150,820...7,161,373
Ensembl chr20:7,149,217...7,159,585
G
Cdkn1b
cyclin-dependent kinase inhibitor 1B
IEP
protein:increased expression:skeletal muscle
RGD
PMID:15799773
RGD:2293627
NCBI chr 4:169,491,273...169,496,500
Ensembl chr 4:167,760,181...167,764,982
G
Cfh
complement factor H
IEP
protein:increased expression:plasma:
RGD
PMID:17263982
RGD:7364988
NCBI chr13:54,063,079...54,164,523
Ensembl chr13:51,511,828...51,613,838
G
Chat
choline O-acetyltransferase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23075401
NCBI chr16:7,663,665...7,723,416
Ensembl chr16:7,657,362...7,717,093
G
Cldn4
claudin 4
IEP
protein:increased expression, altered localization:small intestine epithelium
RGD
PMID:17375208
RGD:2317600
NCBI chr12:27,388,160...27,389,958
Ensembl chr12:21,751,331...21,753,436
G
Cnr1
cannabinoid receptor 1
IMP
RGD
PMID:19372445
RGD:2314674
NCBI chr 5:53,204,867...53,230,396
Ensembl chr 5:48,408,574...48,435,099
G
Cspg4
chondroitin sulfate proteoglycan 4
IEP
RGD
PMID:17565360
RGD:5686869
NCBI chr 8:66,160,942...66,195,987
Ensembl chr 8:57,264,962...57,300,010
G
Ctsb
cathepsin B
IEP
protein:increased expression:cerebral cortex, mitochondrion (rat)
RGD
PMID:18938146
RGD:2315506
NCBI chr15:41,565,607...41,586,479
Ensembl chr15:37,389,629...37,410,500
G
Ctsg
cathepsin G
ISO
RGD
PMID:17322378
RGD:7242055
NCBI chr15:33,901,230...33,907,596
Ensembl chr15:29,931,003...29,937,353
G
Cx3cl1
C-X3-C motif chemokine ligand 1
IEP
mRNA, protein:increased expression:brain
RGD
PMID:19563789
RGD:4891956
NCBI chr19:10,233,326...10,244,856
Ensembl chr19:10,227,340...10,236,833
G
Cxcl1
C-X-C motif chemokine ligand 1
ISO IEP
mRNA:increased expression:liver CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:16526316 PMID:20160675 PMID:10655268
RGD:5134970 , RGD:5135270
NCBI chr14:17,477,542...17,479,321
Ensembl chr14:17,193,365...17,195,215
G
Cxcl10
C-X-C motif chemokine ligand 10
IEP ISO
mRNA:increased expression:liver protein:increased expression:respiratory system fluid/secretion associated with Anemia, Sickle Cell;protein:increased expression:lung
RGD
PMID:18589091 PMID:16709871 PMID:19433855
RGD:2311376 , RGD:5135441 , RGD:5135307
NCBI chr14:15,989,066...15,991,263
Ensembl chr14:15,704,758...15,706,975
G
Cxcl12
C-X-C motif chemokine ligand 12
IEP
protein:increased expression:retina
RGD
PMID:18709383
RGD:2306570
NCBI chr 4:152,060,781...152,073,628
Ensembl chr 4:150,388,325...150,401,168
G
Cxcl2
C-X-C motif chemokine ligand 2
IEP ISO
mRNA:increased expression:jejunum, lung CTD Direct Evidence: marker/mechanism protein:increased expression:liver mRNA:increased expression:liver
CTD RGD
PMID:12468449 PMID:19691980 PMID:10655268 PMID:11580116 PMID:20160675
RGD:5134974 , RGD:5135270 , RGD:5135251 , RGD:5134970
NCBI chr14:17,465,210...17,467,255
Ensembl chr14:17,181,062...17,183,075
G
Cxcl3
C-X-C motif chemokine ligand 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16526316
NCBI chr14:17,571,900...17,573,624
Ensembl chr14:17,270,146...17,289,511
G
Cxcl6
C-X-C motif chemokine ligand 6
IEP
protein:increased expression:liver
RGD
PMID:11580116 PMID:10655268
RGD:5135251 , RGD:5135270
NCBI chr14:17,594,959...17,596,417
Ensembl chr14:17,310,426...17,313,093
G
Cxcl9
C-X-C motif chemokine ligand 9
ISO
associated with Anemia, Sickle Cell;protein:increased expression:lung
RGD
PMID:19433855
RGD:5135307
NCBI chr14:16,007,166...16,012,077
Ensembl chr14:15,722,908...15,728,435
G
Cxcr3
C-X-C motif chemokine receptor 3
IEP
mRNA:increased expression:liver
RGD
PMID:18589091
RGD:2311376
NCBI chr X:70,884,293...70,886,944
Ensembl chr X:66,844,318...66,846,969
G
Cyba
cytochrome b-245 alpha chain
IEP
RGD
PMID:15148062
RGD:1599683
NCBI chr19:67,396,143...67,404,214
Ensembl chr19:50,487,597...50,495,721
G
Cybb
cytochrome b-245 beta chain
IEP ISO
Protein:increase expression:brain CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:19193722 PMID:16766636
RGD:1599677
NCBI chr X:16,030,596...16,065,065
Ensembl chr X:13,359,430...13,392,586
G
Cyp19a1
cytochrome P450, family 19, subfamily a, polypeptide 1
IEP
protein:increased expression:hippocampus (rat)
RGD
PMID:21114983
RGD:4890041
NCBI chr 8:63,449,148...63,476,534
Ensembl chr 8:54,553,165...54,580,758
G
Cyp2e1
cytochrome P450, family 2, subfamily e, polypeptide 1
IEP
protein:decreased expression:liver
RGD
PMID:21094789
RGD:4892235
NCBI chr 1:205,269,967...205,280,365
Ensembl chr 1:195,840,058...195,864,023
G
Cyp3a62
cytochrome P450, family 3, subfamily a, polypeptide 62
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:22749977
NCBI chr12:21,511,763...21,547,598
Ensembl chr12:16,397,998...16,433,833
G
Cyp3a9
cytochrome P450, family 3, subfamily a, polypeptide 9
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:22749977
NCBI chr12:21,919,955...21,960,160
Ensembl chr12:16,806,207...16,846,422
G
Cysltr1
cysteinyl leukotriene receptor 1
IEP
protein:increased expression:kidney
RGD
PMID:18790177
RGD:4781446
NCBI chr X:75,734,281...75,762,873
Ensembl chr X:71,663,821...71,690,121
G
Cysltr2
cysteinyl leukotriene receptor 2
IEP
protein:increased expression:brain
RGD
PMID:21664436
RGD:5144004
NCBI chr15:54,599,043...54,638,314
Ensembl chr15:48,189,073...48,304,136
G
Dcc
DCC netrin 1 receptor
IEP
protein:increased expression:brain
RGD
PMID:17574219
RGD:2314372
NCBI chr18:67,144,272...68,248,159
Ensembl chr18:64,873,898...65,972,740
G
Dsg1
desmoglein 1
IEP
protein:decreased expression:lung
RGD
PMID:19500802
RGD:2316254
NCBI chr18:11,948,098...11,980,455
Ensembl chr18:11,674,402...11,703,443
G
Edn1
endothelin 1
IEP ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:17470888 PMID:18722366
RGD:4892577
NCBI chr17:22,660,799...22,666,687
Ensembl chr17:22,454,420...22,460,885
G
Edn2
endothelin 2
IEP
RGD
PMID:1479622
RGD:1580920
NCBI chr 5:139,036,576...139,042,074
Ensembl chr 5:133,751,217...133,756,814
G
Ednrb
endothelin receptor type B
IEP
RGD
PMID:18722366
RGD:4892577
NCBI chr15:87,055,490...87,086,765
Ensembl chr15:80,643,043...80,672,115
G
Eef2
eukaryotic translation elongation factor 2
IEP
protein:hypophosphorylation:cortex, hippocampus:
RGD
PMID:15211596
RGD:10401223
NCBI chr 7:9,183,836...9,196,255
Ensembl chr 7:8,533,116...8,559,183
G
Efna5
ephrin A5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16526316
NCBI chr 9:109,763,786...110,042,396
Ensembl chr 9:102,320,295...102,597,413
G
Efnb2
ephrin B2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16526316
NCBI chr16:87,485,215...87,529,224
Ensembl chr16:80,783,417...80,824,391
G
Egf
epidermal growth factor
resistance
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:16526316 PMID:16417467
RGD:6906916
NCBI chr 2:220,893,660...220,976,331
Ensembl chr 2:218,219,415...218,302,064
G
Egr1
early growth response 1
ISO IEP
Lung Reperfusion Injury CTD Direct Evidence: marker/mechanism Lung Reperfusion Injury; protein:increased expression:lung, nucleus (rat) Lung Reperfusion Injury; protein:increased expression:lung, nucleus (mouse)
CTD RGD
PMID:12468449 PMID:16551742 PMID:16488723 PMID:19342415
RGD:5131903 , RGD:5131904 , RGD:5131887
NCBI chr18:26,737,078...26,740,877
Ensembl chr18:26,462,981...26,466,766
G
Eif2a
eukaryotic translation initiation factor 2A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19041636
NCBI chr 2:144,911,247...144,944,705
Ensembl chr 2:142,761,416...142,795,068
G
Eif2ak3
eukaryotic translation initiation factor 2 alpha kinase 3
IDA
protein:increased phosphorylation:kidney
RGD
PMID:15936177
RGD:1581062
NCBI chr 4:104,363,838...104,425,271
Ensembl chr 4:102,805,510...102,866,911
G
Eif2s1
eukaryotic translation initiation factor 2 subunit alpha
IDA
protein:increased phosphorylation:kidney
RGD
PMID:15936177
RGD:1581062
NCBI chr 6:103,405,880...103,430,549
Ensembl chr 6:97,672,766...97,706,225
G
Eno2
enolase 2
IDA
RGD
PMID:17683050
RGD:2293745
NCBI chr 4:159,258,371...159,267,220
Ensembl chr 4:157,572,088...157,580,980
G
Ep300
E1A binding protein p300
treatment
IDA IEP
retina retina; protein:altered localization:Hsp70, promoter (rat)
RGD
PMID:22143029 PMID:22143029
RGD:5686888 , RGD:5686888
NCBI chr 7:114,987,857...115,058,652
Ensembl chr 7:113,106,247...113,136,088 Ensembl chr 7:113,106,247...113,136,088
G
Epha2
Eph receptor A2
IDA
RGD
PMID:16735461
RGD:1580976
NCBI chr 5:158,888,629...158,917,100
Ensembl chr 5:153,605,644...153,634,117
G
Ephx2
epoxide hydrolase 2
ISO
RGD
PMID:19471280
RGD:5688359
NCBI chr15:44,465,447...44,503,157
Ensembl chr15:40,289,902...40,327,615
G
Ercc1
ERCC excision repair 1, endonuclease non-catalytic subunit
IMP
RGD
PMID:19440222
RGD:2313668
NCBI chr 1:88,099,308...88,135,966
Ensembl chr 1:78,996,390...79,007,963
G
Ets1
ETS proto-oncogene 1, transcription factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16526316
NCBI chr 8:39,303,936...39,426,022
Ensembl chr 8:31,045,945...31,168,010
G
F2
coagulation factor II, thrombin
IMP
RGD
PMID:20705928
RGD:5147777
NCBI chr 3:98,051,958...98,065,246
Ensembl chr 3:77,596,198...77,609,486
G
Fas
Fas cell surface death receptor
treatment
IDA
RGD
PMID:29568770
RGD:13792595
NCBI chr 1:241,212,155...241,245,774
Ensembl chr 1:231,798,960...231,832,591
G
Fgf1
fibroblast growth factor 1
IDA ISO
Rat model using human FGF1
RGD
PMID:19497570 PMID:16635575
RGD:5509879 , RGD:5509881
NCBI chr18:30,937,670...31,023,786
Ensembl chr18:30,686,581...30,772,357
G
Fgf2
fibroblast growth factor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16526316
NCBI chr 2:122,164,454...122,218,796
Ensembl chr 2:120,236,328...120,291,221
G
Fgf7
fibroblast growth factor 7
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16526316
NCBI chr 3:133,734,557...133,786,678
Ensembl chr 3:113,281,283...113,332,929
G
Fos
Fos proto-oncogene, AP-1 transcription factor subunit
IEP ISO
protein:increased expression:brain CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:7922267 PMID:15121240
RGD:2293779
NCBI chr 6:110,852,188...110,855,054
Ensembl chr 6:105,121,170...105,124,036
G
Fosl1
FOS like 1, AP-1 transcription factor subunit
IEP
mRNA:increased expression:hippocampus
RGD
PMID:15306117
RGD:1642465
NCBI chr 1:212,183,885...212,192,391
Ensembl chr 1:202,754,529...202,764,930
G
Fosl2
FOS like 2, AP-1 transcription factor subunit
IEP
protein:increased expression:brain
RGD
PMID:15121240
RGD:2293779
NCBI chr 6:30,017,952...30,039,269
Ensembl chr 6:24,300,956...24,320,034
G
Gast
gastrin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:10594344
NCBI chr10:85,765,216...85,767,881
Ensembl chr10:85,264,832...85,267,496
G
Gh1
growth hormone 1
treatment
ISO
RGD
PMID:21439711
RGD:10003153
NCBI chr10:91,727,883...91,729,860
Ensembl chr10:91,228,103...91,230,078
G
Ghrl
ghrelin and obestatin prepropeptide
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:16581065
NCBI chr 4:148,421,315...148,431,128
Ensembl chr 4:146,865,712...146,869,621
G
Gjb1
gap junction protein, beta 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25530438
NCBI chr X:70,541,845...70,549,776
Ensembl chr X:66,501,820...66,509,925
G
Glud1
glutamate dehydrogenase 1
IEP
protein:decreased activity:brain
RGD
PMID:7808037
RGD:6484655
NCBI chr16:9,646,569...9,680,215
Ensembl chr16:9,640,312...9,673,957
G
Gnai2
G protein subunit alpha i2
IEP
RGD
PMID:11367746
RGD:13513922
NCBI chr 8:117,167,045...117,187,652
Ensembl chr 8:108,288,401...108,308,979
G
Gnai3
G protein subunit alpha i3
IEP
RGD
PMID:11367746
RGD:13513922
NCBI chr 2:198,430,920...198,468,874
Ensembl chr 2:195,742,642...195,780,742
G
Gpt
glutamic--pyruvic transaminase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:8215636
NCBI chr 7:110,295,599...110,300,134
Ensembl chr 7:108,416,642...108,419,494
G
Gpx1
glutathione peroxidase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23743330
NCBI chr 8:117,905,462...117,906,588
Ensembl chr 8:109,026,905...109,028,024
G
Gria1
glutamate ionotropic receptor AMPA type subunit 1
IEP
mRNA:decreased expression:hippocampus (rat)
RGD
PMID:20408958
RGD:4107069
NCBI chr10:41,710,540...42,030,105
Ensembl chr10:41,210,713...41,527,283
G
Grik2
glutamate ionotropic receptor kainate type subunit 2
IMP
RGD
PMID:17639597
RGD:2316528
NCBI chr20:53,717,564...54,415,283
Ensembl chr20:52,133,851...52,838,375
G
Grik5
glutamate ionotropic receptor kainate type subunit 5
IMP
RGD
PMID:17639597
RGD:2316528
NCBI chr 1:89,733,736...89,795,769
Ensembl chr 1:80,605,892...80,667,125
G
Grin2a
glutamate ionotropic receptor NMDA type subunit 2A
IEP
mRNA, protein:decreased expression:cerebral cortex, hippocampus (rat)
RGD
PMID:20350575
RGD:2325867
NCBI chr10:6,136,458...6,560,003
Ensembl chr10:5,631,369...6,044,637
G
Grin2b
glutamate ionotropic receptor NMDA type subunit 2B
IEP
mRNA, protein:decreased expression:cerebral cortex, hippocampus (rat)
RGD
PMID:20350575
RGD:2325867
NCBI chr 4:170,297,811...170,775,420
Ensembl chr 4:168,599,546...169,042,279
G
Gsr
glutathione-disulfide reductase
treatment
IEP
associated with Diabetes Mellitus, Experimental
RGD
PMID:24904723
RGD:10401882
NCBI chr16:65,185,574...65,228,742
Ensembl chr16:58,482,505...58,525,661
G
Gstp1
glutathione S-transferase pi 1
ISO
RGD
PMID:17142801
RGD:6903953
NCBI chr 1:210,767,237...210,770,242
Ensembl chr 1:201,321,672...201,340,226
G
Hbegf
heparin-binding EGF-like growth factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:7635938
NCBI chr18:28,380,337...28,390,220
Ensembl chr18:28,105,760...28,116,441
G
Hgf
hepatocyte growth factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16526316
NCBI chr 4:19,628,902...19,700,467
Ensembl chr 4:18,677,101...18,745,409
G
Hif1a
hypoxia inducible factor 1 subunit alpha
treatment
IDA
Spinal Cord Reperfusion Injury Limb Reperfusion Injury
RGD
PMID:16465055 PMID:23816242
RGD:9068924 , RGD:9068927
NCBI chr 6:98,357,788...98,405,068
Ensembl chr 6:92,624,390...92,669,261
G
Hmgb1
high mobility group box 1
treatment
IMP
RGD
PMID:22392147
RGD:10402071
NCBI chr12:11,009,236...11,015,941
Ensembl chr12:5,901,586...5,978,565 Ensembl chr16:5,901,586...5,978,565
G
Hmgcr
3-hydroxy-3-methylglutaryl-CoA reductase
IMP ISO
associated with Diabetes Mellitus, Experimental
RGD
PMID:21724106 PMID:16009498 PMID:18398369
RGD:5508445 , RGD:5508473 , RGD:2315888
NCBI chr 2:29,732,163...29,754,276
Ensembl chr 2:27,997,525...28,019,703
G
Hmox1
heme oxygenase 1
IDA ISO IEP IMP
CTD Direct Evidence: marker/mechanism|therapeutic protein:increased expression:serum, Bronchoalveolar Lavage Fluid
CTD RGD
PMID:12352873 PMID:16982915 PMID:17660127 PMID:17906103 PMID:23075401 PMID:25780291 PMID:16699460 PMID:19885035 PMID:12919086 More...
RGD:1582708 , RGD:4145338 , RGD:4145514
NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,467,244...13,474,079
G
Hrh3
histamine receptor H3
IDA
RGD
PMID:17169356
RGD:1626416
NCBI chr 3:187,569,174...187,575,263
Ensembl chr 3:167,191,558...167,196,642
G
Hspa1a
heat shock protein family A (Hsp70) member 1A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:7922267
NCBI chr20:3,875,411...3,877,866
Ensembl chr20:3,856,006...3,873,227
G
Hspa1b
heat shock protein family A (Hsp70) member 1B
ISO IEP
RGD
PMID:10965299 PMID:10550516
RGD:7242748 , RGD:7242749
NCBI chr20:3,859,756...3,863,800
Ensembl chr20:3,856,006...3,873,240 Ensembl chr20:3,856,006...3,873,240
G
Hspa5
heat shock protein family A (Hsp70) member 5
IMP
associated with Diabetes Mellitus, experimental (D003921): protein:increased expression:brain
RGD
PMID:22075494
RGD:5685650
NCBI chr 3:38,453,016...38,457,475
Ensembl chr 3:18,055,405...18,059,891
G
Hspa8
heat shock protein family A (Hsp70) member 8
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:10216529
NCBI chr 8:50,080,514...50,084,376
Ensembl chr 8:41,183,264...41,187,259
G
Hspb1
heat shock protein family B (small) member 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:19193722
NCBI chr12:26,430,640...26,432,301
Ensembl chr12:20,794,028...20,795,743
G
Icam1
intercellular adhesion molecule 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11557319 PMID:23743330
NCBI chr 8:27,829,688...27,841,618
Ensembl chr 8:19,553,645...19,565,438
G
Id3
inhibitor of DNA binding 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16526316
NCBI chr 5:153,656,253...153,657,860
Ensembl chr 5:148,372,762...148,374,349
G
Ifng
interferon gamma
IEP
protein:increased expression:plasma
RGD
PMID:19514843
RGD:2308950
NCBI chr 7:55,789,180...55,793,216
Ensembl chr 7:53,903,337...53,907,375
G
Igf1
insulin-like growth factor 1
ISO
RGD
PMID:16306169
RGD:1598442
NCBI chr 7:24,169,608...24,249,446
Ensembl chr 7:22,282,930...22,359,296
G
Il10
interleukin 10
IEP ISO IDA
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:18460982 PMID:19514843 PMID:12388354 PMID:16141682
RGD:2308950 , RGD:5508171 , RGD:1598625
NCBI chr13:45,024,921...45,029,586
Ensembl chr13:42,472,839...42,477,313
G
Il12a
interleukin 12A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16526316
NCBI chr 2:155,275,734...155,282,997
Ensembl chr 2:152,965,769...152,972,734
G
Il13
interleukin 13
IEP ISO
protein:decreased expression:plasma
RGD
PMID:18354382 PMID:18354382
RGD:2301685 , RGD:2301685
NCBI chr10:38,290,926...38,293,483
Ensembl chr10:37,790,130...37,792,737
G
Il18
interleukin 18
ISO
protein:increased expression:serum
RGD
PMID:19394645 PMID:16052682
RGD:4889555 , RGD:4889825
NCBI chr 8:59,802,072...59,829,275
Ensembl chr 8:50,906,960...50,932,887
G
Il1a
interleukin 1 alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23875703
NCBI chr 3:136,979,804...136,990,236
Ensembl chr 3:116,526,604...116,536,822
G
Il1b
interleukin 1 beta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:10594344 PMID:12468449 PMID:15829914 PMID:19058328 PMID:19673871
NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:116,577,010...116,583,415
G
Il6
interleukin 6
IEP ISO
CTD Direct Evidence: marker/mechanism protein:increased expression:lung
CTD RGD
PMID:15829914 PMID:17032661 PMID:18258783 PMID:19673871 PMID:21940958 PMID:20680426 PMID:20659747 More...
RGD:4143250 , RGD:4143253
NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,213,394...5,219,178
G
Il6r
interleukin 6 receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21940958
NCBI chr 2:177,582,020...177,646,705
Ensembl chr 2:175,298,686...175,347,536
G
Il6st
interleukin 6 cytokine family signal transducer
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21940958
NCBI chr 2:45,798,872...45,839,501
Ensembl chr 2:44,066,130...44,109,936
G
Inpp5d
inositol polyphosphate-5-phosphatase D
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:25780291
NCBI chr 9:95,735,533...95,840,584
Ensembl chr 9:88,287,677...88,392,746
G
Irak3
interleukin-1 receptor-associated kinase 3
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:25780291
NCBI chr 7:57,538,522...57,600,166
Ensembl chr 7:55,653,962...55,713,121
G
Irf1
interferon regulatory factor 1
IEP
mRNA:increased expression:cerebral cortex
RGD
PMID:12437578
RGD:632385
NCBI chr10:38,417,935...38,424,946
Ensembl chr10:37,916,670...37,924,166
G
Itga2b
integrin subunit alpha 2b
IMP
RGD
PMID:11705748
RGD:2316361
NCBI chr10:87,908,697...87,926,225
Ensembl chr10:87,408,536...87,426,168
G
Itga5
integrin subunit alpha 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16526316
NCBI chr 7:136,358,097...136,381,305
Ensembl chr 7:134,478,968...134,502,837
G
Itgb3
integrin subunit beta 3
IMP
RGD
PMID:11705748
RGD:2316361
NCBI chr10:90,009,927...90,067,787
Ensembl chr10:89,509,989...89,564,679
G
Jak2
Janus kinase 2
ISO
RGD
PMID:20440769
RGD:6483026
NCBI chr 1:236,408,905...236,468,769
Ensembl chr 1:226,995,334...227,054,189
G
Jun
Jun proto-oncogene, AP-1 transcription factor subunit
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:7922267
NCBI chr 5:115,009,900...115,012,993
Ensembl chr 5:109,893,145...109,897,656
G
Kcnj8
potassium inwardly-rectifying channel, subfamily J, member 8
IDA
RGD
PMID:10708603
RGD:1581697
NCBI chr 4:177,240,692...177,246,548
Ensembl chr 4:175,508,912...175,515,603
G
Kdr
kinase insert domain receptor
IEP ISO
mRNA:increased expression:hippocampus CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:16526316 PMID:17402857
RGD:5684415
NCBI chr14:32,572,031...32,615,204
Ensembl chr14:32,217,871...32,261,018
G
Keap1
Kelch-like ECH-associated protein 1
ISO IEP
protein:decreased expression:brain, neuron, cytoplasm (mouse) protein:decreased expression:left coronary artery (rat)
RGD
PMID:21075092 PMID:18078953
RGD:6893270 , RGD:6902919
NCBI chr 8:28,044,555...28,054,042
Ensembl chr 8:19,768,375...19,777,862
G
Klk1
kallikrein 1
IEP
RGD
PMID:12746231
RGD:1641806
NCBI chr 1:103,779,152...103,783,270
Ensembl chr 1:94,642,687...94,646,754
G
Ldlr
low density lipoprotein receptor
IEP
RGD
PMID:17288738
RGD:2324630
NCBI chr 8:28,546,191...28,569,075
Ensembl chr 8:20,270,041...20,294,580
G
Lep
leptin
IDA
RGD
PMID:21086559
RGD:5128549
NCBI chr 4:58,626,529...58,640,663
Ensembl chr 4:57,661,131...57,675,262
G
Manf
mesencephalic astrocyte-derived neurotrophic factor
IEP
protein:increased expression:brain
RGD
PMID:19773801
RGD:2325809
NCBI chr 8:116,427,053...116,430,259
Ensembl chr 8:107,548,352...107,551,438
G
Map2
microtubule-associated protein 2
IEP
protein:increased expression:serum
RGD
PMID:21948028
RGD:6483082
NCBI chr 9:75,173,038...75,431,606
Ensembl chr 9:67,723,371...67,979,809
G
Mapk8
mitogen-activated protein kinase 8
IDA ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:20302854 PMID:16699462
RGD:1582310
NCBI chr16:8,645,171...8,728,225
Ensembl chr16:8,638,924...8,721,981
G
Mapk8ip3
mitogen-activated protein kinase 8 interacting protein 3
IDA
protein:increased activity:hippocampus
RGD
PMID:16805806
RGD:2293339
NCBI chr10:14,422,936...14,463,387
Ensembl chr10:13,918,400...13,958,273
G
Mapk9
mitogen-activated protein kinase 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19667931 PMID:20302854
NCBI chr10:34,670,750...34,711,972
Ensembl chr10:34,169,675...34,210,178
G
Mb
myoglobin
ISO
RGD
PMID:12788661
RGD:1582427
NCBI chr 7:110,640,511...110,647,742
Ensembl chr 7:108,759,904...108,767,383
G
Mbl1
mannose binding lectin 1
ISO
protein:decreased expression:serum
RGD
PMID:16982912 PMID:15509537
RGD:1582132 , RGD:6903263
NCBI chr16:17,063,232...17,069,271
Ensembl chr16:17,029,118...17,035,174
G
Mbl2
mannose binding lectin 2
ISO
protein:increased expression:serum
RGD
PMID:15882434 PMID:15509537
RGD:6903262 , RGD:6903263
NCBI chr 1:237,429,873...237,465,567
G
Mc1r
melanocortin 1 receptor
no_association
ISO
RGD
PMID:18757499
RGD:5687323
NCBI chr19:68,360,950...68,363,877
Ensembl chr19:51,453,239...51,454,192
G
Mdk
midkine
ISO
RGD
PMID:15780085
RGD:1582475
NCBI chr 3:98,356,789...98,358,960
Ensembl chr 3:77,901,158...77,903,130
G
Met
MET proto-oncogene, receptor tyrosine kinase
IEP
mRNA:increased expression:retina (rat)
RGD
PMID:17113948
RGD:2317505
NCBI chr 4:46,756,823...46,864,041
Ensembl chr 4:45,790,791...45,897,876
G
Mif
macrophage migration inhibitory factor
disease_progression
ISO
RGD
PMID:18055556
RGD:4891010
NCBI chr20:12,767,138...12,791,222
Ensembl chr20:12,790,902...12,799,504 Ensembl chr 4:12,790,902...12,799,504
G
Mir148b
microRNA 148b
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30308185
NCBI chr 7:136,299,870...136,299,966
Ensembl chr 7:134,421,398...134,421,494
G
Mmp3
matrix metallopeptidase 3
IEP
protein:increased protein, activity:brain
RGD
PMID:15099024
RGD:2325962
NCBI chr 8:12,925,267...12,938,828
Ensembl chr 8:4,640,416...4,653,961
G
Mmp9
matrix metallopeptidase 9
ISO IMP
CTD Direct Evidence: marker/mechanism associated with lung injury; mRNA, protein:increased expression:lung protein:increased expression:limb muscle (mouse)
CTD RGD
PMID:23075401 PMID:16551680 PMID:19545667 PMID:16251419
RGD:1582618 , RGD:5129531 , RGD:1582631
NCBI chr 3:174,103,474...174,111,434
Ensembl chr 3:153,683,858...153,692,120
G
Mpo
myeloperoxidase
IEP ISO
protein:increased activity:lung CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:8869312 PMID:10706834 PMID:12024109 PMID:16971220 PMID:19058328 PMID:20863214 PMID:21470877 More...
RGD:5130958
NCBI chr10:73,092,124...73,102,057
Ensembl chr10:72,594,661...72,604,819
G
Mt-atp6
mitochondrially encoded ATP synthase membrane subunit 6
IEP
RGD
PMID:20450733
RGD:5490294
NCBI chr MT:7,919...8,599
Ensembl chr MT:7,919...8,599
G
Mt-atp8
mitochondrially encoded ATP synthase membrane subunit 8
IEP
RGD
PMID:20450733
RGD:5490294
NCBI chr MT:7,758...7,961
Ensembl chr MT:7,758...7,961
G
Mt-cyb
mitochondrially encoded cytochrome b
IEP
mRNA:decreased expression:kidney
RGD
PMID:7692737
RGD:2298967
NCBI chr MT:14,136...15,278
Ensembl chr MT:14,136...15,278
G
Mt2
metallothionein 2
ISO
mRNA:increased expression:cerebrum (mouse)
RGD
PMID:12122050
RGD:6483850
NCBI chr19:10,837,934...10,838,708
Ensembl chr19:10,832,002...10,832,784
G
Mt3
metallothionein 3
ISO
RGD
PMID:19635467
RGD:6480529
NCBI chr19:10,854,676...10,856,080
Ensembl chr19:10,848,755...10,850,158
G
Muc1
mucin 1, cell surface associated
IEP
RGD
PMID:23977093
RGD:7349380
NCBI chr 2:176,933,312...176,938,497
Ensembl chr 2:174,635,995...174,640,733
G
Myd88
MYD88, innate immune signal transduction adaptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25780291
NCBI chr 8:127,952,161...127,956,230
Ensembl chr 8:119,074,437...119,079,415
G
Nes
nestin
IEP
protein:increased expression:cerebral cortex
RGD
PMID:17569338
RGD:1642074
NCBI chr 2:175,735,715...175,745,631
Ensembl chr 2:173,438,734...173,447,777
G
Nod2
nucleotide-binding oligomerization domain containing 2
IEP
protein:increased expression:small intestine
RGD
PMID:20107953
RGD:5131440
NCBI chr19:34,555,832...34,596,281
Ensembl chr19:18,382,439...18,417,177
G
Nos1
nitric oxide synthase 1
IMP
RGD
PMID:17451676
RGD:1642142
NCBI chr12:44,276,011...44,456,371
Ensembl chr12:38,626,714...38,710,945
G
Nos2
nitric oxide synthase 2
IEP ISO
mRNA:increased expression:liver CTD Direct Evidence: marker/mechanism protein:increased expression:venule, arteriole, endothelium (mouse) mRNA, protein:increased expression:liver
CTD RGD
PMID:10383581 PMID:19673871 PMID:23061969 PMID:23075401 PMID:11592783 PMID:22019501 PMID:14599979 More...
RGD:2325259 , RGD:5509100 , RGD:1580938
NCBI chr10:64,313,335...64,349,221
Ensembl chr10:63,815,308...63,851,210
G
Nos3
nitric oxide synthase 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21968084
NCBI chr 4:11,686,088...11,706,604
Ensembl chr 4:10,793,834...10,814,166
G
Nox4
NADPH oxidase 4
IEP
mRNA:increased expression:cerebral cortex
RGD
PMID:18438942
RGD:2324666
NCBI chr 1:150,313,736...150,491,480
Ensembl chr 1:140,901,097...141,077,406
G
Oga
O-GlcNAcase
IMP
RGD
PMID:16899550
RGD:2305957
NCBI chr 1:254,547,311...254,589,596
Ensembl chr 1:244,598,292...244,634,359
G
Oprm1
opioid receptor, mu 1
IEP
mRNA, protein:decreased expression:hippocampus
RGD
PMID:17360495
RGD:2316611
NCBI chr 1:45,565,371...45,818,722
Ensembl chr 1:43,160,057...43,413,409
G
Otc
ornithine transcarbamylase
IEP
protein:increased activity:serum
RGD
PMID:1499453
RGD:4144083
NCBI chr X:15,126,358...15,202,473
Ensembl chr X:12,453,834...12,566,918
G
Oxt
oxytocin/neurophysin I prepropeptide
IMP
RGD
PMID:18403049
RGD:2304111
NCBI chr 3:138,235,754...138,236,594
Ensembl chr 3:117,782,650...117,783,490
G
Parp1
poly (ADP-ribose) polymerase 1
ISO IEP
CTD Direct Evidence: marker/mechanism protein:increased expression:liver (rat)
CTD RGD
PMID:15696051 PMID:16798486 PMID:9390645 PMID:21850691
RGD:5510018 , RGD:5510020
NCBI chr13:94,839,484...94,871,295
Ensembl chr13:92,307,586...92,339,404
G
Pcsk2
proprotein convertase subtilisin/kexin type 2
IEP ISO
RGD
PMID:19142196 PMID:19142196
RGD:6483555 , RGD:6483555
NCBI chr 3:151,333,938...151,636,628
Ensembl chr 3:130,880,422...131,183,127
G
Pde5a
phosphodiesterase 5A
IMP
RGD
PMID:19474186
RGD:2314462
NCBI chr 2:213,542,822...213,687,638
Ensembl chr 2:210,858,063...210,999,701
G
Pecam1
platelet and endothelial cell adhesion molecule 1
IMP IEP ISO
protein:decreased expression:lung (rat) protein:increased expression:brain (mouse)
RGD
PMID:12121711 PMID:21872880 PMID:22382321
RGD:2311660 , RGD:6771206 , RGD:6766379
NCBI chr10:92,090,263...92,152,002
Ensembl chr10:91,590,521...91,652,116
G
Pik3r1
phosphoinositide-3-kinase regulatory subunit 1
IEP
proetin:decreased dimerization:skeletal muscle (rat)
RGD
PMID:19100383
RGD:4108481
NCBI chr 2:34,612,946...34,697,660
Ensembl chr 2:32,882,032...32,963,631
G
Pink1
PTEN induced kinase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:35312153
NCBI chr 5:155,813,838...155,825,950
Ensembl chr 5:150,530,523...150,542,635
G
Pklr
pyruvate kinase L/R
IEP
RGD
PMID:17013507
RGD:1625588
NCBI chr 2:176,840,779...176,849,637
Ensembl chr 2:174,543,039...174,551,870
G
Pla2g2a
phospholipase A2 group IIA
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12967936
NCBI chr 5:156,359,725...156,362,302
Ensembl chr 5:151,076,442...151,079,014
G
Pla2g4a
phospholipase A2 group 4A
IDA
protein:increased activity:alveolar macrophage
RGD
PMID:1642455
RGD:1642456
NCBI chr13:64,427,921...64,572,352
Ensembl chr13:61,877,813...62,022,266
G
Plat
plasminogen activator, tissue type
IDA ISO
CTD Direct Evidence: therapeutic
CTD RGD
PMID:9472885 PMID:15223382
RGD:2311674
NCBI chr16:75,943,061...76,022,037
Ensembl chr16:69,240,585...69,268,223
G
Plau
plasminogen activator, urokinase
IEP ISO
protein:increased expression:spinal cord (rat) CTD Direct Evidence: therapeutic
CTD RGD
PMID:15181847 PMID:19663807 PMID:18586014
RGD:6483808 , RGD:6483830
NCBI chr15:3,505,485...3,511,987
Ensembl chr15:3,456,232...3,462,775
G
Plaur
plasminogen activator, urokinase receptor
ISO
RGD
PMID:18606671
RGD:6483829
NCBI chr 1:89,181,363...89,196,308
Ensembl chr 1:80,050,324...80,068,595
G
Pld2
phospholipase D2
IEP
protein:increased expression:hippocampus CA1, hippocampus granule cell layer mRNA:decreased expression:brainstem, cerebellum
RGD
PMID:17393174 PMID:17024567
RGD:2299901 , RGD:2299902
NCBI chr10:55,754,957...55,772,819
Ensembl chr10:55,256,359...55,272,808
G
Pnmt
phenylethanolamine-N-methyltransferase
ISO
protein:increased expression:medulla oblongata (human)
RGD
PMID:21061149
RGD:5128821
NCBI chr10:83,881,211...83,882,849
Ensembl chr10:83,384,923...83,386,556
G
Ppara
peroxisome proliferator activated receptor alpha
IDA ISO
liver ischemia/reperfusion injury CTD Direct Evidence: therapeutic
CTD RGD
PMID:19151258 PMID:21305343
RGD:5509942
NCBI chr 7:118,712,261...118,780,723
Ensembl chr 7:116,832,756...116,895,346
G
Pparg
peroxisome proliferator-activated receptor gamma
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:12468449 PMID:24011919 PMID:24433871
NCBI chr 4:150,095,743...150,221,104
Ensembl chr 4:148,423,194...148,548,468
G
Ppp3ca
protein phosphatase 3 catalytic subunit alpha
IDA
RGD
PMID:14762344
RGD:1580702
NCBI chr 2:227,839,058...228,113,560
Ensembl chr 2:225,165,766...225,438,974
G
Ppp3cb
protein phosphatase 3 catalytic subunit beta
ISO
RGD
PMID:14615291
RGD:1580705
NCBI chr15:3,809,182...3,854,204
Ensembl chr15:3,760,030...3,804,981
G
Prdx6
peroxiredoxin 6
ISO
RGD
PMID:16766642
RGD:1580710
NCBI chr13:76,062,082...76,072,631
Ensembl chr13:73,528,210...73,539,355
G
Prkca
protein kinase C, alpha
IMP
RGD
PMID:17905752
RGD:2292474
NCBI chr10:93,388,991...93,787,617
Ensembl chr10:92,894,012...93,288,012
G
Prss1
serine protease 1
IEP
RGD
PMID:11062314
RGD:1599961
NCBI chr 4:71,331,249...71,334,452
Ensembl chr 4:70,364,586...70,367,792
G
Ptafr
platelet-activating factor receptor
treatment
ISO IMP
RGD
PMID:12812996 PMID:11139461
RGD:1581279 , RGD:10043168
NCBI chr 5:150,049,322...150,079,060
Ensembl chr 5:144,765,976...144,795,251
G
Pten
phosphatase and tensin homolog
IMP ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:19038262 PMID:17239858
RGD:2292538
NCBI chr 1:240,043,707...240,110,330
Ensembl chr 1:230,630,338...230,696,838
G
Ptges
prostaglandin E synthase
IEP ISO
RGD
PMID:12431630 PMID:16864802
RGD:2300116 , RGD:2300094
NCBI chr 3:34,575,643...34,586,987
G
Ptgs1
prostaglandin-endoperoxide synthase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:10594344 PMID:16385084
RGD:5688223
NCBI chr 3:39,981,419...40,002,993
Ensembl chr 3:19,584,015...19,605,586
G
Ptgs2
prostaglandin-endoperoxide synthase 2
IEP ISO IMP IDA
protein:decreased expression:kidney CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:10588920 PMID:10594344 PMID:11567657 PMID:16386242 PMID:18258783 PMID:19673871 PMID:21394482 PMID:21944479 PMID:16247333 More...
RGD:5135045 , RGD:5508180 , RGD:1580660
NCBI chr13:64,714,063...64,722,320
Ensembl chr13:62,163,932...62,172,188
G
Ptk2
protein tyrosine kinase 2
IEP
protein:increased tyrosine phosphorylation:kidney
RGD
PMID:17620366
RGD:2292577
NCBI chr 7:107,015,730...107,220,865
Ensembl chr 7:105,126,728...105,331,783
G
Ptk2b
protein tyrosine kinase 2 beta
IDA
protein:increased phosphorylation:hippocampus
RGD
PMID:15970382
RGD:1642621
NCBI chr15:44,536,275...44,656,754
Ensembl chr15:40,360,723...40,481,282
G
Rela
RELA proto-oncogene, NF-kB subunit
IEP ISO
protein:increased expression:nucleus, liver CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:20302854 PMID:23743330 PMID:18621400
RGD:2298777
NCBI chr 1:212,354,336...212,364,815
Ensembl chr 1:202,924,945...202,935,484
G
S100b
S100 calcium binding protein B
IEP
RGD
PMID:18840784
RGD:5508834
NCBI chr20:12,372,345...12,381,159
Ensembl chr20:12,372,881...12,394,743
G
S1pr1
sphingosine-1-phosphate receptor 1
ISO
RGD
PMID:16403835
RGD:1580913
NCBI chr 2:206,309,715...206,314,070
Ensembl chr 2:203,621,587...203,629,681
G
Scfd1
sec1 family domain containing 1
IEP
protein:increased expression:cerebral cortex
RGD
PMID:9195952
RGD:633771
NCBI chr 6:74,531,225...74,609,463
Ensembl chr 6:68,795,878...68,874,078
G
Sele
selectin E
IEP ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:17112405 PMID:23743330 PMID:19489247
RGD:2313598
NCBI chr13:78,935,997...78,945,905
Ensembl chr13:76,403,304...76,412,741
G
Sell
selectin L
IEP
RGD
PMID:19489247
RGD:2313598
NCBI chr13:78,950,100...78,969,604
Ensembl chr13:76,416,915...76,436,456
G
Selp
selectin P
IEP ISO
RGD
PMID:18521901 PMID:21701413
RGD:2312314 , RGD:6218990
NCBI chr13:79,009,379...79,044,994
Ensembl chr13:76,476,295...76,511,845
G
Serpine2
serpin family E member 2
IEP
RGD
PMID:8261109
RGD:2317936
NCBI chr 9:88,573,138...88,637,252
Ensembl chr 9:81,124,804...81,188,826
G
Serping1
serpin family G member 1
treatment
ISO
RGD
PMID:23991040
RGD:8661644
NCBI chr 3:90,249,410...90,259,299
Ensembl chr 3:69,842,739...69,852,034
G
Sftpc
surfactant protein C
IDA
mRNA:decreased expression:lung
RGD
PMID:20560845
RGD:4144062
NCBI chr15:52,006,274...52,009,324
Ensembl chr15:45,596,574...45,610,777
G
Si
sucrase-isomaltase
IEP
RGD
PMID:9724271
RGD:1625550
NCBI chr 2:159,804,568...159,884,902
Ensembl chr 2:157,506,342...157,585,260
G
Sirt7
sirtuin 7
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:28675767
NCBI chr10:106,394,802...106,401,627
Ensembl chr10:105,896,476...105,903,172
G
Slc2a1
solute carrier family 2 member 1
IEP
mRNA, protein:increased expression:brain
RGD
PMID:19781384
RGD:2313601
NCBI chr 5:138,002,522...138,030,742
Ensembl chr 5:132,717,196...132,745,416
G
Slc2a3
solute carrier family 2 member 3
IEP
mRNA, protein:increased expression:brain
RGD
PMID:19781384
RGD:2313601
NCBI chr 4:157,632,887...157,698,034
Ensembl chr 4:155,960,946...156,025,472
G
Slc30a4
solute carrier family 30 member 4
IEP
mRNA:increased expression:brain
RGD
PMID:18289514
RGD:2299950
NCBI chr 3:130,206,852...130,228,888
Ensembl chr 3:109,753,273...109,775,306
G
Slc34a1
solute carrier family 34 member 1
IEP
protein:decreased expression:renal proximal tubule
RGD
PMID:15775707
RGD:2311304
NCBI chr17:9,224,010...9,238,983
Ensembl chr17:9,218,876...9,233,852
G
Slc6a11
solute carrier family 6 member 11
IEP
RGD
PMID:13678673
RGD:1299345
NCBI chr 4:148,853,557...148,968,895
Ensembl chr 4:147,297,969...147,413,443
G
Slc8a1
solute carrier family 8 member A1
IEP
RGD
PMID:18037393
RGD:2316975
NCBI chr 6:18,975,498...19,299,704
Ensembl chr 6:13,194,662...13,535,628
G
Slc8a2
solute carrier family 8 member A2
IEP
RGD
PMID:18037393
RGD:2316975
NCBI chr 1:85,944,752...85,982,900
Ensembl chr 1:76,808,725...76,847,072
G
Slc8a3
solute carrier family 8 member A3
IEP
RGD
PMID:18037393
RGD:2316975
NCBI chr 6:106,605,611...106,739,208
Ensembl chr 6:100,874,369...101,007,508
G
Slc9a1
solute carrier family 9 member A1
IMP ISO
CTD Direct Evidence: therapeutic
CTD RGD
PMID:19027022 PMID:20337040
RGD:6771332
NCBI chr 5:150,859,412...150,913,525
Ensembl chr 5:145,576,334...145,629,624
G
Slco1b2
solute carrier organic anion transporter family member 1B2
IEP
mRNA:decreased expression:liver
RGD
PMID:16858290
RGD:2303111
NCBI chr 4:176,282,577...176,355,557
Ensembl chr 4:174,551,480...174,619,981
G
Slk
STE20-like kinase
IEP
protein:increased expression:kidney
RGD
PMID:12965890
RGD:2304069
NCBI chr 1:256,415,013...256,470,942
Ensembl chr 1:246,473,712...246,526,530
G
Slpi
secretory leukocyte peptidase inhibitor
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:8215636
NCBI chr 3:173,501,573...173,503,822
Ensembl chr 3:153,082,369...153,084,453
G
Socs1
suppressor of cytokine signaling 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:25780291
NCBI chr10:5,389,574...5,391,265
Ensembl chr10:4,882,560...4,884,383
G
Socs3
suppressor of cytokine signaling 3
IDA
associated with Brain Ischemia;mRNA, protein:increased expression:cerebral cortex
RGD
PMID:12437578
RGD:632385
NCBI chr10:103,692,579...103,695,975
Ensembl chr10:103,193,537...103,197,787
G
Socs4
suppressor of cytokine signaling 4
IEP
mRNA:increased expression:hippocampus
RGD
PMID:17880360
RGD:2303397
NCBI chr15:23,003,130...23,017,615
Ensembl chr15:20,523,183...20,542,494
G
Sod1
superoxide dismutase 1
ISO
CTD Direct Evidence: marker/mechanism|therapeutic
CTD RGD
PMID:15364863 PMID:16397181 PMID:23061969 PMID:23743330 PMID:15364863
RGD:1580834
NCBI chr11:42,942,742...42,948,399
Ensembl chr11:29,456,558...29,462,249
G
Sod2
superoxide dismutase 2
IEP ISO
protein:increased expression:liver CTD Direct Evidence: marker/mechanism|therapeutic
CTD RGD
PMID:8215636 PMID:16682413 PMID:19193722 PMID:19917352 PMID:21940958 PMID:23743330 PMID:15612529 PMID:15087276 More...
RGD:1582141 , RGD:1581259
NCBI chr 1:50,043,323...50,050,168
Ensembl chr 1:47,636,528...47,645,189
G
Sod3
superoxide dismutase 3
ISO
RGD
PMID:15778274
RGD:1581264
NCBI chr14:62,822,865...62,828,602
Ensembl chr14:58,609,958...58,615,990
G
Spp1
secreted phosphoprotein 1
ISO
RGD
PMID:20548025
RGD:6903275
NCBI chr14:5,613,569...5,620,695
Ensembl chr14:5,308,885...5,315,162
G
Src
SRC proto-oncogene, non-receptor tyrosine kinase
IEP
protein:increased phosphorylation:hippocampus CA1 (rat)
RGD
PMID:20197063
RGD:2325012
NCBI chr 3:166,511,616...166,559,463
Ensembl chr 3:146,091,841...146,139,476
G
Stat1
signal transducer and activator of transcription 1
IDA IEP
protein:increased serine phosphorylation:brain protein:increased phosphorylation:kidney
RGD
PMID:15262323 PMID:17670769
RGD:1600103 , RGD:2291900
NCBI chr 9:56,911,522...56,951,926
Ensembl chr 9:49,419,340...49,588,540
G
Stat2
signal transducer and activator of transcription 2
IEP
mRNA:increased expression:hippocampus
RGD
PMID:17880360
RGD:2303397
NCBI chr 7:1,287,025...1,302,858
Ensembl chr 7:702,495...718,967
G
Stat3
signal transducer and activator of transcription 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21940958
NCBI chr10:86,311,528...86,363,513
Ensembl chr10:85,811,218...85,863,057
G
Stat5a
signal transducer and activator of transcription 5A
IEP
mRNA:increased expression:hippocampus
RGD
PMID:17880360
RGD:2303397
NCBI chr10:86,285,859...86,310,187
Ensembl chr10:85,785,537...85,809,866
G
Stat5b
signal transducer and activator of transcription 5B
IEP
mRNA:increased expression:hippocampus
RGD
PMID:17880360
RGD:2303397
NCBI chr10:86,205,148...86,276,178
Ensembl chr10:85,705,670...85,775,668
G
Stat6
signal transducer and activator of transcription 6
IEP
mRNA:increased expression:hippocampus
RGD
PMID:17880360
RGD:2303397
NCBI chr 7:65,365,505...65,382,825
Ensembl chr 7:63,479,642...63,498,495
G
Stc1
stanniocalcin 1
IEP
mRNA:increased expression:cerebral cortex
RGD
PMID:15485913
RGD:2324700
NCBI chr15:50,709,439...50,720,093
Ensembl chr15:44,299,621...44,310,264
G
Stc2
stanniocalcin 2
IEP
mRNA, protein:increased expression:cerebral cortex
RGD
PMID:15485913
RGD:2324700
NCBI chr10:16,755,508...16,765,275
Ensembl chr10:16,250,853...16,262,973
G
Sult1e1
sulfotransferase family 1E member 1
IEP ISO
protein:increased expression:serum CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:25922074 PMID:16908442
RGD:2302564
NCBI chr14:20,700,444...20,718,719
Ensembl chr14:20,422,324...20,439,275
G
Tbxas1
thromboxane A synthase 1
IDA
associated with Cholestasis, Extrahepatic
RGD
PMID:15000260 PMID:8680115
RGD:1601451 , RGD:1601475
NCBI chr 4:68,631,841...68,803,959
Ensembl chr 4:67,665,007...67,837,096
G
Tert
telomerase reverse transcriptase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16968891
NCBI chr 1:31,465,766...31,488,650
Ensembl chr 1:29,637,506...29,659,561
G
Tfam
transcription factor A, mitochondrial
IDA
RGD
PMID:22266265
RGD:6767573
NCBI chr20:17,355,373...17,367,422
Ensembl chr20:17,356,197...17,368,292
G
Tgfbr2
transforming growth factor, beta receptor 2
IEP
RGD
PMID:15613744
RGD:1579926
NCBI chr 8:124,672,677...124,761,741
Ensembl chr 8:115,794,537...115,883,228
G
Th
tyrosine hydroxylase
ISO
protein:increased expression:medulla oblongata (human)
RGD
PMID:21061149
RGD:5128821
NCBI chr 1:207,500,959...207,508,276
Ensembl chr 1:198,071,503...198,109,767
G
Thbd
thrombomodulin
ISO
RGD
PMID:19342415
RGD:5131887
NCBI chr 3:156,316,526...156,320,178
Ensembl chr 3:135,862,835...135,867,193
G
Thbs1
thrombospondin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16526316
NCBI chr 3:125,510,250...125,525,402
Ensembl chr 3:105,056,292...105,071,440
G
Thy1
Thy-1 cell surface antigen
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23075401
NCBI chr 8:53,286,396...53,291,541
Ensembl chr 8:44,389,513...44,394,659
G
Ticam1
TIR domain containing adaptor molecule 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25780291
NCBI chr 9:1,189,717...1,197,730
Ensembl chr 9:1,102,366...1,123,147
G
Timp3
TIMP metallopeptidase inhibitor 3
IEP
protein:decreased expression:brain
RGD
PMID:17551674
RGD:2290424
NCBI chr 7:19,408,539...19,459,558
Ensembl chr 7:17,521,919...17,571,839
G
Tjp1
tight junction protein 1
IEP
protein:decreased expression:brain, endothelial cell
RGD
PMID:19374856 PMID:19929946
RGD:2325135 , RGD:2325127
NCBI chr 1:128,260,330...128,505,018
Ensembl chr 1:118,849,838...119,094,432
G
Tlr2
toll-like receptor 2
IEP ISO
mRNA, protein:increased expression:kidney CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:25780291 PMID:15912106
RGD:2312727
NCBI chr 2:171,499,189...171,504,831
Ensembl chr 2:169,197,419...169,206,630
G
Tlr3
toll-like receptor 3
IEP
protein:increased expression:liver (rat)
RGD
PMID:21355876
RGD:5128693
NCBI chr16:53,554,916...53,572,321
Ensembl chr16:46,822,039...46,836,545
G
Tlr4
toll-like receptor 4
IEP ISO
protein:increased expression:liver CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:25780291 PMID:27064547 PMID:19473433 PMID:17126102
RGD:2312503 , RGD:4144169
NCBI chr 5:85,161,247...85,174,882
Ensembl chr 5:80,145,826...80,159,628
G
Tmbim6
transmembrane BAX inhibitor motif containing 6
IEP
protein:increased expression:liver
RGD
PMID:18005084
RGD:2291961
NCBI chr 7:132,405,217...132,422,492
Ensembl chr 7:130,527,316...130,543,633
G
Tnf
tumor necrosis factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:10706834 PMID:12024109 PMID:15829914 PMID:16971220 PMID:17112405 PMID:18460982 PMID:19058328 PMID:23743330 PMID:23875703 PMID:24898700 More...
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,622,011...3,624,629
G
Tnfrsf1a
TNF receptor superfamily member 1A
IEP
RGD
PMID:17109621
RGD:1624182
NCBI chr 4:159,837,119...159,849,817
Ensembl chr 4:158,150,820...158,163,591
G
Tp53
tumor protein p53
IEP
protein:increased expression:brain, mitochondrion
RGD
PMID:17661174
RGD:2290568
NCBI chr10:54,798,871...54,810,300
Ensembl chr10:54,300,048...54,311,524
G
Trpc6
transient receptor potential cation channel, subfamily C, member 6
treatment
IDA
RGD
PMID:20554625
RGD:4891135
NCBI chr 8:14,044,216...14,148,808
Ensembl chr 8:5,758,935...5,828,092
G
Trpm7
transient receptor potential cation channel, subfamily M, member 7
IEP
mRNA,protein:increased expression:hippocampus
RGD
PMID:18395621
RGD:5684390
NCBI chr 3:134,499,617...134,588,113
Ensembl chr 3:114,046,258...114,135,190
G
Txn1
thioredoxin 1
IEP
mRNA:decreased expression:cerebral cortex
RGD
PMID:19128823
RGD:5685030
NCBI chr 5:77,507,455...77,519,685
Ensembl chr 5:72,711,933...72,724,629
G
Txn2
thioredoxin 2
IEP
mRNA:decreased expression:cerebral cortex
RGD
PMID:19128823
RGD:5685030
NCBI chr 7:111,377,338...111,390,940
Ensembl chr 7:109,496,761...109,510,359
G
Txnrd1
thioredoxin reductase 1
IEP
mRNA:decreased expression:cerebral cortex mRNA:decreased expression:spinal cord
RGD
PMID:19128823 PMID:19409971
RGD:5685030 , RGD:5685028
NCBI chr 7:22,717,620...22,802,553
Ensembl chr 7:20,830,045...20,907,863
G
Txnrd2
thioredoxin reductase 2
IEP
mRNA:decreased expression:cerebral cortex
RGD
PMID:19128823
RGD:5685030
NCBI chr11:96,024,321...96,072,475
Ensembl chr11:82,519,999...82,568,156
G
Vcam1
vascular cell adhesion molecule 1
IEP
mRNA:increased expression:kidney
RGD
PMID:18813897
RGD:2313108
NCBI chr 2:206,723,050...206,742,783
Ensembl chr 2:204,038,114...204,057,958
G
Vegfc
vascular endothelial growth factor C
IEP
RGD
PMID:18704465
RGD:2315487
NCBI chr16:44,445,293...44,560,887
Ensembl chr16:37,712,262...37,827,848
G
Vegfd
vascular endothelial growth factor D
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16526316
NCBI chr X:33,704,582...33,740,305
Ensembl chr X:30,074,163...30,108,295
G
Vim
vimentin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23075401
NCBI chr17:81,577,261...81,585,746
Ensembl chr17:76,668,647...76,677,187
G
Vip
vasoactive intestinal peptide
ISO
RGD
PMID:21693218
RGD:5685379
NCBI chr 1:44,470,232...44,478,561
Ensembl chr 1:42,065,120...42,073,216
G
Wnt3a
Wnt family member 3A
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:23875703
NCBI chr10:44,533,734...44,577,919
Ensembl chr10:44,034,194...44,078,324
G
Xdh
xanthine dehydrogenase
treatment
IDA ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:12910483 PMID:23403765
RGD:7247700
NCBI chr 6:27,282,319...27,344,022
Ensembl chr 6:21,530,113...21,592,268
G
Zfp354a
zinc finger protein 354A
IEP
mRNA:decreased expression:kidney
RGD
PMID:8382778
RGD:1300202
NCBI chr10:35,897,217...35,909,063
Ensembl chr10:35,396,231...35,408,068
G
Apaf1
apoptotic peptidase activating factor 1
treatment
IDA
RGD
PMID:22143029
RGD:5686888
NCBI chr 7:27,381,392...27,466,772
Ensembl chr 7:25,494,609...25,579,540
G
Bad
BCL2-associated agonist of cell death
treatment
IDA
RGD
PMID:23056591
RGD:10053711
NCBI chr 1:213,562,719...213,572,034
Ensembl chr 1:204,131,501...204,142,823
G
Bax
BCL2 associated X, apoptosis regulator
treatment
IEP
RGD
PMID:23056591
RGD:10053711
NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:95,938,808...95,945,368
G
Bcl2
BCL2, apoptosis regulator
treatment
IDA
RGD
PMID:25535961
RGD:11522737
NCBI chr13:23,204,464...23,366,900
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
Bcl2l1
Bcl2-like 1
treatment
IEP
RGD
PMID:23056591
RGD:10053711
NCBI chr 3:161,713,777...161,764,844
Ensembl chr 3:141,253,523...141,303,479 Ensembl chr 1:141,253,523...141,303,479
G
Bdnf
brain-derived neurotrophic factor
ISO
RGD
PMID:10549664
RGD:8655861
NCBI chr 3:116,619,633...116,670,212
Ensembl chr 3:96,165,042...96,215,615
G
Casp7
caspase 7
IEP
RGD
PMID:20702827
RGD:5684535
NCBI chr 1:265,442,647...265,481,938
Ensembl chr 1:255,437,172...255,476,729
G
Cat
catalase
treatment
IEP
protein:decreased expression,decreased activity:retina:
RGD
PMID:22509733
RGD:9068919
NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:89,842,399...89,874,478
G
Ccl2
C-C motif chemokine ligand 2
treatment
IDA
RGD
PMID:24325836
RGD:11526144
NCBI chr10:67,503,077...67,504,875
Ensembl chr10:67,005,424...67,007,226
G
Clu
clusterin
IEP
RGD
PMID:15139011
RGD:1581194
NCBI chr15:44,336,619...44,375,861
Ensembl chr15:40,174,617...40,200,315
G
Cntf
ciliary neurotrophic factor
treatment
IDA
RGD
PMID:8125754
RGD:8655591
NCBI chr 1:219,312,512...219,314,535
Ensembl chr 1:209,887,854...209,889,877
G
Dusp1
dual specificity phosphatase 1
treatment
IMP
RGD
PMID:21094639
RGD:7495849
NCBI chr10:17,184,853...17,187,646
G
Fgf2
fibroblast growth factor 2
treatment
IEP ISO
RGD
PMID:9561364 PMID:8125754 PMID:14975212
RGD:8554857 , RGD:8655591 , RGD:8655585
NCBI chr 2:122,164,454...122,218,796
Ensembl chr 2:120,236,328...120,291,221
G
Fxn
frataxin
ameliorates
ISO
RGD
PMID:27537261 PMID:27537261
RGD:401793704 , RGD:401793704
NCBI chr 1:231,300,457...231,323,989
Ensembl chr 1:221,872,420...221,897,540
G
Glul
glutamate-ammonia ligase
treatment
IEP
RGD
PMID:22008240
RGD:401794422
NCBI chr13:68,519,500...68,585,554
Ensembl chr13:66,025,630...66,035,108
G
Hdac2
histone deacetylase 2
treatment
ISO
RGD
PMID:23696608
RGD:9590210
NCBI chr20:42,101,815...42,126,486
Ensembl chr20:40,548,250...40,571,609
G
Hgf
hepatocyte growth factor
treatment
ISO IEP
mRNA,protein:increased expression:retina:
RGD
PMID:11818401 PMID:11818401
RGD:8548551 , RGD:8548551
NCBI chr 4:19,628,902...19,700,467
Ensembl chr 4:18,677,101...18,745,409
G
Hmgb1
high mobility group box 1
IDA
RGD
PMID:21999229
RGD:10402064
NCBI chr12:11,009,236...11,015,941
Ensembl chr12:5,901,586...5,978,565 Ensembl chr16:5,901,586...5,978,565
G
Hmox1
heme oxygenase 1
IEP
associated with Glaucoma
RGD
PMID:20357190
RGD:4145289
NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,467,244...13,474,079
G
Hspb1
heat shock protein family B (small) member 1
IDA
RGD
PMID:21310899
RGD:10402767
NCBI chr12:26,430,640...26,432,301
Ensembl chr12:20,794,028...20,795,743
G
Icam1
intercellular adhesion molecule 1
treatment
IMP IEP
associated with Hypertension
RGD
PMID:10235552 PMID:15007035
RGD:8547704 , RGD:8547707
NCBI chr 8:27,829,688...27,841,618
Ensembl chr 8:19,553,645...19,565,438
G
Il1a
interleukin 1 alpha
IEP
RGD
PMID:7890488
RGD:7401191
NCBI chr 3:136,979,804...136,990,236
Ensembl chr 3:116,526,604...116,536,822
G
Il1b
interleukin 1 beta
IEP
RGD
PMID:7890488
RGD:7401191
NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:116,577,010...116,583,415
G
Il6
interleukin 6
IEP
mRNA:increased expression:retina:
RGD
PMID:16530172
RGD:7829807
NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,213,394...5,219,178
G
Kcnj10
potassium inwardly-rectifying channel, subfamily J, member 10
IEP ISO
mRNA:decreased expression:retina protein:decreased expression:retina, blood vessel
RGD
PMID:16330144 PMID:20132867
RGD:8662868 , RGD:8662890
NCBI chr13:87,334,510...87,367,747
Ensembl chr13:84,802,009...84,835,461
G
Lpar1
lysophosphatidic acid receptor 1
IEP
protein:increased expression:retina
RGD
PMID:17026968
RGD:2317696
NCBI chr 5:78,024,139...78,147,071
Ensembl chr 5:73,229,625...73,369,895
G
Map2k4
mitogen activated protein kinase kinase 4
IEP
RGD
PMID:19668425
RGD:7495824
NCBI chr10:50,842,348...50,947,063
Ensembl chr10:50,344,915...50,447,993
G
Nos3
nitric oxide synthase 3
treatment
IEP IDA
mRNA:altered expression:retina (rat) protein:increased expression:retinal vasculature, retinal ganglion cell layer (rat)
RGD
PMID:9950605 PMID:11496119 PMID:12634478
RGD:7771570 , RGD:7775036 , RGD:7775037
NCBI chr 4:11,686,088...11,706,604
Ensembl chr 4:10,793,834...10,814,166
G
Opa1
OPA1, mitochondrial dynamin like GTPase
IEP
protein:increased expression:retina, cytosol (rat)
RGD
PMID:19122832
RGD:13208943
NCBI chr11:84,612,943...84,690,025
Ensembl chr11:71,109,873...71,185,109
G
Ren
renin
treatment
IMP
RGD
PMID:24709336
RGD:11039406
NCBI chr13:47,348,312...47,359,539
Ensembl chr13:44,796,091...44,807,489
G
Rnf2
ring finger protein 2
IEP
RGD
PMID:20740046
RGD:9491844
NCBI chr13:66,103,943...66,136,038
Ensembl chr13:63,554,862...63,583,099
G
Serpinf1
serpin family F member 1
ISO
human protein in a mouse model
RGD
PMID:16822505
RGD:8554871
NCBI chr10:60,748,504...60,760,898
Ensembl chr10:60,249,708...60,262,646
G
Sod2
superoxide dismutase 2
treatment
IEP ISO
protein:decreased activity:retina:
RGD
PMID:22240151 PMID:22240151
RGD:8158043 , RGD:8158043
NCBI chr 1:50,043,323...50,050,168
Ensembl chr 1:47,636,528...47,645,189
G
Stat3
signal transducer and activator of transcription 3
treatment
IDA
RGD
PMID:21858029
RGD:8694310
NCBI chr10:86,311,528...86,363,513
Ensembl chr10:85,811,218...85,863,057
G
Tlr4
toll-like receptor 4
ISO
RGD
PMID:21031135
RGD:7794771
NCBI chr 5:85,161,247...85,174,882
Ensembl chr 5:80,145,826...80,159,628
G
Tnf
tumor necrosis factor
IEP IMP IDA
protein:increased expression:retina:
RGD
PMID:18660426 PMID:18660426 PMID:18660426
RGD:7387281 , RGD:7387281 , RGD:7387281
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,622,011...3,624,629
G
Vegfa
vascular endothelial growth factor A
IDA
RGD
PMID:17591953
RGD:7421609
NCBI chr 9:22,452,854...22,468,194
Ensembl chr 9:14,955,300...14,970,641
G
Xdh
xanthine dehydrogenase
treatment
IMP
RGD
PMID:9288448
RGD:13210506
NCBI chr 6:27,282,319...27,344,022
Ensembl chr 6:21,530,113...21,592,268
G
H19
H19 imprinted maternally expressed transcript
ameliorates
ISO
RGD
PMID:31127201
RGD:242905201
NCBI chr 1:207,160,175...207,162,851
Ensembl chr 1:197,730,698...197,733,134
G
Hif1a
hypoxia inducible factor 1 subunit alpha
treatment
IEP
RGD
PMID:23537149
RGD:10755711
NCBI chr 6:98,357,788...98,405,068
Ensembl chr 6:92,624,390...92,669,261
G
Hmox1
heme oxygenase 1
treatment
IEP
RGD
PMID:23537149
RGD:10755711
NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,467,244...13,474,079
G
Mmp9
matrix metallopeptidase 9
treatment
IEP
RGD
PMID:23537149
RGD:10755711
NCBI chr 3:174,103,474...174,111,434
Ensembl chr 3:153,683,858...153,692,120
G
Ngb
neuroglobin
IEP
associated with Ocular Hypertension;protein:increased expression:retina
RGD
PMID:22553688
RGD:9854634
NCBI chr 6:112,475,332...112,480,786
Ensembl chr 6:106,744,378...106,749,830
G
Ptger4
prostaglandin E receptor 4
IEP
protein:decreased expression:retina (rat)
RGD
PMID:12821538
RGD:9850261
NCBI chr 2:56,061,699...56,074,594
Ensembl chr 2:54,335,424...54,346,670
G
Thy1
Thy-1 cell surface antigen
treatment
IEP
RGD
PMID:23537149
RGD:10755711
NCBI chr 8:53,286,396...53,291,541
Ensembl chr 8:44,389,513...44,394,659
G
Vegfa
vascular endothelial growth factor A
treatment
IEP
RGD
PMID:23537149
RGD:10755711
NCBI chr 9:22,452,854...22,468,194
Ensembl chr 9:14,955,300...14,970,641
G
Elane
elastase, neutrophil expressed
IMP
RGD
PMID:7858993
RGD:10450555
NCBI chr 7:10,467,877...10,469,725
Ensembl chr 7:9,817,252...9,819,100
G
Itgam
integrin subunit alpha M
treatment
IEP
RGD
PMID:26315464 PMID:19105227
RGD:329901918 , RGD:329902055
NCBI chr 1:192,089,496...192,139,947
Ensembl chr 1:182,659,000...182,709,503
G
Serping1
serpin family G member 1
treatment
ISO
RGD
PMID:29395422 PMID:24585935
RGD:13525001 , RGD:13542089
NCBI chr 3:90,249,410...90,259,299
Ensembl chr 3:69,842,739...69,852,034
G
Bad
BCL2-associated agonist of cell death
treatment
IDA
RGD
PMID:23643992
RGD:10053660
NCBI chr 1:213,562,719...213,572,034
Ensembl chr 1:204,131,501...204,142,823
G
Bdnf
brain-derived neurotrophic factor
treatment
IEP
RGD
PMID:24361987
RGD:10059358
NCBI chr 3:116,619,633...116,670,212
Ensembl chr 3:96,165,042...96,215,615
G
Becn1
beclin 1
treatment
IEP
RGD
PMID:25374587
RGD:11561952
NCBI chr10:86,731,649...86,747,002
Ensembl chr10:86,231,388...86,246,742
G
Cdk5
cyclin-dependent kinase 5
treatment
IDA
RGD
PMID:25301568
RGD:13782374
NCBI chr 4:11,647,098...11,651,606
Ensembl chr 4:10,754,687...10,760,112
G
Cdk5r1
cyclin-dependent kinase 5 regulatory subunit 1
treatment
IEP
RGD
PMID:25301568
RGD:13782374
NCBI chr10:65,981,692...65,985,831
Ensembl chr10:65,483,941...65,488,456
G
Creb1
cAMP responsive element binding protein 1
treatment
IEP
RGD
PMID:17368520 PMID:29310813
RGD:155226865 , RGD:155226868
NCBI chr 9:73,397,333...73,466,339
Ensembl chr 9:65,903,547...65,970,816
G
Cxcl12
C-X-C motif chemokine ligand 12
IMP
RGD
PMID:27760212
RGD:12910551
NCBI chr 4:152,060,781...152,073,628
Ensembl chr 4:150,388,325...150,401,168
G
Cxcr4
C-X-C motif chemokine receptor 4
IMP
RGD
PMID:27760212
RGD:12910551
NCBI chr13:42,630,383...42,634,288
Ensembl chr13:40,077,976...40,081,883
G
Gapdh
glyceraldehyde-3-phosphate dehydrogenase
treatment
IEP
RGD
PMID:30195603
RGD:13792615
NCBI chr 4:159,648,592...159,653,436
Ensembl chr 4:157,962,343...157,966,235
G
Hspa5
heat shock protein family A (Hsp70) member 5
treatment
IEP
protein:increased expression:spinal cord:
RGD
PMID:24463125
RGD:11354961
NCBI chr 3:38,453,016...38,457,475
Ensembl chr 3:18,055,405...18,059,891
G
Proc
protein C, inactivator of coagulation factors Va and VIIIa
treatment
ISO
RGD
PMID:10903607
RGD:11100044
NCBI chr18:24,038,596...24,049,061
Ensembl chr18:23,764,368...23,775,133
G
Siah1
siah E3 ubiquitin protein ligase 1
treatment
IEP
RGD
PMID:30195603
RGD:13792615
NCBI chr19:36,552,165...36,575,773
Ensembl chr19:20,378,439...20,403,808
G
Tlr4
toll-like receptor 4
IMP
RGD
PMID:27760212
RGD:12910551
NCBI chr 5:85,161,247...85,174,882
Ensembl chr 5:80,145,826...80,159,628
G
Abcb1a
ATP binding cassette subfamily B member 1A
treatment
ISO
DNA:SNPs: :rs1045642,rs7779562(human)
RGD
PMID:25217066
RGD:14700903
NCBI chr 4:26,312,403...26,488,456
Ensembl chr 4:25,158,362...25,442,709
G
Atp5mc2
ATP synthase membrane subunit c locus 2
severity
ISO
RGD
PMID:27441480
RGD:14696800
NCBI chr 7:135,669,847...135,680,839
Ensembl chr 7:133,791,342...133,799,733
G
Ccn1
cellular communication network factor 1
sexual_dimorphism
ISO
protein:increased expression:blood serum (human)
RGD
PMID:34597881
RGD:329845519
NCBI chr 2:237,222,730...237,225,689
Ensembl chr 2:234,562,408...234,565,484
G
Lgals3
galectin 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29769800
NCBI chr15:23,099,795...23,111,731
Ensembl chr15:20,607,692...20,632,025
G
Mir208a
microRNA 208a
severity
IEP
miRNA:increased expression:blood
RGD
PMID:32458401
RGD:213230165
NCBI chr15:32,395,552...32,395,634
G
F7
coagulation factor VII
ISO
protein:increased activity:plasma (human)
RGD
PMID:17357481
RGD:11049525
NCBI chr16:83,191,896...83,202,775
Ensembl chr16:76,489,717...76,500,610
G
Mir126a
microRNA 126a
ISO
RNA:decreased expression:plasma
RGD
PMID:27900989
RGD:401850572
NCBI chr 3:29,813,150...29,813,267
Ensembl chr 3:9,415,063...9,415,180
G
Mmp9
matrix metallopeptidase 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20981132
NCBI chr 3:174,103,474...174,111,434
Ensembl chr 3:153,683,858...153,692,120
G
Rbp4
retinol binding protein 4
ISO
protein:increased expression:blood serum (human)
RGD
PMID:25142320
RGD:329845867
NCBI chr 1:245,306,349...245,313,551
Ensembl chr 1:235,893,917...235,901,399
G
Tlr4
toll-like receptor 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20981132
NCBI chr 5:85,161,247...85,174,882
Ensembl chr 5:80,145,826...80,159,628
G
Tnf
tumor necrosis factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20981132
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,622,011...3,624,629
G
Apaf1
apoptotic peptidase activating factor 1
treatment
IEP
RGD
PMID:27748062
RGD:13703108
NCBI chr 7:27,381,392...27,466,772
Ensembl chr 7:25,494,609...25,579,540
G
Bax
BCL2 associated X, apoptosis regulator
IEP
RGD
PMID:26754107
RGD:11555349
NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:95,938,808...95,945,368
G
Bcl2
BCL2, apoptosis regulator
IEP
RGD
PMID:26754107
RGD:11555349
NCBI chr13:23,204,464...23,366,900
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
Casp3
caspase 3
IEP
RGD
PMID:26754107
RGD:11555349
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:45,662,910...45,684,648
G
Casp9
caspase 9
IEP
RGD
PMID:26754107
RGD:11555349
Ensembl chr 5:154,109,046...154,126,626
G
Hif1a
hypoxia inducible factor 1 subunit alpha
IEP
protein:increased expression:testes (rat)
RGD
PMID:12193413
RGD:632997
NCBI chr 6:98,357,788...98,405,068
Ensembl chr 6:92,624,390...92,669,261
G
Hmox1
heme oxygenase 1
treatment
IMP
RGD
PMID:23142244
RGD:10755740
NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,467,244...13,474,079
G
Mapk1
mitogen activated protein kinase 1
treatment
IMP
RGD
PMID:15944243
RGD:13800876
NCBI chr11:97,462,025...97,529,193
Ensembl chr11:83,957,813...84,023,616
G
Mapk3
mitogen activated protein kinase 3
treatment
IMP
RGD
PMID:15944243
RGD:13800876
NCBI chr 1:190,797,189...190,803,411
Ensembl chr 1:181,366,637...181,372,863
G
Nos3
nitric oxide synthase 3
IEP
protein:increased expression:testis
RGD
PMID:18205898
RGD:2292105
NCBI chr 4:11,686,088...11,706,604
Ensembl chr 4:10,793,834...10,814,166
G
Uchl5
ubiquitin C-terminal hydrolase L5
IEP
mRNA, protein:decreased expression:testis
RGD
PMID:24189580
RGD:9588240
NCBI chr13:58,070,947...58,106,825
Ensembl chr13:55,520,729...55,556,502
G
Xdh
xanthine dehydrogenase
treatment
IDA
RGD
PMID:23769121
RGD:7247698
NCBI chr 6:27,282,319...27,344,022
Ensembl chr 6:21,530,113...21,592,268
G
Acvrl1
activin A receptor like type 1
IEP
RGD
PMID:15781474
RGD:1579751
NCBI chr 7:134,117,917...134,135,306
Ensembl chr 7:132,239,729...132,256,591
G
Adamts1
ADAM metallopeptidase with thrombospondin type 1 motif, 1
IEP
mRNA, protein:increased expression:brain
RGD
PMID:16630594
RGD:9681747
NCBI chr11:38,418,565...38,427,384
Ensembl chr11:24,931,761...24,941,103
G
Adamts4
ADAM metallopeptidase with thrombospondin type 1 motif, 4
IEP
RGD
PMID:16630594
RGD:9681747
NCBI chr13:86,203,011...86,212,500
Ensembl chr13:83,670,183...83,680,065
G
Adarb1
adenosine deaminase, RNA-specific, B1
IMP
RGD
PMID:16504947
RGD:10755337
NCBI chr20:11,222,171...11,350,416
Ensembl chr20:11,222,583...11,350,852
G
Adora1
adenosine A1 receptor
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:23437309
NCBI chr13:48,210,922...48,247,826
Ensembl chr13:45,658,872...45,695,801
G
Ager
advanced glycosylation end product-specific receptor
IEP ISO
protein:altered expression:cerebral cortex, striatum (rat) protein:increased expression:brain, plasma
RGD
PMID:22528836 PMID:23288172
RGD:7245542 , RGD:8696004
NCBI chr20:4,152,758...4,155,956
Ensembl chr20:4,147,890...4,151,078
G
Agt
angiotensinogen
IEP
RGD
PMID:21934531
RGD:8549480
NCBI chr19:69,426,540...69,447,017
Ensembl chr19:52,529,185...52,540,977
G
Ahr
aryl hydrocarbon receptor
treatment
IMP
RGD
PMID:32913241
RGD:401793747
NCBI chr 6:57,961,423...57,998,901
Ensembl chr 6:52,234,089...52,271,568
G
Aifm1
apoptosis inducing factor, mitochondria associated 1
IEP ISO
mRNA:decreased expression, altered localization:CA1 pyramidal layer, nucleus: protein:increased expression:nucleus:
RGD
PMID:14526224 PMID:15087715
RGD:10047409 , RGD:10053562
NCBI chr X:132,528,107...132,567,237
Ensembl chr X:127,650,226...127,689,256
G
Ang
angiogenin
treatment
IEP
RGD
PMID:30258350
RGD:155663419
NCBI chr15:26,786,233...26,796,883
G
Ank1
ankyrin 1
IEP
RGD
PMID:9202331
RGD:1599109
NCBI chr16:75,578,824...75,757,464
Ensembl chr16:68,877,504...69,054,759
G
Ank2
ankyrin 2
IEP
RGD
PMID:9202331
RGD:1599109
NCBI chr 2:218,052,555...218,628,414
Ensembl chr 2:215,379,680...215,862,923
G
Apoe
apolipoprotein E
IEP
RGD
PMID:19623195
RGD:6903926
NCBI chr 1:88,481,889...88,485,816
Ensembl chr 1:79,353,916...79,357,932
G
Aqp4
aquaporin 4
treatment
IEP
RGD
PMID:24773551 PMID:28396190
RGD:13207320 , RGD:597978119
NCBI chr18:6,782,389...6,799,034
Ensembl chr18:6,507,903...6,524,856
G
Atf2
activating transcription factor 2
IDA IEP
RGD
PMID:10077326 PMID:9813301
RGD:10047405 , RGD:10047413
NCBI chr 3:79,125,814...79,202,896
Ensembl chr 3:58,718,332...58,795,236
G
Atp5f1b
ATP synthase F1 subunit beta
IEP
protein:increased expression:cerebrum (rat)
RGD
PMID:21950801
RGD:13792582
NCBI chr 7:1,100,058...1,106,461
Ensembl chr 7:515,460...567,273
G
Axin2
axin 2
treatment
IEP
RGD
PMID:31650542
RGD:151356749
NCBI chr10:94,393,379...94,426,579
Ensembl chr10:93,899,245...93,926,231
G
Bace1
beta-secretase 1
IEP
protein:increased activity,increased expression:brain cortex
RGD
PMID:15120577
RGD:13782170
NCBI chr 8:55,038,842...55,061,138
Ensembl chr 8:46,142,116...46,165,876
G
Bad
BCL2-associated agonist of cell death
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12629175
NCBI chr 1:213,562,719...213,572,034
Ensembl chr 1:204,131,501...204,142,823
G
Bax
BCL2 associated X, apoptosis regulator
treatment
IEP
RGD
PMID:21167243
RGD:10054102
NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:95,938,808...95,945,368
G
Bbc3
Bcl-2 binding component 3
IEP
protein:increased expression:hippocampus CA1, pyramidal cell
RGD
PMID:12913114
RGD:634629
NCBI chr 1:86,141,450...86,150,666
Ensembl chr 1:77,014,543...77,022,509
G
Bcl2
BCL2, apoptosis regulator
treatment
IEP IDA
protein:decreased expression:brain protein:increased expression:hippocampus:
RGD
PMID:18083315 PMID:26607632 PMID:22509406 PMID:16732092
RGD:2290557 , RGD:597538583 , RGD:11561910 , RGD:11522725
NCBI chr13:23,204,464...23,366,900
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
Bcl2l2
Bcl2-like 2
treatment
IEP ISO
protein:increased expression:cortex and caudate putamen
RGD
PMID:10724126 PMID:12571640
RGD:14394498 , RGD:14394500
NCBI chr15:32,326,686...32,337,834
Ensembl chr15:28,356,807...28,361,624
G
Bdnf
brain-derived neurotrophic factor
treatment
IDA
associated with middle cerebral artery infarction
RGD
PMID:33227709
RGD:597015753
NCBI chr 3:116,619,633...116,670,212
Ensembl chr 3:96,165,042...96,215,615
G
Becn1
beclin 1
treatment
IEP
RGD
PMID:22509406
RGD:11561910
NCBI chr10:86,731,649...86,747,002
Ensembl chr10:86,231,388...86,246,742
G
Bex3
brain expressed X-linked 3
IEP
RGD
PMID:11124986
RGD:9743974
NCBI chr X:104,064,896...104,066,425
Ensembl chr X:99,273,161...99,274,800
G
Bnip3
BCL2 interacting protein 3
IEP
RGD
PMID:14972662
RGD:2314028
NCBI chr 1:203,137,778...203,154,962
Ensembl chr 1:193,708,167...193,725,359
G
C3
complement C3
treatment
IEP ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:23199288 PMID:22004711
RGD:7411628
NCBI chr 9:2,174,412...2,201,339
Ensembl chr 9:2,087,437...2,114,429
G
Cab39
calcium binding protein 39
IEP
protein:increased expression:brain
RGD
PMID:27798271
RGD:14398833
NCBI chr 9:93,911,099...93,972,542
Ensembl chr 9:86,463,095...86,524,544
G
Camk2a
calcium/calmodulin-dependent protein kinase II alpha
IEP ISO
protein:increased expression:hippocampus
RGD
PMID:12951199 PMID:12199152
RGD:7241547 , RGD:13681927
NCBI chr18:56,648,779...56,711,505
Ensembl chr18:54,378,784...54,438,994
G
Casp3
caspase 3
IDA
RGD
PMID:21712070
RGD:10053706
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:45,662,910...45,684,648
G
Casp7
caspase 7
treatment
IEP
RGD
PMID:25872160
RGD:13782285
NCBI chr 1:265,442,647...265,481,938
Ensembl chr 1:255,437,172...255,476,729
G
Casp8
caspase 8
treatment
IEP
protein:increased expression:cerebral cortex:
RGD
PMID:30148677 PMID:18096138
RGD:13782286 , RGD:4142863
NCBI chr 9:67,747,109...67,806,699
Ensembl chr 9:60,264,075...60,312,542
G
Casp9
caspase 9
IEP ISO
associated with Diabetes Mellitus, Experimental;protein:increased expression:neocortex CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:11333366 PMID:15246841 PMID:21712070
RGD:2311321 , RGD:10053706
Ensembl chr 5:154,109,046...154,126,626
G
Cav1
caveolin 1
treatment
IEP ISO
RGD
PMID:22007835 PMID:22007835
RGD:8661794 , RGD:8661794
NCBI chr 4:46,606,538...46,639,616
Ensembl chr 4:45,634,918...45,673,705
G
Cbl
Cbl proto-oncogene
treatment
IDA
RGD
PMID:18773943
RGD:4108486
NCBI chr 8:53,384,656...53,468,067
Ensembl chr 8:44,489,410...44,571,176
G
Cbs
cystathionine beta synthase
treatment
ISO
XCO:0000348 XCO:0000807
RGD
PMID:22212488 PMID:22212488
RGD:41410880 , RGD:41410880
NCBI chr20:9,709,394...9,733,925
Ensembl chr20:9,708,090...9,732,764
G
Ccl2
C-C motif chemokine ligand 2
treatment
IDA IEP
mRNA:increased expression:brain (rat)
RGD
PMID:21487414 PMID:7860708
RGD:8549519 , RGD:8549729
NCBI chr10:67,503,077...67,504,875
Ensembl chr10:67,005,424...67,007,226
G
Ccl20
C-C motif chemokine ligand 20
treatment
IMP
RGD
PMID:19428685
RGD:7488896
NCBI chr 9:91,837,139...91,839,736
Ensembl chr 9:84,388,904...84,391,629
G
Ccnh
cyclin H
IEP
mRNA, protein:increased expression:hippocampus
RGD
PMID:10501206
RGD:69371
NCBI chr 2:17,570,449...17,591,078
Ensembl chr 2:15,834,833...15,855,819
G
Ccr6
C-C motif chemokine receptor 6
IEP
mRNA:increased expression:brain
RGD
PMID:19428685
RGD:7488896
NCBI chr 1:55,022,037...55,055,857
Ensembl chr 1:52,474,168...52,498,603
G
Cd40
CD40 molecule
severity
ISO
RGD
PMID:15795333
RGD:11352234
NCBI chr 3:174,209,113...174,224,592
Ensembl chr 3:153,790,449...153,805,534
G
Cd40lg
CD40 ligand
severity
ISO
RGD
PMID:15795333
RGD:11352234
NCBI chr X:140,164,341...140,176,057
Ensembl chr X:135,126,969...135,138,306
G
Cdk5
cyclin-dependent kinase 5
treatment
IEP
RGD
PMID:28254431
RGD:13506925
NCBI chr 4:11,647,098...11,651,606
Ensembl chr 4:10,754,687...10,760,112
G
Cdkn2a
cyclin-dependent kinase inhibitor 2A
ISO
protein:decreased expression:striatum, neuron
RGD
PMID:11438580
RGD:8552691
NCBI chr 5:109,100,763...109,114,448
Ensembl chr 5:103,984,949...104,003,149
G
Cebpa
CCAAT/enhancer binding protein alpha
IEP
mRNA, protein:increased expression:hippocampal pyramidal cell layer (rat)
RGD
PMID:9795105
RGD:10401192
NCBI chr 1:96,896,584...96,899,256
Ensembl chr 1:87,759,433...87,762,412
G
Chka
choline kinase alpha
IEP
mRNA:increased expression:cerebral cortex (rat)
RGD
PMID:16300643
RGD:10401831
NCBI chr 1:210,506,069...210,554,753
Ensembl chr 1:201,076,860...201,125,516
G
Cldn5
claudin 5
treatment
IEP
RGD
PMID:28396190
RGD:597978119
NCBI chr11:95,717,172...95,718,598
Ensembl chr11:82,211,475...82,214,992
G
Coq7
coenzyme Q7, hydroxylase
severity
ISO
RGD
PMID:20170652
RGD:10402096
NCBI chr 1:182,270,570...182,285,959
Ensembl chr 1:172,835,188...172,851,158
G
Creb1
cAMP responsive element binding protein 1
IDA
RGD
PMID:10077326
RGD:10047405
NCBI chr 9:73,397,333...73,466,339
Ensembl chr 9:65,903,547...65,970,816
G
Crem
cAMP responsive element modulator
IEP
mRNA:increased expression:cerebral cortex (rat)
RGD
PMID:12437578
RGD:632385
NCBI chr17:58,932,011...59,001,160
Ensembl chr17:54,239,030...54,305,989
G
Csf3
colony stimulating factor 3
treatment
ISO
RGD
PMID:12624302
RGD:10450512
NCBI chr10:84,157,485...84,159,860
Ensembl chr10:83,661,207...83,663,603
G
Cx3cl1
C-X3-C motif chemokine ligand 1
IEP
protein:decreased expression:hippocampus
RGD
PMID:24447880
RGD:9491776
NCBI chr19:10,233,326...10,244,856
Ensembl chr19:10,227,340...10,236,833
G
Cx3cr1
C-X3-C motif chemokine receptor 1
IEP
mRNA,protein:decreased expression:hippocampus
RGD
PMID:24447880
RGD:9491776
NCBI chr 8:128,661,294...128,679,048
Ensembl chr 8:119,782,595...119,800,014
G
Cxcl12
C-X-C motif chemokine ligand 12
IEP
protein:increased expression:hippocampus:
RGD
PMID:24924806
RGD:11352662
NCBI chr 4:152,060,781...152,073,628
Ensembl chr 4:150,388,325...150,401,168
G
Cycs
cytochrome c, somatic
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11333366
NCBI chr 4:80,982,667...80,984,767
Ensembl chr 4:79,651,378...79,654,054 Ensembl chr18:79,651,378...79,654,054
G
Daxx
death-domain associated protein
treatment
IDA IEP
mRNA,protein:increased expression:cerebral cortex:
RGD
PMID:17967739 PMID:18096138
RGD:9587802 , RGD:4142863
NCBI chr20:4,971,973...4,978,062
Ensembl chr20:4,970,092...4,975,843
G
Dbn1
drebrin 1
IEP
RGD
PMID:8583659
RGD:10398814
NCBI chr17:9,155,729...9,170,121
Ensembl chr17:9,150,659...9,164,984
G
Dffb
DNA fragmentation factor subunit beta
IEP
mRNA, protein:increased expression:hippocampus CA1
RGD
PMID:11425895
RGD:628524
NCBI chr 5:169,804,873...169,817,157
Ensembl chr 5:164,522,463...164,534,628
G
Dll4
delta like canonical Notch ligand 4
ameliorates treatment disease_progression
ISO IEP
RGD
PMID:31927543 PMID:30258350 PMID:30653356
RGD:155663354 , RGD:155663419 , RGD:155663383
NCBI chr 3:126,770,945...126,780,769
Ensembl chr 3:106,316,986...106,326,931
G
Dusp1
dual specificity phosphatase 1
IEP
protein:increased expression:brain
RGD
PMID:22197701
RGD:7771582
NCBI chr10:17,184,853...17,187,646
G
Dusp16
dual specificity phosphatase 16
IEP
protein:increased expression, altered localization:hippocampus, cytosol, nucleus
RGD
PMID:23280045
RGD:7775014
NCBI chr 4:169,278,118...169,361,508
Ensembl chr 4:167,548,155...167,629,980
G
Eed
embryonic ectoderm development
IDA
RGD
PMID:24007266
RGD:9588303
NCBI chr 1:153,280,419...153,307,537
Ensembl chr 1:143,867,875...143,894,974
G
Eif2s1
eukaryotic translation initiation factor 2 subunit alpha
ISO IEP
associated with Heart Arrest
RGD
PMID:11520898 PMID:10541873
RGD:10395353 , RGD:11041881
NCBI chr 6:103,405,880...103,430,549
Ensembl chr 6:97,672,766...97,706,225
G
Elane
elastase, neutrophil expressed
treatment
IMP
RGD
PMID:19168036
RGD:10450558
NCBI chr 7:10,467,877...10,469,725
Ensembl chr 7:9,817,252...9,819,100
G
Elk1
ETS transcription factor ELK1
treatment
IEP
RGD
PMID:17091294
RGD:7488902
NCBI chr X:3,692,367...3,709,252
Ensembl chr X:1,139,756...1,155,713
G
Entpd1
ectonucleoside triphosphate diphosphohydrolase 1
IEP
mRNA:increased expression:brain:
RGD
PMID:9634555
RGD:9685492
NCBI chr 1:249,374,810...249,502,310
Ensembl chr 1:239,425,430...239,552,317
G
Ep300
E1A binding protein p300
disease_progression
IEP
mRNA:increased expression:cerebrum, ipsilateral side (rat)
RGD
PMID:22196858 PMID:28230854
RGD:7349341 , RGD:596933303
NCBI chr 7:114,987,857...115,058,652
Ensembl chr 7:113,106,247...113,136,088 Ensembl chr 7:113,106,247...113,136,088
G
Epo
erythropoietin
treatment
IEP ISO
RGD
PMID:22282883 PMID:24702327
RGD:10401060 , RGD:11041699
NCBI chr12:24,841,285...24,844,725
Ensembl chr12:19,204,508...19,207,946
G
Ercc1
ERCC excision repair 1, endonuclease non-catalytic subunit
treatment
ISO
human gene in a rat model
RGD
PMID:19440222
RGD:2313668
NCBI chr 1:88,099,308...88,135,966
Ensembl chr 1:78,996,390...79,007,963
G
Ercc6
ERCC excision repair 6, chromatin remodeling factor
IEP
mRNA, protein:increased expression:cerebral cortex
RGD
PMID:10437118
RGD:10401104
NCBI chr16:7,771,311...7,841,895
Ensembl chr16:7,765,013...7,835,587
G
Esr1
estrogen receptor 1
treatment
IDA
RGD
PMID:24548484 PMID:25098259
RGD:10045843 , RGD:10045845
NCBI chr 1:43,511,685...43,904,454
Ensembl chr 1:41,210,475...41,495,002
G
Esr2
estrogen receptor 2
IMP
RGD
PMID:23593292
RGD:7364962
NCBI chr 6:100,589,553...100,645,240
Ensembl chr 6:94,809,547...94,908,919
G
F11r
F11 receptor
treatment
IEP
RGD
PMID:22868201
RGD:7488943
NCBI chr13:86,406,229...86,429,819
Ensembl chr13:83,873,797...83,897,402
G
F12
coagulation factor XII
treatment
ISO
RGD
PMID:16533887 PMID:16533887
RGD:11041786 , RGD:11041786
NCBI chr17:9,212,819...9,220,664
Ensembl chr17:9,207,683...9,215,530
G
Fadd
Fas associated via death domain
IEP
mRNA,protein:increased expression:cerebral cortex:
RGD
PMID:18096138
RGD:4142863
NCBI chr 1:209,169,245...209,175,423
Ensembl chr 1:199,739,994...199,745,653
G
Fas
Fas cell surface death receptor
treatment
IEP IDA ISO
protein:increased expression:brain protein:increased expression:brain (rat)
RGD
PMID:18410517 PMID:30301943 PMID:18981705 PMID:10972965
RGD:2311437 , RGD:153297779 , RGD:8686422 , RGD:8662928
NCBI chr 1:241,212,155...241,245,774
Ensembl chr 1:231,798,960...231,832,591
G
Fgfr1
Fibroblast growth factor receptor 1
IEP
mRNA:increased expression:cerebral cortex:
RGD
PMID:8858623
RGD:10402044
NCBI chr16:73,194,631...73,249,855
Ensembl chr16:66,494,042...66,547,350
G
Fgfr2
fibroblast growth factor receptor 2
treatment
IEP
associated with Experimental Diabetes Mellitus
RGD
PMID:22432030
RGD:155882598
NCBI chr 1:194,175,703...194,280,914
Ensembl chr 1:184,745,420...184,850,626
G
Flt1
Fms related receptor tyrosine kinase 1
treatment
ISO
RGD
PMID:17077813
RGD:10402150
NCBI chr12:12,333,050...12,504,750
Ensembl chr12:7,297,292...7,468,626
G
Fmr1
fragile X messenger ribonucleoprotein 1
IEP
mRNA, protein:increased expression:striatum (rat)
RGD
PMID:22817682
RGD:11566024
NCBI chr X:152,284,857...152,322,686
Ensembl chr X:147,240,301...147,278,050
G
Fto
FTO, alpha-ketoglutarate dependent dioxygenase
IEP ISO
protein:decreased expression:cerebral cortex mRNA:decreased expression:cerebral cortex mRNA:decreased expression:heart
RGD
PMID:32426101 PMID:36479246 PMID:34413770
RGD:329901764 , RGD:329951019 , RGD:329901768
NCBI chr19:31,456,749...31,865,011
Ensembl chr19:15,349,696...15,692,083
G
G6pd
glucose-6-phosphate dehydrogenase
IMP
RGD
PMID:22580330
RGD:10449127
NCBI chr X:157,352,364...157,372,144
Ensembl chr X:152,201,098...152,220,801
G
Gad1
glutamate decarboxylase 1
disease_progression
IEP
RGD
PMID:20659561
RGD:401900597
NCBI chr 3:75,777,260...75,818,099
Ensembl chr 3:55,369,704...55,410,333
G
Gad2
glutamate decarboxylase 2
disease_progression
IEP
RGD
PMID:20659561
RGD:401900597
NCBI chr17:89,671,718...89,734,246
Ensembl chr17:84,763,628...84,826,155
G
Gamt
guanidinoacetate N-methyltransferase
ameliorates
ISO
DNA:deletion
RGD
PMID:24004504
RGD:329955375
NCBI chr 7:10,099,267...10,102,083
Ensembl chr 7:9,448,628...9,451,778
G
Gatm
glycine amidinotransferase
exacerbates
ISO
DNA:deletion
RGD
PMID:24004504
RGD:329955375
NCBI chr 3:130,112,508...130,137,664
Ensembl chr 3:109,658,951...109,684,129
G
Gch1
GTP cyclohydrolase 1
treatment
IMP
RGD
PMID:9920651
RGD:329961573
NCBI chr15:22,884,006...22,917,412
Ensembl chr15:20,402,527...20,437,698
G
Ghsr
growth hormone secretagogue receptor
IEP
mRNA,protein:decreased expression:brain:
RGD
PMID:17560544
RGD:12907500
NCBI chr 2:112,196,158...112,201,666
Ensembl chr 2:110,268,489...110,271,865
G
Gja1
gap junction protein, alpha 1
treatment
ISO IEP
protein:increased expression:brain
RGD
PMID:22812228 PMID:23328809
RGD:7207263 , RGD:8662426
NCBI chr20:36,302,490...36,315,010
Ensembl chr20:35,755,991...35,768,582
G
Gjb6
gap junction protein, beta 6
IEP
protein:increased expression:hippocampus:
RGD
PMID:21718970
RGD:6480433
NCBI chr15:35,400,147...35,410,649
Ensembl chr15:31,284,419...31,294,582
G
Glrx
glutaredoxin
IEP
mRNA,protein:decreased expression:brain:
RGD
PMID:10329397
RGD:9686043
NCBI chr 2:7,073,737...7,083,548
Ensembl chr 2:5,341,885...5,351,680
G
Glul
glutamate-ammonia ligase
treatment
IEP
associated with carotid artery occlusion protein:increased expression:hippocampus
RGD
PMID:27664163 PMID:25365917 PMID:21272618 PMID:21371894
RGD:401794415 , RGD:401794591 , RGD:401794590 , RGD:401794419
NCBI chr13:68,519,500...68,585,554
Ensembl chr13:66,025,630...66,035,108
G
Got1
glutamic-oxaloacetic transaminase 1
treatment
ISO IDA
human protein in a rat model
RGD
PMID:24407245 PMID:21361730 PMID:20145654
RGD:13504852 , RGD:13504855 , RGD:13504854
NCBI chr 1:252,306,541...252,337,622
Ensembl chr 1:242,357,306...242,380,633
G
Gp6
glycoprotein VI
ameliorates
ISO
RGD
PMID:34237320
RGD:401794450
NCBI chr 1:78,471,900...78,535,374
Ensembl chr 1:69,465,789...69,491,326
G
Gpx3
glutathione peroxidase 3
treatment
ISO
RGD
PMID:30098076
RGD:401827833
NCBI chr10:39,529,335...39,537,406
Ensembl chr10:39,028,570...39,037,035
G
Grin2a
glutamate ionotropic receptor NMDA type subunit 2A
ameliorates treatment
IMP IDA ISO
associated with hyperhomocysteinemia
RGD
PMID:30885791 PMID:12932824 PMID:30885791
RGD:401940141 , RGD:401950480 , RGD:401940141
NCBI chr10:6,136,458...6,560,003
Ensembl chr10:5,631,369...6,044,637
G
Grin2b
glutamate ionotropic receptor NMDA type subunit 2B
ameliorates
IMP
RGD
PMID:30885791
RGD:401940141
NCBI chr 4:170,297,811...170,775,420
Ensembl chr 4:168,599,546...169,042,279
G
Gsr
glutathione-disulfide reductase
treatment
IDA
RGD
PMID:15525350
RGD:10401855
NCBI chr16:65,185,574...65,228,742
Ensembl chr16:58,482,505...58,525,661
G
H2ax
H2A.X variant histone
treatment
IDA
RGD
PMID:20830300
RGD:8693742
NCBI chr 8:53,568,718...53,570,072
Ensembl chr 8:44,671,786...44,673,239 Ensembl chr 4:44,671,786...44,673,239
G
Havcr2
hepatitis A virus cellular receptor 2
treatment
IEP
RGD
PMID:24771108
RGD:9686115
NCBI chr10:31,383,801...31,415,334
Ensembl chr10:30,882,606...30,909,137
G
Hdac5
histone deacetylase 5
disease_progression
IEP
RGD
PMID:28230854
RGD:596933303
NCBI chr10:87,653,139...87,688,078
Ensembl chr10:87,152,978...87,188,235
G
Hif1a
hypoxia inducible factor 1 subunit alpha
treatment
IEP
protein:increased expression:cerebral cortex, caudoputamen (rat)
RGD
PMID:20417628 PMID:30258350
RGD:9068877 , RGD:155663419
NCBI chr 6:98,357,788...98,405,068
Ensembl chr 6:92,624,390...92,669,261
G
Hmgb1
high mobility group box 1
ISO
protein:increased expression:brain, plasma
RGD
PMID:23288172
RGD:8696004
NCBI chr12:11,009,236...11,015,941
Ensembl chr12:5,901,586...5,978,565 Ensembl chr16:5,901,586...5,978,565
G
Hnrnpa2b1
heterogeneous nuclear ribonucleoprotein A2/B1
IEP
protein:altered expression:cerebral cortex, hippocampus (rat)
RGD
PMID:20421594
RGD:10041006
NCBI chr 4:81,867,354...81,875,886
Ensembl chr 4:80,534,651...80,545,249
G
Hnrnpab
heterogeneous nuclear ribonucleoprotein A/B
treatment
IDA
RGD
PMID:22366221
RGD:9999181
NCBI chr10:36,358,004...36,363,898
Ensembl chr10:35,857,041...35,863,344
G
Hrh2
histamine receptor H 2
IEP
protein:decreased expression:caudate putamen (rat)
RGD
PMID:16181737
RGD:9685533
NCBI chr17:10,371,083...10,412,979
Ensembl chr17:10,368,298...10,407,631
G
Hsf1
heat shock transcription factor 1
treatment
IEP IDA
protein:increased expression:brain, nucleus (rat) associated with Heart Arrest
RGD
PMID:26070787 PMID:23528677
RGD:10402389 , RGD:10402772
NCBI chr 7:110,076,710...110,103,665
Ensembl chr 7:108,196,056...108,223,011
G
Hspa5
heat shock protein family A (Hsp70) member 5
treatment
IEP
RGD
PMID:25632565
RGD:11354959
NCBI chr 3:38,453,016...38,457,475
Ensembl chr 3:18,055,405...18,059,891
G
Hspa8
heat shock protein family A (Hsp70) member 8
IEP
protein:increased expression:brain, postsynaptic density (rat)
RGD
PMID:9425004
RGD:10059344
NCBI chr 8:50,080,514...50,084,376
Ensembl chr 8:41,183,264...41,187,259
G
Hspb1
heat shock protein family B (small) member 1
IEP
protein:increased expression:brain,astrocyte:
RGD
PMID:10559386
RGD:10402577
NCBI chr12:26,430,640...26,432,301
Ensembl chr12:20,794,028...20,795,743
G
Htra2
HtrA serine peptidase 2
treatment
IMP ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:15306124 PMID:19462455
RGD:10402932
NCBI chr 4:117,114,631...117,117,793
Ensembl chr 4:115,556,916...115,560,095
G
Htt
huntingtin
IEP
protein:increased degradation:brain
RGD
PMID:12957494
RGD:1304431
NCBI chr14:80,070,456...80,219,668
Ensembl chr14:75,845,836...75,995,070
G
Icam1
intercellular adhesion molecule 1
treatment
IEP
RGD
PMID:22379785
RGD:8547729
NCBI chr 8:27,829,688...27,841,618
Ensembl chr 8:19,553,645...19,565,438
G
Ifnb1
interferon beta 1
ameliorates
IDA
RGD
PMID:12973019
RGD:401851924
NCBI chr 5:108,066,650...108,067,487
Ensembl chr 5:103,020,969...103,021,523
G
Igf1
insulin-like growth factor 1
severity
IEP
protein:decreased expression:serum (rat)
RGD
PMID:25098324
RGD:12904924
NCBI chr 7:24,169,608...24,249,446
Ensembl chr 7:22,282,930...22,359,296
G
Ikbkb
inhibitor of nuclear factor kappa B kinase subunit beta
treatment
IEP
RGD
PMID:24261295
RGD:7495766
NCBI chr16:76,021,968...76,075,717
Ensembl chr16:69,319,554...69,373,250
G
Il10
interleukin 10
treatment
IDA
RGD
PMID:24053818
RGD:7364868
NCBI chr13:45,024,921...45,029,586
Ensembl chr13:42,472,839...42,477,313
G
Il1b
interleukin 1 beta
IDA ISO
RGD
PMID:23147509 PMID:22284622
RGD:7175551 , RGD:7175554
NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:116,577,010...116,583,415
G
Il1rn
interleukin 1 receptor antagonist
IDA ISO
human protein in a rat model
RGD
PMID:15837124 PMID:20412072
RGD:1626674 , RGD:8551852
NCBI chr 3:27,509,836...27,525,738
Ensembl chr 3:7,111,550...7,127,445
G
Ilk
integrin-linked kinase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15472100
NCBI chr 1:169,500,716...169,506,972
Ensembl chr 1:160,088,897...160,095,140
G
Itgam
integrin subunit alpha M
treatment
ISO IEP IMP
mRNA:increased expression:cerebral cortex (mouse) mRNA:increased expression:brain (rat)
RGD
PMID:30123113 PMID:23844255 PMID:22082476 PMID:32407868 PMID:19563786 PMID:8964796 PMID:8581506 PMID:8160235 More...
RGD:329853754 , RGD:329902067 , RGD:329902058 , RGD:329901940 , RGD:329901933 , RGD:329901921 , RGD:329901917 , RGD:329901916
NCBI chr 1:192,089,496...192,139,947
Ensembl chr 1:182,659,000...182,709,503
G
Itgb3
integrin subunit beta 3
IEP
RGD
PMID:18638458
RGD:6907424
NCBI chr10:90,009,927...90,067,787
Ensembl chr10:89,509,989...89,564,679
G
Itpr1
inositol 1,4,5-trisphosphate receptor, type 1
IEP
mRNA:decreased expression:cerebral cortex (rat)
RGD
PMID:7500836
RGD:6482813
NCBI chr 4:142,743,401...143,066,505
Ensembl chr 4:141,187,418...141,510,491
G
Jak1
Janus kinase 1
IEP
RGD
PMID:10756075
RGD:19165138
NCBI chr 5:120,895,606...121,004,207
Ensembl chr 5:115,780,248...115,888,926
G
Jak2
Janus kinase 2
IDA
RGD
PMID:23764464
RGD:8694326
NCBI chr 1:236,408,905...236,468,769
Ensembl chr 1:226,995,334...227,054,189
G
Kcnj10
potassium inwardly-rectifying channel, subfamily J, member 10
IEP
protein:decreased expression:CA1 field of hippocampus, astrocyte, astrocyte projection
RGD
PMID:20833221
RGD:8662899
NCBI chr13:87,334,510...87,367,747
Ensembl chr13:84,802,009...84,835,461
G
Kcnk2
potassium two pore domain channel subfamily K member 2
severity treatment
ISO IDA IEP
protein:increased expression:cerebral cortex (rat)
RGD
PMID:15175651 PMID:24154701 PMID:25062759
RGD:9831121 , RGD:9831178 , RGD:9831122
NCBI chr13:103,297,387...103,494,686
Ensembl chr13:100,766,113...100,963,435
G
Kdm1a
lysine demethylase 1A
IEP
protein:increased expression:cerebral cortex, hippocampus, dentate gyrus (rat)
RGD
PMID:20542065
RGD:9588301
NCBI chr 5:154,066,436...154,121,913
Ensembl chr 5:148,782,976...148,838,319
G
Keap1
Kelch-like ECH-associated protein 1
ISO
protein:decreased expression:brain (mouse)
RGD
PMID:21075092
RGD:6893270
NCBI chr 8:28,044,555...28,054,042
Ensembl chr 8:19,768,375...19,777,862
G
Klf5
KLF transcription factor 5
ameliorates
IMP
RGD
PMID:32272873
RGD:45073134
NCBI chr15:82,472,081...82,487,267
Ensembl chr15:76,064,258...76,079,445
G
Kmt2a
lysine methyltransferase 2A
treatment
IMP
RGD
PMID:34694864
RGD:155888565
NCBI chr 8:54,013,547...54,089,219
Ensembl chr 8:45,118,814...45,193,181
G
Lcn2
lipocalin 2
IEP
protein:increased expression:brain
RGD
PMID:29122651 PMID:24916903
RGD:126781757 , RGD:126790489
NCBI chr 3:36,078,432...36,081,851
Ensembl chr 3:15,680,687...15,684,095
G
Lmna
lamin A/C
IDA
RGD
PMID:17683050
RGD:2293745
NCBI chr 2:176,237,564...176,265,301
Ensembl chr 2:173,939,751...173,960,423
G
Lpar1
lysophosphatidic acid receptor 1
treatment
IDA
RGD
PMID:17173873
RGD:9850154
NCBI chr 5:78,024,139...78,147,071
Ensembl chr 5:73,229,625...73,369,895
G
Ltbp1
latent transforming growth factor beta binding protein 1
treatment
IEP
RGD
PMID:11720783
RGD:10412057
NCBI chr 6:25,781,625...26,177,346
Ensembl chr 6:20,029,629...20,425,349
G
Madd
MAP-kinase activating death domain
IEP
RGD
PMID:12625816
RGD:9588641
NCBI chr 3:97,570,141...97,613,688
Ensembl chr 3:77,114,314...77,157,701
G
Map1lc3a
microtubule-associated protein 1 light chain 3 alpha
treatment
IEP
RGD
PMID:22509406
RGD:11561910
NCBI chr 3:164,243,204...164,244,850
Ensembl chr 3:143,783,024...143,784,670
G
Map2k4
mitogen activated protein kinase kinase 4
IDA
protein:increased threonine phosphorylation:heart, nucleus
RGD
PMID:9195981
RGD:7495830
NCBI chr10:50,842,348...50,947,063
Ensembl chr10:50,344,915...50,447,993
G
Map3k5
mitogen-activated protein kinase kinase kinase 5
IEP
protein:increased nitrosylation, activity:hippocampus:
RGD
PMID:23137546
RGD:10412334
NCBI chr 1:16,505,387...16,723,899
Ensembl chr 1:14,685,492...14,904,800
G
Map3k7
mitogen activated protein kinase kinase kinase 7
ameliorates
ISO
RGD
PMID:32078472 PMID:32349637 PMID:34628598 PMID:32382778
RGD:155791642 , RGD:155804284 , RGD:155804283 , RGD:155804272
NCBI chr 5:51,149,524...51,212,012
Ensembl chr 5:46,357,931...46,415,597
G
Map4k1
mitogen activated protein kinase kinase kinase kinase 1
treatment
IDA
RGD
PMID:18498770 PMID:18382279
RGD:7495845 , RGD:7495847
NCBI chr 1:93,398,460...93,419,996
Ensembl chr 1:84,271,069...84,292,493
G
Mbd1
methyl-CpG binding domain protein 1
IEP
mRNA:increased expression:hippocampus
RGD
PMID:12421618
RGD:9587846
NCBI chr18:70,145,093...70,159,744
Ensembl chr18:67,869,992...67,886,554
G
Mbd2
methyl-CpG binding domain protein 2
IEP
mRNA:increased expression:hippocampus
RGD
PMID:12421618
RGD:9587846
NCBI chr18:66,449,196...66,516,112
Ensembl chr18:64,174,002...64,240,794
G
Mbd3
methyl-CpG binding domain protein 3
IEP
mRNA:decreased expression:hippocampus
RGD
PMID:12421618
RGD:9587846
NCBI chr 7:9,961,053...9,970,845
Ensembl chr 7:9,313,098...9,320,165
G
Mbp
myelin basic protein
IEP
mRNA:increased expression:oligodendrocyte:
RGD
PMID:11460777
RGD:7349336
NCBI chr18:78,130,652...78,241,174
Ensembl chr18:75,855,878...75,966,404
G
Mcfd2
multiple coagulation factor deficiency 2, ER cargo receptor complex subunit
IEP
mRNA:increased expression:hippocampus
RGD
PMID:17610559
RGD:11062141
NCBI chr 6:13,028,036...13,039,388
Ensembl chr 6:7,274,469...7,285,841
G
Mdm2
MDM2 proto-oncogene
treatment
IDA
RGD
PMID:24334056
RGD:10412310
NCBI chr 7:55,176,558...55,201,757
Ensembl chr 7:53,290,664...53,314,915
G
Mecp2
methyl CpG binding protein 2
IEP
mRNA:increased expression:hippocampus
RGD
PMID:12421618
RGD:9587846
NCBI chr X:156,932,481...156,995,981
Ensembl chr X:151,789,930...151,844,689
G
Mff
mitochondrial fission factor
treatment
IDA
RGD
PMID:26116440
RGD:12879457
NCBI chr 9:91,455,931...91,484,171
Ensembl chr 9:84,007,798...84,036,039
G
Mfn2
mitofusin 2
IEP
protein:decreased expression:brain (rat)
RGD
PMID:25147362
RGD:13204807
NCBI chr 5:163,587,463...163,617,363
Ensembl chr 5:158,304,287...158,335,342
G
Mir126a
microRNA 126a
exacerbates
ISO
RGD
PMID:28101763
RGD:401850574
NCBI chr 3:29,813,150...29,813,267
Ensembl chr 3:9,415,063...9,415,180
G
Mir155
microRNA 155
treatment
IEP
RGD
PMID:33081480
RGD:151347423
NCBI chr11:37,261,114...37,261,178
Ensembl chr11:23,774,654...23,774,718
G
Mir195
microRNA 195
severity
IMP
RGD
PMID:32272873
RGD:45073134
NCBI chr10:55,450,495...55,450,581
Ensembl chr10:54,951,838...54,951,924
G
Mir223
microRNA 223
IMP
RGD
PMID:31237865
RGD:25824937
NCBI chr X:65,151,383...65,151,492
Ensembl chr X:61,141,887...61,141,996
G
Mmp2
matrix metallopeptidase 2
treatment
IDA IEP
protein:increased activity, increased expression:brain
RGD
PMID:11592852 PMID:24828425
RGD:8547930 , RGD:8657086
NCBI chr19:30,327,643...30,355,856
Ensembl chr19:14,154,657...14,182,870
G
Mmp9
matrix metallopeptidase 9
treatment
ISO IEP IDA
protein:increased activity, increased expression:brain
RGD
PMID:16197500 PMID:24773551 PMID:23046750 PMID:11592852
RGD:8547921 , RGD:13207320 , RGD:13207323 , RGD:8547930
NCBI chr 3:174,103,474...174,111,434
Ensembl chr 3:153,683,858...153,692,120
G
Mrtfa
myocardin related transcription factor A
disease_progression
IEP
RGD
PMID:28230854
RGD:596933303
NCBI chr 7:114,424,481...114,594,594
Ensembl chr 7:112,544,312...112,714,418
G
Mt1
metallothionein 1
IEP
mRNA:increased expression:cerebral cortex
RGD
PMID:10884303
RGD:10412650
NCBI chr19:10,831,959...10,832,975
Ensembl chr19:10,826,032...10,827,049 Ensembl chr17:10,826,032...10,827,049 Ensembl chr X:10,826,032...10,827,049
G
Mt2
metallothionein 2
IEP
mRNA:increased expression:cerebral cortex
RGD
PMID:10884303
RGD:10412650
NCBI chr19:10,837,934...10,838,708
Ensembl chr19:10,832,002...10,832,784
G
Mt3
metallothionein 3
IEP
mRNA, protein:increased expression:brain
RGD
PMID:10069533
RGD:9685804
NCBI chr19:10,854,676...10,856,080
Ensembl chr19:10,848,755...10,850,158
G
Mtor
mechanistic target of rapamycin kinase
treatment
IEP
RGD
PMID:30712471
RGD:155791663
NCBI chr 5:164,167,985...164,277,438
Ensembl chr 5:158,884,804...158,994,311
G
Myb
MYB proto-oncogene, transcription factor
IEP
mRNA:increased expression:brain:
RGD
PMID:24828495
RGD:11532683
NCBI chr 1:17,759,309...17,793,306
Ensembl chr 1:15,939,761...15,973,057
G
Nampt
nicotinamide phosphoribosyltransferase
treatment
IMP ISO
RGD
PMID:28528966 PMID:25603815
RGD:13781879 , RGD:13781895
NCBI chr 6:55,152,756...55,189,547
Ensembl chr 6:49,424,332...49,462,100
G
Ndrg2
NDRG family member 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23451161
NCBI chr15:27,074,481...27,087,376
Ensembl chr15:24,600,982...24,609,626
G
Ndrg4
NDRG family member 4
ISO
RGD
PMID:21636852
RGD:7247728
NCBI chr19:9,357,470...9,393,465
Ensembl chr19:9,351,404...9,386,914
G
Nefh
neurofilament heavy chain
IEP
protein:decreased expression:hippocampus
RGD
PMID:8726968
RGD:9743938
NCBI chr14:84,044,428...84,054,413
Ensembl chr14:79,830,362...79,840,351
G
Nefl
neurofilament light chain
IEP
protein:decreased expression:hippocampus
RGD
PMID:8726968
RGD:9743938
NCBI chr15:46,477,330...46,481,203
Ensembl chr15:42,301,916...42,305,793
G
Nefm
neurofilament medium chain
IEP
protein:decreased expression:hippocampus
RGD
PMID:8726968
RGD:9743938
NCBI chr15:46,535,857...46,541,161
Ensembl chr15:42,360,454...42,365,755
G
Nf1
neurofibromin 1
IEP
mRNA,protein:increased expression:astrocyte:
RGD
PMID:8820972
RGD:12789703
NCBI chr10:64,803,986...65,037,086
Ensembl chr10:64,306,301...64,536,658
G
Nfkb1
nuclear factor kappa B subunit 1
IEP
protein:increased expression:hippocampal pyramidal neuron, nucleus (rat)
RGD
PMID:9158652
RGD:10045943
NCBI chr 2:226,689,745...226,805,897
Ensembl chr 2:224,016,214...224,110,404
G
Ngb
neuroglobin
treatment
IEP ISO IMP
associated with Hypertension;mRNA, protein:decreased expression:brain
RGD
PMID:16647691 PMID:23342777 PMID:12621155 PMID:12621155
RGD:9743952 , RGD:9743965 , RGD:9743964 , RGD:9743964
NCBI chr 6:112,475,332...112,480,786
Ensembl chr 6:106,744,378...106,749,830
G
Ngfr
nerve growth factor receptor
IEP
RGD
PMID:11124986
RGD:9743974
NCBI chr10:81,012,077...81,030,305
Ensembl chr10:80,515,299...80,533,518
G
Nod2
nucleotide-binding oligomerization domain containing 2
ISO
mRNA, protein:increased expression:brain
RGD
PMID:20863826
RGD:5508733
NCBI chr19:34,555,832...34,596,281
Ensembl chr19:18,382,439...18,417,177
G
Nono
non-POU domain containing, octamer-binding
ISO
protein:altered localization:cerebral cortex (mouse)
RGD
PMID:29426953
RGD:155883175
NCBI chr X:70,594,116...70,611,976
Ensembl chr X:66,554,098...66,571,952
G
Nos1
nitric oxide synthase 1
IDA IEP
protein:increased serine phosphorylation:dentate gyrus protein:altered expression:hippocampus :
RGD
PMID:23806217 PMID:26607632
RGD:7257600 , RGD:597538583
NCBI chr12:44,276,011...44,456,371
Ensembl chr12:38,626,714...38,710,945
G
Nos3
nitric oxide synthase 3
treatment
IEP IDA
protein:increased expression:serum (rat)
RGD
PMID:28944915 PMID:29298658 PMID:29312485
RGD:13450951 , RGD:13503353 , RGD:13503330
NCBI chr 4:11,686,088...11,706,604
Ensembl chr 4:10,793,834...10,814,166
G
Notch1
notch receptor 1
treatment
IEP
RGD
PMID:30258350
RGD:155663419
NCBI chr 3:29,676,040...29,721,613
Ensembl chr 3:9,278,086...9,323,531
G
Nox1
NADPH oxidase 1
ameliorates
IMP
RGD
PMID:25617620
RGD:329955357
NCBI chr X:101,572,338...101,625,571
Ensembl chr X:97,279,056...97,302,236
G
Nqo1
NAD(P)H quinone dehydrogenase 1
treatment
IEP
protein:increased expression:cerebral cortex (rat) protein:increased expression:brain (rat)
RGD
PMID:29017857 PMID:28169530 PMID:28552673
RGD:13439718 , RGD:13442499 , RGD:13439727
NCBI chr19:52,205,374...52,220,267
Ensembl chr19:35,295,573...35,310,557
G
Nrg1
neuregulin 1
treatment ameliorates
ISO
RGD
PMID:31560696 PMID:30206770
RGD:405649728 , RGD:405650589
NCBI chr16:65,954,084...67,007,484
Ensembl chr16:59,250,854...60,296,884
G
Nrp1
neuropilin 1
IEP
mRNA:increased expression:brain
RGD
PMID:33675584
RGD:401901171
NCBI chr19:73,256,557...73,411,705
Ensembl chr19:56,359,455...56,513,633
G
Nrxn1
neurexin 1
IEP
associated with Hypertension;mRNA:decreased expression:cerebral cortex
RGD
PMID:12437578
RGD:632385
NCBI chr 6:8,931,360...10,077,381
Ensembl chr 6:3,177,897...4,322,710
G
Ntrk2
neurotrophic receptor tyrosine kinase 2
treatment
IEP
associated with middle cerebral artery infarction
RGD
PMID:33227709
RGD:597015753
NCBI chr17:5,560,558...5,875,899
Ensembl chr17:5,559,043...5,869,136
G
Ocln
occludin
treatment
IEP
RGD
PMID:28396190
RGD:597978119
NCBI chr 2:33,391,303...33,442,207
Ensembl chr 2:31,657,220...31,764,150
G
Ogg1
8-oxoguanine DNA glycosylase
IEP
protein:increased expression:cerebral cortex
RGD
PMID:14600440
RGD:8657406
NCBI chr 4:148,030,237...148,037,599
Ensembl chr 4:146,474,750...146,484,766
G
Opa1
OPA1, mitochondrial dynamin like GTPase
treatment
ISO IDA
protein:altered expression:brain
RGD
PMID:22345048 PMID:24633199
RGD:7800722 , RGD:13208946
NCBI chr11:84,612,943...84,690,025
Ensembl chr11:71,109,873...71,185,109
G
Optn
optineurin
IEP
protein:decreased expression:cerebral cortex (rat)
RGD
PMID:24235151
RGD:13434905
NCBI chr17:78,118,847...78,169,543
Ensembl chr17:73,209,575...73,260,251
G
Parl
presenilin associated, rhomboid-like
severity
ISO
RGD
PMID:23921894
RGD:12902620
NCBI chr11:94,097,559...94,124,915
Ensembl chr11:80,593,192...80,620,506
G
Parp1
poly (ADP-ribose) polymerase 1
treatment
IDA IEP
RGD
PMID:19840223 PMID:19840223
RGD:2325713 , RGD:2325713
NCBI chr13:94,839,484...94,871,295
Ensembl chr13:92,307,586...92,339,404
G
Pawr
pro-apoptotic WT1 regulator
IEP ISO
mRNA:increased expression:brain: protein:increased expression:cortex,striatum:
RGD
PMID:14705148 PMID:11323519
RGD:1302269 , RGD:9835381
NCBI chr 7:45,531,480...45,611,492
Ensembl chr 7:43,645,084...43,725,028
G
Pax6
paired box 6
IEP
protein:increased expression:cerebral cortex, striatum, astroglial cell (rat)
RGD
PMID:24114637
RGD:8552354
NCBI chr 3:112,590,034...112,611,771
Ensembl chr 3:92,135,637...92,157,014
G
Pcna
proliferating cell nuclear antigen
IEP
RGD
PMID:9757027
RGD:10448974
NCBI chr 3:139,951,948...139,955,820
Ensembl chr 3:119,498,810...119,502,995
G
Pde4d
phosphodiesterase 4D
IEP
protein:increased expression:hippocampus CA1
RGD
PMID:22860212
RGD:7327148
NCBI chr 2:41,748,337...43,262,567
Ensembl chr 2:40,019,933...41,525,884
G
Pdyn
prodynorphin
IEP
mRNA:decreased expression:dentate gyrus, granule cell
RGD
PMID:8914861
RGD:401851049
NCBI chr 3:137,354,161...137,366,503
Ensembl chr 3:116,900,992...116,913,334
G
Pecam1
platelet and endothelial cell adhesion molecule 1
ISO
protein:increased expression:brain (mouse)
RGD
PMID:22382321
RGD:6766379
NCBI chr10:92,090,263...92,152,002
Ensembl chr10:91,590,521...91,652,116
G
Plat
plasminogen activator, tissue type
IEP
Protein:increased expression, increased activity:hippocampus (rat)
RGD
PMID:15882815
RGD:1580875
NCBI chr16:75,943,061...76,022,037
Ensembl chr16:69,240,585...69,268,223
G
Plau
plasminogen activator, urokinase
IEP IDA
protein:increased expression:cerebral cortex (rat)
RGD
PMID:21375013 PMID:19952306
RGD:7241584 , RGD:7241795
NCBI chr15:3,505,485...3,511,987
Ensembl chr15:3,456,232...3,462,775
G
Plxnd1
plexin D1
ameliorates
IMP
RGD
PMID:30653356
RGD:155663383
NCBI chr 4:150,675,377...150,715,706
Ensembl chr 4:149,002,784...149,043,244
G
Pparg
peroxisome proliferator-activated receptor gamma
IMP IEP
RGD
PMID:18378216 PMID:19221220 PMID:18973594
RGD:2301892 , RGD:8553032 , RGD:2301866
NCBI chr 4:150,095,743...150,221,104
Ensembl chr 4:148,423,194...148,548,468
G
Ppp1r15a
protein phosphatase 1, regulatory subunit 15A
IEP
protein:increased expression:cerebral cortex (rat)
RGD
PMID:15255948
RGD:9999154
NCBI chr 1:105,136,521...105,139,596
Ensembl chr 1:96,000,058...96,003,171
G
Ppp1r9a
protein phosphatase 1, regulatory subunit 9A
treatment
IDA
RGD
PMID:21278085
RGD:10043805
NCBI chr 4:33,936,949...34,258,927
Ensembl chr 4:33,024,450...33,286,907
G
Ppp2r5e
protein phosphatase 2 regulatory subunit B', epsilon
treatment
IEP
RGD
PMID:30712471
RGD:155791663
NCBI chr 6:99,904,569...100,053,672
Ensembl chr 6:94,168,846...94,317,872
G
Prkn
parkin RBR E3 ubiquitin protein ligase
ISO
protein:decreased expression:cerebral cortex, striatum:
RGD
PMID:12415119
RGD:10413862
NCBI chr 1:51,236,410...52,430,242
Ensembl chr 1:48,690,556...49,882,555
G
Ptafr
platelet-activating factor receptor
treatment
IEP IMP
mRNA:decreased expression:cerebral cortex (rat)
RGD
PMID:17268849 PMID:8158141
RGD:9999221 , RGD:10043297
NCBI chr 5:150,049,322...150,079,060
Ensembl chr 5:144,765,976...144,795,251
G
Pten
phosphatase and tensin homolog
IEP
RGD
PMID:12414116
RGD:1358425
NCBI chr 1:240,043,707...240,110,330
Ensembl chr 1:230,630,338...230,696,838
G
Ptger4
prostaglandin E receptor 4
IEP
protein:increased expression:hippocampus (rat)
RGD
PMID:16437207
RGD:10043375
NCBI chr 2:56,061,699...56,074,594
Ensembl chr 2:54,335,424...54,346,670
G
Ptgis
prostaglandin I2 synthase
treatment
IMP
RGD
PMID:27834752
RGD:401960086
NCBI chr 3:176,347,589...176,383,251
Ensembl chr 3:155,916,412...155,965,451
G
Ptn
pleiotrophin
IEP
mRNA:increased expression:cerebral cortex, vasculature, macrophage (rat)
RGD
PMID:9570800
RGD:9831440
NCBI chr 4:66,260,764...66,342,614
Ensembl chr 4:65,293,734...65,375,456
G
Ptpn13
protein tyrosine phosphatase, non-receptor type 13
IEP
mRNA,protein:increased expression:cerebral cortex:
RGD
PMID:18096138
RGD:4142863
NCBI chr14:6,412,841...6,587,238
Ensembl chr14:6,108,211...6,282,563
G
Ptpn5
protein tyrosine phosphatase, non-receptor type 5
severity treatment
IEP ISO IDA
protein:decreased phosphorylation, decreased expression:striatum (rat)
RGD
PMID:24198371 PMID:24198371 PMID:24198371
RGD:9835010 , RGD:9835010 , RGD:9835010
NCBI chr 1:106,756,896...106,817,369
Ensembl chr 1:97,620,642...97,679,882
G
Rack1
receptor for activated C kinase 1
IDA
RGD
PMID:24007266
RGD:9588303
NCBI chr10:33,668,560...33,676,031
Ensembl chr10:33,169,169...33,174,975
G
Robo1
roundabout guidance receptor 1
disease_progression
IEP ISO
protein:increased expression:hippocampus protein:increased expression:brain, astrocyte
RGD
PMID:26764532 PMID:23473743 PMID:27686659
RGD:11573340 , RGD:243048431 , RGD:243048429
NCBI chr11:24,067,869...25,108,694
Ensembl chr11:10,580,908...11,620,203
G
Robo2
roundabout guidance receptor 2
IEP
protein:increased expression:brain, astrocyte
RGD
PMID:27686659
RGD:243048429
NCBI chr11:26,015,919...27,583,750
Ensembl chr11:12,528,951...13,041,536
G
Robo4
roundabout guidance receptor 4
IEP
protein:increased expression:hippocampus
RGD
PMID:26764532
RGD:11573340
NCBI chr 8:45,308,739...45,322,522
Ensembl chr 8:37,119,988...37,132,519
G
Rps6
ribosomal protein S6
IDA
RGD
PMID:26556340
RGD:11041643
NCBI chr 5:106,417,680...106,420,540
Ensembl chr 5:101,371,136...101,374,602 Ensembl chr 5:101,371,136...101,374,602
G
Sema3e
semaphorin 3E
disease_progression
IEP
RGD
PMID:30653356
RGD:155663383
NCBI chr 4:21,252,686...21,510,449
Ensembl chr 4:20,299,718...20,555,229
G
Serpine1
serpin family E member 1
treatment
IDA
RGD
PMID:26851971
RGD:11073692
NCBI chr12:25,237,977...25,248,356
Ensembl chr12:19,601,272...19,611,657
G
Serpinf1
serpin family F member 1
treatment
ISO
human gene in a rat model
RGD
PMID:18624913
RGD:8613878
NCBI chr10:60,748,504...60,760,898
Ensembl chr10:60,249,708...60,262,646
G
Sgk1
serum/glucocorticoid regulated kinase 1
IEP
mRNA:increased expression:hippocampus, pyramidal cell
RGD
PMID:15046873
RGD:1580967
NCBI chr 1:24,799,391...24,916,886
Ensembl chr 1:22,980,261...23,098,283
G
Shh
sonic hedgehog signaling molecule
IEP
protein:increased expression:hippocampus:
RGD
PMID:26607632
RGD:597538583
NCBI chr 4:7,687,872...7,697,025
Ensembl chr 4:6,954,017...6,963,170
G
Sin3a
SIN3 transcription regulator family member A
IDA
RGD
PMID:24063527
RGD:9495912
NCBI chr 8:66,377,471...66,432,150
Ensembl chr 8:57,481,573...57,536,192
G
Sirt6
sirtuin 6
IEP
mRNA, protein:decreased expression:brain
RGD
PMID:23899523
RGD:9586062
NCBI chr 7:8,733,056...8,738,543
Ensembl chr 7:8,082,364...8,098,914
G
Slc12a2
solute carrier family 12 member 2
IEP
RGD
PMID:27798271
RGD:14398833
NCBI chr18:53,546,263...53,614,478
Ensembl chr18:51,348,302...51,416,440
G
Slc17a6
solute carrier family 17 member 6
IEP
RGD
PMID:23458738
RGD:9999193
NCBI chr 1:110,348,447...110,388,499
Ensembl chr 1:101,212,489...101,252,542
G
Slc17a7
solute carrier family 17 member 7
IEP
RGD
PMID:23458738
RGD:9999193
NCBI chr 1:104,786,172...104,798,049
Ensembl chr 1:95,649,745...95,661,588
G
Slc17a8
solute carrier family 17 member 8
IEP
RGD
PMID:23458738
RGD:9999193
NCBI chr 7:25,881,557...25,936,837
Ensembl chr 7:23,994,217...24,048,079
G
Slit2
slit guidance ligand 2
IEP
protein:increased expression:hippocampus protein:increased expression:brain, astrocyte
RGD
PMID:26764532 PMID:27686659
RGD:11573340 , RGD:243048429
NCBI chr14:66,829,661...67,168,517
Ensembl chr14:62,617,067...62,955,948
G
Smpd3
sphingomyelin phosphodiesterase 3
IDA
RGD
PMID:24007266
RGD:9588303
NCBI chr19:51,072,209...51,155,639
Ensembl chr19:34,162,341...34,245,749
G
Socs1
suppressor of cytokine signaling 1
treatment
IEP
RGD
PMID:33081480
RGD:151347423
NCBI chr10:5,389,574...5,391,265
Ensembl chr10:4,882,560...4,884,383
G
Sod1
superoxide dismutase 1
treatment
ISO
human protein in a rat model CTD Direct Evidence: therapeutic human gene in a rat model
CTD RGD
PMID:12629175 PMID:15829915 PMID:16538228 PMID:16868554 PMID:21531066 PMID:17110031 More...
RGD:8655885 , RGD:8655986
NCBI chr11:42,942,742...42,948,399
Ensembl chr11:29,456,558...29,462,249
G
Sod2
superoxide dismutase 2
treatment
ISO IEP
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:11333366 PMID:30716316
RGD:27095883
NCBI chr 1:50,043,323...50,050,168
Ensembl chr 1:47,636,528...47,645,189
G
Sox2
SRY-box transcription factor 2
IEP
protein:increased expression:hippocampus :
RGD
PMID:26607632
RGD:597538583
NCBI chr 2:119,465,131...119,467,542
Ensembl chr 2:117,536,929...117,539,338
G
Stat3
signal transducer and activator of transcription 3
exacerbates
IDA IMP
RGD
PMID:23764464 PMID:23884942
RGD:8694326 , RGD:8694331
NCBI chr10:86,311,528...86,363,513
Ensembl chr10:85,811,218...85,863,057
G
Tert
telomerase reverse transcriptase
treatment
IDA
RGD
PMID:21914402
RGD:11038669
NCBI chr 1:31,465,766...31,488,650
Ensembl chr 1:29,637,506...29,659,561
G
Tfpi
tissue factor pathway inhibitor
treatment
ISO
RGD
PMID:18067952
RGD:11062087
NCBI chr 3:89,939,862...89,989,253
Ensembl chr 3:69,533,156...69,576,880
G
Tia1
TIA1 cytotoxic granule-associated RNA binding protein
IEP
RGD
PMID:16055272
RGD:10059581
NCBI chr 4:120,410,180...120,440,676
Ensembl chr 4:118,852,837...118,880,586
G
Tial1
Tia1 cytotoxic granule-associated RNA binding protein-like 1
IEP
RGD
PMID:10700014
RGD:1357161
NCBI chr 1:192,438,794...192,475,520
Ensembl chr 1:183,009,253...183,031,637
G
Tlr2
toll-like receptor 2
treatment onset
ISO IEP
RGD
PMID:22800826 PMID:31056875
RGD:597538505 , RGD:597538523
NCBI chr 2:171,499,189...171,504,831
Ensembl chr 2:169,197,419...169,206,630
G
Tlr4
toll-like receptor 4
treatment
ISO
RGD
PMID:22800826
RGD:597538505
NCBI chr 5:85,161,247...85,174,882
Ensembl chr 5:80,145,826...80,159,628
G
Tnf
tumor necrosis factor
treatment
IDA IEP
mRNA:increased expression:striatum,hippocampus:
RGD
PMID:24053818 PMID:11412877
RGD:7364868 , RGD:13825263
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,622,011...3,624,629
G
Tnfrsf1a
TNF receptor superfamily member 1A
treatment
IEP
mRNA:increased expression:striatum,hippocampus:
RGD
PMID:21868309 PMID:11412877
RGD:8661762 , RGD:13825263
NCBI chr 4:159,837,119...159,849,817
Ensembl chr 4:158,150,820...158,163,591
G
Trpc6
transient receptor potential cation channel, subfamily C, member 6
treatment
IDA ISO
RGD
PMID:23435869 PMID:20811149 PMID:23043486
RGD:7247582 , RGD:7247585 , RGD:7247583
NCBI chr 8:14,044,216...14,148,808
Ensembl chr 8:5,758,935...5,828,092
G
Trpm2
transient receptor potential cation channel, subfamily M, member 2
IEP
mRNA:increased expression:cerebral cortex
RGD
PMID:16777714
RGD:10003026
NCBI chr20:10,703,190...10,752,795
Ensembl chr20:10,707,014...10,753,181
G
Trpv3
transient receptor potential cation channel, subfamily V, member 3
ISO
RGD
PMID:22284622
RGD:7175554
NCBI chr10:58,382,054...58,413,657
Ensembl chr10:57,883,546...57,913,296
G
Ucp2
uncoupling protein 2
treatment
IDA
RGD
PMID:19772611
RGD:7204428
NCBI chr 1:164,251,373...164,257,742
Ensembl chr 1:154,839,209...154,845,611
G
Vwf
von Willebrand factor
treatment
IDA
RGD
PMID:22771326
RGD:7207039
NCBI chr 4:160,042,900...160,177,757
Ensembl chr 4:158,360,152...158,491,539
G
Wnk1
WNK lysine deficient protein kinase 1
IEP
RGD
PMID:27798271
RGD:14398833
NCBI chr 4:154,800,590...154,926,147
Ensembl chr 4:153,128,334...153,253,905
G
Wnk2
WNK lysine deficient protein kinase 2
IEP
RGD
PMID:27798271
RGD:14398833
NCBI chr17:15,709,648...15,818,874
Ensembl chr17:15,504,261...15,612,479
G
Wnk4
WNK lysine deficient protein kinase 4
IEP
RGD
PMID:27798271
RGD:14398833
NCBI chr10:86,702,828...86,719,917
Ensembl chr10:86,188,812...86,231,829
G
Xrcc1
X-ray repair cross complementing 1
treatment
IEP
RGD
PMID:19840223
RGD:2325713
NCBI chr 1:89,268,721...89,296,619
Ensembl chr 1:80,141,207...80,168,701
G
Elane
elastase, neutrophil expressed
treatment
IMP
RGD
PMID:18165924
RGD:10450583
NCBI chr 7:10,467,877...10,469,725
Ensembl chr 7:9,817,252...9,819,100
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all